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Abstract 
Introduction: The expected outcomes from medicines are, frequently not realised due to 
adverse reactions, inappropriate prescribing and patient failure to take their therapy as 
intended.  Whilst medication review provided by pharmacists is designed to address these 
issues evidence for the effectiveness is weak, and sometimes counterintuitive.  Reasons 
postulated are poor study design, inappropriate intervention location and limited 
consultations skills demonstrated by pharmacists.  This thesis is designed to develop, 
feasibility test and pilot a supervised medication review service for patients with type 2 
diabetes (T2DM) in primary care provided by undergraduate pharmacy students as part of 
their undergraduate education. 
Method:  Literature review and focus groups were undertaken to refine the intervention. 
Ethical approval was obtained.  Medication reviews were undertaken within the medical 
practices and supervised by a primary care based pharmacist.  Students reviewed 
patient’s medicines and then one-to-one medication reviews with two patients.  A range of 
outcome measures were utilised and tested.  Recruitment and attrition rates were 
recorded.  Patient and practitioner acceptability of the intervention and education 
experience was obtained. 
Results: 5 medical practices were recruited, from which 133 patients with T2DM 
consented to participate with 67 randomised to the intervention group.  Thirty-two students 
undertook 58 medication reviews with patients.  Patients reported satisfaction with 
student-led medication reviews and information received about medicines.  No 
improvement in patient reported medication adherence or clinical outcomes were 
identified.  The mean change in quality of life and patients’ satisfaction with information 
about medicines was significantly greater in the intervention group.  Pharmacy students 
reported increased confidence and improved communication skills. 
Discussion and conclusions: The feasibility and pilot study provided data which would 
enable delivery of a future definitive trial.  The intervention was deemed acceptable by 
patients and demonstrated improved quality of life and satisfaction with information about 
medicines.  Educational benefits of this study were also observed  
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At the start of my PhD, one of the first references I came across, when searching for 
information about experiential teaching, was this: 
 
"Tell me, and I will forget. Show me, and I may 
remember. Involve me, and I will understand."  
Confucius around 450 BC. 
 
I think that the study proved him right. 
 
 
 
 
 
 
Now, at the end of the study, I would like to take up a quote attributed to be the last words 
of the first British professional cyclist to wear the yellow jersey in the Tour de France.  
However, I would like to make use of it for many years to come. 
 
  
“Put me back on the bike.” 
 
Tom Simpson, Mt. Ventoux 1967. 
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Chapter 1 Introduction 
1.0 Medication use, misuse and iatrogenic disease. 
Medicines are central to the delivery of western health care, being widely used to cure, 
relieve and prevent ill health.  With an ageing population[1] and an expansion in the 
number of medicines available to manage chronic illness, the cost of providing medicines 
continues to increase.  Between 2000 and 2010 the number of prescription items 
dispensed in primary care in the UK increased by 67.9%, with the total bill to the national 
health service increasing by 58% to £8.8billion in 2011[2], or just over 7% of the total 
health bill of £121billion in 2010/11[3].  Safe, efficient and cost effective use of medicines 
is essential within a resource-limited health care system and the current scenario of 
expanding demand makes this more difficult to ensure.  There is significant evidence to 
demonstrate that when medicines are not managed appropriately they can increase 
resource utilisation through iatrogenic disease and also waste resources when sub-
optimally used by patients. 
A systematic review by Garfield et al.[4] (2009) estimated that between 4% and 21% of 
patients in primary care in the UK achieved the optimum benefit from their medication.  In 
addition, they reported that errors occurred at all stages of the process of the medicines 
management system within primary care, with particular areas of concern including repeat 
prescribing review and patients not adhering to their prescribed medication.  In 2002 in 
‘room for review’, a guide to medication review, it was estimated that within an average 
primary care population of 100,000 patients, non-steroidal medicines caused 18 hospital 
admissions for gastrointestinal bleeds and 22 admissions with congestive heart failure 
each year[5].  Whilst the decision to prescribe a medicine is based, in part, on the 
knowledge of the potential risk of adverse drug reaction (ADR), the risk can be reduced or 
prevented by ensuring appropriate prescribing and monitoring to prevent prescribing 
errors and to ensure that patients are not suffering ADRs[6]. 
A recent 2012 review of 6048 prescription items for 1777 patients by the General Medical 
Council (GMC)[7] found prescribing or monitoring errors within one in eight patients, 
involving one in twenty prescribed items.  A further in-depth analysis of prescribing errors 
with 177 patients reported that the odds ratio of a prescribing or monitoring error was 
related to both patient age and the number of medicines prescribed, with increasing age 
and number of medicines displaying higher risk.  Children below 15 years and people over 
75 years were at higher risk, with odds ratios of an error of 1.87 and 1.95 respectively, 
whilst patients between 65 and 74 years displayed a lower odds ratio of 1.68.  The error 
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rates recorded in patients receiving one medicine was 17.8%, increased to 30.1% in those 
receiving 5 or more medicines and 47% in patients receiving 10 or more medicines.  As 
older patients, including those with long-term conditions, are prescribed more medicines it 
is evident that their risk of problems will increase to unacceptable levels. 
A review of UK hospital episode data between 1999 and 2009[8] found that 557,978 
admissions were recorded as primarily due to ADRs, which represented a 0.9% incidence.  
This is, however, likely to be an underestimate as many ADRs are not identified until later 
on within the hospital stay.  In line with the increase in use of medicines and ageing 
population the incidence of hospitalisations due to ADRs was found to increase by 78% 
over the 10 years. 
The issue of recording of ADRs on admission was recognised and resolved by the 
implementation in 2001 of a prospective analysis by Pirmohamed of 18,820 patients 
admitted to two large general hospitals[9] in the UK.  The study which was undertaken 
over six months reported that 6.5% of people admitted to hospital had experienced an 
ADR and that in 80% of those the ADR was the direct cause of admission resulting in an 
annual cost to the NHS of £455million. The incidence of ADRs reported as causing 
hospital admissions is believed to have increased by 45% from 1998 to 2005 when it had 
reached 6.5%[10]. 
The UK picture of adverse drug reactions resulting in additional resource use is mirrored 
within other western healthcare systems.  A meta-analysis[11] published in 1998 of 39 
studies reporting ADRs judged as meeting criteria in US hospitals between 1966 and 
1996 found that 6.7% of patients had suffered a serious ADR, with 4.7% resulting in a 
hospital admission, whilst 0.32% resulted in a fatality.  Analysis of 1994 data produced an 
estimate of 106,000 (95% CI 76,000 to 137,000) patient deaths in USA hospitals making it 
the fourth to sixth (taking the highest and lowest confidence interval) cause of death in the 
USA.  Studies in the USA estimate the consequences of prescription related illness to be 
100,000 deaths or in financial terms $1billion per annum[12], whilst the costs of 
unresolved medication related problems exceeds $177.4 billion with over 200,000 deaths 
per year[13].  Medication related problems are common, with evidence of 61% out of 
2,985 patients in the USA experiencing one or more[14].  A systematic review[15] of 
publications between 1966 and 1999 reported the prevalence of preventable drug related 
admissions to hospital as 4.3% (interquartile range 3.1-9.5%).  Studies were excluded if 
cases were identified by screening instrument, computer alert or spontaneous reports.  It 
is important to note that the 4.3% of admissions noted in the last study were judged to be 
preventable, thus indicating that healthcare intervention may be effective in preventing 
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some or all of them.  Whilst many of the above studies included within the systematic 
review are based on international data, it is now accepted that these findings can be 
transferred to the UK NHS setting[16 17]. 
Preventable drug related admissions are reported to reflect inappropriate management of 
medication therapy in the community[15], with more than 50% judged to be preventable.  
In a review of hospital admissions resulting from preventable ADRs in a US hospital in 
2002[18] the authors concluded that most resulted from inadequate monitoring of a 
patient’s medication or from inappropriate dosing for that patient.  They also reported that 
a failure by patients to take medication as prescribed for them was a common cause of 
ADRs.  There is, therefore, a large body of evidence confirming that ADRs represent a 
large and increasing problem, with resultant health problems for patients and increased 
costs for healthcare providers.  However, it is also reported that many ADRs are 
preventable, if prescribing and subsequent monitoring of medication therapy is adequate. 
Having established that medication related problems and subsequent hospital admissions 
occur because of inappropriate prescribing or monitoring, failure by patients to take their 
medication as intended by the prescriber further compounds the problem.  It has been 
estimated that patients only take 50% of medicines as prescribed for them[19].  Medicines 
adherence is the term used to describe patient adherence to what was agreed with the 
prescriber[20] when the medicine was prescribed, whilst persistence describes the 
patient’s decision to continue with therapy[21].  A retrospective cohort study of 34,501 
primarily female patients aged over 65 years commencing statin treatment in New Jersey 
between 1990 and 1998, reported that adherence to prescribed medication regimes 
reduced over time with the proportion of patients who were adherent with statin therapy 
demonstrated as 60%, 43%, 26% and 32% after 3, 6, 60 and 120 months, respectively 
[22].  The authors conclude that, improving patients' understanding of their health, their 
medication regimen, and the potential benefits of persistence with the medication regimen 
enhance actual persistence and that these and other interventions deserve further study. 
Cramer et al.[23] reviewed 139 papers (published between 2000 and 2005) relating to 
cardiovascular patients and showed that only 63% of patients continued with their 
medication after one year.  Levels of continuation demonstrated for each therapeutic area 
of diabetes, hypertension and dyslipidaemia did not significantly differ.  Whilst persistence 
with therapy declined with time, as reported in other studies, the large variability in 
persistence rates could not be explained.  The authors state that encouraging patients to 
adhere to their medication regimen could improve the clinical management of 
cardiovascular disease.  Patients were only found to take their medication for 72% of the 
24 
 
time, however, good adherence was shown to be important as it displayed a positive 
effect on health outcomes in 73% of the studies which examined its clinical effectiveness.  
Evidence has been provided that poor adherence to medication regimes results in a 
reduction in the desired positive outcomes for patients from medication. 
In addition to lost opportunities for health gain by patients, non-adherence which is 
generally manifested as less medication taken than prescribed, represents probable 
medicine wastage.  In 2008 in the UK it was estimated that the cost of medicines returned 
by patients to GP surgeries or pharmacies exceeded £100million and the cost of unused 
medicines was approximately £800million[24]. 
With an increasing recognition of the need to reduce prescribing errors, improve 
monitoring of medicines and encourage patients to use medicines more appropriately, the 
process of reviewing prescribing at regular intervals has become increasingly important.  
The identification that significant numbers of patients do not take their medication as 
prescribed indicates that the involvement of patients may be beneficial and that processes 
need to be developed to enable this. 
1.1 Medication review 
The process of medication review can include all or some of the following: 
• review of prescribing decision in light of current evidence base, 
• identification of any potential problems such as: 
o side effects, 
o not achieving therapeutic goals, 
o interactions with both co-prescribed and purchased medicines. 
• discussion with patients of their experience of their medicines and their 
information needs to address any identified non-adherent behaviours. 
The current UK definition of medication review is: 
A structured, critical examination of a patient’s medicines with the objective of reaching an 
agreement with the patient about treatment, optimising the impact of medicines, 
minimising the number of medication-related problems and reducing waste.[5] 
The importance of including the patient within the medication review process was 
highlighted by the Department of Health stating in 2004 a desire for fully concordant face-
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to-face medication reviews to be available to all patients who would benefit from them and 
demonstrate a desire to undertake them [25]. 
National guidance produced by a group of experts in 2001[26] recommended an annual 
review of medicine for people over 75 years of age and a six monthly review if they are 
prescribed four or more medicines.  The current GP contract requires a medication review 
to be recorded in the preceding 15 months for all patients prescribed four or more repeat 
medicines as this represents four out of five people over the age of 75 [27].  In addition to 
recommending the frequency at which reviews should take place, the content of the 
review is required to be at 'level 2'.  The UK definition of medication review with respect to 
level or content (2002) is provided below[5]: 
Level 3  Medication Review a complete review with access to medical records, 
laboratory data and all relevant data, e.g. over the 
counter medicines.  The patient should be present 
and able to participate fully. 
Level 2  Treatment Review a review with access to the full records but without 
the patient and may focus on just one therapeutic 
area. 
Level 1  Prescription Review a review of a patient’s medicine(s) without access to 
records or the patient.  It might not cover all 
medicines. 
Level 0  Ad hoc an opportunistic review with or without the patient. 
In 2008 the Medicines Partnership (a collaboration of the National Prescribing Centre and 
Keele University) published a guide to Medication Review[28].  This was due to 
inconsistency in application and levels of implementation of medication review between 
sectors and individuals as well as the desire to incorporate new models of working.  
Examples of changes included community pharmacists providing reviews to improve 
adherence and pharmacists and pharmacy technicians working in primary care with a 
focus on cost-minimisation.  This alternative definition of level and content of medication 
reviews provided by Keele University is focussed on the purpose of the review rather than 
content.  This enables the individual delivering the service to determine how the review 
should be undertaken. 
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Type 1 Prescription review to address technical issues of the prescription 
and does not require the patient or their notes present.  Notes can 
be used if wanted. 
Type 2 Concordance and compliance review to address medicines taking 
issues by the patient and requires the patient to be present but 
notes are optional. 
Type 3 Clinical medication review to address issues relating to medicines 
taking and requires the patient and their notes. 
The medicines partnership additionally recommends that type 3 reviews should be aimed 
at the following groups or situations: 
1. Patient related, e.g. older people >75yrs which once again mirrors the NSF for the 
Elderly. 
2. Condition related, e.g. long-term conditions (LTC) such as diabetes or complex 
conditions. 
3. Medication related, e.g. medication regimes, specialist medications or a 
medication related event. 
4. Environmental triggers, e.g. change in care provider or living in a care home. 
The National Prescribing Centre (NPC) published a “five minute practical guide” to 
medication review[29] based on the Medicines Partnership document[28] stating that the 
components of a level 3 medication review should include: 
• pre planning and advance warning for the patient, 
• determination of the patient’s understanding of treatment, 
• review of physiological test and measurements, 
• review of efficacy, 
• identification of side effects and interactions, 
• review of practicalities of medicine use, 
• agreement of future treatment plans, 
• opportunities for questions and concerns. 
 
Whilst the evidence for the need to reduce adverse events from medicines and improve 
the use of medicines by patients is convincing and provides an excellent premise for 
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medication review, the evidence for the medicines review process itself being an effective 
means of achieving this is not convincing. 
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1.1.1 Evidence of benefit of medication review 
As the process of medication review became incorporated within the UK healthcare 
system, the responsibility for delivering this was increasingly handed over to pharmacists, 
as they were recognised as having appropriate pharmaceutical knowledge and costing 
less to employ than medical practitioners.  As this role was transferred to pharmacists in 
both the UK and internationally, evidence for the value of this now frequently pharmacist-
based intervention has emerged. 
1.1.2 Medication review by pharmacists in the UK 
A prospective study[30], claimed by the authors to be the first controlled trial of the effects 
of medication review by a pharmacist was undertaken over eight months in South 
Manchester by one pharmacist in 2000 with the support of the twenty four GPs serving the 
330 consented patients in nursing homes.  Fourteen nursing homes were randomised to 
paired control (standard care) or intervention which comprised standard care during an 
observational four month period and then medication review during the following four 
months.  The review was undertaken with access to the Medication Administration Record, 
brief medical history and information provided by the care home staff relating to identified 
problems.  Three weeks later the homes were revisited to identify any problems with 
medication changes, or if the changes had been implemented.  Fifty four percent of 
intervention patients were identified as receiving neuroleptic medication which did not 
comply with US OBRA (Ombudsman Reconciliation Act) guidelines whilst the pharmacist 
made 261 recommendations for medication changes of which 91.6% (239) were accepted 
by the patient’s GP.  Patient evaluation was demonstrated to be reliable as it was 
undertaken initially by the pharmacist and a psychiatrist.  Nurses trained in mental health 
care then also evaluated patients during follow-up to ensure consistency and reliability.  
Additionally, standard measures of mental capacity were used such a Mini Mental State 
Examination (MMSE).  The study reported minimal impact on mortality of 26 intervention 
versus 28 control patient deaths over the full study period, however, during the four month 
intervention period they reported eighteen deaths of which only four were in the 
intervention arm.  No significant differences in falls or accidents between groups were 
identified.  Costs of medicines of £131.54 per patient were lower in the intervention group 
compared to £141.24 for control group patients.  When healthcare appointments were 
also factored in, the cost was £314.89 per intervention group patient versus £492.98 for 
control group patients.  This study provides support for the implementation of medication 
review by pharmacists but the generalisability is weakened by using only one pharmacist 
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in a limited setting of care homes in one area with an emphasis on psychiatric outcomes.  
It is interesting to note that the pharmacist utilised existing skills with no additional training, 
however, we are not informed about the level of experience of the practitioner.  In addition 
there was integrated working between the pharmacists and GPs.  The authors claimed 
that this intervention can reduce the number of medicines prescribed to older people, may 
save costs and can be implemented without detrimental effects on the mental or physical 
health of patient participants.  Without a full economic analysis including all associated 
costs and with limited generalisability this study, however, provides some evidence for the 
routine introduction of pharmacist provided medication reviews.  
The Randomised Controlled Trial (RCT) undertaken by Zermansky et al.[31] in 2002 has 
been widely used as evidence of the effectiveness of medication review to support 
government recommendations.  Patients were aged over 65 years and not in nursing or 
residential homes.  One expert pharmacist delivered the service over twelve months, 
which resulted in 97% of the intervention group receiving medication review compared to 
40% who would routinely receive a medication review as part of their usual care.  The 
introduction of the pharmacist into the process increased the number of reviews in the 
intervention group.  Pharmacist advice was acted on in 68% of cases, with the mean 
number of medication changes (primary outcome) found to be significantly higher in the 
intervention group, 2.2 versus 1.9 (95% CI 0.06 to 0.57).  Medication costs rose less for 
the intervention group (£1.80 versus £6.53) with a saving claimed of £4.75 (95% CI, -7.94 
-2.41) per 28 day period equating to an annual saving of £61.75 per patient.  As with the 
Manchester study there was a non-significant lower rate of deaths in the intervention 
group (15 versus 25).  The authors conclude that this provides evidence for suitably 
trained pharmacists to undertake medication review due to reduced numbers of 
prescription medicines used, with consequent savings and no evidence of an adverse 
effect on subsequent use of health services.  No effect was reported by the authors on 
outpatient consultations, GP practice consultations or hospital admissions for the 
intervention group patients.  Whilst this study provides good evidence for the benefit of 
medication review by a pharmacist its generalisability is reduced again by the delivery by 
one very experienced pharmacist working in a medical practice with excellent inter-
professional relationships. 
Another RCT[32] by the same author in 2006 set in care homes and based on 315 
intervention patients, identified a significant reduction in falls (0.8 falls per intervention 
patient versus 1.3 in the control group) as a result of the pharmacist provided medication 
review service.  Falls constituted a secondary outcome measure, which was one of a 
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number of measures included to address the issue of effects on health outcomes.  A non-
significant lower incidence of hospital admissions was seen in the intervention group, 
whilst mortality rates and GP consultation rates showed no significant difference.  GPs 
accepted 75.6% (565/747) of recommendations resulting in a significantly greater number 
of medication changes (primary outcome) for intervention versus control patients (3.1 
versus 2.4).  However, this did not result in lower medication costs, as the pharmacist 
frequently recommended the initiation of new medication, in addition to stopping others.  
The greatest number of medications stopped, almost one third, was central nervous 
system medications and this may partially explain the significant reduction in falls with 160 
potential falls saved in 331 patients.  This RCT, therefore, shows that a pharmacist can 
complete medication reviews for patients in care homes without a significant impact on 
hospital or GP practice use, whilst showing significant reductions in an outcome measure 
of falls experienced by patients.  The service resulted in no real change with respect to 
medication costs but the effect on other costs were not described or determined.  
Additionally the training of the pharmacist was not described which would have provided 
useful information for the conduct of future studies or implementation of a service. 
These studies provide evidence that a pharmacist can provide medication review 
effectively both in care homes and with patients living in the community, whilst potentially 
providing patient benefit.  However, the use of only one pharmacist in each case, allied to 
the lack of knowledge of training reduces both their generalisability and reproducibility.  
The numbers of patients were, however, sufficient to establish an effect, but larger studies 
in other areas need to be undertaken with more pharmacists. 
The RESPECT trial[33 34] undertaken in 2002 addressed the criticisms of not using 
substantial numbers of pharmacists to deliver an intervention, introduced a novel model of 
care which built on the current skills of community pharmacists and encouraged shared 
working with GP Practices.  The trial, a multiple interrupted time series design, was 
undertaken in 2004 in Yorkshire with sixty two pharmacists working with twenty four GP 
Practices within five Primary Care Trusts (PCTs).  Study design enabled the five PCTs to 
be randomised to pharmaceutical care in order to act as controls for each other, with 
pharmacists and GPs being ‘blind’ until three months before intervention to enable training, 
whilst acting as controls for each other thus reducing bias.  Medication reviews were 
received by 563 patients on at least one occasion and 551 patients completed the study.  
Shared sessions aimed at engendering joint working between pharmacists and GPs were 
included in the intervention development.  Patient inclusion mirrored the National Service 
Framework for Older People[26] recommendations which were for patients of over 75 
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years of age with five or more medicines prescribed.  Novel departures from previous 
studies included the medication review location, which could be either a private room in a 
community pharmacy or the patient’s home and the provision of repeat medication 
reviews over twelve months.  This is in line with recommendations regarding the delivery 
of care by pharmacists where emphasis is placed on continuing care rather than one 
event[35], but is found to be the scenario in many studies.  The primary outcome measure 
was UK-Medicines Appropriateness Index (UK-MAI), an ‘anglicised version’ of a USA tool 
providing a score dependent on the number and appropriateness of each patient’s 
medication.  Analysis of this was changed from that stated in the protocol due to previous 
underestimates of medications and time; however, no significant change was seen in UK-
MAI.  In addition, no statistical effect was seen on quality of life, adverse drug events, 
hospitalisation or secondary care use.  These show that implementation of pharmaceutical 
care in this model provided no benefit or reduction in care and taking into account the 
resources involved, the case for pharmacist medication review in this way was not proven.  
One reason provided was that despite shared training sessions, communication between 
GPs and pharmacists was not optimal and may have impacted negatively on the 
outcomes.  Pharmacists experienced difficulties in both access to clinical data and 
arranging meetings with GPs to discuss care plans.  Poor communication resulted in 
reduced implementation of desired actions, and GPs reported frustration when their 
prescribing was questioned, on occasion, by a pharmacist unknown to them. 
Following on from the Respect trial, researchers in Norfolk undertook the HOMER 
study[36] which attempted to demonstrate via an RCT that medication review provided by 
a wide variety of pharmacists, with different levels of experience and training to patients 
over the age of 80 years, immediately after hospital discharge, would result in reduced 
readmissions.  The study recruited 829 patients from four general or community hospitals 
and randomised them to control or intervention.  All pharmacists held a post graduate 
qualification or had undertaken recent continuous professional development (CPD) in 
therapeutics, whilst all received a two day training course which included communication 
skills.  Emergency readmission to hospital was 30% greater in the intervention group (234 
versus 179 ), whilst the secondary outcome of mortality showed a non-significant lower 
rate for the intervention group (49 versus 63 with a hazard ratio of 0.75 ) and a non-
significant lower rate of intervention group admissions to nursing homes.  Quality of Life 
(QOL) was measured for approximately 80% of patient participants with changes in utility 
scores showing a non-significant difference between groups.  The visual analogue health 
scale score fell more for intervention versus control (difference of 4.1 units), possibly due 
to increased anxiety, confusion or dependence on healthcare services resulting from the 
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extended home visit.  Potentially positive outcomes were the recommendation or 
comments to GPs recorded by pharmacists (933) with 120 of these referring to possible 
ADRs or interactions between medicines in 81 patients.  The results are counterintuitive, 
with greater emergency admissions and reduced QOL in the intervention group.  The 
paper provides three possible explanations for results, with the first being that pharmacists 
helped patients to understand their condition better, thus promoting help-seeking 
behaviour which may have resulted in the admissions.  Weak evidence for this is the 
favourable death ratio which may show a competing outcome where more hospital 
admissions resulted in fewer deaths.  The second explanation proposed is increased 
adherence to medication regimes following the pharmacists’ intervention resulting in 
increased adverse effects due to medicines.  Lastly, the long duration home visit may 
have increased anxiety and confusion or dependence on health services amongst 
intervention patients with a greater focus by patients on their health thus resulting in 
deterioration. 
Two papers[37 38] by Zermansky and Silcock & Zermansky and Freemantle discuss 
study design and specifically that of the HOMER RCT[36], and propose a different 
interpretation.  They state that HOMER was “ill-conceived and almost set itself up to fail” 
due to factors including the fact that the pharmacists were ill-equipped, which could 
indicate that they recommend additional training in medication review for pharmacists.  
Criticism is also made of the timing, as patients were approached shortly after discharge 
from hospital when medication should have already been optimised and patients educated 
about their medicines.  This also makes them non-generalisable to most medication 
review situations.  Significantly, doubt is cast upon the likelihood of the possibility of the 
intervention being able to show an effect on the outcome measures and the cost 
effectiveness interpretations as medication costs before and after were not measured, 
with the two domiciliary visits deemed to be expensive.  It may however be that the post-
discharge visit by a pharmacist resulted in an urgent request for a visit by the patient's GP 
and, therefore, earlier identification of patients who had been discharged too early thus 
resulting in their subsequent readmission.  This scenario would explain the improvement 
in mortality in the intervention arm and is supported by the large number of interventions 
made by the pharmacist to request a GP visit.  If this explanation was correct then it would 
demonstrate that the pharmacists themselves had no impact on patient health and the 
outcomes seen were due to earlier access to primary care services post-discharge. 
Holland et al. published the HeartMed study, another RCT in 2007[39], which investigated 
the medication reviews by 17 community pharmacists who provided the intervention to 
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149 patients diagnosed with heart failure, whilst 144 patients were randomised as control.  
Pharmacists were provided with a copy of the discharge letter and arranged a home visit 
within two weeks of discharge, with a follow up at six to eight weeks.  The visit comprised 
a medication review, education about heart failure where appropriate, encouraging 
completion of a signs and symptoms card and removal of discontinued medications with 
the patients’ consent.  The pharmacists then fed back recommendations to GPs and the 
need for adherence aids to community pharmacists.  Pharmacists, as in the previous RCT 
by Holland et al.[36], held post graduate qualifications or had undertaken recent CPD in 
therapeutics, whilst all received a training day on heart failure issues.  The primary 
outcome measure of emergency hospital readmission showed a non-significantly higher 
incidence of 134 for intervention patients versus 112 for control, whilst secondary 
measures showed a non-significant increase in mortality in intervention patients: 30 
intervention patients died versus 24 control patients with p=0.54.  QOL was unchanged for 
intervention but was reduced by 10% for control, whilst health scale did not differ 
significantly between groups.  Pharmacists rated their visit as definitely useful for 50% of 
patients and probably useful for 38%.  Similarly, they reported second visits as definitely 
useful (31%) and probably useful (49%).  The researchers concluded that the intervention 
showed no benefit, with patients’ satisfaction scores not translating into significant 
improvements in heart failure self-care scores.  One explanation proposed for the lack of a 
positive effect was that the intervention may have been too late in the disease course to 
evoke behaviour changes, as patients may have already made any possible changes 
In parallel to the burgeoning UK evidence base for medication review the international 
literature has also developed. 
1.1.3 Medication review by pharmacists outside the UK 
An RCT in Australia[40] published in 2004 was conducted in three states with 177 
intervention patients versus 223 control patients in which 53 pharmacists undertook 
medication review in the patient’s home.  The pharmacists were trained and accredited by 
the Australian Association of Clinical Pharmacists; however, in a minority of cases the 
local pharmacist undertook the visit, with the medication review being completed by an 
accredited pharmacist.  All GPs and pharmacists involved received training via satellite.  
Data for the medication reviews which included patient diagnoses and medication use 
was provided by the GP to the pharmacist, with the home based medication review 
identifying medication-related and other risk factors for discussion at a multidisciplinary 
meeting.  The GP produced an action plan based on this and met the patient for a 
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medication review to agree implementation.  At six weeks, patients were followed-up to 
monitor outcomes of the plan.  The study identified no significant difference in clinical 
outcomes or health-related QOL although they claim other small improvements for 
intervention versus control.  Intervention patients were less likely to report adverse drug 
events (ADEs); however, this displayed non-significance.  Savings were demonstrated in 
health-related costs at eight month follow-up for the intervention group which outweighed 
the slight increase in medication costs and intervention costs which included pharmacist 
and GP time, resulting in a net saving of AUS$54 per patient relative to control.   Ninety 
two percent of intervention GPs and 94% of intervention pharmacists stated that the 
intervention had improved the care of participating patients with 54.4% of 
recommendations acted upon.  Of the recommendations which were acted upon 70.9% 
demonstrated a positive outcome, 15.7% no effect and 3.7% a negative effect.  Twenty 
one of the pharmacists recruited were unable to actively participate because no 
intervention GP could be ‘linked’ to them.  This shows the importance of collaboration 
between pharmacists undertaking medication review and the patient’s GP.  The authors 
comment that “a range of health workers could conduct this intervention with minimal input 
from the research team in a timely and effective manner”.  The home-based medication 
review showed that pharmacists can provide such a service whilst identifying important 
medication related issues with no additional cost, or even a slight saving.  A service 
similar to this intervention was subsequently implemented nationally by the Australian 
government, with participating GPs and pharmacists receiving reimbursement[41]. 
Studies performed to date provide tentative evidence for pharmacist-led medication 
review improving patient behaviours and for reducing potential medication related 
problems.  They also demonstrate that the training of pharmacists to deliver medication 
review requires careful consideration, as does the location of the pharmacist when 
undertaking medication reviews.  It is essential that inter-professional barriers are 
overcome, firstly to ensure that the new role for pharmacists is accepted and secondly to 
integrate them into the patient's immediate care team.  This will provide better 
communication, opportunities for joint decision making and improved access to patient 
records.  In addition, it may enable the implementation of a greater number of 
recommendations. 
Whilst the primary driver for medication review is the improvement of patient outcomes, it 
was the provision of incentives for GPs in the UK to save money on their prescribing 
budgets which was the catalyst for medication review by pharmacists in primary care[42].  
Initially pharmacists were largely employed to substitute medications of similar efficacy but 
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less cost for those currently prescribed and their employment was justified by the cost 
savings realised.  Pharmacists have since developed their role in primary care to 
encompass all elements of medication review where the time spent delivering the service 
may be offset by discontinuing therapy and  prescribing cheaper medicines.  Therefore, 
evidence for the cost-effectiveness of such services has been sought. 
1.1.4 Cost of pharmacist-led medication review 
When providing and evaluating interventions such as medication reviews in the UK it is 
necessary to determine both the costs and effects.  Ideally effects will be measured using 
a quality of life score to enable purchasers of services to compare the value of different 
types of service.  Within the UK, the government adopts healthcare interventions which 
demonstrate a cost per additional gain of a year of perfect quality of life (QALY) of less 
than £30,000[43]. 
An economic evaluation in 2007[44] from an NHS perspective based on the HOMER 
RCT[36] evaluated costs involved in the provision of medication review by twenty two 
pharmacists, with EQ-5D as the primary outcome measure.  The intervention cost per 
intervention group patient was £124.  However, accounting for the increase in hospital 
admission rates, the cost rose to £271.  QOL and mortality showed a non-significant 
decrease in the intervention group.  Calculation of a QALY resulted in a cost of £54,454 
which provides evidence for such services to not be adopted in the UK. 
Zermansky undertook a narrative literature review focussing on costs and effects in 
2009[38] and highlighted that apart from two studies[36 40], there is a lack of quality data  
relating to costs and effects of medication review by pharmacists.  He states that there is 
a need for a large RCT, with long-term follow-up, of periodic clinical medication review by 
pharmacists and significantly calls for documented and appropriate training for 
participating pharmacists. 
A ‘quasi-experimental’ before and after study[45] was published in 2012 on 117 
participants (age >65yrs) who had all been referred to Norfolk Medicines Support Service, 
which provides medicines management support to people living at home.  Patients 
received a domiciliary visit, including medication review by a pharmacist trained in 
medication review, with appropriate recommendations made to the patient’s GP.  At four 
weeks, a follow-up contact was made by the pharmacist to check implementation of 
recommendations and to identify problems.  Costs, which included staff time, 
consumables such as medication compliance aids and overall health costs to the NHS 
36 
 
such as medication and emergency admissions were evaluated.  Questionnaires were 
posted to participants for self-reported QOL and adherence at baseline, six weeks and six 
months.  Service costs were £201 per patient which translated to a saving of £307 per 
patient after inclusion of reductions in medication and hospital costs.  The study states a 
number of limitations, which include a lack of a separate control group which resulted in 
the introduction of a before and after study design.  In addition, the population was 
referred by healthcare workers involved with this patient group and the care provided by 
them may have impacted on overall benefit to patients.  The patients referred to the 
service also exhibited problems likely to benefit from this type of intervention and may, 
therefore, have presented a non-generalisable group.  Because the service was deemed 
to save more money than it cost it was not necessary to calculate a cost per QALY. 
RESPECT was the first study to evaluate the cost-effectiveness of community-based 
pharmaceutical care for older patients[33 46] (2010) over twelve months.  With a reported 
cost of £10,000 per QALY it provides strong evidence for such as service to be cost-
effective with a probability of between 78% and 81%.  Data presented, however, shows a 
marked gradation of costs and QALYs with respect to age of patient and number of 
medications used.  Those patients 75 years old with five repeat medications produced an 
incremental cost-effectiveness ratio (ICER) or £/QALY of £4,661, with results ranging up 
to patients of 90 years old with fifteen repeat medications displaying an ICER or £/QALY 
of £35,185.  These issues provide guidance for the implementation of future studies and 
demonstrate that the evaluation of cost-effectiveness of interventions for different patient 
groups is important when defining the service specification. 
A prospective RCT based at two residential continuing-care hospitals in Ireland in 2005[47] 
with 225 patients (110 intervention) investigated the value of medication review.  
Randomisation was of all patients on wards allocated by random number to each group 
with controls receiving no change in usual care ie standard care.  Intervention patients 
received a review of their medication by a team comprising three consultant geriatricians, 
six specialist registrars in geriatric medicine, two hospital pharmacists and three senior 
nurse practitioners.  Access was available to complete medication lists and 
comprehensive medical assessments and using standard tools (e.g. Beer’s criteria).  
Patient functionality was assessed blind using standard tools such as Barthel Index.  It is 
of interest, that despite the strength of the intervention team only 80.1% of interventions 
were acted upon by the medical team responsible for daily care and this supports 
recommendations made elsewhere, that medication review must be part of the standard 
care package rather than separate from it.  No changes in functional outcomes were 
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identified, whilst mortality was non-significantly higher in the intervention group.  Average 
total length of stay was 101 days for intervention patients versus 63 days for control 
patients.  Medication costs fell by £19,753 for the combined groups due to reductions in 
the intervention group but surprisingly separate costs were not shown.  Cost of the 
intervention was £56,113 after deduction of medication savings and inclusion of staff costs 
etc and demonstrated that the intervention was not cost-effective. 
In the USA and UK there is evidence that the time spent by pharmacists undertaking 
medication review may be justified by savings in medication costs, assuming that there 
are no additional healthcare costs resulting from the intervention.  This assumption may, 
however, not be appropriate as healthcare resource utilisation costs such as medicines 
usage, visits to the GP and hospital should be expected to change as a result of improving 
prescribing quality and patient adherence.  RESPECT[33] provides some evidence of cost 
effectiveness in the UK[46], but currently the evidence base for pharmacist based 
medication review in primary care is limited.  Further research is required to establish 
costs and effects in terms of QALYs which is the NHS preferred method of evaluating if a 
service is suitably cost-effective to implement[43]. 
Various factors have prevented research studies from definitively demonstrating the 
expected effectiveness and benefit of pharmacist-led medication review.  These include 
poor trial design, particularly with respect to study outcomes, and limited identification of 
costs.  Consistently, studies have failed to provide suitably in-depth training to participant 
pharmacists before they undertake medication review, and two days is often seen as 
sufficient.   
Pharmacy undergraduates do not routinely receive significant amounts of consultation 
training or mentored patient experience during their undergraduate course.  Furthermore 
graduates frequently receive post-graduate training and mentoring, from pharmacists who 
themselves have received no formal training in consultation skills or the provision of 
medication reviews.  Consequently, this impacts on the outcomes of studies considering 
the potential value of pharmacist delivered services to improve prescribing and patient 
medicines related behaviours. 
Lastly, evidence supports integrated working whereby pharmacists undertaking 
medication review are part of the primary care team.  However, many trials, such as 
Homer[36], have used the model of a pharmacist unknown to the team undertaking 
medication review and communicating recommendations in written form.  Evidence shows 
this method to be less likely to achieve positive results. 
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Research suggests that studies surrounding pharmacist delivered medication review 
services must be more rigorously planned and implemented. 
1.2 Complex interventions 
The provision of medication review by pharmacists is defined as a complex intervention 
when measured against recent UK based guidance by the Medical Research Council 
(MRC)[48] as it consists of several interacting components and there are a range of 
possible outcomes.  The MRC also strongly recommends that the evaluation of such 
interventions requires a much more structured approach prior to their implementation. 
Randomised controlled trials (RCTs), which are the preferred method of testing complex 
interventions, should be based upon evidence from a systematic review of the literature, 
stakeholder involvement, feasibility testing, piloting and introducing elements to ensure 
intervention fidelity.  None of the large UK based[36 45 49] studies include all or many of 
these elements and issues such as training needs, communication barriers and identifying 
the most appropriate primary outcome measures may have been resolved more 
effectively if such guidance had been in place prior to their implementation. 
Whilst RCTs are the recognised method for testing complex interventions, MRC[48] 
guidance also suggests that mixed methods are suitable for development and evaluation 
of complex interventions.  Kitzinger[50] and Jones[51] support mixed method research 
with quantitative methods providing information and an explanation and qualitative data 
enabling us to understand perspectives, identify problems and solutions in addition to 
explaining processes and outcomes.  Kitzinger[50] states that focus groups are better for 
exploring how opinions are constructed.  Silverman[52] talks of the quantitative/qualitative 
dichotomy being open to question, with polarities between the methods being dangerous.  
Researchers are frequently pigeon holed into quantitative or qualitative and traditionally 
the two have been mutually exclusive.  MRC guidance identifies the need for both 
approaches in the development of complex interventions as it is necessary to understand 
the system within which the intervention is to operate.  Barbour[53] writes from a primary 
care background, and whilst she supports the case for the role of studies employing either 
qualitative or quantitative methods, he also asserts that the judicious combination of the 
two research methods at various stages in a study are supported.  In addition to providing 
triangulation, mixed methods provide insights into processes of data construction, enable 
identification of relevant variables to be studied, and explain unexpected findings. 
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The approach recommended by the MRC which supports a mixed methods approach to 
test complex interventions is not reported within many of the pharmacist-led medication 
review studies [30-32 36 47 54 55].  The lack of intervention testing and development may 
provide some explanation for the lack of compelling evidence being identified for this 
intervention.  Zermansky[37], when discussing the effectiveness of studies which sought 
to evaluate pharmacist-led medication review, criticises the design and set-up of studies.  
Specifically this includes, detailing the content or ‘nature’ of the medication review, 
population characteristics, outcome measures and whether cost-effectiveness is 
evaluated.  There is no mention, however, by the author of the need for literature review 
and piloting or feasibility testing.  An exception is the Respect study[34] which undertook 
both significant literature review and feasibility testing. 
1.2.1 Systematic review 
A systematic review by Holland et al.[56] in 2008 may provide some insight into the 
provision of medication services and their evaluations and consequently, in line with MRC 
guidance, can be used to underpin future studies of the same nature.  Including all RCTs 
in any setting for older people (mean age >60yrs) aimed at improving medication 
regimens and improving patient outcomes, the primary outcome of concern was 
emergency hospital admission.  The review yielded seventeen studies with 9,900 patients 
providing significant strength for interpretations.  Despite different findings in some, there 
was moderate heterogeneity showing an overall lack of effect by pharmacist-led 
medication review: Relative Risk (RR) 0.99.  The review also yielded twenty two trials 
reporting mortality and meta-analysis of these, representing a total of 11,700 patients, 
suggested no effect on mortality from pharmacist-led medication review, RR 0.96.  
Marked heterogeneity was observed within the fifteen trials identified as reporting 
prescribing.  With five positive and one negative study, it could be suggested that 
pharmacist-led medication review reduced the number of medicines prescribed.  
Interestingly, intermediate outcomes such as effects on medication-related problems, 
knowledge, adherence, improving storage, reducing unnecessary medicines, all showed a 
positive effect.  In spite of these positive outcomes, QOL showed positive benefit in only 
one third of relevant trials. 
The study summary informs us that there is a rapidly growing body of high quality 
evidence, but that no trial has yet been of a sufficient size to identify a small but important 
gain in quality of life and that the inability to demonstrate patient benefit may result from 
variations in delivery of care and patient selection.  This leads to the conclusion that, in 
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spite of positive outcomes such as adherence and medicines knowledge, these have not 
translated into an increase in QOL.  The authors, therefore, state that there is not yet 
sufficient evidence to recommend the introduction of pharmacist-led medication review. 
Further research is, therefore, required and must be of high quality, whilst following MRC 
guidance.  In order to enable such a study and to follow MRC guidance, key stakeholders’ 
views must be sought. 
1.2.2 Acceptability of pharmacist-led medication review 
The stakeholders within medication review services are traditionally medical practitioners 
and patients.  Consequently a review of literature to identify their perspectives may 
provide further insight into how such interventions can be enhanced. 
1.2.3 Medical practitioner acceptance of pharmacist led medication review 
A postal questionnaire surveying the views of 258 GPs in 2003 in Glasgow[57], regarding 
pharmacists-led medication reviews received a response rate of 84%.  The questionnaire 
was developed from semi-structured interviews with six GPs and used a five point Likert 
scale, open questions and free text.  Five themes, or messages, emerged with a wide 
variation in responses observed, with no overall consensus being demonstrated on any 
theme.  The first was a positive impact on prescribing by the pharmacist but with a small 
sub-set stating that the pharmacist only demonstrated minimal clinical benefit, which 
demonstrates that it is important to demonstrate clinical benefit to convince prescribers of 
value.  Patient impact also displayed differences in GPs opinions, with large support 
demonstrated that there had been patient benefit, whilst others quoted problems for 
patients; mainly patients feeling “unsettled”.  This informs us that pharmacists must 
provide a service which feels part of the patient’s usual care.   Impact on GPs varied, with 
some stating an increase in workload and a smaller proportion a reduction.  This 
demonstrates that pharmacists must ensure integration of working with the healthcare 
team.  Some GPs reported feeling reassured whilst only two GPs reported feeling 
“unsettled”, although it is reported that both were older.  Process issues reported to create 
barriers included lack of space.  Divergence was displayed on the topic of pharmacists’ 
role development, with suggestions of new roles such as prescribing changes, monitoring 
with blood test and blood pressure measurement: however, some stated that monitoring 
requests were outside of a pharmacist’s remit.  Recommendations were made to further 
improve communication between pharmacists and GPs.  Overall, 95% of GP respondents 
agreed that the service was useful to their medical practice and that benefits outweighed 
41 
 
problems, which provides support for the provision of medication review by pharmacists in 
the community.  An important consideration was that this service, was funded, which 
eliminated the barrier of GPs providing this funding.  In addition, the service was situated 
in GP practices which reduced barriers to implementation through further facilitating the 
recommended communication with GPs.  This evidence, in spite of some negative 
responses, provides support for pharmacists undertaking medication reviews in GP 
practices. 
An editorial in 2009[58] reviewed current evidence and, in common with others, decided 
that the problem is that pharmacists are distant from the healthcare team, and that 
interventions come too late in the process.  Significantly, there is a call to abandon the 
shop and to learn new ways of interacting with patients and medical colleagues.  There 
was support for adopting the model existing in UK hospitals, where pharmacists work 
more closely with other members of the healthcare team. 
A non-empirical article by an Australian GP[59] aimed at informing other GPs about 
medication review by pharmacists recommended a home medication review service which 
is delivered through co-operation between a GP, a community pharmacist and an 
accredited pharmacist.  The author stated that the benefit of the service is improved 
patient outcomes through teamwork and improved communication, whereas these 
elements are not always evident in studies involving pharmacist medication review, when 
recommendations may often be provided in writing.  The Australian service, however, 
required a written report, followed by a GP: Pharmacist discussion which demonstrates 
good communication opportunities.  However, the uptake of the service by 2003 involved 
only 6.13% of GPs.  Reasons identified in focus groups with GPs were lack of knowledge 
of the scheme, fear of change partly due to feeling that the present service was adequate, 
and a fear of pharmacists taking over.  These views demonstrate that pharmacists may 
need to communicate the benefits of the scheme to those GPs not currently participating 
in pharmacist-led medication review schemes in order to overcome existing barriers to 
implementation.  
Face-to-face semi-structured interviews were undertaken in 2010 with thirty eight GPs 
who had experienced the pharmacist-led medication review service in New Zealand in 
2010[60].  The key theme identified was that GPs evaluated the benefits of services in 
terms of patient outcome against resource utilisation (both pharmacist and GP time) in 
order to arrive at a concept of value.  This approach supports evidence presented earlier 
that cost-effectiveness of services must be proven.  Some participants called for funding 
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to pay GPs for the time taken to meet pharmacists, whilst importantly this face-to-face 
feedback mechanism was the preferred method of communication of medication review.  
Some negative views were displayed when territoriality emerged, with GPs stating that it 
may be an issue for other GPs, but not themselves, whilst many emphasised the role of 
GPs controlling the clinical decision-making with this not being the pharmacists’ territory.  
A dichotomy emerged, with ambivalence for the future for community pharmacist-led 
medication review.  Whilst over half of the GPs supported the service, there were caveats 
that “reviews had to be done well if they were going to work and the pharmacists had to 
have credibility”.  Those who had experience of hospital services were impressed by 
pharmacists’ skills (“fantastically useful”) whilst emphasising the close working relationship 
there as a key issue.  This study provides useful views on barriers to the introduction of 
medication review, such as territoriality demonstrated by GPs and that pharmacists must 
be seen to be part of the team, however, support did exist for pharmacists undertaking 
medication review. 
1.2.4 Patient acceptance of Medication Review 
Whilst there is research exploring GPs and pharmacists opinions regarding medication 
review, patient opinions have not been extensively explored.  Room for Review[5] in 2002 
reports opinions from forty patient interviewees aged 50 years to ‘nearly’ 100yrs, most of 
whom had never heard of medication review.  Of those who had previously received a 
medication review from specialist consultants, or for older patients from a GP, all but one 
found it helpful.  Some patients who had not experienced medication review had 
reservations due to the possibility of medicines being stopped, or concerns that healthcare 
professionals would not have time, which shows us that information must be provided to 
patients in advance of a review.  However, the majority of interviewees stated that they 
would welcome medication review.  Many patients had implemented their own 
compensatory mechanisms in the absence of medication review, such as reading leaflets, 
stopping medicines without advice or taking a list of medicines to their doctor or 
pharmacist.  One patient is quoted as saying “I review it. I drive the pharmacist mad”.  The 
people involved stated that they “simply wished to tell their health professional how they 
felt and to see if they were taking the best medicines for their problems”. 
To achieve a useful medication review the interviewees stated that they would require: 
• specific time set aside for medication review, 
• someone to listen carefully to questions, 
• clear explanations in simple language, 
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• an open interaction where they could be honest about what they were actually 
taking, and the health professional would be honest about the consequences of 
taking (or not taking) the medicines. 
These last issues indicate that patients have requirements of consultation styles, and a 
literature search to establish the ideal style is appropriate. 
1.2.4.1 Patients’ preferences for consultation style 
Where a medication review involves a consultation the healthcare professional 
undertaking it must take account of the patient’s needs and or preferences in order to 
ensure patient benefit via agreed outcomes.  It is important to identify patients’ 
preferences in order to improve patient acceptability and enhance the effectiveness of 
medication reviews. 
A study undertaken in USA in 2011 which evaluated 207 patient consultations with twenty 
nine doctors, showed that full involvement of patients in the consultation is important in 
order to gain better understanding of the patients’ health beliefs[61].  However, they found 
that doctors showed poor understanding of patients’ health beliefs and, therefore, 
expected that the patients’ own health beliefs were not dissimilar to their own.  Also, it was 
established that a closer match existed between the patient’s self-reported beliefs and the 
physician’s understanding of them, when patients proactively sought and gave information 
within a consultation.  It is, however, unreasonable to expect patients to provide the drive 
for good communication resulting in effective information transfer and the person 
conducting the consultation must be aware of these issues and manage the consultation 
accordingly. 
Support for this view is provided by Kaae[62] in 2011 in an evaluation of pharmacy 
students, based in Danish pharmacies, who undertook medication review with patients 
with diabetes.  Eighteen pairs of letters sent by the students to GPs and patients after the 
medication review were analysed.  Inter-student variation was displayed in communication, 
with a marked difference in feedback to GPs as well as patients who were found to be 
given too little information or options about their own condition.  The paper concludes that 
students did not automatically think “in terms of equal partnerships with patients” with this 
resulting in an asymmetric and potentially paternalistic behaviour.  Patients were not 
encouraged to become involved in their disease management process, providing further 
evidence of the requirement for the provision of effective communication skills training to 
students prior to undertaking experiential training. 
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Little[63] et al. in 2001 reported a study undertaken in three Hampshire GP practices 
utilising pre and post-consultation questionnaires.  These were developed locally from 
data of patients’ requirements in consultations and utilised five point Likert scales: there 
were 865 participants with 824 (95%) returning pre and 661 (76%) returning post 
consultation questionnaires.  Patients reported a preference for a patient centred 
approach with good communication, partnership and health promotion.  Little also 
reported that patients described as more unwell had a greater desire for good 
communication, whilst a reported positive approach by the doctor resulted in a reduced 
symptom burden[64]. 
A study in 2009 at one GP practice in Norfolk[65] undertook pre and post consultation 
semi-structured interviews with twenty patients to establish expectations and the degree 
to which these were met.  Doctors were expected to be professional, authoritative, 
competent, confident, helpful, and courteous whilst showing empathy or sympathy.  
Interestingly, listening by doctors was not always expected.  Doctors were also expected 
to be interested, demonstrate understanding, provide information and give sufficient time.  
Negative doctor attributes were associated with the patient feeling uneasy, defensive and 
inhibited about talking about their condition, which could seriously affect the outcome of 
the consultation.  This is a small study with limited generalisability, however, it identified 
interesting issues which can be applied to other consultations. 
Nair et al.[66] in Canada in 2002 undertook focus groups with 88 patients, 27 doctors and 
35 pharmacists and established an apparent conflict between the information that patients 
want and the information that doctors or pharmacists think the patient wants or needs.  
Patients want specific information about side effects, duration of treatment and, 
interestingly, the treatment options available.  Doctors or pharmacists conversely think 
that too much information about side effects may deter patients from taking their 
medicines.   
There appears to be agreement that a patient centred approach using good 
communication, and ensuring that the patient is encouraged to provide information is 
more effective, whilst the information given to patients must be sufficient to enable full 
appreciation of the facts.  However, evidence suggests that pharmacists providing 
medication review services in the UK may not demonstrate the required consultation skills 
and that, therefore, communication skills training focussing on these aspects is required. 
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1.3 Improvement in consultation skills training is required for UK 
pharmacists 
Salter[67] undertook a qualitative study with participants (twenty nine patients and eleven 
pharmacists) of the previous HOMER[36] RCT when medication review consultations 
were undertaken one to one.  These were observed, taped and transcribed for future 
analysis, whilst observations were made directly of the body language of participants by 
the researcher.  Patients were interviewed up to one month post-medication review to 
collect data on their perceptions of the encounter and in-depth interviews were carried out 
with pharmacists both pre and post-medication review.  Finally the pharmacists received 
formal feedback and attended a focus group.  Discourse analysis revealed a lack of skills 
by the pharmacists, as they continued to provide advice to patients both in the absence of 
identified problems and after demonstration of competence by the patients.  This was 
interpreted as potentially undermining and “threatening the patient’s assumed 
competence, integrity and self-governance”, with ultimately a loss of confidence by the 
patient in their healthcare regimen.  The researcher clearly states that we should question 
the advice-giving role of the pharmacist and demonstrates “the pharmacy professions’ 
need for further training in communication skills”.  Further, it is stated that pharmacists are 
not traditionally trained in communication skills to the same extent as other healthcare 
professionals.  It is possible in interpreting these results to conclude that the pharmacists 
may have been overenthusiastically attempting to record the maximum level of input, as 
they were being observed.  This paper provides support for a review of the consultation 
skills training provided to pharmacists and recommends identification of novel approaches 
for delivery. 
Further analysis of the Homer study[36] reported in 2009[68] yielded similar conclusions, 
although greater detail is given of discourse, with comment that the pharmacists’ 
employed an interrogative style on occasions with a target of medical compliance.  The 
lack of current communication training for pharmacists is once again highlighted.  “This 
study reinforces the importance of the pharmacy profession addressing the 
communicative competencies required in practice that can take into account the unique 
interactional dynamics of intimate consultations”.  Further comment is made of the 
complex nature of communication within the counselling context.  The author 
recommends that pharmacists receive effective communication training, specifically in the 
area of consultation.  The comment that effective communication is included in pre and 
post-registration syllabi possibly supports further training for qualified pharmacists as they 
are tasked with evaluating competencies of pre-registration pharmacists.  It could be 
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argued that without effective skills themselves, academics and pre-registration tutors 
cannot evaluate others.  Salter refers to technical-rational pharmacy discourse and it is 
interesting to note that Schon[69] forecasted the need to re-evaluate the use of technical-
rational approaches which were defined as ‘problem solving with the application of 
science’.  He goes on to point out that agreement in deciding ‘ends’ should be undertaken 
and that this is a non-technical process, whilst encouraging the use of learning in practice.  
Both of these approaches are not yet approaches undertaken in teaching UK pharmacists. 
It is essential that healthcare professionals, including pharmacists recognise that effective 
communication is essential when they interact with patients.  Cipolle Strand and Morley[35] 
in ‘Pharmaceutical Care Practice’ state that “the ability to communicate with each other 
and with patients will be the best predictors of whether a practice will succeed.  Quality 
care means quality communication”.  Silverman, Kurtz and Draper[70] in Skills for 
Communicating with Patients, state that communication is a core clinical skill, an essential 
component of clinical competence.  They also state that communication skills within 
consultations (which include medication reviews) are not an optional extra and that 
without these skills, knowledge and intellectual efforts are wasted.  These statements from 
respected practitioners provide strong evidence that communication skills within 
consultations are a basic requirement of modern healthcare practitioners.  This teaching 
must prove to be effective for pharmacy undergraduate students to ensure that they 
become effective practitioners.  Silverman et al.[70] state that these skills need to be 
taught and learned, as it is not simply a personality trait.  However, they state that a 
variety of methods are required to teach these skills and that “experience alone can be a 
poor teacher”. 
Evidence, therefore, exists for the need to train pharmacists in communication skills, 
particularly within consultations and that this should not be confined to the pre-registration 
setting.  The provision of medication review services in the USA and Australia as an 
education tool to develop clinical decision making and consultation skills of pharmacy 
undergraduates has been reported. 
1.4.1 Involvement of pharmacy students in medication review 
Whilst consultation skills can be improved whilst working, it has been recognised by other 
healthcare professions that such training needs to start within the undergraduate 
degree[71-73].  In addition, the modernising pharmacy careers programme[74] recognises 
the need to teach these skills within the undergraduate education programme.  Outside of 
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the UK, Schools of Pharmacy have reported utilising the provision of medication review 
services to patients as one approach to improving consultation skills.  
A non-controlled study by Boyatzis and Batty[75] in 2004 in Western Australia was 
undertaken on thirty six fourth year pharmacy students participating in a programme of 
domiciliary medication reviews.  The study demonstrates positive results and, therefore, 
increases the sustainability of such training.  This form of medication review is an 
Australian government recognised, and funded method of patient care[41].  Students were 
recruited during a community pharmacy placement during which they undertook 
continuous training with university support and a one week series of lectures and 
workshops prior to intervention.  In liaison with a preceptor pharmacist and the patient’s 
GP each student generated a list of patients over 60 years of age with greater than three 
prescribed medications.  The students then used this list to enable recruitment of 189 
patients by telephone.  During the telephone call students asked questions to estimate 
patients’ recall of medication names and indications.  They then undertook a domiciliary 
medication review (DMR) of approximately one hour duration using a data collection form 
to guide and standardise the process.  Evaluation of the medication review was sought 
from students and patients by postal questionnaire utilising five point Likert scales.  This 
was undertaken after the medication review, with recommendations forwarded to the 
patients’ GP after moderation by the supervising pharmacist.  Incorrect or unknown 
indications for medicines were provided by 39% of patients, but no data is given for 
knowledge post DMR.  Students identified 2.1 (1.7) problems per patient for 80% of 
patients with the GPs endorsing 1.1 per patient for 49% of patients, whilst the GP and 
pharmacist only identified a further 0.4 and 0.2 respectively.  Mean scores for patient 
feedback on the medication review ranged from 4.1 to 4.7 out of 5, with student feedback 
on themselves showing lower scores of 3.4 to 4.8 out of 5.  Qualitative comments from 
patients showed that patient knowledge regarding their medicines improved, they found 
the review interesting, important and they would recommend it to other people.  No clinical 
benefit can be claimed following the DMRs by the student pharmacists as no clinical data 
was collected.  The process was found to be acceptable to students, GPs, preceptor 
pharmacists and patients and provided a method of teaching communication skills to 
pharmacy students through experiential learning in a DMR. 
A novel ‘Wellness Center’ set up in the USA to provide training to pharmacy students in 
2007[76] included risk factor identification, patient counselling and clinical decision making.  
Over five weeks students undertook activities primarily focussed on health promotion but 
also including ‘disease management’ which took the form of a medication review.  83-93% 
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of participating students agreed via a questionnaire that the experience had helped them 
to understand their role in ‘wellness’.  Analysis of student ‘before and after self-rated’ 
scores demonstrated significant improvement in students’ confidence and effectiveness at 
communication and problem solving. 
In a study in a large USA city[77] in 2007, pharmacy students participated in a six week 
‘hands-on’ programme where they provided medication evaluation, counselling, screening 
services and immunisation to elderly patients.  Again, working with patients prompted 
students to report “confidence building, strengthened communication skills” and being 
more aware of patients’ needs.  Students consistently scored the programme very 
positively, with free text comments demonstrating that they enjoyed the learning 
experience whilst learning.  Importantly for continuation of such schemes, patients 
expressed satisfaction with all aspects of the medication review including students’ skills 
and consultation content. 
In 2007 a USA based prospective observational study[78] with fourth year pharmacy 
students participating on internal medicines rotations at a 616 bed community teaching 
hospital found that ten students made 625 recommendations (42.5% oral) over the five 
month period.  Over 90% of recommendations were medication-related with examples 
including indication, dose, route, inappropriate medication, allergy, duplication of therapy, 
with 68% accepted showing that the students are capable of a wide range of patient care 
activities related to medicines.  Of recommendations made, 227 (36.3%) were formulated 
from evidence based medicine guidelines, with 123 of these provided to the doctor in 
written form.  Oral recommendations were made to resident physicians, in a learning 
environment, with whom a relationship had been established, whilst written 
recommendations were made to community physicians.  This study provides evidence 
that communication about medication review is more effective when face to face.  It also 
demonstrates that pharmacy students are capable of identifying recommendations for 
improving care in real life situations and, as the authors state, undergraduate pharmacists 
may have the ability to positively impact on patient care. 
The University of Illinois developed a programme[79] for pharmacy students to undertake 
medication review plus falls risk assessment and blood pressure (BP) measurement in 
patients’ homes.  Preparation included lectures on undertaking medication review, 
identifying falls risk, undertaking BP measurement, and practical sessions undertaking 
medication review with ‘mock’ patients.  Then groups of three students, with a “medically 
trained chaperone”, completed medication review with volunteer patients, and forwarded 
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interventions to the patient’s physician for action.  The primary outcome was to establish 
whether trained undergraduate students could undertake a home medication review and 
demonstrate patient benefit.  57 (48%) of the 118 patients visited by one of three students 
had prescription changes made, after student recommendation to their primary care 
physician  These included nine drug interactions judged to be potentially major by a 
hospital pharmacist.  Many changes were housekeeping issues such as removal of 
antibiotics or use of over the counter medicines.  The authors state that they “expect that 
this program can be successfully duplicated in other locations”, and state anecdotally that 
patients were appreciative of time and effort, implying that they would participate in a 
similar programme.  
1.4.2 Students working with patients with diabetes 
Studies presented previously demonstrate that undergraduate pharmacy students can 
undertake work with patients whilst providing benefit for both students and patients.  It is 
of note that a number of these studies are based around providing services to patients 
with diabetes. 
A USA conducted study undertaken in 2009 by one school of pharmacy[80] investigated 
fourth year pharmacy medication reviews with patients with diabetes in a “diabetes care 
and education centre” situated within a community pharmacy.  Patients were referred by 
their primary care provider or by pharmacy staff for the service which was provided for 
free in a system where all services are usually charged for.  Then students met individual 
patients face-to-face for a medication review supervised by a trained pharmacist.  In 
addition to medication review and providing health advice, students undertook HbA1c, 
total cholesterol, low density lipoprotein (LDL), high density lipoprotein (HDL) and blood 
pressure measurements.  Students were present for six week periods, with access to 
electronic medical records, and patients returned for up to six visits, therefore, patients 
met multiple students.  Students made 533 recommendations which were faxed to the GP; 
acceptance varying from zero (four doctors) to over 50% (three doctors).  Overall 
acceptance was 35% for dose changes and 28% to start or stop of medication.  However, 
214 recommendations were duplicates, demonstrating a possible lack of records or 
effective communication between participating students.  The study fails to state if the 
acceptance rate quoted is of all 533 recommendations or the 319 non duplicates as they 
represent only approximately 60%.  In spite of this, significant improvements were 
observed in patients’ HbA1c, cholesterol, LDL, HDL, BP and body weight, with the control 
of all of these parameters important for controlling the health of patients with diabetes. 
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Experiential inter-professional learning was developed in San Francisco[81] with trainee 
doctors (‘medicine residents’), nursing students and fourth year pharmacy students 
providing care in teams to patients with type 2 diabetes (T2DM).  All students participated 
in a training course for half a day each week during their rotation comprising a lecture on 
aspects of diabetes care, a clinical discussion session and clinical visits with patients.  An 
on-line course focusing on practical aspects of diabetes care was also made available.  
Whilst collectively responsible for quality of care, the student team divided the work, with 
pharmacy students primarily responsible for medication therapy management, insulin 
initiation, smoking cessation and patient education.  Patients were randomised to 
intervention or usual care and those in the intervention arm attended repeat appointments 
with the member of the team appropriate for any needs identified.  Team rotation resulted 
in patients seeing more than one person of each discipline as medicine residents 
participated for two months, nursing students for ten to twelve weeks and pharmacy 
students for twelve weeks.  Intervention group patients received more tests and 
examinations than control (not significant other than foot care with p<0.001) and, 
unsurprisingly, statistically more planned general medicine visits (p<0.006).  An important 
finding was that there was a non-significant reduction in ‘emergency room visits’ for 
intervention patients.  The authors conclude from this that overall there was an increase in 
healthcare visits, but a reduction in cost and improved care through utilisation of the 
appropriate care setting.  Both patient groups improved in clinical status, although it is 
stated that both groups improved possibly due to a confounding factor, the introduction of 
new treatment guidelines for diabetes, released during the study period.  Data for 
intervention students compared to non-participant students showed significant 
improvement in ability to provide diabetes care.  Problems with team working are 
mentioned, mainly around communication, as the team was frequently changing.  The 
study is interesting in demonstrating that students of different disciplines can work 
together, provide benefit to patients with type 2 diabetes and develop clinical competence. 
Whilst the results from student led medication reviews have been published outside of the 
UK there is currently no evidence of a similar nature from within the UK.  Additionally, no 
single model of teaching consultation skills within a medication review has been agreed, 
either within or outside the UK. 
It was established earlier in this chapter that evidence exists demonstrating that 
pharmacists lack consultation skills, however, these skills have also been demonstrated to 
be important for effective patient care.  Evidence has also been presented that the 
teaching of these skills to undergraduate pharmacists, within the context of medication 
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review, has been demonstrated to be effective outside the UK.  It is important to identify if 
providing training in consultation skills within the context of medication reviews to 
undergraduate pharmacy students in the UK can be demonstrated to be effective.  
1.5 Summary 
Medicines are central to the provision of western healthcare and as such need to be 
utilised appropriately.  Whilst medication review is identified as the process to promote 
this there is no compelling evidence of effectiveness and cost-effectiveness for 
pharmacist-led medication review with patients in the community.  Whilst aspects of 
research design have potentially contributed to the failure to prove this, a lack of effective 
communication skills by pharmacists has also been identified and reported as an 
additional factor. 
Most research which seeks to evaluate pharmacist-led medication review provides brief 
training, including consultation skills, prior to implementation.  However, this has failed to 
produce positive results, thus indicating that more intensive training is required.  
Consultation skills can potentially be developed within the undergraduate taught 
curriculum through the provision of patient services by students, as demonstrated by 
research published outside the UK.  Such teaching is, however, complex and expensive to 
deliver.  Consequently evidence to demonstrate its potential benefit for patients and 
students is required to support its implementation.  Following MRC guidance for complex 
interventions, this thesis will, therefore, involve stakeholders in the introduction of such a 
service, feasibility test and pilot it and then obtain stakeholder views post implementation.  
The education intervention will also be evaluated to enable enhancement and future 
repetition in a definitive trial.  Mixed methods will be utilised to triangulate and enable a 
fuller understanding of the results obtained and the acceptability of them to stakeholders. 
For services to be adopted within the UK it is necessary for the cost-effectiveness to be 
demonstrated.  This is generally achieved through randomised controlled trials (RCT), 
with MRC guidance recommending that these should be preceded by a pilot study.  This 
thesis seeks to develop a pilot study with the aim of providing sufficient data to enable the 
design of a definitive study. 
1.6 Aims and Objectives 
In preparation for a future definitive study the aim of this thesis was to develop a 
supervised student led medication review service for patients with T2DM and to feasibility 
test and pilot it as a complex intervention in primary care. 
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The rationale for choosing patients with Diabetes Type 2 (T2DM) as the patient group for 
inclusion in this study is that they are representative of patients with a Long Term 
Condition (LTC).  They are potentially able to benefit from medication review input to 
improve the use of medications, adherence to prescribed medication regimens, 
information about medication and lifestyle advice.  T2DM is a disease with a high and 
growing prevalence, both in the UK and other countries. This results in a rising demand 
for healthcare resources and, therefore, increased pressure in terms of cost to the NHS.  
NICE CG66[82] stated that only 11% of people with T2DM have received structured 
education, yet it is a LTC managed predominantly by the patient or their carer.  It also 
highlighted the need to ensure lifestyle advice whilst reminding us of the need for patients 
to take medicines correctly; a theme also identified in other publications[23].  Government 
advice, therefore, recommends that healthcare professionals should interact with patients 
with T2DM in order to promote improvements in health.  Teaching pharmacy students 
through the provision of medication review for patients with T2DM potentially presents 
benefit by both parties. 
Objectives 
• to develop the medication review service and research design through stakeholder 
engagement 
• to develop and assess a training course designed to prepare pharmacy students to 
undertake medication reviews. 
• to describe the educational effect of utilising medication review with real patients, 
• to test the feasability of pharmacy student-led medication review for patients with 
T2DM in primary care, 
• to describe recruitment and retention rates and provide reasons for non-retention 
and to test the randomisation process, 
• to determine the acceptability of the medication review service to patients and 
students i.e. describe the contribution made to patient care by students during the 
medication review process, 
• explore the potential effect of student medication review on a range of outcome 
measures and identify those which are most suitable as primary outcome 
measures. 
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Chapter 2 – Methods 
2.1. Design 
This was a randomised controlled feasibility and pilot trial involving patients recruited from 
general practices in Norfolk. The intervention was provided by final year pharmacy 
students recruited from the School of Pharmacy at the University of East Anglia. 
2.2  Ethical approval 
An application was made for ethical approval via the Integrated Research Application 
System (IRAS) under the title “Supervised Pharmacy Student-Led Medication Review of 
Patients with Diabetes in Primary Care”, with full approval being granted by 
Cambridgeshire 3 Research Ethics Committee (REC) on 18th January 2011 Reference: 
10/H0306/77 (Appendix D1). 
2.3 Participants 
Recruitment and sample size were determined pragmatically based on numbers of final 
year pharmacy students likely to volunteer to join this study which involved input outside 
their usual curriculum.  Assuming that 40 students would volunteer to participate and that 
each student could review two patients, then 80 patients would be required for the 
intervention arm and 80 for the control. 
As a feasibility study no formal power calculation was required.  However, a calculation to 
provide an estimate of the accuracy of the outcome data was undertaken and is included 
in the protocol (Appendix B). 
2.3.1 Medical Practices 
Medical practices were required as part of this study to facilitate recruitment of patients, 
enable integrated working of the students and medical practice and provide access to 
patient medical records once consent had been obtained.  The GPs in the medical 
practices were also funded to meet students post review to discuss recommendations. 
2.3.1.1 Medical practice recruitment 
Assuming that each general practice could recruit 30 to 40 patients with T2DM, four or five 
medical practices were, therefore, required.  
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A representative of the Primary Care Research network (PCRN) based in the research 
and development department at NHS Norfolk, the local primary care trust (PCT), was 
used for recruitment purposes and deemed that the study should be performed in 
‘research active’ medical practices.  Only practices utilising Systmone® as their medical 
record access software were included as this is the most common system in Norfolk and it 
was more practical to train students in only one system. 
A medical practice information sheet (Appendix B) was circulated to all research active 
medical practices deemed suitable for the study by the PCT and included the following: 
• trial design including student activities, 
• recruitment and patient numbers, 
• activity requirements for the Practice, 
• costs and methods of reimbursement. 
2.3.2 Patient 
2.3.2.1 Inclusion and Exclusion criteria 
Patients within recruited medical practices were deemed eligible for inclusion if they met 
the following criteria: 
Inclusion criteria: 
• registered with one of the four participating medical practices, 
• prescribed non-insulin medication for T2DM for at least two years, 
• over the age of 16 years. 
Exclusion criteria: 
• deemed unsuitable for inclusion in the trial for any reason by their GP, 
• enrolled into other clinical trials, 
• terminal illness. 
The timescale of prescribed non-insulin medication for T2DM for at least two years was 
chosen as it was believed that students would not have the skills to influence patients or 
their clinicians when the disease was not stabilised.  Additionally it was considered that an 
intervention at that stage may affect patient/physician relations. 
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2.3.2.2 Patient recruitment 
To estimate the potential response rate, eligible patients from one medical practice were 
initially identified by medical practice staff and randomly selected from the practice 
records.  A letter inviting participation, a patient information leaflet, a consent form and a 
stamped addressed envelope were all posted out (Appendix D2).  The response rate was 
20%.  This suggested that approximately 160 patients should be mailed in each practice 
so as to ensure recruitment of 32 patients.  The number of patients required in each 
practice was reduced from 40 to 32 because an additional fifth practice expressed interest 
and ethical approval was provided to make this change.  Consent forms (including 
permission to access medical records) were returned to the researcher at the UEA.  
Consent was provided for: 
• joining the study, 
• access to the patients’ medical records, 
• filming of the student-led consultation. 
Full details of required involvement was provided in the patient information leaflet. 
(Appendix D2) 
2.3.2.3 Randomisation 
Randomisation was conducted using a web-based system provided by Norwich Clinical 
Trials Unit (CTU).  This process used a pre-prepared list of codes in random order to 
allocate study participants to either the control or intervention group.  Participants were 
stratified according to their GP surgery.  Within each stratum, codes were grouped into 
blocks of four to ensure an approximately equal number of control and intervention 
patients in this study. 
The CTU database manager provided details of the randomisation process as follows: 
“The randomisation database was built using MSQL Server and the access pages built 
using MS Visual Studio, ASP.NET and VB.NET.  The web-site and database both resided 
on the Norwich CTU secure server at UEA.  Access to the randomisation web-site was 
protected by username and password and web-traffic was encrypted using SSL 
technology.” 
Access to the database itself was restricted to the Norwich CTU database manager. 
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Randomisation was performed by the researcher utilising the database created and 
managed by the Norwich CTU database manager who had no knowledge of, or contact 
with, the patients recruited.  Patients were randomised at the point of recruitment.  Results 
were maintained on the database (the researcher had read-only access to this data) and 
on a spreadsheet held in the School of Pharmacy. at the UEA.  This web-based 
randomisation process ensured concealed allocation. 
2.3.3  Students 
2.3.3.1 Recruitment 
It was estimated that within the time available each student could undertake a medication 
review for two patients. With a target number of 80 intervention patients, 40 final year 
pharmacy students were recruited.  A simple email survey of all final year pharmacy 
students (n=83) the previous year established that a 50% recruitment rate was probable 
which would result in approximately 40 students potentially able to be recruited for this 
study. 
All final year pharmacy students in 2011 (n=84) were eligible for inclusion in the study and 
were, therefore, sent an email at the end of their third year providing information about the 
study, including the information leaflet (Appendix D3), and inviting expressions of interest.  
All students who replied were sent an invitation letter, information leaflet and consent form 
(Appendix D3) with all replies to be sent by internal UEA post to the researcher.  Any 
student who was unsure whether to join the study was offered the chance to discuss this 
with the researcher.  It was agreed that if more than 40 students volunteered to join the 
study that they would be accepted in order of recruitment, with those in excess of 40 held 
on a reserve list.  For practical reasons, students on the reserve list were offered the 
training package to enable them to join the study later if any student withdrew. 
2.3.4  Primary care trust (PCT) pharmacists 
The rationale for recruiting PCT pharmacists was that students undertaking activities 
within medical practices, and with patients, required supervision to ensure patient safety 
and to enhance the learning experience.  PCT pharmacists were chosen as they work 
regularly with practices, including undertaking medication reviews.  They, therefore, 
should have developed relationships and skills which would effectively facilitate the 
student-patient medication review. 
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No recruitment target was set, as the decision to include the pharmacists was pragmatic 
and based upon their availability, experience with a medical practice and the pharmacists’ 
skills.  Logistics were an additional factor, as pharmacists with suitable knowledge and 
relationships would enable working within a medical practice, as they knew the staff and 
systems.  The final decision of which pharmacists to enrol in the study was, therefore, 
based on the above, as three of the six pharmacists expressing interest in the study 
already worked with medical practices recruited to the study.  The researcher also had 
experience of working with medical practices and was currently working with one of those 
recruited to the study. 
2.4  Development Phase – Confirmation of study design 
2.4.1  Focus groups 
Focus groups were arranged comprising six to eight participants from each of the 
representative stakeholder groups of general practitioners (GPs); specialist nurses; 
patients with T2DM; final year pharmacy students at the School of Pharmacy, UEA; and 
PCT pharmacists.  Each focus group consisted of representatives from only one 
stakeholder group in order to maintain group homogeneity and encourage discussion.  It 
has been stated that qualitative research methods, such as focus groups, enable the 
establishment of improved protocols[51].   The rationale in this case was to explore the 
current protocol and method to establish if planned interventions were acceptable to 
potential participants as well as identifying any changes required in order to obtain 
maximal recruitment and an improved intervention. 
2.4.2.  Recruitment for focus groups 
Participants for the focus groups stakeholders were recruited as detailed below.  Up to 
two weeks was provided for all potential participants to decide if they would agree to 
provide consent, by signing the forms sent to them. 
2.4.2.1 Medical Practice Staff 
A letter of invitation, information leaflet, consent form and stamped addressed envelope 
were sent to all GPs from the recruited medical practices (Appendix D2) with replies sent 
to the researcher at the UEA.  It became apparent that recruitment of GPs to the focus 
groups was problematic, and that recruitment would not achieve its target, as medical 
practices stated that the GPs were too busy.  An application was made to the Local 
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Research Ethics Committee (LREC) for an amendment to ethical approval (Appendix D1) 
to allow the inclusion of practice nurses, in addition to GPs, and to allow individual 
interviews with staff at the medical practices instead of centrally arranged focus groups.  
Nurses were then provided with the same recruitment documentation as GPs.  The aim of 
this change was to improve recruitment and ensure that all key opinions were captured.  
This was agreed and approval was granted (Appendix D1 - approval letter). 
2.4.2.2 Primary care based pharmacists 
A letter of invitation for a focus group, information leaflet, consent form (Appendix D2) and 
stamped addressed envelope was sent to all Norfolk Primary Care Trust pharmacists from 
the Medicines Management Team office at NHS Norfolk, with replies returned to the 
researcher at the UEA. 
2.4.2.3 Patients 
A letter of invitation, information leaflet, consent form (Appendix D2) and stamped 
addressed envelope was sent to people recruited as representative of participants in the 
intervention.  They were patients recruited via the local diabetes patients’ advice group 
and by advert for people with T2DM in the staff newsletter at the UEA.  Replies were sent 
to the researcher at the UEA. 
2.4.2.4 Students 
All current final year students (who had just completed their course) were invited by email 
to express interest in focus group participation, after their final examinations.  A letter of 
invitation, information leaflet, consent form (Appendix D2) and SAE were sent to all 
interested students.  These students were recruited as representative of the student 
participants in the intervention. 
2.4.3 Focus group and semi structured interview design and delivery 
2.4.3.1 Logistics 
Locations and times of focus groups and semi structured interviews were chosen as being 
acceptable to potential participants. 
Because the focus group for the medical practice staff proved to be impossible to arrange, 
discussions were undertaken as a series of semi structured interviews.  This was a purely 
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pragmatic decision, as the alternative was that the views of these stakeholders would be 
lost.  The interviews were undertaken in meeting rooms at the GP practices at lunchtime, 
with a buffet lunch provided.  
The focus group for the PCT pharmacists was undertaken in a meeting room at a local 
hotel chosen as accessible for all participants.  A buffet was provided prior to the meeting. 
Focus groups for students and patients were undertaken (separately) in committee rooms 
at lunchtime at the UEA, which appeared an acceptable location for all participants.  A 
buffet lunch was provided prior to each meeting. 
2.4.3.2 Delivery 
All meetings were run by the researcher with supervision by a senior member of the 
academic staff at the first meeting. 
The researcher and one other person, not trained in qualitative research techniques, were 
present at each focus group, but only the researcher at semi structured interviews.  It is 
recommended[83] that two team members are present to overcome problems with 
recording and logistics, including meeting participants, dealing with problems with the 
location etc.  This left the facilitator free to concentrate and focus on the meeting, however, 
this was not deemed necessary for interviews due to the simpler logistics. 
A suitably trained person was not available to take notes and assist with transcribing by 
noting the identity of speakers as recommended[84].  This would have enabled more 
effective analysis by providing the identity of the participant of individual quotes and thus 
revealing if those relating to one, or related themes, were all from one person. 
Participants received a five to ten minute presentation of the proposed study from the 
researcher at the start of the session, following which the meeting lasted for approximately 
one hour.  The following themes were considered: 
• perceived benefits, 
• identified concerns, 
• barriers to recruitment and participation, 
• methods for optimising recruitment and participation, 
• opinions on the patient questionnaire and covering letter (patients only), 
• logistical issues. 
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See Appendix C for introduction and questions used during each meeting. 
Open questions (see Appendix C) were asked, with subsequent questions asked as 
appropriate to probe and establish the meaning of replies when judged by the researcher, 
as moderator, that this was required.  Consensus was sought in the first (student) focus 
group, but when the error was realised this did not reoccur.  The researcher sought to 
obtain the views of all participants through direct questioning of individuals who had not 
commented on a particular issue. 
All focus groups and semi structured interviews were later transcribed by an administrator.  
Analysis was then undertaken by the researcher to identify common themes and issues 
as well as solutions which could be used to modify the final intervention. 
The main findings from the four focus groups and interviews were presented to the 
management and steering committees, together with the data from the literature review, to 
enable the study design to be optimised.  Following this, ethical approval was sought for 
amendments to study documents and methods. (Appendix D) 
The main changes requested and approved include: 
• location of the medication reviews moved from the university to the patients’ 
medical practice, 
• students were provided with transport to medical practices, 
2.5 Intervention 
2.5.1 Medication review process 
Figure 2.1 displays the process of medication review commencing with preparatory 
training of students and subsequent level 2 and level 3 medication reviews.  It 
demonstrates that each part of the process was undertaken in sequential order to provide 
preparation and experience from each activity to inform and prepare for the next process. 
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Figure 2.1 Medication review process 
63 
 
2.5.2  Preparative training and development of participating students 
All final year pharmacy students had already received the following training as part of their 
usual undergraduate experience: 
• basic lectures and practicals on communication skills, 
• lectures and workshops on data protection and confidentiality, 
• attendance at a GP Practice to observe GP/patient consultations for at least two 
hours, 
• diabetes aetiology, pathophysiology and therapeutics. 
The preparative training for study student participants was designed to include the 
following knowledge and skills: 
• ability to access the IT system at medical practices: 
o identify information required, 
o identify relevant information, 
o understand the relevance of information and where to find related data. 
• process of care planning for people with diabetes, 
• ability to communicate effectively , 
o in a medication review. 
o when feeding back issues to medical practice staff, 
• knowledge of lifestyle issues (diet, smoking, alcohol) and guidance of how to apply 
them in a medication review, 
• motivational interviewing (via a lecture, and workshop practice session) to facilitate 
healthy lifestyle promotion, 
• knowledge of diabetes pathophysiology, pharmacotherapy, management and 
evidence based guidelines. 
Students obtained research passports and smartcards to enable secure access to 
electronic patient records via the Primary Care Trust. 
Recognition that there was limited time available for teaching participant students, as they 
were all volunteers undertaking this in their own time, resulted in the following training 
structure: 
• podcasts over the summer vacation, 
• three half day teaching sessions, 
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• an interactive role-play session with actors to practice skills learned. 
Time required to be provided by each participating student to undertake the preparative 
training. 
• each podcast would require one hour of private study, 
• each teaching session would require three hours attendance.  Due to unavailability 
of training rooms at the PCT, travel of thirty minutes each way was required to an 
alternative training venue, 
• each student was allocated a two hour session within the role-play. 
No additional private study was requested of students. 
2.5.2.1 Podcasts 
Two podcasts consisting of voiced-over lectures were provided over the summer.  These 
included updates on National Institute for Health and Care Excellence (NICE) guidance, 
discussion of recent evidence, treatment options, case studies, prioritisation of treatment 
and treatment targets.  In addition, information was provided on therapies relating to 
diabetes plus cardiovascular disease management with respect to people with diabetes. 
The podcasts were made available to both study participants and non-participants on the 
UEA teaching intranet site.  The system provides notification to students of new content, 
such as these podcasts, in order to facilitate access. 
2.5.2.2 Use of electronic medical records 
A three hour training session to provide the skills required to access participating patients’ 
medical records was provided by the IT training department at NHS Norfolk.  During this 
session, a dummy patient record created by the researcher and entered into the IT system 
by the IT training department, was used by students to practice data capture and use of 
the system (Appendix E).  To structure care planning by students and to enable data 
capture of individual patient care plans, an electronic care planning document was 
produced by the researcher (Appendix G).  During level 2 and level 3 medication reviews 
the protocol plan was to utilise and record the care plan on the laptops used in the study.  
Within this training session, students utilised this care plan on computers in order to 
practice retrieval and recording of relevant information in the manner planned within the 
study. 
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2.5.2.3 Pharmaceutical care planning 
Session content included care-planning and lifestyle issues relating to diabetes.  Students 
were provided with a copy of the dummy patient profile used in the previous session.  This 
included patient details to enable practising the creation of care plans using the electronic 
form.  Students were required to identify factors within the dummy patient’s medical record 
which required changes to ensure optimal health gain(s).  Additionally, they were required 
to identify gaps in information in the record which required questioning of the patient to 
establish if a problem existed.  These constituted care issues.  Examples of lifestyle 
issues, with targets and methods of resolution of problems were provided to students as a 
short discussion.  
2.5.2.4 Consultation skills 
A podcast providing guidance on consultation skills and motivational interviewing was 
made available on the UEA intranet one week before the workshop. 
A workshop of three hours duration comprised: 
• a short lecture to explain key issues of consultation skills and motivational 
interviewing, 
• a practical demonstration of a good consultation. 
Pairs of students practiced consultations with each other using a ‘dummy’ patient script.  
Supervisory assistance was provided and students then practiced motivational 
interviewing in pairs, in order to either modify or initiate behaviours in their partner, to 
which they may be resistant.  For pragmatic reasons and due to limited time, the duration 
of the motivational interviewing training session was only one hour. 
2.5.2.5 Role-play session with actors 
All student participants in the study took part in a role-play session after the preparative 
training, but prior to meeting patients for the first time. 
Professional role-players, or actors, were used as ‘patients’ during medication reviews to 
ensure good quality role-play. 
Case studies for two patients were produced which mapped onto real life and attempted 
to provide a realistically long case history, similar to that seen in medical records at GP 
practices to include: 
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• demographics including age, BMI and latest data, eg BP, 
• social history, 
• drug history (including medications stopped), with dates started, dates of issues, 
dates stopped and allergies, 
• medical history including all problems over the lifetime of the patient.  Each case 
included T2DM, as the students will be meeting similar patients for real 
consultations, 
• details of lifestyle such as smoking, alcohol use etc. but gaps were purposely left 
to allow students to gather information and provide an opportunity for practising 
motivational interviewing with respect to lifestyle, 
• character details to include cases which tap into the emotions, e.g. fears, wants, 
expectations, force of character, to enable direction of actors. 
Each student undertook a role-play medication review with two different actors, each of 
whom utilised one of the case studies. 
2.5.2.5 Delivery of role-play sessions 
To ensure realism and gain maximum benefit from the exercise: 
• consultation rooms in the UEA clinical trials unit, which display great similarity to 
GP consultation rooms, were used for the session, 
• six actors were used to take the role of patients, thus enabling three parallel 
groups.  Scenarios were amended to accommodate age, sex and BMI to ensure 
that actors mirrored the scenario as closely as possible, 
• scenarios were emailed to actors in advance to enable preparation, 
• patient details taken from the scenarios and reflecting the data available in patients’ 
records were emailed to students a week before the session to enable preparation 
(Appendix E), 
• each session was facilitated by academic pharmacists and four PCT pharmacists, 
• a general practitioner was present to receive recommendations from students and 
to provide feedback, 
• administrative assistance was available for logistical support. 
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2.5.3 Intervention. Medication reviews 
2.5.3.1  Level 2 medication review 
The researcher allocated students (with sight of student names) to medical practices 
using an Excel spreadsheet algorithm.  Student names were visible to the researcher, for 
pragmatic reasons, but it was not expected that this randomisation would affect study 
results. 
At each medical practice students, under the supervision of a PCT pharmacist, worked in 
pairs to undertake medication reviews for four recruited intervention patients who had 
provided consent.  The review took the form of a level 2 medication review[85] ie, utilising 
the full medical records but without the patient present. 
NB: Each student would later meet two patients for a level 3 medication review, but 
undertaking the level 2 medication review with another student provided practice with 
more patients i.e. four, whilst dual working provided student support.  
For each medication, the student compared prescribing and monitoring with NICE 
guidance.  They identified issues for recommendation to the patient’s medical practitioner, 
or for further investigation in the subsequent medication review.  In addition, the students 
identified, as far as possible from the records, issues relating to adherence, lifestyle, side 
effects, allergies and use of over-the-counter medicines.  Gaps in information constituted 
a potential pharmaceutical care issue.  All identified potential issues were checked and 
agreed after discussion with the PCT pharmacist and then recorded on a custom-
designed form (Appendix G).  The PCT pharmacist then, for safety reasons, checked the 
form prior to communication to the medical practice staff.  Additionally, the PCT 
pharmacist recorded on the form if issues had been identified: 
• by the students alone and accepted by the PCT pharmacist, 
• by the students alone but rejected by the PCT pharmacist, 
• by the students with assistance from the PCT pharmacist, 
• by the PCT pharmacist. 
Students completed a pharmaceutical care plan (Appendix G) using the forms previously 
utilised during the development training programme.  Care plans were recorded and 
retained on laptops which were securely stored by the researcher.  The care plan later 
acted as a reminder for students when meeting the patient during the face to face element 
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of the level 3 medication review process.  It also acted as a tool for structuring both the 
level 2 and the level 3 medication reviews. 
A PCT pharmacist moderated student questions for a one hour GP/specialist nurse 
practitioner feedback session.  This was pre-arranged for the students at the end of their 
visit to enable discussion of identified medication issues.  Agreed therapy changes were 
implemented, with GP consent, by the PCT pharmacist unless the GP preferred to 
implement them.  Practices were offered a copy of the care plan and for that purpose the 
forms were produced in duplicate.  Any changes recommended by the GP, nurse or 
pharmacist were recorded on the care plan. 
It was deemed inappropriate for the students to undertake the level 2 medication review 
as a part of the face-to-face level 3 medication review, as they could potentially identify 
medication related problems which they were not in a position to implement or correct.  
This could have created difficulties when providing information to the patient, therefore, 
the level 2 medication review was undertaken first and was followed by a period of at least 
two weeks before the face-to-face level 3 medication review.  This enabled 
recommendations to be implemented, by the medical practice, and for student reflection. 
2.5.3.2 Level 3 medication review 
The original protocol aimed to invite all intervention patients to attend a medication review 
at the UEA NHS clinical trials unit.  During the development phase focus groups, it 
became clear that the intervention should be undertaken at the patient’s medical practice.  
Therefore, an amendment was requested and approved by the Local Research Ethics 
Committee (LREC) to achieve this (Appendix D1). 
A range of dates and times were offered for appointments and were planned, including 
some outside of normal working hours, to maximise participation.  Patient appointments 
were made by telephone using administrative support at the UEA whilst attempting to 
achieve a balance between patient, GP practice and student needs. 
Students were randomised to two intervention patients with whom they would undertake 
the level 3 medication review.  One week prior to the medication review each student was 
provided with copies of the care plans relating to those patients.  These had been 
produced by the same student when they had accessed patient records previously.  The 
care plans were anonymised, i.e. patient identifiable information was removed for 
confidentiality reasons.  The student was given the patient names on arrival at the medical 
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practice.  Students were allowed a 45 minute appointment time to update their knowledge 
of the patient with access to the medical record (via computer in the medical practice); 
undertake the face-to-face medication review with the patient; and receive feedback from 
a pharmacist supervisor.  The supervisors were present throughout the medication 
reviews to ensure patient safety, facilitate access to medical records, deal with any 
logistical problems and support the student.  Supervisors also operated cameras and 
completed Medication Related Consultation Framework MRCF forms to provide student 
feedback.  A summary of the MRCF is presented in section 2.5.4, with a full copy 
presented in Appendix G. 
Early in the study one student, for personal reasons, left the study after undertaking the 
level 2 medication review utilising the records of patients.  It was decided that the two 
patients randomised to participate in a level 3 medication review with the student would be 
removed from the study as their records had already been seen by the student.  Later in 
the study similar situations arose when it was apparent that recruitment of patients would 
not reach the full target.  The pragmatic decision was taken that a second student would 
be allowed to view those records and undertake the level 3 medication review. 
Students were expected to discuss: 
• each medication separately, including any ‘over-the-counter’ medicines identified. 
• patient information needs relating to medicines, eg side effects, correct dose, 
actions, uses and indications, etc.  The student was then expected to address the 
needs identified accordingly, 
• adherence to prescribed regimens, 
• disease states, with a particular emphasis on diabetes, 
• relevant lifestyle issues and provide advice. 
The care plan created from the level 3 review was updated and retained for later analysis. 
All medication reviews undertaken by students were video recorded to facilitate feedback 
and self-reflection in addition to later evaluation of student performance.  Patients 
provided verbal consent in addition to original written consent, although they were not 
visible in any recording.  Video recordings obtained within this study were not analysed 
and discussed as part of this study, due to the lack of availability of researchers trained in 
this technique.  However, training of a researcher in the Roter Interaction Analysis System 
(RIAS)[86] is planned and it has been decided that evaluation of the recordings using this 
technique should be undertaken within another research study, following ethical approval. 
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The protocol provided an opportunity for patients to provide verbal feedback on the 
medication review before leaving the medical practice.  During the literature review it was 
identified that studies in USA and Australia had used short questionnaires to formalise this 
process.  A questionnaire was produced (Appendix G) based on one used in a study by 
Boyatzis et al. in Australia (2004)[75].  The questionnaire consisted of a 5 point Likert 
scale in which patients could express their views on 7 questions, plus free text, after the 
medication review had ended.  It was planned that the student should complete an almost 
identical questionnaire about their own performance.  This questionnaire was discussed at 
a project steering group meeting consisting of patients with T2DM, last year’s final year 
pharmacy students, a member of the academic staff and the researcher.  This resulted in 
the addition of three questions: the first two related to student competence and confidence 
and would be answered by both student and patient, whilst the third question, provided to 
students only, related to students’ self-assessed knowledge.  Approval was sought and 
gained from the local Research Ethics Committee for this amendment. (Appendix D) 
A PCT pharmacist or the researcher was present throughout each session when a student 
met a patient for medication review.  Their role was to answer identified problems, provide 
supervision and safety, and to manage the logistics of the process.  At the end of each 
session the supervising pharmacist evaluated student recommendations resulting from 
the medication review.  They agreed with the students which of these recommendations 
should be forwarded to the GP/specialist nurse practitioner.  This would be either face-to-
face, or by a copy of the care plan if a doctor or nurse was not available. 
2.5.4 Medication Related Consultation Framework (MRCF) 
The Medicines Related Consultation Framework (MRCF)[87] (Figure 2.2) was chosen as 
the assessment tool for use during the medication reviews (including those involving role 
play) as a validated tool with which the research team have experience. (Appendix G). 
During each medication review between a student and a patient in the study, scores were 
allocated by the researcher or a supervising PCT pharmacist, using the short form MRCF 
(Appendix G).  In some cases two pharmacists (the researcher and a PCT pharmacist or 
two PCT pharmacists) evaluated performance of the student whilst the researcher trained 
the pharmacists in the use of the form.  In addition, PCT pharmacists, when commencing 
supervision without the researcher, worked in pairs.  These actions were designed to 
minimise variation in evaluation.  Analysis was undertaken using an average of the two 
scores, in each case when two pharmacists completed the MRCF. 
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Figure 2.2 displays the content of the MRCF.  Each section A to E is scored one to four, 
with four representing ‘fully’ able to effectively undertake the activity within that section.  
The form finishes with a 5 point scale represented by boxes ranging from poor to very 
good to represent overall impression.  The MRCF was developed and validated by Abdel-
Tawab et al.[87]. 
(A) INTRODUCTION 
A.1 Introduces self 
A.2 Discusses purpose and structure of the consultation 
A.3 Invites patient to discuss medication or health related issue 
A.4 Negotiates shared agenda 
(B) DATA COLLECTION & PROBLEM IDENTIFICATION 
B.1 Medication history, social history   
B.2 Patient’s understanding of the rationale for prescribed treatment   
B.3 Patient’s (lay) understanding of his/her illness   
B.4 How often patient misses dose(s) of treatment   
B.5 Reasons for missed dose(s) (unintentional or intentional)   
B.6 Identifies and prioritises patient’s pharmaceutical problems (summarizing)   
(C) ACTIONS & SOLUTIONS 
C.1 Relates information to patient’s illness & treatment beliefs (risk – benefit discussion)  
C.2 Involves patient in designing a management plan   
C.3 Gives advice on how & when to take medication, length of treatment & negotiates 
follow up   
C.4 Checks patient’s ability to follow plan (are any problems anticipated?)   
C.5 Checks patient’s understanding   
C.6 Refers appropriately to other healthcare professional(s)   
(D) CLOSING 
D.1 Explains what to do if patient has difficulties to follow plan and whom to contact  
D.2 Provides further appointment or contact point   
D.3 Offers opportunity to ask further questions   
(E) CONSULTATION BEHAVIOURS  
E.1 Listens actively & allows patient to complete statements  
E.2 Uses open & closed questions appropriately  
E.3 Demonstrates empathy & supports patient  
E.4 Accepts patient (i.e. respects patient, is not judgemental or patronising)  
E.5 Adopts a structured & logical approach to the consultation  
E.6 Manages time effectively (works well within the time available)  
Figure 2.2 Content of the medication related consultation framework. 
(A) INTRODUCTION 
A.1 Introduces self 
A.2 Discusses purpose and structure of the consultation 
A.3 Invites patient to discuss medication or health related issue 
A.4 Negotiates shared agenda 
(B) DATA COLLECTION & PROBLEM IDENTIFICATION 
B.1 Medication history, social history   
B.2 Patient’s understanding of the rationale for prescribed treatment   
B.3 Patient’s (lay) understanding of his/her illness   
B.4 How often patient misses dose(s) of treatment   
B.5 Reasons for missed dose(s) (unintentional or intentional)   
B.6 Identifies and prioritises patient’s pharmaceutical problems (summarizing) 
  
(C) ACTIONS & SOLUTIONS 
C.1 Relates information to patient’s illness & treatment beliefs (risk – benefit 
discussion)  
C.2 Involves patient in designing a management plan   
C.3 Gives advice on how & when to take medication, length of treatment & negotiates 
follow up   
C.4 Checks atient’s ability to follow plan (are any problems anticipated?)   
C.5 Checks patient’s understanding   
C.6 Refer  appropriately to other health are professi nal(s)   
(D) CLOSING 
D.1 Explains what to do if patient has difficulties to follow plan and whom to contact
  
D.2 Provides further appointment or contact point   
D.3 Offers opportunity to ask further questions   
(E) CONSULTATION BEHAVIOURS  
E.1 Listens actively & allows patient to complete statements  
E.2 Uses open & closed questions appropriately  
E.3 Demonstrates empathy & supports patient  
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2.5.5 Patient outcomes 
Co-primary outcome measures: 
• HbA1c, 
• Cholesterol, 
• Blood pressure. 
Secondary outcome measures: 
• health status measure (EuroQol EQ-5D)[88 89], which is a standardised measure 
of health status developed by the EuroQol Group in order to provide a simple, 
generic measure of health for clinical and economic appraisal.  Applicable to a 
wide range of health conditions and treatments, it provides a simple descriptive 
profile and a single index value for health status that can be used in the clinical 
and economic evaluation of health care as well as in population health surveys, 
• patient satisfaction with information about medicines[90], comprises 17 items and 
provides a profile of patients satisfaction with the information they have received 
about prescribed medication. It has been shown to be valid and reliable in studies 
involving several illness groups, 
• patient reported medication adherence[91] using the Medication Adherence Report 
Scale (MARS), which is a five item scale, which asks respondents to rate the 
frequency with which they engage in each of five aspects of non-adherent 
behaviour. 
• patient reported autonomy[92 93] using Beliefs about Medicines Questionnaire 
(BMQ) which is an eleven item scale, 
• Diabetes Treatment Satisfaction Questionnaire[88] (DTSQ) which is an eight item 
scale which askes respondents to rate their views about treatment.  It includes 
hypoglycaemia and hyperglycaemia scores. 
The Medical Research Council (MRC) guidance[48] states that inappropriate choice of 
outcome measures may result in negative outcomes by research studies. 
Co-primary outcome measures of HbA1c and blood pressure were initially chosen as they 
are key measures which are known to reduce the risk of significant events[82 94].  They 
were also chosen because pharmacist-led medication review in patients with diabetes 
have demonstrated significant reductions in blood pressure[95 96] and HbA1c[94].  At the 
ethics committee review of the study it was requested that cholesterol should be added as 
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a co-primary outcome.  Good control of cholesterol is also necessary to reduce long term 
morbidity[82] and this was accepted.  Studies are only available outside the UK with 
respect to reduction of lipids following pharmacist-led medication review[97 98]. 
Co-primary outcome measures of HbA1c, BP and total cholesterol, rather than one 
primary outcome measure, were used to establish the most suitable outcome measure for 
a definitive study.  This is accepted by MRC guidance[48] and was also recommended by 
the approving ethics committee. 
2.6 Data collection – outcomes 
2.6.1 Patients 
2.6.1 1 Baseline patient data 
Questionnaire 
Both intervention and control patient participants were posted a copy of the baseline 
questionnaire, (Appendix G) with a covering letter and stamped addressed envelope.  
Experience from other studies showed that the questionnaires should take 20 minutes to 
complete. 
The questionnaire was compiled from the following validated questionnaires: 
• EQ5D health questionnaire (Euroqol)[89]. 
• SIMS – satisfaction with information about medicines[91]. 
• MARS – medication adherence report scale[99]. 
• BMQ – beliefs about medicines questionnaire[93]. 
• DTSQ – diabetes treatment satisfaction questionnaire[100]. 
A further non-validated question asked whether the participant used a medicine 
compliance aid. 
Questionnaire analysis: 
The sum of the seventeen SIMS[91] question responses produced a total score, with a 
score of one allocated if the patient rated the question ‘about right’ or ‘none needed’ or 
zero if the patient rated the question ‘too much’, ‘too little’ or ‘none received’  Sub-scale 
analysis was undertaken by generating a sum for the ‘actions and uses’ of medicines, or 
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‘potential problems’ of medication questions.  In each case high scores indicated greater 
satisfaction with the amount of medicine information received.  Comparison of intervention 
and control group data post intervention was undertaken for ‘total’, ‘action and uses’ and 
‘problems’. 
For the five items of MARS[99] the score for each question which ranged from one to five 
was summed, with a maximum of 25.  High scores indicated higher adherence to 
prescribed medication. 
Use of medicine compliance aids was answered ‘yes’ or ‘no’ to give an indication of 
support obtained with taking medicines. 
BMQ[91 93] questions 30-40 in the patient questionnaire, with each question scored one 
to five.  The sum of the questions 31, 33, 35, 37 and 38 in the questionnaire produced a 
score of maximum twenty five where higher scores indicated high concern about potential 
adverse effects of prescribed medicines.  The sum of the questions 30, 32, 34, 36 and 39 
in the questionnaire produced a score of maximum twenty five where higher scores 
indicated strong belief in necessity and efficacy of prescribed medicines.  
DTSQ[88 100] questions 41- 49 in the patient questionnaire with each question scored 
one to six.  The sum of the questions 41 and 44-48 in the questionnaire produced a score 
of maximum of 36 where higher scores indicated greater satisfaction with each aspect of 
treatment for diabetes.  DTSQ[88]Questions 42 and 43 in the questionnaire related to 
perceived frequency of hyperglycaemia and hypoglycaemia respectively with a score of 
zero to six for each.  Low scores indicated blood glucose levels closer to the ideal whilst 
higher scores indicated problems. 
Demographics 
Patients’ age and gender was obtained from their medical records to enable comparison 
of control and intervention groups at baseline. 
Follow up questionnaire for patients 
Both intervention and control patient participants were posted a copy of the follow-up 
questionnaire (Appendix D3) with a covering letter and stamped addressed envelope. 
This questionnaire was identical to the baseline questionnaire apart from containing 
additional questions to identify frequency of contacts with pharmacists.  Analysis followed 
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the same methods as at baseline, with the additional questions analysed by Mann-
Whitney U.  
The latest result after six months from the medication review for HbA1C, BP and serum 
cholesterol for each patient were obtained from the patients’ medical records.  Where BP, 
cholesterol and HbA1c had not been measured, medical practices were requested to 
undertake the test.  Patients had given written consent for this, and a fee for these tests 
had been agreed with the practices.  In cases where the medical practice had still not 
undertaken measurements one year after the student-led medication review, the result 
was marked as unavailable, as analysis would have been inaccurate due to the length of 
time following recruitment. 
Clinical data 
Clinical results for both intervention and control patient participants were collected from 
the medical records of each patient. 
Baseline data was collected post-intervention, for logistical reasons, with the most recent 
results for HbA1c, BP and total cholesterol recorded prior to the intervention collected. 
Post intervention data was collected at the same time with the most recent results after six 
months post-intervention taken.  Where results were not recorded, the medical records of 
those patients were searched at a later date for the first result.  If a result was not 
available for one year after the intervention, no result was recorded, as beyond that date it 
would have no clinical relevance to the study due to other confounding factors.  Control 
patients had no intervention and in order to decide on a suitable start point for the six 
months, discussions were undertaken with a researcher in the Norwich School of 
Medicine who was undertaking supervision with this study.  It was agreed that data would 
be collected at a point six months from the mid-point between the first and last medication 
review at each medical practice.  Where data was not collected, medical practices were 
requested to invite the patient to attend and have a blood test (ethics approval and patient 
consent obtained Appendix D).  These tests were funded (time to make appointments and 
take blood plus the cost of the blood test) within the study and formed part of the 
agreement with medical practices. 
When data was collected, it was established that data relating to LDL cholesterol in serum 
was not available for all patients.  It was, therefore decided that total cholesterol would be 
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collected as the results would enable comparison between groups, whereas LDL 
cholesterol would present problems due to missing data. 
2.6.2 Student and patient opinions 
Post level 3 medication review questionnaire 
Immediately post medication review both the student and the patient were asked to 
complete the questionnaire described in section 2.5.2.7 (Appendix G).  Pens were 
provided and physical separation was ensured, with the patient assured that the results 
would be used for study analysis and not to judge the student. 
No pressure was made to ensure completion of the survey as that may have affected 
results. 
All statements were rated using a five point likert scale, with five = fully agree. 
Statements for both patients and students were: 
• The student was well organised.  
• The student had a very professional attitude. 
• The student communicated well. 
• The student showed good confidence 
• The student was an appropriate person to review my medicines. 
• I learnt something useful about my medicines. 
• The review of my medicines was interesting. 
• The review of my medicines was important for my health. 
• I would recommend this medication review to other people. 
Students were also asked to rate an additional statement: 
• I was comfortable with the level of knowledge that I had to carry out this review. 
2.6.3 Students 
On-line survey of students’ opinions of the training programme. 
All students commencing training for the study (n=47) were asked to complete two on-line 
surveys with requests sent by emails with each including a link to a survey with a request 
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to complete.  These two surveys sent at approximately two week intervals.  Students 
(n=15) leaving the study at any point were included as their views may show reasons for 
their action. 
The surveys consisted of a mixture of questions, using 5-point Likert scales, which related 
to various aspects of the training were used.  The use of free text in some sections was 
expected to elicit true feelings that may not be expressed in answer to other questions.  
Free text answers were subjected to simple content analysis. 
Survey one sought the views of the students about the role-play session in which students 
undertook medication reviews with actors as patients (Appendix G). 
A reminder regarding each survey was sent after two weeks. 
Questions rated on a five point likert scale were used to ascertain student opinions on: 
1. Timeliness and adequacy of preparation information. 
2. The suitability and appropriateness of the location. 
3. The use of actors as a learning tool. 
4. The quality of the feedback provided. 
5. The time allocated to different elements of the session. 
6. The overall experience in particular with respect to personal feelings. 
Survey two sought the views of the students about the whole course, which included 
preparative training, undertaking level 2 medication reviews at medical practices and 
undertaking level 3 medication reviews with patients at medical practices (Appendix G). 
Questions were included about the preparative training to assess its effectiveness and 
sought their opinions on: 
• Its effectiveness with respect to developing communication skills. 
• Additional skills developed. 
• The most and least rewarding aspects of the experience. 
• How their feelings have changed during the process. 
• Whether they would recommend this programme to another student. 
• What changes could improve the process. 
• The individual elements of the training. 
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Respondents were anonymous in order to gain the maximum response possible and 
unbiased answers.  Therefore, results could not be distinguished between those students 
who continued and those who discontinued. 
A reminder to complete each survey was sent by email after 2 weeks. 
Interventions or care issues identified by students 
During both level 2 and level 3 medication reviews students utilised a care plan.  The 
content and structure was devised by the researcher using the principles detailed in 
Pharmaceutical Care Practice[35] and an electronic pharmaceutical care plan obtained 
from Assurance System.  The care plan was devised to be utilised electronically with 
drop-down boxes for ease of use. 
Sections included are displayed in Table 2.1 (section 2.7.4.3) with a copy of the care plan 
included in Appendix G. 
Students completed the care plan during the level 2 medication review, with 
recommendations or planned actions recorded in the relevant section.  This plan was 
updated at the level 3 medication review. 
Recommendations and planned actions recorded by students represented the data 
collected, as they each represented a care issue.  Forms were collected from students 
after each medication review. 
Students’ academic attainment 
During the literature review it was identified that a criticism of some studies was that only 
the highest academically achieving students would have volunteered.  However, no 
information was available of effect on overall academic attainment in literature reviewed.  
Therefore, a request was made to UEA ethics committee (Appendix D5) to collect the 
academic results obtained by all final year pharmacy students at the end of their third year 
(at the point of recruitment) and at the end of their fourth year (post intervention).  The 
rationale for using the data of all the students in the year was that volunteers would 
represent intervention and non-volunteers would represent control.  This request was 
approved by the ethics committee.  Student names were anonymised to the researcher. 
These were collected at the same time, after the final year examination results were 
announced.  The rationale was that data could all be requested from administrative staff 
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as one set of data.  Earlier collection could possibly have produced bias with respect to 
teaching within the curriculum or of study results.  This was unlikely but was avoided. 
Results requested included mean of exam results for year 3 and year 4 for both 
intervention (students participating in the study) and control (students not participating in 
the study).  In addition, Objective Structured Clinical Evaluation (OSCE) results for year 4 
were requested for the same groups. 
OSCE stations, which assessed communication skills and which are, therefore part of the 
results shown include:- 
• medication history taking, 
• responding to symptoms, 
• medicines information query taking, 
• counselling. 
(Appendix G - Objective Structured Clinical Evaluation marking forms OSCE). 
Results were recorded as pass, distinction or fail.  A pass required at least 70% within 
both skills and detail sections with no ‘essential’ items missed.  If, in addition, the student 
attained over 90% in a section with no ‘essential’ items missed they attained a distinction.  
An OSCE station is recorded as a fail if the student fails any element of the OSCE 
deemed to be essential by academic staff, even if a distinction is achieved in any other 
element. 
2.7 Review Focus Groups and Semi structured interviews 
Repeat focus groups and semi structured interviews were undertaken at the end of the 
study using the same methods as during the development phase.  These occurred with 
four groups representing the stakeholders in the study: 
• intervention patients who had received a medication review, 
• members of the GP practices involved in the study, 
• students who had participated in the study and met a patient at medication review, 
• PCT pharmacists who had participated and provided supervision for students 
during MR. 
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Moderation of the students’ focus group was undertaken by two independent people (PhD 
students with experience of this function) who were unknown to the students.  This was to 
ensure that no bias resulted from the researcher undertaking the focus group as he was 
well known to the students. 
Recruitment was identical to the previous focus groups with invitation letter, consent form 
and stamped addressed envelope being posted to the individuals (Appendix D3). 
2.7.1 Questions 
Questions (Appendix H) were developed from information arising during the intervention in 
order to identify:  
• intervention benefits, 
• intervention problems, 
• acceptability of the training method (relevant to students only), 
• changes if the research was repeated. 
Sessions were managed identically to those conducted in the development phase.  Tapes 
were transcribed and thematic analysis undertaken to identify issues for possible follow-on 
studies or publication. 
2.8 Data Analysis 
2.8.1 Development and Review Stage Focus Groups and Semi structured 
interviews. 
All interviews were recorded on an Olympus VN 510, transcribed verbatim by one 
secretary and then analysed for themes and categories by the researcher. 
To provide structure, analysis followed the general principles proposed by Pope, Ziebland 
and Mays[101] as five stages of data analysis in the framework approach.   
Initially this consisted of familiarisation, or ‘immersion in the raw data’ by searching for 
themes[102] related to the research question.  As Krueger states “the research plan 
guides the analysis but is not carved in stone”[103] but must be practical and appropriate 
for the situation.  The level of analysis was guided by researcher expectations, which in 
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this case was improvement of the research protocol.  To achieve this, the recording was 
listened to once without making notes and then once more whilst checking the accuracy of 
the transcript.  The transcript was then read by the researcher a number of times to 
ensure true familiarity or immersion in the data.  Information was identified and relevant 
phrases or words marked up; what Ryan calls initial pawing and marking of text[102].  Re-
reading the transcript a number of times enabled key ideas and recurrent themes to be 
identified[102].  Ryan[102] notes that the more the same concept appears in the text, the 
more likely it is a theme and also states that “the terms theme and expression more 
naturally connote the fundamental concepts we are trying to describe”; which in this case 
are issues relating to the study. 
A thematic framework was then identified, with NVivo 10 software used to facilitate and 
record this.  To achieve this, questions posed at the meetings and the aims and objectives 
of the research were explored.  Issues raised by participants were noted.  At the end of 
this stage a detailed index of the data, labelled into manageable chunks was achieved.  
NVivo enabled themes to be merged or deleted, when in some cases it became apparent 
that the initial designation of a theme was inappropriate.  A theme was designated as 
significant after deciding if it had an impact on study design or to participants.  It is 
possible to be too close to data, therefore, a space of a few days was left, before 
reanalysing, to identify major themes[103].  These generally resulted, naturally, from an 
accumulation of evidence, words or phrases. 
An additional stage was implemented when an Excel spreadsheet was compiled to enable 
comparison of themes identified between each stakeholder group.  This may be said to be 
a form of thematic framework.  Following checking of this spreadsheet, a number of 
themes were renamed or changed when it became apparent that different descriptors had 
been utilised for the same, or similar, themes in different interview/focus groups.  The 
spreadsheet was also used to identify missing data within stakeholder groups, with an 
example being the issue of confidentiality which was not discussed by nurses during 
interviews.  The structure of the spreadsheet facilitated the researcher in ensuring that he 
was not simply finding what he was looking for[102].  Issues of missing data required 
considerable deliberation to ensure that they were truly missing.  Ryan[102] points out that 
searching for missing data will produce the least number of new themes and deciding 
when participants are unwilling to discuss an issue or when they assume the researcher 
already knows about the topic requires a lot of familiarity with the subject”[102].  In 
addition to identification of themes, unusual and unique quotes, often referred to as 
deviant quotes, were identified as they are potentially important[50 103]. 
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Indexing[101] did not totally follow the five stage analysis framework , as numerical codes 
were not assigned to the thematic framework. 
Charting[101] followed, with sample text assigned to themes, or sub-themes.  However, 
the principles of Pope, Ziebland and Mays[101] were not followed, as distilled summaries 
of views and experiences were not abstracted and synthesised.  Instead, cutting and 
sorting, as recommended by Ryan[102] was employed, which he terms the most versatile 
technique. 
Finally, interpretation was undertaken by reading the sample texts and checking the 
association with themes and interpretation.  The prime aim was to identify issues 
applicable to the study design. 
Review of the data by participants in the focus groups has been suggested as a method to 
provide greater meaning of data during analysis[102 103], however, this was not possible 
because of time constraints. 
There was no independent analysis of the data, which may also have provided greater 
insight into meanings and a check for bias, however, a suitably trained colleague was not 
available. 
Development and Review stage focus groups were analysed identically. 
2.8.2 Statistical analysis 
SPSS version 16 was used for all statistical analysis. 
Independent samples t test (or paired t test if comparing before and after results) were 
used for parametric data and Mann Whitney-U for ordinal or non-parametric data.  
Fisher’s exact was used for comparing dichotomous data.  All tests were performed on 
data provided post-intervention. 
2.8.3 Patient Questionnaire Responses 
2.8.4 Student Measures 
2.8.4.1 Students’ academic attainment 
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The mean overall academic attainment at baseline, which was the examination score at 
the end of the 3rd year and post-intervention which was the final examination score, for 
control and intervention students’ was compared using independent t test. 
The mean OSCE score for control and intervention students’ OSCEs at the final 
examination was compared using Mann-Whitney test. 
As each student left the study, the mean of final year exam results of the remaining group 
of students was calculated, using comparison of mean using independent t test. 
2.8.4.2 Student Training 
An on-line survey tool utilising Likert scale questions and free text boxes was used to 
ascertain student opinions of the preparative training course and medication reviews 
(student assessment) within which the following topics were covered: 
• preparative training course, including podcasts and three workshops 
• role-play training session, including preparation, location, use of actors, feedback 
and the effect of stress, 
• free text comments with the on-line survey relating to the preparative training 
course. 
Simple content analysis was undertaken of free text responses to identify issues. 
Presentation of percentage results of each answer option, with charts produced in excel, 
2.8.4.3 Student consultation (medication review) performance 
Results for the MRCF were used to evaluate the students’ first and second consultations 
with a patient.  Comparison of the mean score was undertaken (first v second medication 
review) using paired t test for each activity score, in addition to the mean of overall 
summed score (first v second medication review). 
Post-medication review questionnaires were completed by both the student and the 
patient after the medication review.  Comparison of mean was calculated using 
independent t test. 
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Care plan issues identified and recorded by students during level 2 and level 3 medication 
reviews undertaken for intervention patients were assessed and counted.  Identification 
was undertaken of numbers of: 
• level 2 and 3 care plan issues, 
• level 2 and 3 issues by approval category,  
• level 2 and 3 issues assessed against criteria stated in the care plan. 
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A full record of interventions identified and recorded by students on care plans devised for 
use within the study are available in Appendix G.  Analysis of these was undertaken by 
grouping into intervention type.  These were pragmatically identified as the individual 
sections within the care plan and are displayed in Table 2.1.  Intervention types were not 
validated, therefore, identify a weakness in the analysis.  Published versions were 
identified by literature search but it was decided that maintaining the same decision-
making criteria as used by the students would be effective. 
1. Allergy status (including side effects). 
2. Special needs including mobility, dexterity, swallowing, hearing, sight, 
literacy/reading. 
3. Compliance aids used or needed. 
4. Lifestyle-obtaining information includes alcohol, smoking, exercise, diet 
(general), diet special, eg vegetarian, lactose free. 
5. Medical history. 
6. Medication history. 
7. General compliance issues. 
8. Over the counter medicines, herbal preparations or homeopathic. 
9. Issues related to use of a pharmacy. 
10. Monitoring. 
11. Specific patient advice recommended for use at level 3 medication review. 
12. Questions to ask the patient at level 3 not stated elsewhere. 
13. Patient education about medicines. 
14. Patient education about disease or lifestyle. 
15. Other issues.  
 
Table 2.1 Descriptions of interventions displayed in Figures 5.1 and 5.2 
  
86 
 
2.9 Sample size calculation 
Utilising clinical data collected at baseline and post-intervention for control and 
intervention patients, a sample size calculation was undertaken to identify the number of 
patients required in each group to enable the identification of an effect from a definitive 
study.  Primary outcome measures of HbA1c, BP and total cholesterol were used 
separately to calculate a sample size, with subsequent choice of outcome based on 
clinical relevance, likelihood of achieving a target within an outcome and the practicality of 
recruitment of numbers required. 
The mean difference displayed between intervention and control means for each primary 
outcome measure, and the standard error (SE) of mean difference were calculated by 
independent t test. 
The Standard deviation (SD) of difference in mean was calculated using the formula: 
SD	of	difference	in	mean = SE	of	difference	in	mean
 . + 
 
A = no. of patient results for control group and B= no. of results for intervention group. 
Sample size was calculated by using the formula: 
  	 = 	 × 2	 ×	 "#$# 
Where x = a factor taken from tables provided by  Campbell and Machin representing 5% 
significance and 80% power  
 = 7.849 
Ref Campbell and Machin[104] 
2.10 Health economics 
Health economics data was analysed by the health economist funded within the study 
grant.  This data included EQ5D, medicines use and costs, use of health resources and 
cost of providing the preparative training of students and the cost of providing the 
intervention. 
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Data was collected as part of this study for logistical reasons, but does not form part of 
this thesis and is reported elsewhere. 
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Chapter 3 Development Stage Focus Groups and Semi Structured 
Interviews 
3.0  Introduction 
In Chapter 1 it was recognised that there is limited evidence of effectiveness and cost-
effectiveness for medication review by pharmacists in the community in the UK.  Aspects 
of study design, including the choice of outcome measures, were demonstrated as 
contributing to the failure to provide this evidence.  The MRC guidance on complex 
interventions[105] states that preparatory work in research is “often skimped”, with 
evaluations often undermined by problems of acceptability of the study to potential 
participants.  This leads to problems with recruitment and retention of participants, 
compliance with protocols and delivery of the intervention.  To develop this intervention it 
was, therefore, thought to be necessary to obtain the views of potential participants in the 
study, to enhance the original protocol.  Key areas to explore were acceptability and 
recruitment within the study, to ensure that recruitment met the target, whilst also 
maintaining retention of participants.  Issues identified, which were able to improve the 
intervention, would be incorporated into the study design, if appropriate. 
Bradburn et al.[106] recommended the use of focus groups to evaluate clinical trial 
protocols, whilst Kreuger[107] states that focus groups can be used at any stage of a 
study.  Kreuger warns that the small numbers of participants in focus groups limits their 
ability to generalise findings to a population.  Within this study participants in each focus 
group represented the characteristics or role of the proposed participants in the final study 
and, as far as possible, the proposed populations[106] to aid generalisation. 
Powell and Single[108] define a focus group as a group of individuals selected and 
assembled by researchers to discuss and comment on, from personal experience, the 
topic that is the subject of the research.  Morgan[109] states that focus groups are group 
interviews, in which a small group discusses questions raised by a moderator (or 
interviewer), whilst what the participants say forms the data.  He recommends the use of 
focus groups by professionals who may think differently to those of the people with whom 
they need to work, resulting in “a powerful means of exposing the sponsors to the reality 
of those they need to understand”.  In this study, the researcher needed to identify the 
views of potential participants in order to improve the protocol. 
Focus groups offer a quick, cost-effective and convenient method of obtaining the 
views[50 106] of participants (stakeholders) who could provide easily accessible, detailed 
90 
 
information to help improve the design of a study[106] in situations where the outcome 
cannot be predicted.  Additionally, focus groups potentially identify data which would not 
be identified via individual questionnaires or interviews[50 107 110].  Ethical approval was 
obtained for the focus groups. (Appendix D) 
3 1.1 Aim 
The aim of this element of the research was to identify the views of stakeholder groups 
representing the overall participants in the study through focus group interviews and 
through semi structured interviews.  
3.1 2 Objectives 
The objectives of this element of the research were to: 
• determine the perceived value of participation to inform the design of information 
leaflets, 
• identify changes required to improve the study, 
• identify processes likely to improve recruitment and retention of potential 
participants, 
• identify logistical issues which may be encountered by participants, 
• optimise training of participating students, 
• identify issues relating to the conduct of the student-led medication reviews, 
• confirm elements within the existing protocol where appropriate, 
3.2  Recruitment 
3.2.1  Medical Practitioners 
Recruitment of medical practitioners for focus groups yielded no response and contact 
with the medical practices confirmed that the reason for this was lack of time.  After 
discussion with medical practice staff it was agreed that practice nurses, specialising in 
diabetes, would be recruited as they provide much of the diabetes-related care for these 
patients and could, therefore, answer the questions required.  An ethical amendment was 
sought and approved (Appendix D) to enable this.  Six nurses were recruited from four 
practices (3, 1, 1, 1,), yet owing to pressure of work it proved impossible to agree a date 
and time for a focus group.  Therefore, for practical and pragmatic reasons, individual 
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semi structured interviews were undertaken at the medical practices, resulting in a 
meeting for three nurses at one practice followed by three individual interviews at further 
practices.  This approach potentially reduced the effectiveness of the focus group as a 
means of obtaining consensus views.  One practice was unable to provide any member of 
staff for interview or focus group attendance due to staff shortages.  Questions devised for 
the focus group were used throughout each interview. 
3.2.2  Primary Care Trust (PCT) Pharmacists 
Ten PCT pharmacists were recruited, with one unable to attend on the agreed date 
because of previous arrangements. 
3.2.3  Patients 
The researcher planned to recruit patients via Diabetes UK as this is an organisation 
providing support for diabetes research.  However, this proved unsuccessful because 
there was no local network in Norwich.  Recruitment via a local diabetes group also 
proved unsuccessful, as the majority of its members were already involved in other 
studies and unable to attend. 
Three people from a local diabetes support group were recruited in addition to three 
people comprising two staff and one friend of a member of staff, via an advertisement in 
the staff online newsletter at the UEA.  All had T2DM.  One person was unable to attend 
on the agreed date because of work commitments. 
3.2.4  Students 
Six final year pharmacy students were recruited after their final exam, with one unable to 
attend on the agreed date owing to sickness. 
3.4  Results 
The themes identified were: acceptability of the study to potential participants, suitability of 
pharmacists for this new role, patients need for information about medicines, study 
process (with sub themes of recruitment, location of and travel to medication reviews, 
consultation), training and the questionnaire. 
Acceptability 
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Strong agreement existed within all stakeholder groups that the overall project concept 
was a good idea. 
“I think it’s good because it’s an opportunity to see some patients which is 
something we don’t really get.” (student) 
“I think it’s a really good idea.  I think trying to get the students to get more 
involved...” (practice nurse) 
Recruitment of the required numbers of participants for the study was described by all 
groups of stakeholders as being no problem, with a desire to help students with their 
training as a possible reason. 
“Most patients here are quite good in donating their time to help with the students, 
they quite like it.” (nurse) 
Suitability of pharmacists for this new role 
Nurses said that the different approach of the pharmacist would provide complementary 
support to healthcare.  In addition to comments such as “a good idea”, patients expressed 
indirect support for pharmacists undertaking medicines reviews by discussing the relative 
knowledge of pharmacists, doctors and nurses with respect to medicines: 
“….a pharmacist would probably have more specific information on a drug regime 
than maybe a practice nurse or even a GP in some cases,  because GPs are 
covering a wide gamut of people.  If, for instance, the pharmacist I would imagine 
that he would be more in touch with the current medications, the side effects of 
medications and possibly long term effects with that type of thing.” (patient) 
Patient participants also gave opinions about gaps in the information provided to them by 
doctors and nurses, whilst saying that. 
“..it becomes harder and harder if you like for the GP to be on top of what is the 
best remedy for the patient given the other conditions they may have.” (patient) 
Patients’ need for information about medicines 
Statements displayed a perceived need for patients with long-term conditions to obtain 
information which may assist with self-management of their condition. 
“….so I think to have a good understanding, because I mean as a patient, I think 
it’s important that you’re at least offered, even if you don’t take on board, as much 
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education and understanding as you can about your condition which is going to 
help you to control that condition long term.” (patient) 
Patients also discussed a failure to fully resolve their own and other patients’ information 
needs by the current system, through the provision of patient information leaflets supplied 
with medicines, as these were not accompanied by verbal explanation. 
“Quite worrying if their GP doesn’t give them the advice which is on the paper, if 
you like.  I worry about, the GP’s busy.” (patient) 
“…the number of times I’ve been a given drug by the doctor which when you read - 
of course one carefully reads the little bit of paper that comes with it - and it says 
this is contraindicated to people with diabetes and you think why have they given it 
to us?” (patient) 
The sources, other than healthcare professionals, that are said to be used by patients to 
obtain information about their medicines included newspapers and support groups such 
as local diabetes groups. 
“I personally like as much information as I can,…you’ll often pick the paper up and 
read such and such a drug has been found to cause this, that or the other, ….. I 
found out at a meeting only a few weeks ago, which was one of the drugs that I 
was on, so I thought that’s interesting so I shall be having a chat when I go back 
for my review over this…” (patient) 
Within a medication review the patient would normally be educated about their medicines 
if they desire, with a particular emphasis on the risks or side effects.  Patients said that 
this information can be provided via a pharmacist if they display competence. 
“……so I mean if we find that the pharmacists are more in touch with the 
medication regimes and that - I think and the patient can be educated in either the 
side effects or the risks involved in taking that particular medication, then I think it 
gives you a more informed choice.” (patient) 
Whilst endorsing the need for pharmacists to be more involved with patient education 
about medicines, one patient said that there may not be time available to do this as, in 
spite of supporting pharmacists’ skills, they see this role as new. 
 “But the question is I mean okay pharmacists will get training as part of their 
courses, will they then have time to actually interact with patients, I mean will the 
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system provide that flexibility if you like, that time, to do the job that they’ve been 
trained to do - or the additional job.” (patient) 
Process 
Recruitment 
Patients and students made numerous suggestions for changes to recruitment 
documentation to encourage participation.  Both groups recommended “less dense” 
documentation, with an initial précis to explain the project, within which the importance of 
the potential participants to the study must be stated. 
“If you want somebody to participate, first of all you’ve got to get their attention; so 
your initial letter in effect sort of highlights what the thing is about and then let them 
have the information at a simple level and then still provide more information at a 
slightly higher level as they require it.” (patient) 
Views were expressed by patient participants that a potential participant should be 
encouraged to participate by the use of positive statements which also enhance their 
feelings of personal importance.  Statements like this which are intended to enhance 
patient recruitment could be interpreted as further patient support for the study. 
“Saying how much you appreciate their help, and you know you’ve got to make 
them feel like you can’t do it without them if you know what I mean and that 
particular respect in just a few words you know that they’re partaking in a study 
which is going to benefit not only their self but the whole of the diabetic community 
long-term, but if you give people a bit of sense of self-importance as I said it’s the 
whole traffic warden’s hat sort of thing then they’re more likely to take, certainly 
looking at the marketing thing, but that can help them sort of draw them in and they 
may take the trouble to read it.” (patient) 
Patients stated that the documentation within the patient information leaflet should say 
that the study would not result in the loss of a current service.  
“You might get some people who may think that it’s some devious way of taking 
their treatment away from their GP.” (patient) 
Other recruitment documentation issues raised by patients related to comprehension of 
the wording in the patient information leaflet.  Recommendations included the use of a 
glossary, a reduction in the use of abbreviations and proof-reading to ensure readability. 
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“Did you include a glossary of terms?  That would be quite useful, you know…” 
(patient) 
 “The invitation to patients I thought was pretty good, except my bug bear is things 
that are abbreviated..” (patient) 
“…once you’ve got a package ready, you know say like a dummy package which is 
going out to a patient, you sit and read it, you personally…” (patient) 
A firm dislike of the terms ‘control’ and ‘intervention’ within documentation was stated, 
which was further supported by one patient participant displaying a misinterpretation of 
the terms during discussions.  It was recommended that control and intervention should 
be replaced by terms which simply describe the role undertaken by a patient within a 
study. 
“Intervention is not a very good word. I think assessment or something…” (patient) 
Patient participants recommended that the importance of the role of patient controls in 
studies should be stressed in order to promote both recruitment and retention of patients. 
“I think they need to have a good understanding, the fact that their role in the study 
is just as important as the other, that’s got to be very much emphasised.” (patient) 
Process 
Location of and travel to medication review. 
The topic of the medication review between the student and the patient generated 
considerable discussion within each stakeholder group, with strong opinions expressed 
about the proposed location of the medication review.  All stakeholder groups agreed that 
this should take place at the medical practice at which each patient participant was 
registered.  Reasons for this decision were generally that it was more convenient for the 
patient, but also that the patient would feel more relaxed as they know the location, rather 
than the UEA which they do not know, where they may get lost and also find intimidating.  
The students observed that the medical practice would provide more realistic experiential 
training. 
“They’re familiar with it, I mean to come up to a place like this (UEA) in some 
people it would be a little bit intimidating, if you know what I mean, it’s like you’re 
going to go on the slab in Dr Frankenstein or you could get lost like we did, so I 
think they’d feel under less pressure and they wouldn’t have all the rigmarole of 
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coming up to find the place, you’ve got to find them, and they’ll just go to the 
surgery, they’ll know where to park, they’ll know who to ask for and they’ll have a 
little room that they can go in and do what they normally do really.  So they’re 
doing exactly what they do, the only thing that’s different is the student.” (patient) 
 “I just feel like why?  Why should they have to come here (to the UEA)? (student) 
“That could be good for us as well because we’re then going even more into a real 
life situation if we’re going to be going back to the surgery where the patient’s more 
comfortable they’re probably, therefore, more likely to tell you honestly stuff and 
act more like they would in a proper consultation, whilst if they come here, they 
might feel more out of place and less likely to open up.” (student) 
Students expressed strongly held and unexpected opinions about travel to medical 
practices, which were influenced by their previous experience during undergraduate 
training.  They reported that travel to medical practices can be very long, particularly in a 
rural area like Norfolk.  In addition to travel to the medical practices, they voiced concerns 
about arriving there in case they were not expected.  It was said that groups of students 
arriving together may provide mutual support, thus relieving worry. 
“…when you got group transport you were a little bit less worried about it as well 
because you’re all going, you’re all going at the same time, you’ll all talk to the 
same person whilst we had GPs where three or four of us would go to the place, 
but they wouldn’t put any transport on for all of us so you’d go each separately, 
you’d then arrive all separately and then you’d stand there and someone would go 
to you oh is so and so coming and you’re like I don’t know if they’re coming or and 
it’s quite an awkward introduction plus if you’re just there, you arrive there and you 
start off it’s quite a nice way, it’s a comforting way to start something which is 
unfamiliar if that makes sense (student).” 
Process 
Consultation (medication review) 
Patients said that the consultation should be about the patient and that during a 
consultation students should appear confident and competent. 
“But if they come through as being very timid and not sure of their grounds then 
yes it could upset a few people.” (patient) 
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Safety was raised by all stakeholder groups, other than the students. Supervision by a 
trained pharmacist was perceived as essential, in order to ensure that the students did not 
provide incorrect advice to patients during a medication review. 
A protocol, care plan or script to guide students during the medication review was said to 
be essential by all groups other than students.  The students had not experienced a 
medication review with a patient and perhaps did not understand the issues. 
“I think it (a protocol) would clarify it for the students that would give them the 
limitations of where they should not step out of, the parameters would be actually 
marked out for them.” (patient) 
“They’ve got to look at the care plan for the patient coming in before the patient 
comes in...” (pharmacist) 
Access of medical records by the students was discussed by both nurses and 
pharmacists.  They said that students should be instructed to read the patients’ medical 
records to establish what actions or recommendations have already been made by 
healthcare professionals.  Some nurses expressed strong views based on previous 
problems when student nurses had not referred to medical records.  This had resulted in 
the student providing advice to patients which contradicted with that provided by qualified 
staff and, therefore, undermined the patient’s confidence in their treatment.  Nurses in 
addition stated that training must prepare students to be aware of the consequences of 
their statements. 
“Well, she (student nurse) shouldn’t have said that, she hadn’t read the notes, she 
hadn’t seen the list of dressings he’d had previously, as a student she had no right 
to do that over an experienced nurse and she wasn’t in the good books, she found 
out when that patient had gone……” (nurse) 
Strongly held views were voiced by practice nurses about another medical records issue: 
students must access patients’ records to gain an understanding of the rationale for 
previous decisions.  This was to ensure that any advice offered to patients did not simply 
follow guidelines, as previous decisions by nurses or doctors may have followed a 
different course, for valid reasons. 
“…if you find your patient, being an individual, is not going to suit that particular 
one then you try a different drug, so it’s okay having the students coming in to say 
well you should go in there, step one, step two, step three, step four and then they 
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suddenly find we’ve gone a different way and there’s a different thinking behind it 
as to why we’ve gone that way…“ (nurse) 
Practice nurses expressed concern about pharmacy students’ ability to interpret patients’ 
medical records, particularly in relation to the interpretation of missing data.  Not all 
actions undertaken by a healthcare professional are recorded which could result in 
students contradicting recommendations made by nurses to patients.  The solution 
proposed was for pharmacy students to access medical records under the supervision of 
a qualified pharmacist, as previously planned. 
“….unless we’ve actually documented every single thing, because we normally 
know why we’ve done something, we can read between the lines, but you know if 
you’ve got students coming in that don’t know these patients and aren’t used to 
these treatment plans then they just may find they’re in deep, deep water as to 
wondering why.  And the other thing I’m worried about, in fact they say oh well you 
shouldn’t be on that, you should be on this and that is another worry...”(practice 1 
nurse) 
“Read the notes.”  (practice 1 nurse) 
Following the theme of medical records, both practice nurses and PCT pharmacists stated 
that students should refresh their information immediately prior to the medication review 
by accessing the medical records.  Both these groups are experienced in undertaking 
patient consultations including medication review, and, therefore, should know the value 
of last minute checks, which may explain these comments.  In addition pharmacists 
recommended that the students should access records during consultations. 
“It would be good for them to look at the computer record just before, or in the five 
minutes before they saw them just to check whether there had been any 
consultations since they looked at the record last.” (pharmacist) 
“It would be good if they could access records while…they’re talking to the patient.” 
(pharmacist) 
All stakeholder groups, other than nurses, expressed concerns regarding confidentiality 
and wanted safeguards, such as student contracts which contain a requirement for 
confidentiality.  A PCT pharmacist, though, noted that ‘fitness to practice’ guidance, which 
is imposed by the regulatory authority, already covers this situation for students. 
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“...they know what confidential means and it’s drilling it into to them what will 
happen to them, because there’s fitness to practice, isn’t there?” (PCT pharmacist) 
Students expressed concern that patient records transferred to laptops should be securely 
transported and stored. 
Practice nurses did not raise the issue of confidentiality, and whilst it is impossible to know 
why, it may be because of their regular experience with medical and nursing students 
which means that they no longer see this as a problem, or simply that they focussed on 
activities within their sphere of work, i.e. the medical practice. 
Practice nurses and PCT pharmacists raised the matter of care issues identified by 
students and information provided by them to patients during medication review.  They 
said that these should be recorded in the patient’s medical record, by a pharmacist for 
safety and logistical reasons. 
“It’s always nice to know what somebody else has said, you know because one 
we’re responsible for a treatment plan of any kind…” (practice nurse) 
“….and somebody’s advised them something differently and we don’t know 
anything about it.” (practice nurse) 
Recommendations made by practice nurses about the style and content of medication 
review conducted by students included: 
• being polite and using Mr. and Mrs. until told that the patient is willing to be called 
by their first name, 
• listening to patients, 
• taking care with statements if patients are or have been shown to be intolerant of 
recommendations, 
• ensuring recognition of side effects, 
• inclusion of patient beliefs which also implies being able to recognise those beliefs, 
• lifestyle advice must be included.  This last issue was stated in strong terms as it 
was obviously a major issue. 
“I think it’s (lifestyle) important that anybody who is in contact with people with type 
2 diabetes, I think they do need, you know, need to go through it, it’s so important I 
mean we know that it’s the mainstay of the care really, they need to be looking 
after their health and I think any opportunity to promote that needs to be taken, 
doesn’t it?” (nurse) 
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Varying views were expressed regarding the duration of the medication review, although 
there was general agreement that at least 15 minutes should be allowed.  Patients in 
particular differed, with some suggestions of unlimited time, whilst others stated that a 
time limit would focus the student on relevant issues.  They appeared to base opinions on 
consultations with their GP which are time limited and result, according to some patients, 
in unresolved issues.  Practical solutions were recommended which included an open-
ended medication review which the supervisor could terminate if the student was not 
progressing. 
“…will it be like ten minutes, twenty minutes and then you’re out?” (patient) 
“…as long as is reasonable I suppose, but if it’s twenty minutes and you’re out and 
someone’s got things they still want talk about.” (patient) 
“…if you give them twenty minutes or half an hour even and if you see after fifteen 
minutes you conclude the student has completed all the information that they need 
to do so and all it’s going to be is fifteen minutes of waffle you could say oh well I 
think you’ve done very well there and we can bring the interview to an end.” 
(patient) 
PCT pharmacists did not suggest durations for medication review but recognised that they 
should be ‘longer’ than usual consultations with GPs or practice nurses, due to complexity 
of patient issues. 
“Students are going to face complicated patients, sometimes I know we run away 
from the really complicated ones...”(pharmacist) 
“You just need more time.” (pharmacist) 
Students by contrast did not specify a time duration for medication review, possibly due to 
their lack of experience, or they may not have thought about the face-to-face time with 
patients.  Practice nurses did not state an opinion about the duration of the medication 
review. 
Training 
Need 
Evidence of the need for pharmacists to improve communications skills was expressed by 
practice nurses and patients.  They said that there was uncertainty about the current 
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medicines use reviews (MUR).  An MUR is a meeting between a patient and a pharmacist 
to explore medication issues but in less depth than a medication review.  The uncertainty 
appears to be because pharmacists had not communicated the aims of an MUR to 
patients and nurses, or explained why they were undertaken by pharmacists.  There were 
indications of possible patient concerns about the overlap of roles with GPs, with these 
concerns potentially resolved if the pharmacists had explained the MUR to the patient. 
“…they don’t quite understand why they’re (pharmacists) getting involved, that 
seems to be, you know why did the pharmacist want to talk to me because my 
doctor’s put me on this and they can’t, there seems to be a bit of gap.” (patient) 
Training 
Preparative training course 
Patient participants questioned the preparative training planned for the students prior to 
undertaking a medication review with a real patient. 
“How much training will they have had to consult with actual patients?” (patient) 
Further comments were made, in the form of questions, by patients in relation to 
preparative training, with one appearing to suggest that students should experience role-
play before the patient medication review.  Another patient developed this theme further 
by suggesting that group feedback during such a session would enhance students’ 
learning. 
“Would they do a dry run before they actually get on to a real patient?” (patient) 
“…so they’re doing dry runs is there going to be a formal feedback within the group 
so that they can all experience what they’ve found, what the person felt, etc..” 
(patient) 
Practice nurses were supportive of the proposed preparative training, with a suggestion of 
ensuring that compliance issues and negotiation skills were included. 
Patients and pharmacists agreed that we should ensure that students acknowledge gaps 
in their knowledge when undertaking a consultation.  The inference is that this should be 
included in the preparative training. 
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“…it would be much better for them to honestly say to the patient you know I’m 
afraid I don’t really know the answer to that at the moment, but I will find out for 
you and let you know or get back to you.” (pharmacist) 
Pharmacists made other recommendations including that conditions other than diabetes 
should be included in the preparative training of students.  This was to enable discussion 
about those conditions during a medication review, because people with diabetes 
frequently have other conditions.  One pharmacist also suggested that the use of insulin 
devices should be taught to the students.  Pharmacists agreed that student participants 
should feedback to a GP after a medication review, as exposure to this activity would 
improve their confidence when meeting GPs in the future. 
Level 2 medication reviews, when students would access the medical record of participant 
patients at the medical practice, was supported with practice nurses stating that it was 
practical and achievable.  Pharmacists also noted that undertaking level 2 medication 
reviews would be good training for students  
Students discussed at length the time that they would be required to spend if they took 
part in the training, and came to the conclusion that the amount stated in the information 
leaflet was appropriate and acceptable to them. 
Feedback was an issue raised by all stakeholder groups but with a different emphasis.  All 
agreed that feedback to students after training would be beneficial as it would enhance 
the training.  Students debated the relative merits of group feedback versus individual 
feedback, with some saying that they found individual feedback to be uncomfortable in 
some situations.  
“I think individual feedback is better for reflection but group feedback helps 
everyone then.” (student) 
Students agreed that feedback to them would be beneficial after preparative training, 
including role-play sessions, and that they would be willing to receive feedback from 
patients after medication review in order to enhance learning. 
“…having a patient say that really makes you think about what the way you come 
across to people, and I think that’s probably quite good as long as it was positive.” 
(student) 
Students and PCT pharmacists said that the supervising pharmacist should check 
recommendations to GPs made by students following medication reviews with patients, to 
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ensure accuracy and correctness.  Both practice nurses and PCT pharmacists agreed that 
feedback to a GP or nurse of recommendations resulting from the medication review 
would provide training opportunities for the students, whilst nurses also wanted the 
feedback in order to know what had happened during the medication review. 
“And they’ll feedback to us and it’ll be interesting to know what the students said so 
that we can either back-up what the student has said or you know say actually well 
we’re going to carry on with our previous plan, this is it, so it would be interesting 
just to have a knowledge of what they’re saying.” (nurse) 
One patient raised feedback to patients as an issue in the form of a question by asking: 
“Would it be beneficial to give a feedback sheet to the patient which the student 
could then keep as a record, as a reference, to his documentation.  …...the 
patient’s actually got something to go home with..” (patient) 
The patient expanded the idea with the view that the patient would then have 
documentation of recommendations to take away and that this would also provide 
evidence to the GP. 
“That way if the GP starts complaining about what’s going on, you’ve actually got 
proof as well, you’ve got an audit trail basically of what actually went on in that 
particular consultation.” (patient) 
Nurses expressed the opinion that if pharmacy students were trained in the method 
proposed in the study, they should endeavour to become more integrated into the team 
with doctors and nurses when they qualify.  This resulted from recognition that patients 
and healthcare professionals expect pharmacists to act independently.  
“   when you’re talking about an older group of people they are very used to 
dealing with nurses and more used to dealing with doctors even when it comes to 
medication reviews so it’s just a cultural, you know, shift to include, and also even 
with nurses and doctors we don’t work that closely with pharmacists generally so it 
would be, it needs to be more of a team.” (nurse) 
A nurse expressed concern about the security of her own role if pharmacists take on 
medication reviews with patients, yet also displayed support for the need for the role. 
“I think that that’s a concern because I think everyone’s worried about their job and 
somebody else taking over their job, but I think it’s complementary to what we do 
and I think it is, it’s another place for people to visit as well, isn’t it?  We’re trying to 
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make healthcare etc accessible to people so going down to their dispensary and 
talking to their local pharmacist about the drugs that he dispenses or she 
dispenses to them all the time, no I think it’s complementary and it’s all for the 
patient benefit to be honest.” (practice nurse) 
Further comments by participating patients supported the development of additional 
training of pharmacy students with recognition that pharmacists have unique skills which 
need enhancing. 
“I just think it’s one of those, utilising the skills that somebody has got, I mean I 
know you’re teaching these to become, so I do, I think it’s a, I also think that 
pharmacists probably come at things from a different angle to doctors and nurses 
that patients are used to getting so I think that, yeah, I think it’s a very good idea.  
Utilising the skills that you’re trained to use really.” (patient) 
Practice nurses raised logistical issues which could contribute to the effective introduction 
of medication review training with patients for pharmacy students in medical practices.  
One suggestion involved pharmacy students booking patients on the same day as the 
nurse review in order that patients could move straight between appointments, therefore, 
increasing efficiency and possibly patient recruitment.  Another practice nurse commented 
that undergraduate medical students work in pairs to undertake training with patients, 
which might provide a scenario for future roll out of the pharmacy student led medication 
reviews.  However, it was added that medical students are not supervised and it has 
already been established that supervision of pharmacy students within a medication 
review is required.  A practice nurse expressed views that if the training within this study 
was repeated in the future, supervision by a qualified pharmacist should still be 
undertaken. 
Nurse“… if we were to roll this out in the future that the final year pharmacy 
students would do the consultations, I’m not sure if that’s appropriate ..“ 
Researcher: Would you have a different opinion if they were supervised? 
Nurse:  Yes, rightly or wrongly, yeah, but that’s my personal view. 
The group of three practice nurses discussed the existing training of medical and 
nursing students, where a ‘building’ or iterative approach is utilised, and recommended 
the use of this approach with pharmacy students in the future. 
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“…medical students come out and we would get patients to come in with specific 
problems for that specific group, so say for instance, in a couple of weeks I’m 
doing a vaccination morning and I will have students coming in and out and they 
just will be observing me consulting and vaccinating so it’s all dependent on their 
level, but they, in general they aren’t actually making any decisions, it’s kind of 
basic learning that they’re doing really…” (nurse) 
“The UEA are trying to sort of build-up with the nursing students where they will 
actually, they’re hoping that they will get placements within general practice and 
that those placements as they go through their training will become more 
independent so at the end of their course they could perhaps do certain clinics..” 
(nurse) 
Students, within their focus group, commented that this form of training, if implemented in 
the future, would encourage more of them to apply for positions in the community, as 
currently many students apply for jobs in secondary care because of its clinical focus. 
Both final year pharmacy students and PCT pharmacists said that the preparative training 
will potentially ‘fill a gap’ in the current training of pharmacy students.  They also stated 
that they would have wanted to take part in this training if the opportunity had presented 
itself.  Students suggested that we should check the knowledge of participating students, 
with respect to the podcasts, to ensure comprehension.  They also aired various views 
relating to the scheduling of sessions but with no conclusion reached. 
Questionnaire  
Lastly, significant discussion took place amongst the patient participants about the 
questionnaire which was designed to be completed both at baseline and after the 
intervention to identify potential changes.  Patients expressed critical views about wording 
of questions and their interpretation, with discussion of individual words.  They did agree 
that it could be completed easily in the stated time, with one patient suggesting that the 
researcher should sit down and read it themselves to check comprehension. 
“I think you’ll find that once you’ve actually tried it yourself you will find things 
yourself which may need tweaking.” (patient) 
Another patient recommended asking volunteers to read and assess the questionnaire. 
“The thing that again may be beneficial to you is to sample the forms and then just 
send them out random to a few, half a dozen people, a dozen people, get them 
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back and have a look, just analyse them before you actually include them into a 
main study.” (patient) 
3.5 Discussion 
The purpose of this chapter was to obtain stakeholder views on the perceived value of 
participation to enable better design of information leaflets, the design of the study to 
improve recruitment and logistics, proposed student training and conduct of the student-
led medication reviews.  The rich data obtained demonstrates the benefit of undertaking 
focus groups and semi structured interviews with participants representing the 
stakeholders within the study.  The process enabled the identification of previously 
unidentified issues, which improved all of the elements stated and, therefore, improved 
the conduct of the research. 
Stakeholders stated that the project is a good idea, with good acceptance by medical 
practice staff.  Universal support was provided within focus groups and there was 
agreement that the study should proceed.  There was recognition that pharmacy students 
require training to improve their consultation skills and undertake medication reviews with 
patients. 
Patients showed a trust in the knowledge of pharmacists, and supported their provision of 
medicines information to patients.  This was due in part to their perception that 
pharmacists show competence in this respect in reality and that they provided more up-to-
date information than that provided by doctors or nurses. 
Participants reported that recruitment of all stakeholder groups to the study would be “no 
problem”, although this could not guarantee that the rate of recruitment was sufficient.  A 
significant number of useful issues were also raised by patients and students about 
acceptability of recruitment documentation.  Patient participants also made considerable, 
yet constructive, criticism of the wording of the questionnaire. 
The major change to the protocol was for the location of medication reviews to be 
undertaken at the medical practice used by each patient rather than the university.  Due to 
the distance travelled it was requested that students should travel in groups by taxi or with 
a supervisor. 
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Training to prepare students for the medication reviews with patients should include role-
play medication review, compliance with medication, lifestyle issues and negotiation skills, 
whilst feedback was recommended. 
Recommendations were made to improve the conduct of the student-led medication 
reviews, including access to records, content of the review, and the disease on which to 
focus.  Specific requests were made concerning the time allowed for the medication 
review, supervision, use of care plans or protocols, and feedback. 
Some issues raised at focus groups did not result in changes and mainly involved the 
wording of the baseline questionnaire which could not be changed due to the use of 
validated tools. 
The themes or issues were identified from the data obtained and were not pre-determined 
in advance of analysis, which reduces the likelihood of bias in the findings.  It could be 
argued though that these were unintentionally pre-determined, as the objective of the 
focus groups and semi structured interviews was to identify issues which may result in 
changes to the protocol in order to improve the research. 
Focus groups and semi structured interviews comprised participants whom were 
representative of each stakeholder group in the research and, therefore, possessed a 
similarity which was important to the research.  They also displayed a homogeneity which 
facilitated recruitment and ensured that participants were comfortable with each other 
which potentially helps the process, although it may mean that diverse opinions may be 
lost[107 110].  The focus groups were undertaken in the manner recommended by 
researchers in the field by being composed of five to ten people[107], and in a neutral 
location[110]. 
Analysis followed a structured approach utilised by researchers in this field[102 103] with 
results presented in a manner which allows the reader to, as far as possible, distinguish 
the data, analytical methods and the interpretation[111].  Minority or deviant data were 
included which added to the strength of results[50].  Due to the small numbers of 
participants, it is not possible to generalise the results obtained to the whole population; 
however, it has been stated that results can be transferred by the researcher to another 
environment, if appropriate[107].  The use of small numbers of participants in focus 
groups is an accepted technique[50]. 
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Whilst the process demonstrated strengths it was also apparent that focus groups and 
semi structured interviews undertaken earlier would have enabled more changes to be 
made, as in some cases timescales precluded inclusion of recommendations.  A more 
experienced researcher may have obtained data representing a wider understanding of 
the answers to questions under consideration, although the experience he obtained during 
early meetings enabled development and subsequent improvement of this skill.  An 
example of omissions in early meetings is that the researcher occasionally failed to ask 
follow up questions to identify the reason for opinions and to establish if they were based 
on experience or supposition.   
Results were not reviewed by another researcher reading and analysing the transcripts, 
which may have identified additional themes or interpretations of them[111].  This would 
have reduced the potential impact of “limited perceptions and introspections of the 
investigator”[111 112].  Returning the transcripts to participants of focus groups and semi 
structured interviews was not undertaken, which may have also resulted in additional 
data[103 112].  Participants may have provided greater understanding of meaning rather 
than simply content.  Ryan[102], however, observes that ‘some investigators also 
recommend that respondents be given the opportunity to examine and comment on 
themes’.  The wording of ‘some’ implies that this step is not essential.  Following analysis 
of the data there was not sufficient time to involve participants and, in addition, a suitably 
trained researcher was not available to undertake second analysis to provide inter-rater 
reliability. 
Focus groups with practice nurses proved impossible to organise, which resulted in 
undertaking separate semi structured interviews with three nurses and the organisation of 
a further meeting at an individual practice for three nurses.  The data obtained may be 
different to that obtained by groups due to the interactions which are enabled by focus 
groups[50]. 
The need to provide preparative training to undergraduate pharmacy students prior to 
undertaking medication reviews is in agreement with published research.  In a study in 
Australia Boyatzis and Batty[75] provided lectures and workshops about communication 
skills, medicines, ethical issues, the principles of medication review and communication 
with general practitioners.  O’Neill et al.[76], in a study in the USA provided in-depth 
preparative training for the students prior to meeting patients.  The protocol in the current 
study included preparative training for participating students in addition to that provided 
within the undergraduate course.  This was planned because previous experience by the 
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researcher and colleagues suggested that it would be necessary.  The information 
provided by focus group and semi structured interview participants, in addition to 
published research, provides strong evidence that this was the correct view and therefore 
the additional training was retained in the study. 
Nurses displayed a poor understanding of the role of pharmacists within Medicine Use 
Reviews (MURs) and this affected the nurses’ perceptions of the potential impact and 
value of this service.  These comments support the need for improved and effective 
communication of the rationale and content of the service to healthcare staff.   
Evidence was provided by patient statements that the pharmacy students need to ensure 
the use of additional and effective methods to educate patients with diabetes about their 
medicines.  The gap in patient medicines information knowledge had prompted them to 
seek alternative non-professional sources.  The need for information about medicines has 
been widely researched and is a key component of a level 3 medication review[28] which 
should include ‘full and accurate information’ about the ‘pros and cons’ of treatment 
options, including side effects.  Dickinson and Raynor[113] identified that patients require 
four aspects of information about drugs (what it does and what it’s for, side effects, do’s 
and don’ts, how to take it).  Consequently the training must ensure that students are 
aware of these needs and address them during consultations.  Participants in the patients’ 
focus group did, however, report valuing the knowledge of pharmacists, which was 
perceived as being up to date. 
The recruitment of stakeholders for the research study was identified as ‘no problem’; 
however, whilst this provided support for the protocol it provides no insight into the 
anticipated rate of recruitment. 
Patients identified a number of very interesting issues relating to the documentation 
designed to recruit patients for studies, and these were included in this study.  
Comprehensive guidance is provided by the National Research Ethics Service[114], 
however, the use of a patient focus group here shows that improvements can still be 
made which have the potential to optimise recruitment and retention of subjects.  The 
National Research Ethics Service guidance already recommends an invitation paragraph.  
This is shorter than that recommended by the focus group, who suggested a précis of the 
document to encourage further reading of it.  In addition, the National Research Ethics 
Service guidance also warns against the use of longer complex information and suggests 
the use of short easily read sentences or areas of text.  This concurs with the focus group 
suggestions, but does not take account of the concerns with respect to the terms control 
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and intervention.  In describing the dislike of them one participant muddled up the two 
groups, thus proving the point.  The suggestion of using a simple description of each 
group is sensible.  Stakeholders also reported that documentation should clearly state that 
patients would not lose their current service, unless this is planned. 
Possibly the most important issue identified was the location of the patient medication 
review: this was expressed in strong terms by all groups as being wrong.  They did not 
want this to be at the university, but at the medical practice of each patient.  The original 
location was chosen because undergraduate students in other disciplines, such as 
optometry[73] and dentistry[71], routinely offer care to patients in university-based clinics.  
It is possible, however, that patients are accustomed to attending a more distant location 
for services such as these.  Most patients, however, expect to receive medical services, 
other than hospital-based ones, at their GP’s medical practice.  Pharmacy in England 
recommended[115] that specialist services can be provided in convenient locations. 
The other key issue identified was student travel to medical practices.  The number and 
strength of the comments in the focus group was unexpected.  As students’ participation 
in the study was voluntary and also essential for the implementation of the study, changes 
were made to the protocol.  Instead of leaving students to travel by bus or their own car, 
taxis were arranged for them.  This enabled up to four students to travel together, thus 
solving both the logistical problem and, in addition, it provided group support when they 
arrived, therefore, addressing the concern expressed about arriving alone at a practice. 
The issues identified by focus groups and semi structured interviews which required 
changes to the study were sometimes unexpected, but useful.  A number of these related 
to preparative training of participating students.  Other issues, including appearing 
confident and competent; admitting to a lack of knowledge; patients’ beliefs, and care with 
statements form part of consultation skills requested.  These issues were included in the 
preparative workshop dealing with consultation skills. 
The use of role-play medication review to train students had been planned as part of the 
protocol, and focus group and semi structured interview support for this was encouraging.  
Most published research relating to role-play has been conducted with medical students.  
However, the scenarios encountered by medical students and pharmacy students often 
have great similarities, with one such scenario being the undertaking of medication 
reviews.  Nestel[116] (2007) investigated the use of simulated patients with pre-
registration pharmacists (PRP), with this being an alternative terminology for role-play.  
The situations encountered by PRPs are similar to those of undergraduate pharmacy 
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students.  This study identified that the use of role-play provided effective training, 
although they were unable to state that this would provide lasting benefit.  In our scenario, 
however, the benefits were only required for a short period to provide practice and 
feedback for the students prior to meeting a real patient.  Joyner[117] in providing 
guidance for undertaking role-play training with medical students, provides evidence that 
the use of role-play is a widely used technique.  Undertaking medication review is a role 
that is taught to medical students and, therefore, the evidence is relevant to this study 
which utilises pharmacy students.  Bokken et al.[118] (2009) conducted focus groups with 
medical students who had experienced role-play, and found that it provided good 
preparation for real patient interactions.  In addition, it provided an opportunity for giving 
constructive feedback on communication skills. 
Feedback to a GP during the role-play session had been recognised as important, due to 
the widely recognised benefits of feedback during this form of teaching[116-118] and this 
was retained in the protocol following comments by stakeholders. 
It was recommended that students must access patient records with supervision prior to a 
patient medication review and must use a protocol or care plan during the medication 
review.  Access of patient records is also regarded as an important element in studies 
which investigated the teaching of undergraduate students with patients[81]. 
Other changes required the inclusion of conditions other than diabetes in preparative 
training and ensuring that during medication reviews students appear confident and 
competent.  Preparative training should include recognition of side effects, patient beliefs, 
and care with statements (especially if patients have previously shown intolerance or non-
acceptance of advice).  It was stated as important that feedback should be ensured during 
training and that this should take the form of group feedback, if possible. 
During medication reviews, it was recommended that students must admit to lack of 
knowledge.  Medication reviews should not be time-limited, although they should have a 
nominal time of 20 minutes, and that patient feedback should be obtained at the end.  
After the medication review (level 2 or level 3) it was recommended that students should 
feedback issues identified to a GP to increase student confidence, and that written 
records should be provided to the GP of the medication review.  Patients should also be 
provided with a written record of the medication review. 
Stakeholders stated that supervisors must ensure confidentiality and prevent students 
providing contradictory advice.  Confidentiality and the need to supervise students are 
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issues recognised and dealt with on a regular basis by academic staff in the School of 
Pharmacy at the UEA.  Issues of confidentiality are a requirement of all registered 
pharmacists and pharmacy students in the UK[119 120], and are taught as part of the 
undergraduate course.  In addition, all participating students were to apply for honorary 
contracts for the PCT which would ensure further confidentiality control.  Therefore, it was 
already decided to leave the teaching of confidentiality unchanged as part of the protocol. 
Consensus on time allocation for student-led medication review within the study was not 
achieved.  Research has focussed on the needs of patients for time during consultations.  
A study in the UK (2004) Ogden et al.[121] identified interesting results.  They found that 
the majority of patients underestimated how long the consultation took, whilst a large 
minority would have preferred more time.  A key finding was that a preference for more 
time was correlated with dissatisfaction with the emotional aspects of the consultation and 
a lower intention to comply with doctors’ decisions.  They suggested that more time could 
be given, but stated that a doctor who listens and tries to understand their patient may 
make the patient feel more satisfied with the consultation length.  It was decided that, with 
the current study, consultations would not be limited, but that supervisors were advised to 
stop the consultation if it went on for too long.  A nominal duration of 45 minutes was 
allocated for the student to access the patient’s medical record and update records, 
undertake the consultation, write a record of the issues raised for feedback to the medical 
practice and obtain feedback from the patient.  This incorporated two other issues raised: 
accessing the records and feedback. 
It was decided that the supervising pharmacist would check recommendations made by 
students following a medication review, before forwarding them to the GP.  By taking 
professional responsibility, the pharmacists ensured accuracy, as the students are not 
qualified.  A similar suggestion asked that recommendations and observations from 
student-led medication reviews were recorded in the patients’ medical record.  
Supervising pharmacists were asked to undertake this role as they are qualified and also 
know how to make such records. 
Finally, two issues raised were not implemented.  The first was a series of disagreements 
by patients with the wording of questions in the baseline questionnaire.  These comments 
may have been very relevant and useful, but the questionnaires were developed from 
validated tools.  It was not, therefore, possible to make changes without the permission of 
the author(s) and this, if implemented, could adversely affect interpretation of results.  The 
second issue was that undergraduate pharmacy students should receive training with 
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patients earlier in their training.  In particular, nurses in one practice recommended this 
following their experience with nursing and medical students.  Their recommendation, that 
students should start in year one with simple tasks and develop in complexity each year 
until undertaking medication reviews in year four, is sensible.  However, this is a pilot 
study with the aim of identifying effects, so this issue could not be implemented at this 
stage.  The perceived need for early training of undergraduate pharmacy students with 
patients is one of the drivers for the integrated model of education being proposed for 
pharmacy in the UK.  Pharmacy students said that if roles in the primary care sector, 
involving medication review were available, then more pharmacists would apply for such 
posts as it involved clinical work. This demonstrates evidence that pharmacists who have 
received training in consultation skills within medication reviews during their 
undergraduate course could be recruited to these roles.  Support, therefore, is provided 
for the future sustainability of the model of training if the study proves to be successful. 
The use of focus groups and semi structured interviews comprised of stakeholders 
representing participants groups within this study proved to be very useful.  The data 
generated enabled confirmation of some aspects of the protocol, whilst important changes 
were made which potentially improved the evaluation which follows recommendations by 
the MRC[48] to evaluate protocols using potential users of the service. 
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Chapter 4 Education: training undergraduate pharmacy students in 
medication review 
4.0  Background 
This chapter seeks to define the educational approach undertaken and to provide an 
evaluation of its effectiveness and appropriateness to prepare pharmacy students to 
undertake medication reviews. 
In earlier chapters it has been demonstrated that not only is there a need for pharmacists 
to undertake medication reviews with patients, but that pharmacists in the UK are lacking 
in the consultation skills required to effectively undertake them.  Leikola[122] reported that 
society’s increasing expectations of pharmacists’ involvement in assuring rational drug 
therapy and appropriate medication review creates pressure to maintain current and 
develop new competencies.  Kassam[123] recognised that pharmaceutical care, which 
encompasses roles such as medication review, ‘takes the profession beyond simple drug 
distributing and counselling responsibilities to a broader mandate of patient-centred care 
to maximize the positive outcomes of patients' drug therapies’.  This was reported to have 
resulted in the Canadian authorities requiring pharmacy schools to ensure that students 
are provided with these skills.  Owen and Stupans[124], in a report on quality standards in 
pharmacy placements in Australia stated that universities provide the underpinning skills, 
whilst the supervisor provides guidance and facilitates learning during experiential 
placements.  In the UK, the modernising pharmacy careers programme[74] states that 
their proposals will not result in the teaching of less science, but that students will be 
applying their knowledge, largely in the context of a patient-facing setting. 
Skledar (2006)[125] when discussing the development of a pharmacy internship stated 
that experiential learning is the application of classroom learning in a real-life interactive 
environment and is a teaching strategy commonly used by schools of pharmacy.  When 
discussing the need to develop pharmacists for new roles, Hall et al.(2012 Canada)[126] 
stated that patient-centred care requires a different set of skills and training including 
collaborative interpersonal practice skills.  They also recognised that experiential training 
is an essential requirement for the development of these skills. 
Dewey[127] provided support for undertaking education in the real world by stating that 
“there is an intimate and necessary relation between the processes of actual experience 
and education.”.  Kolb[128] later developed this further by defining experiential learning 
theory as “the process whereby knowledge is created through the transformation of 
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experience”.  This could be related to the current study, as students undertaking 
medication reviews with real patients.  Schon[69] discussed reflective practice as an 
important tool in practice-based professional learning settings, with people learning from 
professional experiences, rather than from formal teaching.  He writes that this may be the 
most important source of personal professional development and improvement, as it 
brings together theory and practice.  However, Dewey[127] also recognised that individual 
students obtain different experiences from these experiences and that, therefore, not all 
experiences “are genuinely or equally educative”.  He suggests that in progressive 
education, the quality of the experience is essential.  This, therefore, must require the 
evaluation of experiential education.   
Kimberlin et al.[129] (Florida 2006) reviewed the assessment of communication skills by 
US schools of pharmacy.  They stated that communication skills are essential to establish 
effective therapeutic relationships with patients and that these cannot effectively be 
improved simply by practice, thus requiring education and training.  This provides support 
for training and evaluating communication skills rather than relying on work experience.  
The measurement or assessment of communication skills by student pharmacists was not 
undertaken in a consistent or unified manner across the universities.  This resulted in a 
call from the author for a consensus conference to establish the best methods for teaching 
and evaluating communication and personal skills.  This provides evidence that until a 
consensus is agreed within the pharmacy teaching community, including the UK, we are 
justified in choosing available validated assessment tools. 
Silverman et al.[70] state that experience alone is a “poor teacher”, and that knowledge is 
required in addition, which provides support for the provision of underpinning knowledge 
in the at the university prior to the experiential element.  Kolb[128] states that the focus of 
experiential placements differs from the structured university and that the experiences of 
each student varies and is dependent on the particular site and supervisor’s knowledge 
and skills.  It, therefore, follows that, as training pharmacy undergraduates with real 
patients in the UK is a new approach and as both Kolb and Dewey identify possible 
variation in resulting outcomes, that evaluation of this form of training must be undertaken. 
The Department of Health[115] recognised that pharmacists’ clinical skills and expertise 
are an important part of delivering better care to patients, which must require consultation 
skills.  Silverman, Kurtz and Draper in ‘Skills for communicating with Patients’[70] state 
that “ the prize on offer from communication skills training is improved clinical performance.   
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The process for effectively developing consultation skills in pharmacists from 
undergraduate to postgraduate level in the UK is yet to be defined.  Within other 
professional groups this is undertaken by initial class-based training, usually with actors 
followed by students providing simple services to real patients.  Development of the 
requisite skills is traditionally assessed by OSCE within the undergraduate programme 
and by tutor observation within real practice. 
This project is designed to test the translation of a new model of education and training 
into the pharmacy setting.  This chapter, therefore, considers the effectiveness of a new 
preparative training course; the suitability of using actors and artificial scenarios to 
prepare students for real patients; and then the provision of a structured service to the 
patients under close supervision.  The optionality of this research project is one factor 
which requires evaluation as this may bias selection, resulting in a non-generalisable 
sample.  Delivering this training programme and experience alongside a traditional 
programme also provides an opportunity for determining its effect on student performance 
within those elements of the degree which are potentially enhanced by this experience.  
Consequently, an opportunity to triangulate observation of practice and its development, 
alongside student experiences and student performance, measured by an independent 
means, is provided.  Due to the small numbers of students involved, however, it may be 
difficult to draw many conclusions as there will be limited power within any quantitative 
comparisons. 
4.1  Aims and Objectives 
Aim 
The aim of this section of the thesis is an evaluation of a novel training course designed to 
prepare students to undertake medication reviews. 
Objective 
The objectives of this element of the research were: 
• to assess the suitability of the training course for developing consultation skills in 
pharmacy students, 
• to assess the academic status of participant and non-participant pharmacy 
students to enable evaluation of the generalizability of student cohorts who self-
118 
 
select for participation in a study which is designed to provide and evaluate 
education, 
• to describe recruitment and retention rates and provide reasons for non-retention, 
• to determine the participant students’ perceived effectiveness of the delivered 
training programme after its delivery. 
• to assess and describe the effect of the training on student consultation skills 
within medication reviews, 
• to describe participant student opinions regarding the experience of undertaking 
medication reviews with real patients; 
• to describe the opinions of patients regarding the value of the medication review 
service with final year pharmacy students. 
4.2  Results 
Forty-seven undergraduate pharmacy students were recruited to participate in the study.  
Six (12.75%) were male.  Seven volunteers were placed on a waiting list, whilst forty 
students were enrolled into the study.  As volunteer students left the study, students from 
the reserve list were included. 
Thirty-two students completed the project.  The principal reasons for students not 
completing the project were workload (n=3) and inability to cope with the difficulty or 
complexity of the tasks involved in undertaking a role-play medication review (n=3). 
4.2.1  Student Participants 
The CONSORT flow diagram (Figure 4.1) describes the numbers of students joining 
and/or leaving the study at each stage.  Reasons for students leaving the study are 
provided to enable evaluation. 
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         Figure 4.1 Flow diagram for student recruitment, attrition and replacement 
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4.2.2  Academic ability of students volunteering to participate in a study 
Data in Table 4.1 demonstrate the mean of exam results at the end of year 3 (at 
recruitment) and at the end of year four (post-intervention) for both control (non-
participating) and intervention (participating) students, with volunteers displaying 
academic superiority and therefore self-selection bias. 
 
 
Non-participant students, i.e. 
the remainder of year 4 
students. 
(Control) 
Participant students n = 40, i.e. 
all those recruited and enrolled 
at the beginning of the course. 
(Intervention) 
p value 
(Independent 
samples 
t-test) 
 Mean (SD) Mean (SD)  
Year 3 average 
mark 58.91 (7.91) 62.80 (7.98) 0.035 
Year 4 average 
mark 66.89 (4.87) 69.26 (4.77) 0.032 
Table 4.1 Mean exam results year 3 and 4. 
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4.2.3  Individual students leaving the study 
Data in Table 4.2 describe the academic ability of students leaving the study in addition to 
timing and reasons for leaving.  Students informed the researcher of their decision to 
leave either verbally or by email. 
Student 
leaving the 
study 
Mean mark 
year 3 
Mean mark 
Year 4 
Stage at which student left 
the study 
Reason stated by 
student for leaving 
the study 
Student A  70.88 71.84 During initial training Workload 
Student B  70.58 67.77 During initial training Workload 
Student C  57.67 64.96 Before role play Health 
Student D  57.21 70.88 Before role play  Too busy/workload 
Student E  59.38 66.93 Before role play  Not ready for 
consultation 
Student F 59.89 61.35 After role play Too difficult 
Student G  56.03 66.90 After role play  Too stressful as not 
competent or 
confident 
Student H  67.78 71.02 After review of patient’s 
medical record 
Personal reasons 
Student I  76.54 84.25 After review of patient’s 
medical record  
To concentrate on 
exams 
Student J  46.63 57.97 On the day of the 
consultation with patients. 
Last session so no later 
sessions to fit into 
Health 
Student K 45.87 75.94 On the day of the 
consultation with patients. 
Last session so no later 
sessions to fit into 
Personal reasons 
Table 4.2:Student leavers’ mean exam results and leaving information. 
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4.2.4  Objective Structured Clinical Evaluation (OSCE) results 
Data in Table 4.3 display comparison of final year summative OSCE results between 
participating students and non-participating students.  Distinctions are assessed 
independently of passes. 
Intervention group refers to all those students completing preparative training and 
medication reviews with patients. 
Control group refers to all students not volunteering or completing preparative training and 
medication reviews with patients 
Scores are zero to four which equals the number of OSCE stations, with four representing 
the highest possible.  Scores are presented as the mean of combined pass and distinction. 
OSCE status 
Intervention (n=32) 
Mean (SD) 
Control (n=48) 
Mean (SD) 
p value 
Independent 
samplest-test 
Pass + Distinction 3.53 (0.76) 3.49 (0.67) 0.769 
 
   
Table 4.3 Final year Objective Structured Clinical Evaluation results for intervention and 
control students. 
4.2.5 Online student surveys 
4.2.5.1  Role-play session 
Seventeen (40.5%) out of 42 students who completed the preparative training completed 
the survey.  Twelve (70.8%) students fully agreed and four (23.7%) agreed that practising 
consultation skills with professional actors is an ideal way to learn consultation skills, 
whilst 1 (5.8%) was unsure.   
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Data in Figure 4.2 represents student’s opinions in response to questions seeking to 
establish the usefulness and timeliness of information sent to students prior to the role-
play session. (n = 17) 
 
Figure 4.2 Preparative information sent prior to the role-play session. 
Data in Figure 4.3 represents students’ opinions of the suitability or effectiveness of the 
location when undertaking the role-play session. (n = 17) 
 
Figure 4.3 Effect of the location for role-play training. 
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Data in Figure 4.4 represents students’ opinions of the value and possibly the 
effectiveness of the actors in training them for consultation skills during role-play. (n = 17) 
 
Figure 4.4 Effectiveness of using professional actors for role-play training. 
Figure 4.5 displays student opinions presented about feedback provided after each 
consultation within the role-play session and also the GP feedback session which followed 
the two student/actor consultations. (n = 17) 
 
Figure 4.5 Effectiveness and time allocation for role-play feedback 
0% 20% 40% 60% 80% 100%
Different actor characters helped
learning
Actor so realistic I forgot they were acting
Fully agree Agree Unsure Disagree Fully disagree
Percentage
0 20 40 60 80 100
Feedback after consultations helped
improve my future performance
Time for feedback by observers after
consultations appropriate
Time for feedback to GP appropriate
Group feedback to GP helped future
performance
Fully agree Agree Unsure Disagree Fully disagree
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Data displayed in Figure 4.6 presents students’ opinions relating to the effect of stress 
within the role-play session on future actions. (n = 17) 
 
Figure 4.6 Effect of stress during the role-play session 
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The stress made me less likely to
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Percentage
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Data presented in Table 4.4 display free text words used by students to describe the role-
play session.  The words are collated according to perceived meaning.  Simple content 
analysis identified three groups of words, planning and delivery, effectiveness or outcome 
and the effect. 
Where a word has been used by more than one student the number of occasions in which 
it was used is stated. 
Words relating to the 
planning and delivery of 
the role play session 
Words relating to the 
effectiveness or outcome of 
the role play session 
Words relating to the 
effect of the role play 
session on the students 
Good preparation Interesting Apprehensive 
Well organised Helpful (4) Motivating 
Organised (4) Useful (2) Challenging 
Practical Relevant Fun 
Realistic (9) Effective Reflective 
Informative (6) Constructive  
 Unique  
 Invaluable  
Table 4.4 Free text words by students describing the role-play session 
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Table 4.5 presents free text comments made by participating students in relation to the 
role-play training session.  Comments were subjected to simple content analysis to 
answer the question posed by the research plan[103].  Objective was identifying issues 
requiring changes to improve the role-play session if repeated. 
Content identified Student’s text (unedited) 
Information supplied to 
students prior to the role play 
I wasn’t sure about what I was going to do whether it 
was  medicine use review or a pharmaceutical care 
plan-this information was not disseminated explicitly 
prior to the mock consultation 
Reality of the scenario I think the set-up of the consultation was a very real 
environment and this helped for me to get into my 
role 
Location – effect Obviously it does make it more realistic to practice 
consultation skills in a consultation room, but I think 
valuable gains can be achieved outside of this 
setting. 
Characters Not every patient will be the same. You need to 
learn how to adapt your skills to different types of 
people. 
Actors - script and its use Even though these actors had a lot more detailed 
information to give then perhaps in a regular 
counselling or responding to symptoms workshop, 
there was still an element of them only having a 
limited number of things to say unlike a real patient, 
who can respond to any question you may ask. 
Feedback - by academic staff 
and/or PCT pharmacists 
The feedback by observers was fantastic, especially 
getting feedback after the first session, which then 
allowed me to improve in my performance the 
second time and then receive even more helpful 
feedback after this.     
Feedback time allowance with 
the GP 
Not enough time to feedback to GP. I feel this 
adversely affected how useful the GP feedback 
session was. 
Feedback - GP style I found the GP's manner rather abrupt and critical 
which didn't give students enough confidence to 
feedback as much. 
Stress - effect 
 
I was really nervous before this as I knew we were 
being assessed at the same time but it was good in 
increasing my confidence for the real thing and 
giving me ideas for improvement 
Table 4.5 Student free text responses regarding the role-play session. 
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4.2.5.2 Overall course survey 
This data presents views and opinions of student participant views of the overall training 
programme, including preparative training, medication review (level 2) at a medical 
practice and a medication review with patients.  Data presented includes the effectiveness 
of aspects of the course, students’ feelings about undertaking a medication review with a 
patient and opinions about repeating the exercise. 
All forty seven students who provided consent to join the study, irrespective of whether the 
student completed the study, were requested to complete the survey. The response rate 
was twenty four (51%). 
4.2.5.3 General comments  
All seventeen participating students replying to this question stated that they would 
recommend the programme to another student.  Sixteen students (66.7%) students 
strongly agreed, and seven (29.2%) students agreed that the course helped them to 
communicate with patients in a medication review. 
4.2.5.4 Podcasts 
Podcasts posted on the university intranet and which were designed to improve 
background knowledge were accessed as follows: 
• fifteen students stated that they accessed Podcast 1 Blood Glucose, 
• five students stated that they accessed Podcast 2 Cardiovascular, 
• fourteen students stated that they accessed Podcast 3 Consultation skills. 
Of those students replying: 
• nine students stated that they strongly agreed or agreed that podcast one was 
useful, 
• five students strongly agreed or agreed that podcast two was useful, 
• nine students strongly agreed or agreed that podcast three was useful. 
No students stated that they strongly disagreed that any of the podcasts were useful. 
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4.2.5.5 Skills learned (as stated by students in the on-line survey) 
Table 4.6 represents free text comments made by participating students about skills that 
they may have learned during the preparative training course.  Themes identified were 
communication, mainly within consultations such as medication reviews, use of medical 
records, confidence, clinical knowledge and the role of healthcare professionals. 
Skill learnt No. of students stating 
that they learnt or 
improved this skill 
A. Communication - mainly within consultations  18 
• Listening skills 
• Questioning including use of open questions 
• Controlling a conversation 
• Patient focussed 
• Counselling 
• Clarity in expression 
• Types of patient 
B. Use of medical records 9 
• Accessing information 
• Interpretation of records 
C. Confidence 3 
D. Clinical knowledge  4 
• Diabetes 
• Monitoring 
• General 
E. Role of healthcare professionals 1 
Table 4.6 Skills students stated that they learned during the course 
4.2.5.6 Most rewarding aspects 
Data presented demonstrate the opinions of students about the most rewarding aspects of 
participation in the study.  These were expressed through free text comments in the on-
line survey. 
Thematic analysis was undertaken to identify issues important to participating students 
and the design of the training course.  Themes and sub-themes identified include a theme, 
quoted throughout, of improvement in consultation skills; consultation skills learned 
(controlling the conversation, patients as individuals, open questions, listening skills); 
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feedback; provision of benefit to patients; improved confidence due to demonstration of 
competence; use of medical records; clinical knowledge of diabetes and the role of 
healthcare professionals within a medical practice. 
Consultation skills learned 
Controlling the conversation 
Students stated that due to the study their consultation skills improved, and that this was 
partly due to the interaction with real patients rather than actors, and that real patients act 
differently. 
“I feel my ability to adapt during a consultation was improved. By that I mean that 
real life patients will communicate in certain ways, go off on tangents and have 
varying degrees of knowledge on their own condition and it is very difficult to 
replicate this with actors.” 
The theme of controlling the conversation or consultation was expanded by other students, 
with comments which show the difficulty of talking to real patients. 
“Getting the required information out of patients, while staying within the time and 
not hearing their life story!! This was more difficult than many of us thought.” 
Use of open questions within consultations 
Other students repeated the theme of improving consultation skills and in this case there 
was recognition that the use of open questions is an effective method of conducting a 
consultation. 
“My consultation skills were improved greatly after completing the course and I 
was able to use more open questions to gain large volumes of information from the 
patient compared to one word answers when closed questions are used.” 
Recognition of several of these issues was displayed within one statement when the 
theme of keeping the patient on track and the use of open questions was once more 
highlighted. 
“Consultation skills - before this course i would have found it very difficult to be 
able to lead a consultation as it is often difficult to allow the patient to talk 
throughout whilst staying on track. I feel I have developed this skill to be able to do 
this rather than asking lots of closed questions.” 
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Patients as individuals 
This was developed further, with recognition that patients are individuals and that, 
therefore, a consultation must be adapted to the patient rather than relying on a formulaic 
approach.  
“I felt the course help me to appreciate the patient as an individual and thus led me 
to rely on adapting as the conversation progressed rather than relying on a 
planned routine.” 
Feedback 
Feedback provided to students by supervising pharmacists or medical practice staff was 
quoted as providing guidance for students’ consultation performance. 
“Feedback gave us pointers on what we did well and what we could improve when 
we have conversations with patients.” 
One statement by a student displayed the positive feelings resulting from patient feedback. 
“Hearing the patients say they enjoyed working with the students and that they 
thought we were good at what we were doing. This made it all feel worthwhile as it 
was a real patient and not somebody who was acting.” 
Provision of patient benefit. 
The issue of working with real patients was further expanded to show recognition that a 
student had found that providing benefit to patients was rewarding to themselves. 
“Hopefully making a difference in one of the patients’ lives, or at least helped them 
to understand their medication/condition more.” 
Another student further developed this idea to state that the consultation skills practice 
within a medication review provided benefit to the student because they perceived that 
they helped the patient. 
“Being able to make a contribution to the care of the patient while learning 
invaluable skills.” 
Improved confidence due to demonstration of competence. 
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Students stated that their confidence improved after they had undertaken medication 
review with patients due to demonstrating competence in a real scenario. 
“Actually being able to have contact with real patients! I think in the MPharm 
degree it is essential to have contact with patients in order to be able to build 
confidence when talking to them, but it also allows yourself to gain confidence that 
the information you give them is correct and you begin to understand that you 
know more than you thought you did.” 
Use of medical records 
There was recognition that due to the need to access and interpret patients’ medical 
records as part of the training programme this was, therefore, one of the rewarding 
aspects of the study training programme. 
“…the opportunity to use patient records as part of the learning process.” 
This study involved patients with T2DM as the group receiving the medication review and 
students stated they were able to learn more about the management of that long-term 
condition.  This included practical aspects of the management of diabetes for a patient 
such as monitoring and lifestyle advice. 
“Clinical knowledge about diabetes and what should be given first line, safe ranges 
of blood glucose level to be in, also a bit about dietary and lifestyle advice.” 
Role of healthcare professionals in the medical practices 
Students experienced professional contacts with healthcare professionals during the study 
and in response to the question “what was the most rewarding part of the study”, one 
student stated: 
“More about the roles of diabetic nurses at doctors’ surgery.” 
4.2.5.7 Least rewarding aspects 
The on-line survey provided students with the opportunity to include free text comments 
relating to the least rewarding aspects of the study, and themes identified related primarily 
to preparative training and included content, delivery and usefulness. 
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Preparative training 
Some students expressed dissatisfaction with aspects of the preparative training, with 
mention that some training sessions, such as care planning or the use of IT medical 
records were too long. 
“Some of the sessions at the start of the year. Although relevant I think they could 
have been reduced into less time as we had a very busy year work-wise.” 
Time allocation was further discussed, with one student stating that all the preparative 
training should have been an integrated part of the undergraduate pharmacy course.   
“A large amount of time was taken up spending time on aspects that we have or 
should have already covered in the Masters course.” 
Another important issue of time allocation was highlighted with students stating that 
because this training was undertaken as outside their undergraduate course they 
experienced problems managing their time.   
“The stress and fitting these long sessions into the already packed 4th year schedule.” 
“….. having to manage my time for the study and other university commitments..” 
A student quote suggests that the solution may be to incorporate the training into the 
undergraduate curriculum. 
“It could be very time consuming at times as it was not timetabled as such.” 
Positive comments 
A number of student respondents stated that there was nothing wrong with the training in 
answer to the question which sought to identify the least rewarding or useful aspects of 
the students’ experience. 
“I think all aspects were useful.” 
4.2.5.8 Feelings of students at the start of the study 
The on-line survey provided students with the opportunity to include free text comments 
about their feelings at the start of the study.  Themes and sub-themes identified included 
nervousness, real patient consultation, lack of previous patient contact, uncertainty of 
what a consultation would involve, lack of consultation skills; positive anticipation of the 
project; uncertain expectation if course would improve consultation skills; helping patients. 
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Nervousness 
Students reported feeling nervous at this stage about what they were about to undertake. 
“……really nervous….” 
Real patient consultation 
Another student explained that the reason for their nervousness was due to undertaking a 
real consultation (medication review), thereby requiring a level of responsibility for 
displaying competence. 
“Perhaps a little apprehensive about talking to real patients in a consultation 
environment.  It felt daunting to be responsible for obtaining information from them 
and giving them advice.” 
Lack of previous patient contact 
One student explicitly stated that they were nervous (or apprehensive) about talking to 
patients. 
“Also I was apprehensive about talking to patients.” 
Uncertainty of what a medication review would involve 
Quotes showed that whilst students stated that they were unsure of what the study 
involved; in reality, in some cases, they may have been unsure about how to conduct a 
medication review.  This is demonstrated because the preparation training helped to 
resolve the problem. 
“That I was not really sure what was expected of me. The practice with the actors 
helped a lot with this.” 
Lack of consultation skills 
The students’ lack of confidence in their own skills or knowledge at that stage may also 
have contributed to the nervousness. 
“….possibly being unsure about how to answer a question if the patient had asked 
one.” 
Positive anticipation of the project 
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Some students, however, recognised their lack of skills and reported positive feelings 
whilst looking forward to the experience, particularly to improving their consultation skills. 
“I feel like my communication skills with patients is poor and expecting to become 
more competent in giving medication reviews at the end.” 
The use of the word exciting was used by more than one student.  In addition, a currently 
unmet need with respect to student expectation of training is mentioned. 
“Excited that I was going to build on consultation skills as don't have much of an 
opportunity to do this on the course.” 
Expectations of the course to improve consultation skills 
There is not universal assurance that the course would succeed in the stated aim of 
improving students’ consultation skills. 
“Excited. It was interesting to find out whether pharmacy students could actually 
master the skill of consulting patients.” 
Helping patients 
One student reported positive feelings in relation to a desire to help patients. 
“Curious if I would be able to make any significant interventions.” 
4.2.5.9 Feelings of students at the end of the study 
The on-line survey provided students with the opportunity to include free text comments 
about their feelings at the end of the study and provides a comparison to feelings at the 
beginning of the study.  Themes identified include improved confidence and knowledge 
through patient contact; reflection and self-assessment; supervision; patients as 
volunteers; knowledge of disease states; and support for the course. 
Confidence and knowledge through patient contact 
The issue of confidence which was highlighted at the start of the programme was raised 
again at this stage by many students, but more positively and related to consultation skills.  
Comments demonstrated that improved confidence was due to the patient contact, 
enabled by the study.  Knowledge and confidence were highlighted. 
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“I feel the interaction with the patients has made me more confident in myself and 
my knowledge.” 
Further evidence was presented that improvement in skills and, therefore, confidence was 
due to meeting real patients rather than classroom teaching.  A specific issue was stated 
as the technique of consultation involving open and closed questions.  
“Developed a more realistic approach when speaking with patients as in the past it 
was all theory that we had learnt and practiced with our colleagues. I feel more 
confident in speaking with patients and have also learnt how to ask particular 
questions in an open manner and closed questions when it is necessary.” 
Reflection and self-assessment 
Comments were made which show students being able to make valued reflective 
judgements of their ability to develop consultation skills. 
“Although competency in consultation skill has grown, the awareness of my 
incompetence was more important.” 
One student showed an understanding that a medication review is more than just the skill 
of communication: it also required utilisation of knowledge to evaluate the effectiveness of 
therapy which is another skill. 
“I enjoyed it because I learnt a lot and it was not just about talking to the patient but 
going through their medical history and investigating if their therapy was effective.” 
There was recognition that not all input to patients during medication review has to be 
major in order to be effective. 
“Little changes also matter, does not have to be really significant.” 
Supervision 
Recognition was displayed, of the significant part played by supervision in effectively 
training students, as it provided them with confidence that supervisors would correct 
errors. 
“I feel more confident.  Having observers in the consultation room with me, 
although initially a little apprehensive, helped me to feel more confident as I knew if 
I did say anything that was incorrect or gave inappropriate advice they would be 
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able to step in and correct.  The fact that this did not happen made me feel more 
confident that I understood what I was talking about.” 
Patients as volunteers 
There was recognition by a student that because the patients were volunteers, they did 
not totally represent the real world.  This, however, was quoted in a positive manner: the 
issue raised was that the use of volunteers enabled the student to show gaps in 
knowledge or training. 
“I think that because the patients knew we were students they didn't mind if 
sometimes there were pauses while looking at notes and checking, and although 
real patients in practice possibly wouldn't have this patience, it was an invaluable 
experience.” 
Knowledge of disease states 
Comments showed that students had improved knowledge of a disease state in addition 
to consultation skills, as the patient group within this study were patients with T2DM. 
“I have more confidence and increased understanding of diabetes. “ 
Support for the course 
Students’ comments demonstrated that the course was received positively, and in one 
case would result in recommendation of the course to other students. 
“I am very glad I took part in the programme.” 
 “I learnt a lot more than I thought I would from the experience and would 
recommend the opportunity to all pharmacy students.” 
This is stated in a more explicit manner by another student. 
“After completing the whole course I think pharmacy students can indeed carry out 
consultations with patients and I think it should be a regular part of the pharmacy 
degree.” 
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4.2.5.10 Recommended course changes 
Data presented represents the views and opinions of students about changes that they 
would recommend to the training programme.  A number of issues replicate those raised 
earlier. 
Themes identified included, content, scheduling, medication review with patients; 
feedback and student training cohort. 
Content 
More demonstration of, and practice of, consultation skills was requested even before the 
role-play session with actors. 
“More realistic demonstrations on examples of consultations skills rather than just 
theories and simple role-play, before the practice session with the actors.” 
Sessions undertaking role-play consultations with actors received strong support, with 
requests for more of these due to their effectiveness.  
“I feel another session with the actors would have been helpful as I feel I learnt a 
lot from that experience.” 
Scheduling 
Because the study was undertaken by volunteer students, in addition to their 
undergraduate course, the frequent comments by students which relate to scheduling or 
duration of training sessions could be expected. 
“The time-frame between the training courses and medication review - closer 
together.” 
Another student’s comment about scheduling, sought to identify a solution. 
“The time schedule can be changed but since it will be part of the course, I believe 
it will be on the timetable and safeguarded.” 
Disagreement was displayed by statements about scheduling of the training session 
designed to provide training to students about the IT medical record system (Systmone®). 
“Some training sessions may have been too long, for example when using the 
system on the computer, students are able to pick things up quickly.” 
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“Perhaps more training on the SystmOne® programme “ 
Medication review with patients 
The study protocol provided for each student to meet two patients for a medication review.  
Patients were volunteers recruited via medical practices, with consent provided.  Students 
stated that they would wish to meet more patients. 
“I would have liked to see more patients - although I know recruitment would be difficult.” 
An alternative view of increasing the number of medication review was raised with a 
recognition that meeting the patient(s) again would be desirable. 
“…. and perhaps seen the patient again a few months later to follow-up.” 
Feedback 
The protocol included the opportunity for students to feedback issues identified during the 
level 2 or level 3 medication reviews to the patients’ GP.  Comments received from 
students included: 
“At the final session it would have been nice to be able to talk to the patient’s GP about 
the issues raised with them and the information gathered so it could be discussed 
properly.” 
Student training cohort 
One student identified that not only was this course of value, but that it should be offered 
to undergraduates in their third year. 
“Suggest you run this with the third years as part of the PP3 course.” 
4.2.5.11 Additional free text comments by students 
Students were invited to add any comment that they wanted at the end of the on-line 
survey which resulted in three comments received, all of which were very supportive of 
the training course.   
“It was a precious training opportunity that was enjoyable and educational. I sincerely 
appreciate the time and hard work to arrange this training for us. Thank you very much.” 
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I think this was a great experience and am glad I participated in it. 
The final comment, whilst supportive, suggests that the preparative training requires 
improvement. 
Extremely advantageous and a learnt a lot. With more structured training sessions would 
be hugely beneficial to our course to go out into practice. 
4.2.6  Medication Related Consultation Framework (MRCF) 
Data in Table 4.7 presents results obtained by students after undertaking their first and 
second consultations with patients (medication review).  N.B. each element of the MRCF 
short form is scored on a scale of 1 to 4 where 1 = not able to undertake the activity and 4 
= fully able to undertake the activity. 
Order of 
consultation 
MRCF: 
activity measured 
N 
Mean (sd) score 
(range 0 to 4) 
P value 
(paired 
samples 
t-test ) 
1st Introduction 
 
17 
2.80 (0.58) 
0.134 
2nd 3.02 (0.43) 
1st Data collection and 
problem solving 
 
21 
2.68 (0.68) 
0.289 
2nd 2.80 (0.40) 
1st Actions and solutions 
 
14 
2.46 (0.77) 
0.159 
2nd 2.86 (0.57) 
1st Closing 
 
14 
2.60 (0.14) 
0.655 
2nd 2.70 (0.46) 
1st Consultation behaviours 
 
18 
2.67 (0.51) 
0.003 
2nd 3.08 (0.39) 
1st Total of scores 
 
14 
13.64 (1.30) 
0.084 
2nd 14.83 (2.94) 
Table 4.7 MRCF mean scores for first and second patient consultation. 
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4.2.7 Post level 3 medication review questionnaire 
Fifty eight patients received a medication review from one of thirty two students.  Twenty 
six students reviewed two patients whilst eight only reviewed one patient, due to a 
shortfall in recruiting patients. 
Fifty five patients (95%) completed post-medication review questionnaires. Three patients 
declined to complete the questionnaire: two gave no reason, whilst the other had 
completed the baseline questionnaire (approximately 20 minutes) prior to the medication 
review, as he had previously forgotten, and stated that he had completed enough forms 
for the day.  Students completed fifty two questionnaires (89.5%) out of a possible 58.    
Table 4.8 displays a comparison of patient and student questionnaires completed 
immediately after the student-led level 3 medication review. 
 
Question 
Mean (sd) patient 
score of student 
n=55 
Mean (sd) 
student self-
assessment 
score 
N=52 
p value 
Independent 
samples t-
test 
The student was well organised 4.84 (0.37) 3.61 (0.70) <0.001 
The student had a very professional 
attitude 
4.80 (0.40) 4.08 (0.61) <0.001 
The student communicated well 4.84 (0.37) 3.84 (0.69) <0.001 
The student showed good 
confidence 
4.66 (0.56) 3.63 (0.76) <0.001 
I was comfortable with the level of 
knowledge I had to carry out this 
review 
 3.65 (0.63) N/A 
The student was an appropriate 
person to review my medicines 
4.70 (0.57) 3.76 (0.63) <0.001 
I learnt something useful about my 
medicines 
4.20 (1.00) 3.47 (0.94) <0.001 
The review of my medicines was 
interesting 
4.60 (0.70) 3.52 (0.70) 0.001 
The review of my medicines was 
important for my health 
4.60 (0.73) 4.07 (0.83) 0.001 
I would recommend this medication 
review to other people 
4.90 (0.30) 4.02 (0.86) <0.001 
Table 4.8 Patient and student questionnaires post consultation 
 
Only 4 patients chose to add free text comments : 
1. “It was a good opportunity to ask questions.” 
2. “Very good.” 
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3. “Too many coloqualisms in student’s speech such as ‘cool’. Other than that a 
positive experience.” 
4. “I hope this has proved useful for the student.” 
Figure 4.7 provides a comparison between the mean scores provided by patients to 
questions asked after a student led medication review in this study and in a similar study 
using an almost identical questionnaire in Australia 2004[75].  UK results show a higher 
mean for all questions. 
 
Figure 4.7 UK versus Australian patient provided scores of student consultations. 
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4.3 Discussion 
This chapter evaluates an education intervention which consists of distinct phases, the 
development of underpinning knowledge and ability to apply it, skill development in an 
artificial setting and, finally, further development of skills and application of knowledge with 
real patients. 
Those students who completed all three phases were very positive about the experience 
with 100% of them recommending the course to other students.  The main benefits were 
improvement in consultation skills and self-confidence.  
The first phase of the training was the least well received as some elements were too long 
and some were not accessed.  This element which was designed to develop knowledge 
needed to better consider what had already been previously taught within the 
undergraduate course and should be provided closer to the initial practice with actors. 
The role play of medication reviews with actors was very well received, with students 
reporting improvement in consultation skills, assisted by feedback after the first 
consultation.  Students provided useful data regarding the actor scenarios, including a 
recommendation that these should not include full details and not always include a need 
to resolve problems, in order to mirror the real world with patients.  However, the time 
available for feedback by the GP, in addition to the style of presentation was criticised.  A 
small number of students left the study at this stage, with stress of undertaking the 
session identified as a cause.  In common with other timescale issues, students stated 
that this session must be closer to the medication reviews with real patients 
Following the final phase, when students met real patients for a medication review, the 
students reported good development of their consultation skills and a better understanding 
of the processes within a medication review and GP practices. 
A high rate of completion was demonstrated for post-medication review questionnaires.  
Inviting all participating students, including those who had left the study, to complete the 
on-line survey increases the strength of the data, as those views may provide fuller 
explanations.  However, because the surveys were anonymous it was not possible to 
identify if any students who had left the study had participated.  Triangulation of data from 
different sources enhances confidence in findings[111].  Mays and Pope[111] describe 
triangulation as referring to ‘an approach to data collection in which evidence is 
deliberately sought from a wide range of different, independent sources and often by 
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different means’.  In this case, different sources (students) were used, in addition to 
different methods of data collection.  Students volunteering to join the study were self-
selected and demonstrated academic superiority over non-volunteers.  
MRCF forms were used within the role play session to provide feedback to students on 
their performance, and were given to students.  Retention of a copy by the researcher 
during the role play session would have enabled further evaluation of the effectiveness of 
that session.  Similarly, the forms were used to provide feedback following each 
medication review with a real patient, but in this case forms were retained.  Evaluation of 
the study using MRCF forms was not initially planned and this provides a lack of potential 
bias in scoring of the forms. 
Response rate, of the students’ on-line survey was low, possibly due to their course 
workload at the time, which would represent their key priority, and reduces the 
generalisability of results and conclusions.  However, those results obtained displayed 
strong evidence that students valued the course (podcasts, preparative training 
workshops, role-play, level 2 medication review at a medical practice and a patient 
medication review at their medical practice). 
Almost one third of students who initially consented to participate left the study, with the 
main reason stated to be workload created by undertaking this course alongside their 
undergraduate studies.  Those leaving for health, personal or family reasons cannot be 
adequately discussed as no details are available.  Of concern were those students who 
left due to the stress or not being prepared, as these demonstrate a failing of the 
preparative training.  Inclusion of the whole course into the undergraduate curriculum 
would enable management of workload issues and provide better preparation for students, 
therefore, potentially resolve stress issues. 
The information provided in podcasts was primarily revision of knowledge provided within 
the undergraduate curriculum and this may explain why these were poorly accessed.  
Additionally, this work was expected to be undertaken in the students’ free time and 
motivation was probably lacking to undertake additional learning over the summer.  A 
student in a development focus group suggested subjecting students in the study to a 
multi-choice question test after the vacation to increase uptake of learning within the 
podcasts.  This was considered but it was decided not to use multi-choice questions 
because this may have increased drop-out rates of volunteers. 
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Students requested changes to the structure of the preparative training with more practical 
demonstrations on how to carry out consultations, rather than theory, to aid learning of 
consultation skills.  Whilst students may wish to commence practice of consultation skills 
straight away, knowledge of the underlying structure and theory is believed to be 
important.  Silverman[70] et al. state that knowledge and communication skills are two of 
the four essential components of clinical competence, and ‘experience alone can be a 
poor teacher’. 
Disagreement was displayed regarding the duration of the training in the use of the IT 
medical record system, which may demonstrate variation in underlying students’ IT skills.  
This may require pre-assessment to establish skills levels, with more intensive training for 
those reporting greater learning needs.  The teaching of care planning was stated as 
being too long and this was possibly due to extensive teaching of this subject within the 
current curriculum. 
A key comment made by students, related to scheduling of preparative training, was the 
need to ensure shorter timescales between completion of training and undertaking 
medication reviews.  Whilst students displayed criticism of the delivery of the preparative 
teaching, they recognised its value and want such teaching to be part of the 
undergraduate curriculum. 
The students all believed that role-play training with professional actors is an ‘ideal’ way to 
teach consultation skills, resulting in requests for more role-play opportunities.  Agreement 
was shown that pre-training information of organisation of the session and the ‘patients’ 
was sent in a timely manner, however, students wanted more information about both 
factors.  Better information to fully inform students of what they are about to undertake 
would enable improved student preparation, resulting in reduced stress or concern. This 
could improve performance and, therefore, increase the benefit of teaching.  Joyner[117] 
recommends good preparation for role-play sessions.  Full agreement was demonstrated 
that using real consultation rooms was a good location to undertake role-play. 
Students provided support for the use of actors, rather than other students or university 
staff to role-play, is a good way to learn consultation skills in preparation for real life 
medication reviews.  Joynor[117] and Nestel[130] utilise students as patients, although 
Nestel[131] also suggests the use of actors.  Students reported that different characters 
given to the actors within their scripts added to the experience.  In most cases students 
forgot that they were talking to an actor, which adds to the effectiveness of the experience.  
Joyner[117], suggests the creation of challenging cases, including conditions, emotions, 
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opportunities for motivational interviewing and raising ethical issues.  There is not an 
explicit recommendation that actors should learn the full script but it is stated that actors 
should provide information in ‘challenging cases’ on demand.  Student comments 
demonstrate actors’ responses being limited compared to patients’ responses, showing 
the need to ensure that actors know and utilise the script fully.  This important issue, 
which must be addressed in future role-play, is supported by Nestel[130] who identified 
that good acting of the role is essential for realism and effectiveness.  Student 
questionnaire responses about the role-play display proactive and supportive words such 
as organised, realistic and informative appearing several times and demonstrate that the 
role-play session was well planned and organised, which would have facilitated effective 
training. 
Comparing first and second medication reviews with patients demonstrated no significant 
improvement in the combined scores of the individual elements of the MRCF, or in any of 
the individual elements other than that a significant improvement for ‘consultation skills’ 
scores was observed.  ‘Data collection and problem solving’ and ‘actions and solutions’ 
whilst essential parts of consultation skills, represent more technical rationalist functions 
which had been practiced extensively during the undergraduate course.  Students would 
have developed those skills, therefore, providing less room for improvement within a 
medication review.  ‘Closing the consultation’ demonstrated lowest improvement; however, 
the MRCF scoring system ‘closing’: explains what to do if patient has difficulties to follow 
plan, whom to contact, provides further appointment or contact; offers opportunity to ask 
further questions.  Silverman, Kurtz and Draper[70] state that closure is partly a reflection 
of the consultation skills throughout the medication review; however, the students met 
each patient once and, therefore, it is possible that they would not know what to do about 
future appointments, or follow-up.  Interim analysis after the first cohort of participating 
students may have identified the issue of poor performance during closure of the 
consultation thus enabling identification of the cause, which should have resulted in 
feedback to later students to resolve the issue. 
It is impossible to predict if meeting more than two patients for a medication review would 
have improved the skills of the students further, although students did request that they 
should meet more patients.  Research including Boyatzis et al.[75] and O’Neill et al.[76] 
demonstrates pharmacy students’ education benefitting from meeting more than two 
patients for medication review and for repeat consultations.  Janson et al.[81] undertook a 
study of interprofessional learners including medical, pharmacy and nursing students, 
during which repeated consultations with patients demonstrated improved consultation 
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skills by the students.  A student suggested in the on-line survey that there should be 
repeat meetings to undertake medication reviews with patients.  Nuffer et al.[132] reported 
a study of pharmacy student facilitated diabetes clinics, in which students stated a positive 
perception of their experiences when providing self-management education about 
diabetes to multiple patients. 
Data show patients scoring student-led medication reviews significantly higher than 
students’ self-assessments and may demonstrate a desire by patients to help the students, 
whilst students’ previous self-assessment experience may have led to increased self-
criticism.  Even the lowest score provided, for the question “I learnt something useful 
about my medicines”, shows patients receiving benefit from students during a medication 
review.  Patients reported finding the experience acceptable, would recommend it to 
others and report some benefit, which suggests that such training may be sustainable. 
Data demonstrates a clear relationship between the Australian study[75] mean scores and 
the UK study mean scores, with a slight superiority of scores recorded by patients in the 
UK study.  Interpretation by Boyatzis and Batty of the Australian study[75] was that 
“feedback indicated that students had demonstrated a professional approach and that 
there was general approval of the process of DMR (Domiciliary Medication Review) by 
this group of patients”.  It is reasonable to propose the same conclusion for this study, 
whilst the close relationship between scores indicates an effective questionnaire.   
Australian study patients were given the evaluation form to complete and post 
anonymously, directly to the investigators, whereas in this study patients were asked to 
complete the questionnaire immediately post-medication review.  Within this study 
patients were told that results would not be used against any student and would remain 
confidential.  An area separated from the student to ensure privacy, but in the same room 
was allocated to complete the form; however, results may still have been affected by the 
student’s presence.  Response rate in Australia was 70% compared to 96.5% in this study.  
An immediate response may produce a more accurate score, as time elapsed may affect 
recollection of events and it is also not known what effect non-responders in the Australian 
study would have on mean scores. 
Communication skills, essential for effective implementation of medication reviews, were 
the most commonly reported improvement by students.  All but one of those skills stated 
as learned by students are included in the Calgary-Cambridge guide[70].  The one not 
included is ‘controlling a conversation’ which, as worded in student responses, is not in 
the guide.  However, the definition of ‘agenda setting’ includes the healthcare professional 
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taking into account their own needs, including managing limited time.  A degree of ‘control’ 
may be required to focus discussion on patients’ problems to ensure effective patient 
outcomes, which may explain the use of the term controlling a conversation.  Other skills 
stated by students: use of medical records; clinical knowledge and the role of healthcare 
professionals, all represent knowledge required to support the use of consultation skills.  
Because students stated that they learned skills during the study, evidence is displayed of 
effectiveness of the training.  
The most rewarding part of the course was ‘working with real patients’ which formed a 
repeated theme in student responses.  This is not surprising as it was the first opportunity 
for those students to undertake medication review with patients.  Students stated that they 
partly enjoyed working with patients because contributing to patient care is rewarding and 
this provides support for a repeat of the study.  A student recognised that healthcare time 
is limited and that medication reviews cannot be open-ended.  Knowledge and skills 
learned, including clinical, use of medical records and the role of healthcare professionals, 
is highlighted again, providing further evidence of the need to provide teaching in medical 
practices to support the teaching of consultation skills.  The modernising pharmacy 
careers programme[74] states that skills are required to enable utilisation of knowledge.  
In this case, the process of skills acquisition enabled an increase not only of skills but also 
of knowledge, such as diabetes care.  Students’ wanted further experiential learning 
opportunities within the undergraduate course. 
Students volunteering to participate in this study demonstrated academic superiority over 
those not volunteering.  There is increasing evidence, mainly from USA and Australia, in 
which pharmacy students have undertaken activities similar to those in this study, 
including practising consultation skills within a medication review.  In the majority of cases 
students were volunteers and a potential criticism of their research is that, because 
students were self-selecting the probability is that those with a higher academic ability 
and/or achievement would volunteer.  The effect could be that the students were more 
effective at learning consultation skills and, therefore, results generated would not be 
generalisable.  In a study in Vancouver (2008)[123], in which pharmacy students 
participated in an experiential programme, a stated limitation was that student participants 
were volunteers, and therefore, self-selected.  This potentially resulted in a “Hawthorne-
like upward drift in both interest and performance”.  They also suggest that it is not known 
if “more mainstream” participants would generate similar results. 
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No conclusive evidence is provided by data for an effect by the study on students’ grades 
in final year exams.  This study was undertaken with volunteer students, thus requiring 
them to undertake activities in addition to their undergraduate course.  This further 
compounds the difficulty in interpretation, as the extra workload could have exerted a 
negative effect on participating students.  It is also possible that a ceiling effect applied to 
exam results, in which both groups reached their limit of improvement, potentially enabling 
the controls to reduce the academic gap.  This may be supported by the smaller standard 
deviation in both groups in the final year, which demonstrates a smaller spread of means 
of grades, which may indicate ‘bunching’ at a ‘ceiling’ or limit. 
The academic status of students leaving the study potentially affects self-selection bias of 
remaining students.  It is, therefore, justifiable to identify the academic status of students 
choosing to leave the course.  Data shows that as each leaving student departed the 
study, until student G, a general trend was observed of increase in the mean of remaining 
intervention students’ scores in the final year exam.  However, the increase in mean of 
final year exam results of students leaving the study is only 0.41% and does not represent 
a significant change.  Students leaving the study due to workload could be predicted, as 
this study was undertaken in addition to students’ undergraduate course.  Statements of 
‘not being prepared’ or ‘competent to undertake consultations’ are concerning as this 
could be evidence of a failure to effectively prepare students for the medication reviews.  
The data shows a number of possible reasons, including skills, language and confidence, 
all of which could be resolved by more effective training, therefore, provision of the 
preparative training as part of the undergraduate curriculum would present considerable 
academic and logistical benefits. 
The OSCE stations which were evaluated were medication history taking, responding to 
symptoms, medicines information (taking a request: not answering) and counselling about 
a medicine.  Through additional training, participating students had learnt to undertake 
fully interactive medication reviews with patients.  It could be anticipated that they would 
perform better than non-participating students in an OSCE, but only a very small non-
significant superiority was observed.  Possible interpretations include: OSCEs test simple 
actions rather than complex medication reviews; the assessment method used within 
OSCEs is not effective at testing consultation skills; the scenarios used do not reflect that 
of a medication review; or simply that the small numbers of students did not enable the 
identification of a statistical effect. 
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An OSCE is defined as “an approach to the assessment of clinical competence in which 
the components of the competence are assessed in a planned or structured way with 
attention being paid to the objectivity of the examiner”[133].  Hodges[134] (2003) and 
Brannick et al.[135] (2011), in a systematic review of OSCEs in the medical field, both 
discuss problems with OSCE scenarios.  Assessment in an artificial environment, such as 
a university room, is more difficult with this not reflecting true ability in a real situation.  
The Cambridge-Calgary guide[136] lists 70 skills to employ in consultations, therefore, 
requiring adaptation by the practitioner.  It may be effective to utilise an alternative OSCE 
scoring tool, which focuses on consultation skills.  The Medication Related Consultation 
Framework (MRCF)[87], assesses a range of skills, rather than actions, and has been 
used in a variety of scenarios and is, therefore, appropriate.  
It was appropriate to use the MRCF to evaluate student performance in medication 
reviews, however, it was incorporated into the study to enable structured feedback to 
students on their performance in medication reviews.  It was only during analysis of the 
study that it was decided to include evaluation of this potentially useful data, which 
reduces the likelihood of marking bias.  Support for modifying or adapting research 
methods is provided by the guidance from the Medical Research Council[48] on 
developing and evaluating complex interventions: this allows changes to data use during a 
study of a complex intervention. 
Supervision during medication reviews and feedback at all stages of the training to 
enhance student learning was fully supported due to enabling students to identify 
weaknesses and strengths in their consultation skills.  This resulted in improvement in 
students’ performance, with particular comment being made of the benefit of feedback by 
academics or supervisors between medication reviews in the role-play and real patient 
sessions. 
Responses regarding the GP (medical practitioner) feedback after the role-play session 
display far less agreement.  The GP was seen as abrupt and critical and this may 
represent a failure to undertake the role required effectively, or difficulty by students to 
adapt to meeting a GP.  The GP had previously provided medical clinical training and may 
have expected a similar standard of student performance.  Any repeat of the session 
requires better preparation of students and better briefing of the GP about their role.  
Students wanted more time for this feedback as they stated that it would improve 
performance, which is also support for retaining the session. 
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It was planned that students should present recommendations to a GP or nurse following 
each medication review session; however, this did not always occur due to availability of 
staff.  Students reported this to be a failing which affected their effective learning.  
Schon[69] provides support for feedback through discussion of thinking in action which 
entails ‘thinking on your feet’.  In this scenario, a practitioner draws on previous 
experience or experiences to enable them to resolve problems encountered.  Schon, 
however, also refers to reflection on action, or ‘retrospective thinking’, which occurs after 
the unexpected event and has particular relevance to feedback.  Discussion of what has 
taken place, feedback, can help the practitioner to improve subsequent performance(s) 
and to add to effective experience, which may be used in future reflection in action.  
Feedback facilitated by observers or more experienced practitioners enables improvement 
and learning.  Nestel and Tierney[130] (2007) support the use of feedback to medical 
students after role-play to improve subsequent student performance.  However, they 
advise caution, as students report disliking ‘unstructured, vague, non-specific feedback’ 
which they considered unhelpful.  Evidence exists that feedback is useful and effective 
and should, therefore, be retained within role-play sessions and medication reviews. 
Stress and nervousness was displayed at the start of the study, partly due to a previous 
lack of patient contact, knowledge of conducting a consultation or specifically how to 
answer patients’ questions.  Students referred to needing to know how to apply 
knowledge, which is a key recommendation in the modernising pharmacy careers 
programme[74].  Students’ stress may, therefore, result from a lack of knowledge and 
experience.  Students also reported being excited and looking forward to the study, whilst 
displaying a desire to improve consultation skills and resolve their unmet need to 
undertake learning with patients.  Research with pharmacy students undertaking patients 
consultations, e.g. O’Neil et al.[76] (2007 USA) reported that students were nervous prior 
to meeting patients, with their confidence, competence and ‘preparedness’ subsequently 
improving. 
Students recognised that whilst role-play is stressful, it provides benefit as preparation for 
medication reviews with real patients.  One student reported leaving the study due to the 
stress of role-play and the aim of teaching must be to provide an effective outcome for 
every student, with the stress they encounter managed.  Hodges[134] states that students 
can fail OSCEs due to ‘examination nerves’, yet may perform that role competently and 
regularly in practice.  Students reported experiencing stress during the role-play session 
due to assessment. 
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Student performance was observed and scored as recommended in Joyner and Young’s 
guide[117], and was to enable effective feedback, which was supported by students.  After 
meeting patients for medication reviews students stated that the experience had provided 
confidence for future contact with patients, thus relieving stress through experience. 
Students’ comments about beneficial aspects of the study are supported by Kassam et al 
(2008 Canada)[123] who reports good indicators ‘that direct interaction with patients is a 
most powerful learning tool’.  When reflecting on feelings at the end of the study, students 
displayed overwhelmingly positive opinions.  They reported being more prepared and 
confident about planning and undertaking medication reviews.  Comments display an 
understanding of individual aspects of undertaking medication reviews. 
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Chapter 5 Feasibility/Pilot Study 
5.0 Background 
The purpose of this chapter is to describe the feasibility testing of the intervention and the 
piloting of the trial.  This study is a pilot study to test the training of undergraduate 
pharmacy students within the context of providing medication reviews to patients.  The 
National Institute for Health Research[137] states that a feasibility study is a piece of 
research undertaken before a main study to answer the question “can this study be done?”  
They enable the estimation of important parameters required for study design including 
standard deviation (to enable sample size calculation), recruitment and retention of 
subjects and acceptability of the intervention.  However, the NIHR also states that pilot 
studies, similar to this study, are smaller versions of full studies, designed to test the 
working together of the main study components.  These include many of the elements 
within a feasibility study. 
In line with MRC guidance[48] on complex interventions, feasibility and pilot studies are 
performed to test procedures for their acceptability; estimate rates of recruitment and 
retention of subjects; identify the most suitable outcome measures, the effect of 
randomisation and to provide the parameters required to enable the calculation of 
appropriate sample sizes.  In evaluating the process, part of the rationale is to test the 
feasibility of experimental design.  Importantly this is stated by MRC to be an essential 
step in the development and testing of an intervention in addition to the use of theory and 
existing evidence from systematic reviews or literature reviews. 
Specifically it was stated by Arian, Campbell and Cooper[138] that the definition of a 
feasibility study is a piece of research done before a main study used to estimate 
important parameters that are needed to design the main study, which include standard 
deviation of the outcome measure in order to estimate sample size.  In addition to 
elements stated in MRC guidance, they refer to the willingness of patients to be 
randomised, willingness of clinicians to recruit participants and responses to 
questionnaires.  They also state that a pilot study is a version of the main study that is run 
in miniature, to test whether the components of the main study can all work together and 
is focused on the processes of the main study, and this must, therefore, be analysed.  
They agree that a pilot will resemble the main study in many respects. 
MRC states that a crucial aspect of the design evaluations is the choice of outcome 
measures, recommending that they are evaluated to assess importance and that whilst 
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single primary outcomes are preferable, more may be used in such a study.  Within this 
study co-primary measures were used to establish the most appropriate for use in a full 
trial.  Co-primary outcome measures were utilised as allowed within pilot studies by MRC 
guidance[48] and represented best practice.  Patients’ questionnaires provided additional 
secondary measures which MRC states should be evaluated.   
5.1 Aims and Objectives 
The aim of this study was to identify the feasibility of repeating this study as a full study. 
 
The objectives of this study were to: 
• describe the recruitment rates and retention rates for patients, 
• describe the response rates for questionnaires, 
• observe effects on the primary outcome measures, 
• explore the potential effect of student medication review on a range of outcome 
measures, 
• describe and characterise student interventions, 
• describe the interventions made by the supervisor with student care issues during 
the medication review process, 
• calculate the standard deviation of the outcome measures and then calculate the 
sample size required for a full RCT, 
• identify the most appropriate outcome measure. 
5.2 Results 
5.2.0 Patient Recruitment and Retention. 
All medical practices were in market towns in Norfolk apart from one practice which is 
situated in a city suburb of Norwich. 
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Table 5.1 displays characteristics of the participating medical practices.  It demonstrates 
that no major differences existed, other than the lower level of people in Costessey who 
were classed as healthy. 
The source of data was Norfolk insights (available at http://www.norfolkinsight.org.uk/).  
Data collected 2011.  
Area 
% of 
people 
over 65 
years of 
age 
% of 
people 
classed 
as 
healthy 
% of people 
with pre-
existing 
health 
problem 
% of 
people 
with 
adult 
obesity 
% of people 
over 17 years 
of age with 
type 1 or 2 
diabetes  
Wymondham 20.5 53 15 25 5 
East Dereham 22.0 41 22 27 6 
North Walsham 25.1 47 16 25 6 
Costessey 21.0 33 13 23 5 
Hoveton & Wroxham 24.0 49 13 24 6 
Norfolk average 21.4 45 18 24 6 
Table 5.1 Characteristics of areas in which medical practices situated 
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Table 5.2 demonstrates the patient recruitment rates for each of the five medical practices 
within the study.  Expected rates of recruitment predicted by medical practice staff were 
approximately achieved in all but one practice.  One practice (Wymondham) telephoned 
30 non-responding patients but recruited no additional patients.  On their advice no further 
telephone calls were made.  The researcher received three comments from patients at 
Hoveton & Wroxham medical practice about postal charges.  They had been asked to pay 
additional postal fees in order to receive letters with insufficient postage paid, which 
transpired to be recruitment letters. It was later found that the practice had used second 
class stamps for those patients which was insufficient.  It is not known if other letters were 
similar. 
Medical Practice 
location 
No. of 
registered 
patients 
No. of 
GPs 
 
No. of 
letters 
posted 
No. of 
patients 
recruited 
Recruitment 
rate (%) 
demonstrated 
Wymondham  18,238 13 151 26 17.2 
East Dereham  9,500 6 163 32 19.6 
North Walsham  7,198 6 174 35 20.1 
Costessey  11,938 9 124 23 18.5 
Hoveton  8,231 6 180 17 9.4 
Totals 
  792 133 16.8 
Table 5.2 Patient recruitment statistics. 
Figure 5.1 displays a summary of patient recruitment and retention. Of 792 patients 
approached by unsolicited letter via their medical practice (Appendix D), 133 were 
recruited and randomised to control or intervention (n=67, i.e. 83.75% of target number of 
160).  The overall recruitment rate was 16.8%.  
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Figure 5.1 Patient recruitment process. 
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5.2.1 Patient baseline clinical, questionnaire and demographic data 
Table 5.3 presents baseline data (at recruitment) for control and intervention patients.  
This includes demographic and clinical data in addition to results of patient completed 
questionnaires.  Data demonstrates that randomisation resulted in reasonably comparable 
groups.   
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Characteristic Measure Intervention 
patients 
(n=67) 
Control 
Patients 
(n=66) 
Age Mean (SD) 69.18 (10.46) 68.31 (9.46) 
Male No. (%) 45 (68%) 38 (58.5%) 
HbA1C mmol/mol Mean (SD) 56.81 (11.12) 59.71 (13.92) 
Total Cholesterol mmol/L Mean (SD) 4.14 (0.99) 4.19 (0.91) 
Blood pressure mm Hg 
Systolic 
Diastolic 
 
Mean (SD) 
Mean (SD) 
 
132.48 (11.98) 
73.22 (8.15) 
 
131.65 (10.90) 
72.13 (9.54) 
Euroqol QOL scale 
 
Median (IQ) 
(n=45) 
80 (70,90) 
(n=48) 
80 (70,90) 
SIMS 
Total 
Action and use 
Potential problems 
 
Median (IQ) 
Median (IQ) 
Median (IQ) 
(n=43) 
12 (7,17) 
7 (4.75,9) 
5.5 (2.25,8) 
(n=47) 
12 (8,15.5) 
7 (5,9) 
5 (2,8) 
BMQ 
Necessary 
Concerns 
 
Median (IQ) 
Median (IQ) 
(n=43) 
18 (16,21) 
11.5 (10,14) 
(n=47) 
19 (17,21) 
13 (10,16) 
MARS 
 
Median (IQ) 
(n=43) 
24 (23,24) 
(n=47) 
24 (23,24) 
DTSQ 
Treatment satisfaction 
Problem-hyperglycaemia 
Problem-hypoglycaemia 
 
Median (IQ) 
Median (IQ) 
Median (IQ)s 
(n=45) 
30 (26,35) 
1 (0,3) 
0 (0,1) 
(n=48) 
31 (26,34) 
2 (0,3) 
0 (0,3) 
Using a Medicine 
Compliance Aid (MCA) No. (%) 44 (47.7%) 
48(43.8%) 
 
Table 5.3 Baseline data for control and intervention patients. 
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5.2.2 Patient Six Month Follow-up Data (Clinical and Questionnaire) 
Table 5.4 presents a comparison of follow-up data (six months post-intervention) including 
clinical data and results of patient completed questionnaires.  Completed questionnaires 
were returned by 101 (85.6%) of patients.  Not all questions were answered by all 
patients.  Data demonstrates significant differences existing between intervention and 
control groups only for change in quality of life and some elements of SIMS. 
Within the results the test used to identify the p value is indicated by # Independent 
samples t test, * Mann Whitney U, $ Fisher’s exact test 
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Table 5.4 Follow-up data for control and intervention patients. 
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Figure 5.2 presents the results of SIMS questionnaire at follow up (six months post 
intervention) comparing intervention and control group patients’ responses and 
demonstrates that patients in the intervention group were significantly more satisfied with 
five parameters (one action and uses, four concerns) 
Control n= 34 Intervention n= 36 
 
Figure 5.2 presents a comparison of individual SIMS questions 
0 20 40 60 80 100
Will it affect your sex life
Will it make you drowsy
Intefer with other meds?
Can you drink alcohol
How to manage side effects
Risk of side effects
If the drug has a side effect
What to do if forget a dose
How to get a further supply
How to use them
How long need to be on them
How to tell if meds working
How long they take to act
How they work
What they do
What medicines for
What medicines called
Intervention Control
Percentage of patients answering questions 
*
*
*
*
*
* denotes p value < 0.05, 
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Data in Table 5.5 provides a comparison of control and intervention patients’ responses to 
additional questions asked in the follow up questionnaire at six months post-intervention. 
No significant difference exists between control and intervention.  The data demonstrates 
that during the previous three months very few patients in either group spoke to their 
pharmacist regarding any issue. 
Question regarding previous 3 
months 
No. Median 
(IQ) 
No. Median 
(IQ) 
P value. 
Mann 
Whitney 
Intervention Control 
No. times spoke to pharmacist 50 0(0,1.25) 48 0(0,1) 0.738 
No. times asked pharmacist 
about extra information 38 0(0,0.25) 34 0(0,0) 0.634 
No. times asked pharmacist 
how to use medicines (MUR) 40 0(0,0.75) 35 0(0,0) 0.742 
No. times asked pharmacist 
about minor condition 39 0(0,1) 36 0(0,0.25) 0.415 
No. times asked pharmacist 
about whether to see doctor 38 0(0,1) 36 0(0,0) 0.225 
No. times asked pharmacist 
about other things 35 0(0,0) 33 0(0,0) 0.110 
 
Table 5.5  Additional question responses (follow-up questionnaire) 
Twenty five (55.5%) patients who had met a student for a level 3 medication review 
agreed or strongly agreed that they were far more likely to speak to a pharmacist about 
their medicines or their health following the medication review, whilst 11 (24.5%) were 
unsure. 
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5.2.3 Intervention approval 
Table 5.6 displays the category, number and percentage of pharmacist approvals of 
student interventions at level 2 and 3 medication review (where recorded).  This 
demonstrates that the majority of interventions were identified by students unaided, and 
approved by a pharmacist without changes.  In a very small number of cases additional 
advice was required by the student.  Very small numbers of intervention were rejected by 
the supervising pharmacist or raised by them because student had not identified the issue. 
Pharmacist approval category Level 2 Level 3 
 No. 
 
No. 
 
A. Issue identified by student and approved by 
pharmacist. 
420 (92.4%) 40 (90.9%) 
B. Issue identified by student and accepted but 
with pharmacist input. 
18 (4.0%) 1 (2.3%) 
C. Identified by student but rejected by 
pharmacist 
2 (0.4%) 0 
 
D. Issue identified by supervising pharmacist. 
 
15 (3.3%) 3 (6.8%) 
Total 
 
455  44  
Table 5.6  Summary of intervention approvals 
5.2.3 Intervention examples 
To aid interpretation examples of interventions identified by students during level 2 
medication reviews are provided in Appendix F, with pharmacist approval status and 
intervention type displayed.  The issues displayed demonstrate a wide range of 
intervention type. 
Full data is also presented in Appendix F. 
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5.2.4 Supervisor Observations. 
Pharmacists supervising medication review observed that, on a regular basis, students 
failed to record all care issues identified during level 3 medication reviews.  Observation 
identified that the most likely reason was concentration on the patient and general 
consultation issues, with time constraints creating pressure. 
Whilst an electronic care plan utilising drop down boxes of options and formatting to 
enable easy data entry was devised and tested with students the pharmacists undertaking 
supervision of medication review observed that students preferred to use a paper version 
of the care plan during medication reviews.  Care plans were printed and used by the 
students during both level 2 and level 3 medication reviews to record issues and data, and 
as a reference source. 
It was planned to have a GP available after each level 2 or level 3 medication review for 
students to present any recommendations arrived at during the process, and for the GP to 
then provide feedback.  Due to the availability of GPs, this was only possible on one 
occasion.  Specialist diabetes practice nurses undertook this function, but were 
unavailable on ten out of twenty seven occasions.  In addition, nurses stated that, whilst 
students identified care issues for all conditions exhibited by patients, they could only 
respond to issues related to diabetes. 
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5.2.5 Student identified care issues 
455 interventions (range 2 – 12 per patient) were recorded during the level 2 medication 
reviews for 64 patients.  These were classified as in Chapter 2.  Figure 5.3 shows the 
reasons for the different types of intervention recorded by students at level 2 medication 
review.  The most frequent interventions identified were allergy or side effect status, 
obtaining and providing information about lifestyle issues, issues related to medical or 
medication history, and adherence with prescribed medication regimes. 
Figure 5.3 Summary of level 2 medication review interventions. 
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44 interventions were recorded for 18 patients by 15 students during level 3 reviews and 
these are summarised in Figure 5.4.  The most frequent interventions identified were 
allergy or side effect status, issues related to medication history or medical history in 
addition to education of the patient regarding their medication, disease or lifestyle.   
 
Figure 5.4 Summary of interventions identified during level 3 medication reviews. 
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Figure 5.5 displays the 204 medication related interventions recorded by students at level 
2 medication review by BNF section.  This demonstrates that Gastro intestinal, 
cardiovascular and endocrine and central nervous system medications represent the 
majority of interventions recorded by participating students. 
Figure 5.5 Summary of level 2 medication review interventions coded by BNF. 
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Figure 5.6 displays the 25 medication-related care issues recorded by students at level 3 
medication review, coded as percentage by BNF section.  This demonstrates that Gastro 
intestinal, cardiovascular and endocrine, and central nervous system medications 
represent the majority of interventions recorded by participating students. 
 
Figure 5.6 Summary of level 3 medication review interventions coded by BNF. 
5.3 Sample size calculation 
The target level of HbA1c reduction used for the calculation of the sample size required 
for a definitive study was 0.5% (5.5mmol/mol), which is the level generally accepted to be 
of clinical relevance[139].  
The target level of systolic blood pressure reduction used for calculation was 3.3mmHg 
which was the level calculated in a study by Lee(2006)[140].  In this study a pharmacist 
intervention programme produced a reduction in SBP of 3.3mmHg which was claimed to 
be significant.  This is in accordance with the greatest significant SBP reduction in the 
trials reported by Staessen(2005)[141], of 3.2mmHg, where new versus old medications 
were tested. 
Total cholesterol was collected because data relating to LDL and HDL cholesterol in 
serum was not available from all participating GP practices.  This prevented comparative 
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analysis.  However, publications such as that by the Cholesterol Treatment Trialists[142] 
and NICE guidance[143] recommend that LDL cholesterol in serum is used to guide 
research and treatment, in addition to overall reduction in cardiac risk calculated by Qrisk.  
No clinically important reduction quantities in relation to total cholesterol are provided.  It is 
not appropriate to calculate the sample size, as this would entail using non-evidence 
based data.  With no target reductions published by regulatory authorities, a reliance on 
target levels would not enable calculation of sample size.  It is recommended that Total 
cholesterol is not used as the primary outcome measure for a full study 
Table 5.7 displays the sample sizes which data provided from the study would suggest 
would be required for a future definitive study based on clinically important differences.  
The numbers of patients required in each group to provide 80% power are stated. 
Utilising clinical data collected from patient participants in this study it was calculated that 
159 patients would be required in each group (intervention and control) to demonstrate a 
clinically significant effect by the intervention if HbA1c is used as the primary outcome 
measure.  If the current level of student intervention (two medication reviews per student) 
is maintained then, using a figure of 160 patients per arm, 80 students would need to be 
recruited to enable each student to undertake two medication reviews. 
Only 3 of 67 (4.47%) intervention arm patients left the study for unavoidable reasons. 
Other patients leaving the intervention arm could be avoided following observation of 
reasons documented in this study.  Therefore, to allow for losses to the study an 
additional 7 patients would be required in each group.  
Output measure Standard 
error of mean 
difference # 
Standard deviation 
of mean difference 
Clinically 
important 
difference 
Unit of 
clinical 
measure 
No, of 
patients 
required 
in each 
group 
HbA1c 2.28 17.5 5.5 mmol/mol 159 
Systolic blood pressure 2.27 12.47 3.3 mm Hg 224 
Table 5.7 Sample size calculation for future definitive study 
# = calculation by independent samples t test in SPSS 
5.4 Discussion 
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The study identified that approximately 20% of patients approached by their GP would 
consent to participate in student-led medication review clinics.  Questionnaire response 
rates were high, both at baseline and at follow-up, for both control and intervention groups 
and drop-out rates were minimal.  Consequently a cohort of 100 students would be 
sufficient to provide the intervention to 159 patients in a definitive trial utilising HbA1C as 
its primary outcome measure with a desire to demonstrate a clinically important difference. 
Randomisation resulted in comparable groups; however, clinical parameters before 
intervention were largely within normal treatment ranges resulting in limited opportunities 
for students to demonstrate a positive effect. 
Whilst there were no significant differences observed for clinical parameters after 
intervention, patients in the intervention group demonstrated significant superiority with 
respect to change in quality of life at follow-up. 
Scores relating to information about medicines, measured by SIMS, displayed statistical 
significance for intervention patients for subjects which would be expected to improve 
adherence, however, adherence was not identified to be improved by the intervention. 
The high reported multi-compartment device use and good level of control may explain 
this. 
The number and range of care issues identified by students demonstrates that they 
possess and can utilise, in a patient-focussed manner, the technical skills required within 
medication reviews.  Data suggest some students conducted effective medication reviews, 
as illustrated by the issues identified and accepted during patient medication reviews.  
Data recording by students after level 3 medication reviews was poor and this must be 
addressed if an RCT is undertaken, as it prevents a full analysis of consultation 
competence. 
Lack of GP availability for meetings to review care issues must be addressed in a full RCT.  
It is unsurprising that GPs failed to implement care issues, as some may not have been 
passed to them by specialist nurses, but this may have reduced the potential clinical effect 
of the student-led medication review.  Utilising the medical supervisors working with the 
study to negotiate with the GPs may prove more effective if a full study is undertaken. 
The data obtained enabled the calculation of a sample size and definition of the most 
appropriate primary outcome measure for a full trial. 
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This is a feasibility and pilot study which is recommended by MRC guidance[48] to 
evaluate interventions prior to implementation of larger studies.  The range of outcome 
measures represented sensible measures which could be readily and accurately obtained 
and which provide a good means of measuring the effects.  Recruitment and retention of 
participants, in particular patients, demonstrated very good rates, with the majority of loss 
of retention due to external factors such as illness.  The data obtained are of a quality and 
quantity to enable the effective design and implementation of a future study. 
Relatively large numbers of patients were recruited to the feasibility/pilot study thus 
enabling some significant differences to be identified, although this was not the aim of the 
study.  Data collection was demonstrated to be effective with accurate data recorded for 
recruitment and retention rates thus enabling the effective design of a future full study.  
The response rate for completion of patient questionnaires was high.  Students 
demonstrated technical competence and consultation skills which is evidence of success 
in a number of elements of this trial.  The quality of life data obtained will enable the 
estimation of cost-effectiveness. 
However not all care issues identified at medication review were recorded, making 
analysis difficult.  A meeting between a student and a GP only occurred on only one 
occasion, and it is not known if issues presented to specialist nurses were passed to the 
GPs for implementation.  Intervention codes used to evaluate care issues identified by 
students were not validated. 
Data demonstrate that whilst patient recruitment for this pilot study was possible it did not 
achieve the full target.  It is noteworthy that the overall rate was reduced because one 
medical practice achieved only approximately 50% of the recruitment rate of the others.  
Evidence is, therefore, presented that, as a pilot study, success was achieved in 
establishing the likely recruitment rate for a full study which was 83.75% of anticipated 
rates.  The low rate in one practice may have resulted from a clerical error when posting 
recruitment documentation.  A sensible solution may be for documentation to be put into 
envelopes and stamped at the university and delivered to medical practices for posting.  If 
that practice had recruited at the same rate as other practices the overall recruitment rate 
would have been approximately 94% of target (160).  Telephone follow-up of non-
responding patients in one medical practice resulted in no additional recruitment, 
suggesting that reliance on the initial posting may be sufficient. 
This study sought to recruit patients with T2DM, due to the availability of national 
guidelines for prescribing and the potential population size.  In a full study, it may prove 
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useful to consider widening the potential pool of patients for recruitment by including other 
medical conditions.  MRC guidance[48] recommends that pilot studies establish 
recruitment rates[82 144 145], and that these should relate to the wider community.  
However, recruitment was designed to achieve maximum achievable rates for the desired 
patient group of patients with T2DM and changing the target medical condition may 
require further piloting to ensure recruitment reaches desired rates. 
Baseline data show the mean age of recruited patients was over 68 years with 
approximately 10 years standard deviation in each group.  In 2011, 56.5% of people with 
T2DM in England were over 65 years of age[146].  The recruitment of a greater number of 
younger patients may have presented more opportunities for improving patient care.  
Younger patients with diabetes present a greater potential for preventable long-term 
complications due to their greater potential lifespan.  If a full study is undertaken in 
another part of the country, a different demographic profile may be recruited. 
Retention rates were high, with only one patient lost prior to the first intervention (level 2 
medication review), due to inappropriate inclusion by the medical practice.  Early in the 
study, two patients were removed from the study after their records were accessed by a 
student who then left the study.  On reflection, they could have been retained in the study 
for a medication review with another student, and this was the case with a small number 
of other patients.  In those cases, the student taking on the case was given access to the 
patient’s medical records as preparation for the medication review.  The remaining 
withdrawal of intervention group patients included four unavoidable ones due to health 
and two people who forgot to attend for their appointment.  These last people indicate that 
patients should be provided with written appointments, rather than the verbal ones 
employed in this trial. 
The high response rate to questionnaires demonstrated by patients, both at baseline and 
follow-up enabled a greater confidence in results.  In addition, high response rate to 
questionnaire data show a large commitment to participation in this form of research and 
provides further confidence that a full trial may be successful in recruiting patients and 
obtaining reliable results.  During the development phase focus groups it was 
recommended that the need for control patients must be stated in recruitment 
documentation.  These results demonstrate further, that this was achieved. 
Intervention and control groups of patients did not display significant differences at 
baseline (recruitment) which provides confidence that any effects seen at follow-up are 
due to the intervention. 
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Follow-up was undertaken at six months post-intervention to allow any effects to stabilise, 
Individual clinical measures, such as HbA1c, would not normally be measured before this 
time-point (certainly not before three months[82]) because it is a long-term measure of 
glucose control.  No significant clinical effect was observed, with both intervention and 
control patients displaying a mean BP within targets[82] for patients with type 2 diabetes.  
The large standard deviation indicates a potential for optimisation of some individuals.  
The desired target for patients with T2DM who also exhibit cerebrovascular disease or 
microalbuminuria is lower (130/80).  Data were not collected to establish the incidence of 
those patients, although a small number being diagnosed with these conditions and 
aggressively treated could exert a large effect on a group mean.  It, therefore, appears 
sensible to collect this data for a full study. 
Total cholesterol for both groups was within generally accepted targets, and guidance[82] 
suggests focussing on overall cardiovascular risk, rather than absolute cholesterol levels 
unless new cardiovascular disease or increased albumin excretion, is observed, when the 
target is <4.0mmo/l.  Levels observed are close to 4mmol/l, and a similar situation exists 
to that with BP, i.e. it is recommended that albuminuria and new cardiovascular conditions 
should be recorded in a full study to allow for required tight control.  In routine clinical 
practice total cholesterol of approximately 4mmol/l is generally accepted. 
Whilst many studies state the importance of BP in the control of micro and macrovascular 
events[94], diabetes is a condition characterised by raised blood glucose, the control of 
which is still important[82 147].  It is acceptable to recommend that HbA1c is utilised as 
the primary outcome measure in a future full trial, however, HbA1c results indicate that no 
significant change occurred for either group.  Guidance[82] recommends a target HbA1c 
of 6.5% (48mmol/mol), with acceptance that negotiation may be undertaken with 
individual patients for a higher level of up to 7.5% (58mmol/mol).  It is agreed that lower 
HbA1c levels predispose patients to hypoglycaemia[147] and, in some cases, to weight 
gain due to the medicines required to achieve this.  This has led to the commonly 
accepted scenario of higher HbA1c levels.  It is not, therefore, surprising to see the levels 
identified in clinical practice. 
Within the scenarios displayed above it would have been difficult for a pharmacy student 
to make a significant change to the intervention group patients.  There may have been 
opportunities for individual patients, but the utilisation of group means as outcome 
measure makes individual changes harder to detect.  It is possible that inclusion of 
patients nearer to diagnosis would have presented more opportunities for improvement.  
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With the uncertainty demonstrated and with the acceptance that HbA1c may be 
negotiated for individual patients, the use of HbA1c as a sole outcome measure may 
present an insuperable barrier for students.  Therefore, the inclusion criteria for 
participating patients should ideally be amended.  Whilst this may affect recruitment rates, 
the process in this study was to randomly select sufficient patients to approach from the 
pool available.  It therefore may have been more appropriate to only select from those 
with raised HBA1C levels.  
The lack of available GPs for all but one session for students to discuss care issues 
reduced the likelihood of implementation.  This would have prevented students from 
exerting a direct effect on patient outcome measures, other than via changes in patient 
behaviour.  Recommendations were provided to nurses in paper form or sent by email, 
but again did not appear to result in implementation.  McCollum[80] identified that only 32% 
of issues sent to a medical practitioner by a pharmacy student were accepted with a range 
of zero to 60%.  Studies by Lindquist[148] and Pound[149] both identified that care issues 
which are presented to a medical practitioner orally result in a higher acceptance rate.  
Further evidence, therefore, exists that a repeat of this study should seek to ensure oral 
presentation of recommendations to GPs by students. 
Few significant effects were demonstrated within the results from patient completed 
questionnaires (baseline and at six months post-intervention).  However, a significant 
positive effect was demonstrated for change in patient reported quality of life (QOL) for the 
intervention group.  It was stated above that improvements in clinical outcomes were not 
demonstrated for the group mean.  Individual patients may have benefitted clinically but 
without data this cannot be discussed effectively.  Therefore, the improvement in QOL 
may be assumed to be due to an appreciation of the medication review; changes to 
lifestyle resulting from the medication review; improvements in medicine taking; a 
reduction in concerns about medicines; or at this stage could be a type 1 error. 
Little[64] (2001), in contrast to Pilnick[150], observed doctor:patient consultations and 
concluded that patients prefer a patient-centred consultation and that “if doctors don't 
provide a positive, patient-centred approach, patients will be less satisfied, less enabled, 
and may have a greater symptom burden and higher rates of referral”.  This provides 
support for the student-led consultations being of a good quality and resulting in improved 
QOL.  However, a Royal College of General Practitioners (RCGP) report[151] 
recommends research into medication reviews by non-medical professions (including 
pharmacy) as they may help adherence, because some patients are reluctant to express 
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doubts or concerns about medicines due to a fear of displeasing the doctor.  It is possible 
that patients enjoyed simply talking about their medicines to a student who did not 
represent an authority figure. 
Significant intervention group superiority was observed in some elements of SIMS[91] 
which demonstrates improvement in satisfaction with information about medicines.  The 
majority of significantly superior results for questions relate to ‘potential problems’ rather 
than ‘actions uses’, where many items would already be known by patients who had taken 
medicine for an extended period.  Patients in this study had a diagnosis of diabetes for at 
least two years, which can be described as an extended period.  Horne et al.[91] (2001) 
state that higher levels of satisfaction with medicines information were associated with 
higher levels of reported adherence.  The current study demonstrates that patients who 
had received a student-led medication displayed lower concern about potential problems 
with their medicine than patients who had not received a consultation.  The improvement 
in reported SIMS by participating patients did not result in an improvement in adherence 
as reported by MARS.  This displayed no significant difference between control and 
intervention patients, which is potentially unexpected[91].  It has been stated, however, 
that MARS should not be used as an exact measure of medicine-taking behaviour, but 
rather to provide an indication of their overall standing with regard to adherence[152].  
Additionally, doubt has been cast on the accuracy of self-reported scales of adherence 
including MARS[153 154], due to a desire by patients to be viewed in a good light and 
maintain self-esteem through socially acceptable responses.  However, the use of postal 
questionnaires and confidentiality, as undertaken in this study, has been stated to reduce 
this risk[154].  Farmer[154] also discusses the wording of MARS in which the questions 
refer to ‘not taking medicine’ rather than ‘taking medicine’, which could conflict with the 
theories of Ajzen and Fishbein[155]. 
Ajzen in his theory of planned behaviour[156], states that the dispositional prediction of 
behaviour is problematic, with poor predictive validity of attitudes to predict behaviour.  
However, aggregation of specific behaviours across occasions, situations and forms of 
action has more validity.  Planned behaviour is stated to be an extension of reasoned 
action in which a central factor is the individual’s intention to perform a behaviour such as 
taking a medicine.  A strong intention will result in positive action, but requires, amongst 
other things, resources, which in this case would include skills and knowledge.  By 
providing a patient with information about medicines, they have gained knowledge and 
possibly skills.  A central element of planned behaviour is perceived behavioural 
control[156], which again relates to resources and opportunities, which dictate the 
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likelihood of behavioural achievement (medicine taking in this case) through reduction of 
barriers.  Ajzen reports that perceived behavioural control refers to people’s perception of 
the ease or difficulty of performing a task, with expectancy of success being a major 
factor.  With effective consultation with a patient during a medication review, a pharmacy 
student could be expected to provide information (knowledge) and reduce barriers through 
reduction in fears about side effects or provision of information of how to manage side 
effects. These factors would all reduce concerns if undertaken correctly and the students 
could provide patients with an expectancy of success with medication taking.  It is 
surprising, therefore, that the positive effects in SIMS did not result in a significant effect 
displayed in MARS, especially as the students used recommended techniques and 
endeavoured to provide assistance rather than treat non-adherence as a failure[157]. 
Both groups of patients displayed a high use of multicompartment aids to assist with 
medicines taking.  It is probable that this would have exerted a considerable positive effect 
on adherence prior to participation in the study, thus reducing any possible effect from the 
student-led medication review.  The inclusion of patients closer to diagnosis may present 
further opportunities for students to influence factors such as adherence or medicines 
information as, at that stage, patients will have a greater need for education about their 
medicines.  Returning to Ajzen’s[156] theory, an early provision of support and information 
may enable greater adherence and satisfaction through the provision of resources, which 
in this case would be represented by information. 
A systematic review by Cramer[158] (2004) in patients with type 1 and 2 diabetes reported 
that adherence to oral hypoglycaemic agents ranged from 36-93%.  Cramer, when 
discussing information provided to patients, only states that information should be 
provided to the patient about what to do if they miss a dose or if adverse effects are 
‘bothersome’.  The questions in SIMS which display a statistically significant effect, related 
to side effects, drowsiness and what the medicines are for.  A report by the Royal College 
of GPs[151] states that patient concerns, including side effects, should be addressed as 
they can affect adherence to medication.  The failure to influence adherence, therefore, 
cannot fully be explained. 
An alternative tool to test adherence would be the Morisky Medication Adherence Scale 
(MMAS-4)[159 160], which provides a ‘reasonably accurate’ estimate of adherence[159].  
The scale is also short and easy to complete for patients, which is important to ensure 
completion.  Collection and evaluation of the frequency and amount of issues of patients’ 
prescriptions, as an alternative method of adherence testing, would only provide an 
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indication of adherence, as in reality it would only inform us how many unit doses of 
medications the patient potentially received.  This would take no account of collection of 
the medicine or of subsequent administration, and therefore, the MMAS-4 is 
recommended. 
No significant difference was observed between the intervention group or control group 
results for DTSQ or BMQ at the six month follow-up, as reported by self-completed 
questionnaire.  This included self-reported incidence of hypo or hyperglycaemia, which 
displayed good glucose control at both baseline and post-intervention.  With low incidence 
of these problems at baseline, there was little potential for students to make any 
significant positive impact on outcomes for patients seen at medication review. 
To provide more opportunities for students to demonstrate effectiveness and patient 
benefit, other patient recruitment strategies may be recommended.  The recruitment of 
patients with known, or suspected non-adherence, would meet the requirements.  In order 
to achieve this, the patient criteria of T2DM may require amending to include a range of 
conditions, in order to provide a suitable pool of patients for recruitment.  In addition, 
researchers would need to ensure effective identification of suitable patients at 
participating medical practices.  An alternative recruitment approach would be to recruit 
patients with a recent diagnosis, rather than greater than two years.  These patients would 
have a greater requirement for education about medicines and, therefore, provide greater 
opportunities for students to provide patient benefit and effectiveness. 
The data demonstrate that fourth year pharmacy students are capable of identifying 
pharmaceutical care issues, during level 2 medication reviews, which in the opinion of the 
experienced supervising pharmacists, are appropriate for use in patient care.  
Participating students identified a wide range of issues, as coded against intervention 
criteria, during both level 2 and level 3 medication reviews.  Fewer care issues were 
identified for intervention criteria of ‘special needs’, ‘compliance aids’ and ‘pharmacy use’ 
at level 2.  ‘Special needs’ is surprising, as this is taught and included as a key care 
planning issue within the undergraduate course.  The reason is not known, but it may be 
that the issues were recorded already in the medical records or that they were forgotten 
by the students.  As the students do not yet work on a regular basis in practice, they 
would not be used to advising on compliance aids or use of a pharmacy.  Results show 
allergy status, obtaining lifestyle information, medical and drug histories and compliance 
as the majority of issues identified.  These factors are practiced by undergraduate 
pharmacy students and, therefore, would be expected to perform well.  The small number 
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of issues related to over-the-counter medicines and herbal products, as well as education 
about medications, is surprising as these factors are well practiced at the university and 
may show a need for additional preparative training.  Issues identified at level 3 
medication review are harder to interpret due to the lack of recording.  However, there is 
some evidence of a concern to ensure checking of allergy status and obtain good drug 
history data, whilst educating patients about lifestyle and medicine use.  Allergy status has 
been shown to be poorly recorded in medical records[161] and identification of this by 
students presents possible patient benefit.  In a full trial, the recording of all student 
interventions is essential. 
The patients in this study had been diagnosed with T2DM for at least two years and 
therefore the opportunity for intervention may have been minimal. Participating students 
demonstrated that they are also capable of identifying a range of care issues for other 
disease states suffered by intervention group patients.  The most commonly identified 
issues were related to BNF sections for endocrine and cardiovascular.  Diabetes is 
frequently referred to as a cardiovascular disease[147] and it is appropriate that this 
frequency of cardiovascular issues was identified.  In addition, the students identified 
issues for a wide range of BNF sections, which, also shows an attempt, and possible 
competence, at applying a holistic approach to patient care.   
The small number of issues rejected by the supervising pharmacists demonstrates that, 
although students still require supervision, they are capable of safe and effective work.  
Supervising pharmacists identified a very small number of issues which had not been 
identified by a student.  Some of these appear to represent the normal day-to-day work of 
a PCT pharmacist, such as the requirement to change glucose testing strips.  Such a 
change would be undertaken for financial reasons and it is unlikely that an undergraduate 
student would be aware of these issues.  In addition, the need to monitor 
Dronedarone[162] would not have been known by a student as it was a recent Drug 
Safety Update from the MHRA and the medical practice were apparently not even aware 
of the new requirements.  This issue presents an unexpected patient benefit from student-
led medication reviews, as it was identified and implemented only because the researcher 
reviewed the medical record with the students. 
Data demonstrate students capable of identifying pharmaceutical care issues during level 
3 medication reviews which were not previously identified at level 2 medication reviews.  
Unfortunately it was found that students did not record all of the identified care issues and 
this prevents a full description of the activities undertaken within the medication reviews.  
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In any subsequent research this issue must be addressed.  The most likely solutions 
would be either a simpler recording system, or more time made available at the end of the 
medication review for completion of records.  Alternatively, the supervising pharmacist 
could record issues identified.  With more consultation experience the students may find 
the issue of recording to be easier. 
The benefit of undertaking student-led level 3 medication reviews cannot be fully 
assessed.  However, results obtained demonstrate a number of patient-focused issues 
which could only have been identified whilst consulting with a patient.  An example is a 
female patient stating that her most important issue was ankle oedema which prevented 
her from wearing dresses, due to embarrassment.  The care issue was not recorded, or 
even known about by the medical practice.  A student identified a patient with asthma 
prescribed propranolol and exhibiting respiratory problems.  Data also displays a student 
possessing and using effective consultation skills by identifying that a patient was willing 
to join a smoking cessation programme. 
Specialist nurses involved in the study also reported that pharmacy students had identified 
care issues, which had not been previously identified because patients had not mentioned 
these to doctors.  Pilnick[150] (2011) identified that ‘an asymmetry lies at the heart of 
medicine’ and that it is unreasonable to expect doctors to change consultations to be 
totally patient-centred, as the asymmetry is why patients and doctors are there.  In a 
scenario where patients recognise doctors as in control, they may be hesitant in informing 
doctors of some issues.  Patients may, as suggested earlier, still like to tell somebody 
about some health or medication problems, and may tell a student as representative of a 
non-threatening or non-authoritative presence. 
Students’ preference for paper copies of the care plan, compared to electronic ones, was 
surprising.  This does identify, however, that assumptions must not be made within a 
research study.  In spite of the electronic care plan being trialled with one student, and 
also used by students during a preparative training workshop, no formal feedback was 
requested from the students.  Had this been undertaken, the preference for a paper copy 
may have been identified earlier.  Data in Chapter 3 showed one patient in a focus group 
recommending that a guide was required for students during a medication review.  The 
care plan was initiated not only to act as a record at level 2 and level 3 medication reviews, 
but also to act as a guide for the students.  It detailed those elements of a consultation 
which should be discussed and recorded (see Chapter 2 for development).  The wide 
range of care issues identified by students, which include each intervention group (each 
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intervention group describes one section of the care plan) is partial evidence of care plan 
effectiveness as a guide to care planning.  Students were instructed about NICE 
guidelines[82 144 163] during the undergraduate degree and reminded during the 
preparative training.  These guidelines provided additional structure for identifying care 
issues. 
When patients were asked additional questions at follow-up which related to pharmacy 
use, they did not present evidence of any significant effect on the number of times that 
patients spoke to a pharmacist about a range of issues.  Reasons cannot be speculated 
with accuracy; however, it is possible that intervention patients had no need to seek 
further advice during that period as they had been provided with information at the 
medication review.  Support for this view is provided because a large percentage of 
intervention patients (55.5%) are more likely to speak to a pharmacist for advice in the 
future.  If true, this represents a useful indicator of benefit from, and confidence in, the 
student medication review. 
The data obtained in this study enabled a sample size calculation to be undertaken for a 
future full trial.  It is recommended that if a full trial is undertaken, that HbA1c is used as 
the primary outcome measure, with systolic blood pressure retained as a secondary 
outcome measure.  The numbers of patients required to undertake a full trial with a full 
final year cohort of pharmacy students is possible.  Five medical practices recruited 133 
patients and with information collected in this study it is anticipated that this may be 
increased.  The recruitment of more medical practices is expected to be possible, with the 
inclusion of city practices and other rural towns providing a suitable pool for this. 
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Chapter 6 Review phase focus groups and Semi Structured Interviews 
6.1 Background and context. 
The MRC guidance on implementing and evaluating complex interventions[48] 
recommends that appropriate ‘users’ should be involved at all stages in research, 
including evaluation, as this is likely to result in better and more relevant science with a 
greater chance of producing implementable data.  
Kreuger[107] states that focus groups can be used at any stage of a study to assist in the 
exploration and generation of hypotheses or specific study issues.  Huston and 
Hobson[83] state that the results generated by focus groups provide insight into past, 
present, or future actions, providing support further support for the review of a study. 
Having completed the feasibility study and pilot, it is, therefore, necessary to determine 
the opinions of all stakeholders on the student-led medication review service, the 
education experience and the research process.  To enable stakeholders to compare and 
exchange views, focus groups and semi structured interviews were chosen as the most 
appropriate method to obtain qualitative views on the service.  
6.2 Aims. 
The aim of this chapter is to obtain opinions of stakeholders in the study to enhance the 
research process and future service delivery.  
6.3 Objectives. 
The objectives of this element of the research were to explore stakeholder opinions on the: 
• research process, 
• supervised student led medication review service, 
• preparation for the delivery of the service, 
• educational value of the experience. 
6.4 Results. 
6.4.1 Recruitment. 
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Questions for each focus group and semi structured interviews followed set topic guides 
(Appendix H) and consisted of open questions with subsequent questions to explore or 
clarify issues. 
6.4.1.1 Medical practices. 
Five specialist diabetes nurses and one GP, who had participated in the study, were 
recruited.  Due to work commitments, one group meeting was undertaken with two nurses 
and the GP from one medical practice, whilst the other nurses were interviewed 
individually.  In each case, the meetings were undertaken at their place of work. 
6.4.1.2 Primary care trust (PCT) pharmacists. 
Four PCT pharmacists were recruited.  It proved impossible to achieve consensus for a 
meeting date due to holiday and work commitments.  The pragmatic decision was, 
therefore, made to undertake a semi structured interview with one pharmacist and a focus 
group with the other three, to ensure that all views and opinions were captured. 
The individual pharmacist met the researcher at his home, whilst the meeting for the three 
pharmacists was undertaken in a meeting room at a local hotel. 
6.4.1.3 Patients. 
Due to variable recruitment rates, patients from two medical practices undertook 
medication review with students much earlier than the other three medical practices.  
Therefore, two focus groups were undertaken; one with seven patients from the early 
recruiting practices and one with ten patients from the later recruiting practices.  This 
reduced the time gap between the medication review and the focus group for the early 
patients.  The aim was to ensure greater recall of events.  In addition, this method enabled 
two focus groups which captured opinions from a greater number of patient participants. 
Meetings were arranged in meeting rooms at two local hotels, with each being chosen as 
geographically easy for travel. 
6.4.1.4 Students. 
Nine final year pharmacy students, who had participated in the study, were recruited after 
their final exam.  No students who had left the study volunteered to join the focus group. 
The student meeting took place in a meeting room at the UEA. 
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All focus groups and semi structured interviews were undertaken as detailed in Chapter 2. 
6.5 Themes. 
The main themes identified were: general observations and overall opinions of the study, 
recruitment to the study; preparative training; undertaking level 2 medication reviews; level 
3 medication review; patient questionnaire; future methods of undertaking this study. 
Sub-themes were also identified and a description of each, based on the evidence 
obtained from the interviews is presented below. 
6.5.1 Theme descriptions. 
6.5.2 General observations and overall opinions of the study. 
Participants described their opinions of the value of the study.  Sub- themes included 
good idea and cost effectiveness. 
6.5.2.1 Good idea. 
Consensus was displayed amongst participants of different groups that the study was a 
good idea. 
The most frequent quote was the following: 
“I think it’s a good idea.” 
Recognition of the need for undergraduate pharmacy students to undertake 
communication skills training in the ‘outside’ world was displayed by patients: 
“I would have thought somewhere in the course there should be an element of 
communication for students, the students and the outside world…” 
Another patient stated that pharmacy students working on a one-to-one basis with 
patients is more beneficial for learning than standard teaching: 
“I think the more one-to-one work they get with potential patients is the best way of 
moving forward because you can read up and learn as much as you like, but it’s 
when you actually get in touch with people in real life situations that you start really 
learning.” 
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There was consensus amongst patient participants in one focus group that this teaching 
can benefit patients: 
“Well I think it’s a brilliant service (general agreement) and if you can help them to 
help us it will be better.” 
Patient participants displayed a general enjoyment from participation in this programme: 
“I enjoyed it.  I must confess I enjoyed it.” 
One patient said that patients would listen to a pharmacy student: 
“.. because of the environment you have a tendency to listen whereas in the 
doctor’s surgery you’re sitting there and all you really want to do is get out, .. so 
even though they tell you things . .don’t necessarily sink in, …” 
A specialist nurse, whilst supporting the training of undergraduate pharmacy students with 
real patients, identified that a possible benefit was the promotion of inter-professional 
communication: 
“I think it’s brilliant, yeah.  I think, as I’ve said before, the more disciplines that 
understand each other’s jobs, the better.” 
It was identified that there is poor awareness amongst patients of pharmacists’ knowledge: 
“I think a lot of patients maybe don’t know that pharmacists have this kind of 
knowledge and so it’s kind of a good process to raise awareness (laughter) that 
they can go to the pharmacist and talk about these things (general agreement)…” 
It was hoped by the students that participation in this study would stimulate future contact 
between patients and pharmacists in the future: 
“…not just picking up issues in that one session and maybe they’re opening up 
future conversations with the pharmacist.” 
A PCT pharmacist observed that patient contact may be of benefit by raising awareness. 
“Even raising awareness of what pharmacists can spot must be I mean that’s 
going to be building relationships for the future, ….” 
Students displayed satisfaction that their expectations of participation in the study had 
been met, which is apparently supported by other members of the group.  The students 
also benefited by obtaining useful data to support their portfolio: 
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“I think I got what I initially wanted out of it and I also got to put some stuff in my 
portfolio so that was always useful, but I was, I am really glad I did it (murmurs of 
agreement).” 
Comments from some PCT pharmacists showed that they enjoyed the experience 
themselves, partly due to the opportunity to interact with students: 
“…it’s a nice chance to meet with the students and to do, to discuss some ideas 
with them.” 
A PCT pharmacist stated that undergraduate pharmacy students do not normally obtain 
any consultation skills training on placements: 
“…on placements all they see is dispensing, they don’t see any of the consultation 
skills whatsoever.” 
Another PCT pharmacist provided support for the training programme: 
“If I’d been given that opportunity, twenty years ago I would have thought it would 
have been brilliant, absolutely brilliant.” 
Participating patients suggested that undergraduate pharmacy students should undertake 
training in communication skills in the ‘real world’: 
“I would have thought somewhere in the course there should be an element of 
communication for students, the students and the outside world,...” 
Consensus was displayed amongst the patients within one focus group that the study was 
worthy of repeating: 
“I think you should repeat it, yeah.” 
The students recognised that the location would be important, possibly for a number of 
reasons: 
“If it could become a regular thing that there was a pharmacist at the GP surgery 
then it would work.” 
6.5.2.2 Cost effectiveness. 
A PCT pharmacist observed that, whilst students obtained educational benefit, the 
logistics of the training made it too expensive and inefficient to pursue: 
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“The students did learn things from it, but not enough to benefit all the man hours 
that were put in by the patient coming in and the two pharmacists who were there 
and the taxi fares to get them there.” 
Further explanation demonstrated that comments relating to time were not in relation to 
patients: 
“…I thought it was inefficient for the pharmacists and the students, but not for the 
patients.” 
Another PCT pharmacist identified that the training programme required a lot of 
organisation: 
“…it did take an awful lot of organising the placements so it was quite hard work I 
think for those who were having to book all the appointments. “ 
6.5.2.3 Timing. 
Students stated a recurrent theme, which demonstrated firmly held beliefs, that the time 
between each of the elements of preparative training, role-play, level 3 medication review 
and then level 3 medication review were too long.  They stated that this reduced the 
effectiveness of any preparation as they had forgotten elements of it: 
“...and because we were saying there was such a long gap between doing things, 
it was hard to try and think back to what we’d done previously and how to apply it 
to that situation.” 
6.5.3 Recruitment. 
Opinions were stated about individuals’ reasons for joining the study, and these are 
presented according to the group to which the individual belonged, with each group 
representing one sub-theme. 
6.5.3.1 Students. 
Reasons for student enrolment included not only perceived personal benefit as expected, 
but also a desire to benefit the wider community of students and pharmacists: 
This issue of benefiting other students is demonstrated by one student: 
“The reason I signed up to do this study was because I felt that it would be, I 
thought it was a really good idea to see if this would work for pharmacy students.” 
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This student stated that one reason for joining the study was to demonstrate that 
pharmacists possess, and can utilise, useful skills and may also demonstrate a method of 
working with other healthcare professionals: 
“I think pharmacists are under-utilised and so it would be an opportunity to show 
what a pharmacist can do and show our skills and how we can be integrated into 
doing things like that...” 
A number of students quoted a desire to increase knowledge and/or skills by participation 
and the following quote shows that the experiential teaching methods were important: 
“…from the way I learn it’s kind of through experiential type, if I’m doing something 
I learn it better than if I’m just reading it,…” 
This was developed further to show that students had realised the benefits would be 
useful after qualifying: 
“…this would be useful kind of development of skills that will be useful like when 
I’m a pharmacist.” 
The opportunity to undertake an experiential element of teaching or learning was a major 
theme of discussion about student recruitment and is exemplified by the following quote: 
“…dealing with patients on a one to one basis and we don’t often get the 
opportunity to do that in practice as a pharmacist or a student, so I wanted to take 
that opportunity to be with the public and practice my consultation skills and 
communication skills.” 
One student hoped that participation would provide practice and experience which would 
benefit confidence when undertaking duties after graduating: 
“…also to help make it less scary I suppose when you start work.” 
The issue of specifically improving consultation skills was quoted as a reason for joining 
the study and one student hoped that this would benefit them when undertaking OSCEs: 
“I also wanted to do it just to help me like with my skills for during the year because 
well when we have the OSCE then it’s kind of you need to know how to 
communicate…” 
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Students identified a need for opportunities to participate outside the normal 
undergraduate curriculum and combining this with improving skills was a reason for 
volunteering: 
“I guess I just wanted to get involved in something that was sort of extra-curricular 
and it just seemed to be something sensible to improve my pharmaceutical skills.” 
Improving communication skills was repeated as a reason for volunteering: 
“I think any opportunity where we can use your communication skills is really 
important to take at the moment.” 
One student provided an unexpected reason of the kudos of participation in a research 
study for enjoying participation: 
“...yeah, like other people would ask like where you going and I’d say I’m going to 
my study (laughter) I liked that feeling.” 
6.5.3.2 Patients. 
A specialist nurse who undertook patient recruitment at one medical practice observed 
that the timing of patient recruitment affected the response: 
“I know there were certainly some patients who would liked to have helped but 
because I think it was around Christmas or before Christmas felt that they couldn’t 
at that time of year.” 
A specialist nurse related the recruitment of patients to meet medical students to this 
study and said that recruitment is difficult with the same patients volunteering each year: 
“…we struggle with the medical students finding people for them to talk to, so 
you’d have the same issues, wouldn’t you?”  “I’m sure the doctors seem to have 
the same list of people who are happy to come up here, but it’s always them, 
always the same patients.” 
A specialist nurse demonstrated the opinion that posting information to patients was a far 
more effective method of recruiting than using a poster (at the medical practice): 
“I think by mailing patients was the most sort of sure fire way of getting the 
information to them. If you just have a look at a poster people will fleetingly look at 
it and then kind of disregard it and forget about it, whereas a bit paper addressed 
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to them, they’re more likely to at least read it even if they then discard it 
afterwards.” 
Consensus was displayed amongst patient participants that they were happy to volunteer 
for projects such as this. 
One reason given was that they were happy to volunteer now that they are retired.  No 
patients below retiring age participated in the focus groups: 
“…it makes a change, doesn’t it, (laughter) when you live a hum drum life as a 
retired person anything is better than nothing, change of scene, change of face, 
chance to talk to somebody, whatever.” 
Some patients expressed a desire to help, with statements suggesting that future 
recruitment may be possible: 
 “…I personally like to volunteer for these things because now I’ve retired I think I 
can put something back in finally and I’d be quite happy to put my name on a list 
that you have, and not my GP had, provided you ask. (General agreement with the 
comment).” 
General consensus was demonstrated with respect to the recruitment documentation: 
“Friendly and considerate letter.”  
When asked about the possibility of repeating the study, one patient said that recruitment 
should be by written invitation, as some patients do not visit the medical practice regularly. 
“I think writing is more reliable I mean I try only to go to the practice every six 
months…” 
Consensus was displayed by patients in one patient focus group that they thought that 
patients would volunteer: 
“Well I personally like to volunteer for these things.” 
Differing opinions were displayed about including a wider range of disease states in order 
to deal with all the patients’ problems: 
“I think the whole patient…” 
“I think it should be restricted, I think it’s too wide to be assessed.” 
Discussion amongst patient participants identified that a number of them would be willing 
to volunteer again, with suggestions made of a database of patients’ details: 
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“You could ask for information which you put on database like what would you be 
prepared to do, you know come to UEA, come to the local hospital, etc.” 
One patient said that he would be prepared to volunteer in the future if he was asked to 
undertake medication review with more than one student, as that was more time efficient: 
“Having talked about time, if I was dealing with more than one student, I would 
then be prepared.” 
One patient said that an additional problem was the low likelihood of difficult patients 
volunteering: 
“You can’t really find volunteers who are the real worriers and health fanatics, can 
you?” 
6.5.4 Preparative training. 
Participants described their opinions of the value of the preparative training provided for 
students within the study.  Sub-themes included podcasts, workshops and role-play. 
When asked their views about the preparative training, no specific comments were made 
by patients, however, based on their experience during the medication review, differing 
views were expressed, with some stating that the students displayed good preparation: 
“They ought to be good at that stage because you primed them well, got them 
ready.” 
Other patients stated that students displayed differing levels of preparation: 
“Variable, some were very well prepared, the very first ones I had but the second 
lot they were quite, they were fishing…” 
A specialist nurse expressed the view that underpinning knowledge is required to facilitate 
the learning of communication skills: 
“...you get your underpinning basic knowledge in the class room but it’s not until 
you deal with real people that you start gaining your skills, do you,……. but you 
have to have the theory to underpin what you’re then doing because if you have 
good theoretical knowledge you can then ease and tweak, can’t you, with the 
person...” 
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6.5.4.1 Podcasts. 
There was unanimity amongst participating students that the podcasts provided the least 
benefit in the context of this project. 
One student’s comments are displayed as representing the views of others, and 
demonstrate a lack of engagement with the pod-casts due partly to internet access as well 
as having received sufficient education relating to diabetes: 
“In terms of the pod-casts, I’ll be honest, I don’t think I found them that useful.  I 
think I listened to one and half another one and that’s partly because my internet at 
home is really bad, but I think, because it was on diabetes and we’ve done so 
much, I don’t know if anyone else agrees, but over the last kind of three, four 
years, we’ve done so much on it, I think we probably had that basic knowledge 
already.” 
No comments were received in relation to the pod-cast concerned with consultation skills 
and motivational interviewing: 
6.5.4.2 Workshops. 
Comments received in relation to workshops were only from students.  No other 
participants had any contact with workshops. 
A quote from one student demonstrates a number of issues raised by students that the 
workshop sessions could have been condensed, possibly due to the full timetable, with 
only an overview required for diabetes: 
“In terms of the workshops we had quite early on, I kind of felt that they could have 
been condensed quite a lot more, especially like XXXX was saying, we could have 
had just a quick overview of diabetes.  I think it was because our time table was 
really, really packed in the first semester and I think they were important ...” 
One student also identified that more structure was required: 
“…….a lot more structured.” 
Comments demonstrated the view that the content of the workshops was acceptable, but 
that they were simply too long. 
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“I think that the content was fine, what we were taught, if was just the 
presentations, or the way it was delivered, was perhaps too long or not done, not 
in an incorrect way, but it just made it quite hard to concentrate.” 
Comments received about individual workshops are displayed below.  
No consensus was displayed by students about the workshop designed to teach students 
how to use the IT medical records.  One student identified that the session was useful, but 
that the problem experienced was logistical, due to the training room entailing a thirty two 
mile round trip: 
“I think the first workshop where we learned about Systmone was useful. The 
trouble was it was off-site in Dereham so it made it seem like a much longer 
afternoon than it actually was.” 
Another student, however, had found the system to be complicated and that a longer time 
may be required: 
“…you can’t really learn how to use a system within like an afternoon really, it’s 
quite complicated, isn’t it? “ 
A possible solution to the problem with this session was proposed by one student who 
recommended the use of a checklist: 
“It might be more useful to kind of have a sheet which kind of explains the key 
things that you’ve got to do.  And then do it as you go along the first time you go 
into the ...” 
The second workshop provided revision of care planning and practice in using the 
electronic care plan.  Comments received demonstrated that some students thought that 
this session was of no value: 
“The second one, I distinctly remember just that, I felt like I didn’t achieve anything.  
I think it was just like filling out the care plan on the computer or something like 
that.  It was largely based on what we’d already done in the first workshop, wasn’t 
it?” 
Students concurred that the workshop on consultation skills and motivational interviewing 
was useful.  They recognised that not only was undertaking a medication review with a 
patient different to counselling, but also that they required background theory: 
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 “I think it was useful that one because it did show you how it was going to be 
different because obviously we knew how to do counselling and stuff but then it’s 
slightly different structure this one, so this was quite good this session because it 
showed you what you needed to ask before you had the practice session.” 
 “Yes, because you always need a bit of theory,…… because you don’t know 
where to start otherwise.” 
One student provides a useful insight into ways of improving the structure of this particular 
workshop: 
“It was long, we did have a break and have food in between, but in some respects I 
think you lose your concentration when that happens and it was hard to then, and 
because we were doing little miniature role-plays in between so it was stopping 
and starting and it was quite difficult, I found it quite difficult to follow.” 
6.5.4.3 Role-play. 
Supervising PCT pharmacists displayed consensus in their support for the role-play 
session: 
“I thought they were exceptionally good and I thought the students learnt an awful 
lot.” 
Criticism was made by a PCT pharmacist that students had not received or remembered 
sufficient information and preparation in advance: 
“I had to explain to the student what they were having to do because the first 
couple of students just thought they were coming in for data collection, so I needed 
to explain to them what they were then going to go on and do with the actor. But I 
don’t know whether it was given to them and they haven’t actually registered it or 
whether they haven’t been given it, but they didn’t really appear to know it.” 
A PCT pharmacist recommended that the students should be given the opportunity to 
meet the actors prior to the practice medication review in order to reduce the stress of the 
situation: 
“…meeting them sort of informally just for five, ten minutes in the morning as they 
got there perhaps, not to discuss anything but just to see the faces and know that 
they’re kind of normal beings as such and reassure them that it’s not an exam it’s 
just a simple chat, but a development of their skills.” 
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One PCT pharmacist said that the organisation of the role-play was good: 
“The efficiency of it, the way you’d constantly got it moving and there was a 
continuous stream.” 
The pharmacist stated that role-play would provide more benefit than medication review 
with real patients: 
“….whether it would be worth doing it with the real patients in the practices.  I felt 
that they learnt an awful lot more working with the actors.” 
Participating students displayed consensus that the role-play session with actors 
was useful preparation for undertaking a medication review with a real patient: 
One student expressed the view that role-play was the most important session as it 
mirrored the medication review, and that the workshops could have be dispensed with: 
“I felt that the session with the actors was the main session that prepared me 
because it was so realistic to what we were going to be doing, looking back in 
hindsight looking at when I was with my patient and then looking at the acting 
session before, it was a carbon copy, it was exactly what we were going to do so 
that was good.  I don’t think, personally I don’t feel that the other sessions gave me 
anything more than what that session did,…” 
However, another student observed that role-play sessions did not mirror real life where 
some patients do not exhibit care issues to be identified, whereas within role-play the 
‘patients’ always exhibit a number of important issues: 
“I felt my patient sessions were kind of different from my actors one because the 
actors ones had issues whereas the patients ones they didn’t, I mean that’s true to 
real life, it’s not something that I was expecting maybe but yeah so.” 
One PCT pharmacist also discussed the differences between real patients and role-play 
actors, concluding that actors potentially provide more benefit for the students due to the 
full script: 
“Well I suppose in that they had a story, whereas a real patient very often didn’t 
have a story and there was nothing the student should be looking for really that 
was just a yeah okay, there’s nothing there, whereas at least with the actors there 
was usually a string in there for the student to hang on to. They did a really good 
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job.  They were very believable. Yes, they pulled it out at the right time as well, as 
a real patient would.” 
A PCT Pharmacist stated that the session was good practice for meeting patients, as it 
was still in a ‘protected’ environment: 
“I think it settled their nervousness as well, (unclear) their thoughts about oh my 
goodness I’m going to be talking to a real patient, but to get that before they leave 
university, before their sort of mollycoddling almost is gone, ...” 
A difficulty with the organisation of role-play sessions was identified by one student, with 
the recognition that actors cannot always mirror the characteristics of the patient within the 
script. 
“I mean it was a little bit difficult with the actors because mine was supposed to be 
really obese and she was a really skinny lady.” 
However, the same student also reported that in spite of the problem the scenario 
provided realism which benefitted practice. 
“….but I forgot, I forgot she was an actor and I totally believed that she was the 
real patient and you do, you sort of learn to respond to their, and also to think on 
your feet as well a bit more when they ask you questions.” 
One student said that that the role-play session was less stressful than communication 
skills training within the current curriculum when they felt judged by their peers: 
“It’s weird, I found like on the day when we had the actors that I was less nervous 
than when we do it in dispensary because the actor, or patient, doesn’t know all 
the technical terms or I don’t feel I was judged by my knowledge by the patient and 
I know that I need to simplify things whereas in dispensary if I get things wrong 
everyone knows (laughter).  I found that more like a relief in a way.” 
The feedback provided to students after each medication review with an actor was 
supported as it provided guidance and reassurance: 
“…there was a feedback session bit and I remember that being useful for like 
pointers of how you could improve and things like that.  It was also reassuring 
when they said oh yeah you did well because you think okay maybe I can do this.” 
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Students displayed consensus that feedback between the first and second actors 
provided student benefit, as this enabled the supervisors to give advice on how to 
improve: 
“And you got feedback in between the two patients as well so I found that really 
useful because I did the first one completely wrong and then xxxx said no this is 
what you need to do so then to then do the second one that was really useful.” 
Pharmacists agreed that feedback provided was of benefit, and it was requested by the 
participating students: 
“Every single student wanted feedback, individual feedback, so giving the 
feedback after the first session, after the first actor, invariably they were so much 
better on the second actor.” 
PCT pharmacists who had assisted with the role-play training displayed consensus that 
more time was required for feedback: 
“The only thing I would have said against it is that it was too efficient in that there 
should have been a bit more time for talking in between.…so we need a bit longer 
than that for the feedback… if you could add an extra five minutes on to those 
times for feedback.” 
The actors, who regularly undertake sessions such as this for medical and nursing 
schools, provided feedback to the students, with one student commenting that this was 
beneficial: 
“……I think the actors’ feedback was quite realistic because I mean they do it a lot 
more.” 
Feedback was also provided to groups of students by a GP after they had undertaken two 
medication reviews.  A student said that the session with a real GP was good: 
“And I think it was really good after we’d seen the actors that we got to see the GP 
afterwards who wasn’t an actor, who was a GP, and so we got to kind of feedback 
what we would do in those situations and so that was good.” 
A PCT pharmacist said that the MRCF was an appropriate validated tool to assess 
students’ performance during the role-play medication review, but that it required 
explanation to the students: 
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“The MRCF form, it probably is the right form because it’s an official form, it’s a 
recognised documented, got all the things on that you’re looking for, but it’s not 
self-explanatory, it’s just tick boxes so if you just give that MRCF form to the 
student, they have no idea what they’ve done wrong, it doesn’t give any 
explanations.” 
A PCT pharmacist, when asked if any changes could be made to the role-play session to 
reduce stress for students, said that not having academic staff present might help: 
“…if they haven’t got their particular professors in charge who they’re trying to 
impress, that might help but I wasn’t aware of that at the time, it’s only now that 
you ask the question, you know, possibly they’re nervous because their tutor are 
there, whereas if they were complete strangers there then they might be less 
nervous.” 
One PCT Pharmacist identified a possible reason and solution to student stress: 
”… the most stressful thing is just doing it for the first time with somebody else 
observing and not knowing how you’re going to do.  I think once you’ve done it 
once or twice its better.” 
6.5.5 Level 2 medication review. 
Participants described their opinions of the level 2 medication review.  Sub themes 
identified were the benefit of the sessions, organisational aspects of the level 2 medication 
reviews and students’ performance. 
6.5.5.1 Benefit of the sessions. 
Participating students demonstrated consensus that the level 2 medication reviews were 
useful, as they provided preparation and possible interventions for the level 3 medication 
review: 
“It was good to have like a background because then when you talked to them like 
it’s you’re not just like going in there blind, at least you’ve got some background of 
what the issues they might kind of pre-empt you what they might bring up and 
things.” 
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6.5.5.2  Organisational aspects of the level 2 medication reviews. 
Participating students displayed no consensus about the duration of the session during 
which level 2 medication reviews were undertaken.  The planned duration of each session 
was half a day: 
“I think that session was dragged out longer than it had to be…and it just seems 
realistically you could do that in like 20 minutes, have a look at someone’s 
records.” 
“I kind of disagree with that we could just do it in 20 minutes.  I think we took quite 
a long time to get through (agreement from another student) because we have four 
patients to get through and we really did take almost up the full amount of time to 
get through the whole of the records.” 
A student said that the method of two students accessing the medical records of four 
patients to create a care plan provided shared learning: 
“…I think doing it as a pair was really helpful as well because you weren’t faced 
like all on your own, you’d find you could sort of like you could discuss it with each 
other…” 
A student commented upon the difference between classroom and real life care planning: 
“… it was a bit different in compared to what you do in the classroom.  These 
patients all had other conditions and some of them we’d never heard of and it’s 
trying to find out what they are and then deciding how that could affect their 
diabetes….” 
One student said that the format of the medical records and the care plan assisted the 
structuring of the level 3 medication review: 
“I think at least the notes that we saw wrote out was tailored so that we could look 
at it and then think you know this is the key things we need to ask them and then 
we had the clinical management plan as well so that sort of helped us to structure 
what we were going to say to them before, so I think that helped a lot.” 
6.5.5.3 Student performance in level 2 medication review. 
A specialist nurse commented on the difficulty of obtaining data from medical records and 
that, with experience, the students would find it easier: 
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“I think there’s an awful lot of places to find information in records and I think it 
highlighted a little bit that we know our patients quite well, this group of patients in 
particular, so we know certain things about them and we know where to find that 
information about them and I think because they’re new to it and they’re new 
probably to the system and all that sort of thing, they didn’t perhaps know where to 
look for the information about people.” 
A PCT pharmacist’s comments demonstrate criticism of the participating students during 
level 2 medication reviews and provided examples, but suggested that with more practice 
they might improve: 
“They accessed the records and very often missed obvious things.” 
“Ahh, such that the diabetic patient wasn’t on an ACE, they hadn’t noticed that a 
patient had just been into hospital and come out again on the records.  Sort of 
really quite glaring things that would ring bells for me, but they didn’t even notice.  
A person who was on huge numbers of Ventolin inhalers, it wasn’t anything to do 
with the diabetes, but it was something that leapt out at me whereas they didn’t 
even notice it.” 
“I’m sure it was just lack of experience. The more they did, the more experience 
they would get and the better at it they would get.” 
A PCT pharmacist identified that although the students possessed knowledge, they were 
reticent about using it. 
“Sometimes it was like pulling teeth, but they’d actually got a lot of ideas and it was 
just getting them to write it down.” 
The same pharmacist identified that questioning by the supervisor provided benefit: 
“….but once you started asking them questions then they came up with all sorts of 
things and sometimes things that I’d not spotted.” 
A possible reason for the reticence of students to identify issues was proposed by a 
pharmacist who suggested that committing issues to paper for forwarding to a doctor may 
be the reason: 
“…actually writing it down on this carbon paper where if you wrote the wrong thing, 
you couldn’t rub it out.” 
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A PCT pharmacist said that the sessions required students to draw upon their acquired 
knowledge and put it into real life practice: 
“… it was a lot of learning, because I think they’re putting everything they’ve had 
taught to them into practice, real life situation.” 
6.5.6 Level 3 medication review. 
Discussions identified a number of issues relating to undertaking level 3 medication 
reviews with patients which are presented as sub-themes of location; organisational 
aspects; students’ identification of care issues, students’ performance; patient 
expectations or benefit; comparison of level 3 medication reviews and OSCEs; 
presentation of care issues after medication review (level 2 or 3); benefits for students and 
completion of the questionnaire immediately post- medication review. 
Specialist nurses displayed general consensus regarding record keeping, that all of the 
medication reviews between pharmacy students and patients should be recorded in the 
medical notes: 
“…you should record in the patient notes.  You’ve reviewed the patient, you’ve had 
access to the patient notes, I think yes you should record in the patient notes. 
6.2.5.1 Location. 
Consensus was demonstrated amongst PCT pharmacists and patients that the GP 
practice is the best location for the medication review: 
“The patient will quite easily go to their own surgery, but they’re not going to be 
willing to go somewhere else.” 
A patient also said that the location would be better for the student: 
“I think it’s, for me anyway, on these types of thing, I think it’s better to get the 
student out of the academic institution.” 
6.2.5.2 Organisational aspects. 
One student displayed the view that they did not feel that all academic staff supported 
them in the study: 
“… I didn’t feel all kind of maybe the staff in the department were kind of on board 
with it, because sometimes X (the researcher) would be like can you do this, can 
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you arrange this with your project tutor and then you’d arrange it and they’d go well 
this is more important, you’ve got to make that choice and it’s kind of a bit like 
when you’re trying to do a study because you find it interesting but then you’ve got 
your kind of project tutor you know well this is your project, why aren’t you focusing 
just on this. So maybe if all the staff, if it could be something where all the staff 
agree that time can be made for it, it would be better.” 
Students displayed consensus that the effect of support from research staff during the 
study was beneficial.  One student said that the organisation and regular contact helped: 
“….I found that the organisation or just the constant emails and things like that 
helped me like keep it on my mind (agreement) and just the general involvement ... 
(agreement) helped a lot.” 
Consensus was demonstrated amongst students that undertaking medication reviews with 
more than two patients would provide further learning, but in addition there was 
recognition that this provides an additional recruitment challenge: 
“I know it’s difficult the get patients on board, the whole recruiting thing but it’d be 
really good to have more than just two patients or one patient just because I think 
it’s something that is experience based learning and the more you do (murmurs of 
agreement) the more just sort of gets stored away.” 
A possible reason for the benefit of meeting more than one patient is provided in a quote 
from another student: 
“…we’ve still got to approach each patient in the same way so keeping that 
consistency is something, that’s why it’s good to have a lot of different patients if 
possible.” 
An organisational problem, with respect to finding and booking rooms for student-led 
medication reviews, was highlighted by specialist nurses when discussing making 
appointments for patients: 
“I know that we had issues with rooms so from our point of view you were, I think 
we had to delay it a bit didn’t we, so we could’ve probably been a bit smoother for 
you…” 
Patients displayed a variety of opinions about the ideal duration of the student-led 
medication reviews; however, they agreed that some form of limit should be applied: 
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“I think as long as long as you draw a line somewhere (general agreement).” 
One patient said that lack of a time limit for the medication review was a good thing: 
“I think another good think about it was that, at least in my case, it seemed to be a 
bit open ended, there wasn’t a time limit…” 
One patient identified a practical issue when discussing the time allocation for student-led 
medication reviews, by questioning the students’ ability to terminate the conversation: 
“Do you teach them how to terminate these interviews politely, when somebody 
doesn’t want to?” 
One student said that supervision helped: 
“…I think (X the supervisor) helped because he ran through everything with me 
first because we were in the room where you can kind of bring it back and say that, 
I was nervous.” 
A PCT pharmacist recognised that problems had existed due to participants in the study 
being unable to complete the commitments made: 
“…there was a lot of people perhaps let you down, whether it was surgeries or 
things like that, so quite intensive work ...” 
6.2.5.3 Care issues identified. 
Students demonstrated consensus that they not only wanted to learn from the experience 
but to also provide benefit to the patients and that supervisor support helped them.  One 
student’s comments exemplify this: 
“I wanted to be able to answer like their questions and stuff but sometimes like 
they put quite like challenging questions and I found myself like X (supervisor), 
help me.  I wanted to be able to help them and like I wanted to be able to find 
something that I could kind of help them because I didn’t want them coming all this 
way and then like them just be like know everything and it’s a waste of my time.” 
Students’ desire to benefit patients is demonstrated by a student suffering disquiet due to 
their inability to identify pharmaceutical care issues, which resulted in the patient feeling 
that they had wasted their time by attending: 
“…. one of my patients she like she wasn’t very pleased that there was nothing 
wrong (laughter)…… she thought that that .. she had issues, but like she didn’t so I 
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like felt really bad for her, but so yeah I really wanted to, I expected myself to be 
able to answer their questions and you know respond to anything, their needs and 
whatever needed changing, but yeah I felt really disappointed when I couldn’t for 
her.” 
One student said that not every patient would have issues which require resolution at 
every review meeting, and this was a useful learning point: 
“I think that’s another thing we can gain from the study, the fact that every patient 
we see we’re not going to be able to make a massive difference like obviously we 
want to, but it’s something that we have to learn that we can’t constantly be solving 
every problem” 
One student said that the patients are self-selected (volunteers) and, therefore, may not 
represent the general patient population: 
“...maybe they were the ones that were more adherent because they’re the ones 
that are more likely to come in and talk anyway.” 
One student recognised, however, that education was the primary objective of this 
exercise for the students: 
“…definitely more swayed towards us like learning and picking stuff up...” 
A student said that the development of a professional relationship with a patient over a 
series of meetings to identify knowledge of the patient’s background may enable improved 
medication reviews: 
“… it’s very hard when you’ve got no relationship or prior relationship with the 
patient, …. and it’s very hard to make suggestions then without knowing the rest of 
the family situation or building up that relationship as a doctor or a normal 
pharmacist may have with a patient, so although I could make suggestions 
whether they were actually any use or not it’s hard to know.” 
A student said that speaking to a patient during a medication review provided patient 
benefit which could not be gained from a level 2 medication review: 
“…even if you think from their records that they might not have any issues, is it still 
worth speaking to them because I had one of my patients … his doses of 
metformin ……….he was taking them before he’d had his food…. but when I 
actually spoke to him about it…. then I could say to him oh you know you’re meant 
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to take it with your meals because that’s how the drug works …So it is useful to 
actually speak to people …” 
6.2.5.4 Student performance in level 3 medication review. 
A PCT pharmacist identified that feedback after the first medication review had improved 
performance by most students: 
“…and I think most of them, unless they were very good to start, actually improved 
on their second patient (unclear) from the feedback…..you could see the difference 
in them once they’d had the feedback if they didn’t maybe do so well the first time.” 
A specialist nurse said that pharmacy students had identified previously unidentified care 
issues which they passed to the GP for action. 
“There were one or two things that were picked up that had been overlooked. … 
you know it’s good to have a third party looking at these things sometimes, things 
do get missed if you see the same patients every day.” 
A specialist nurse gave a specific example of a previously unidentified issue: 
“One of mine was buying something abroad in Belgium, one of the patients, and 
they’d never said that to either J or S but said it to the pharmacy student.  ……but 
they’d never told us that.” 
A possible explanation was proposed by a specialist nurse: 
“…there were obviously things they wanted to ask and they obviously, for some 
reason, felt they could ask a pharmacy student about it.  Maybe they thought the 
pharmacy student would know the answer…” 
A specialist nurse mentioned further issues identified by students during medication 
reviews: 
“And then medication wise,…I often look at results and think oh cholesterol is fine, 
sugar level a bit high, I must talk to them about their diabetic medications and then 
don’t … check that they might actually be on a cholesterol tablet, so quite a few 
things sort of flagged, although their cholesterol was up five they weren’t actually 
on a statin … that was quite nice to have that.” 
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A specialist nurse said that they had utilised care issues identified by participating 
students as a prompt during her own consultations with the patients at a later date, as 
exemplified by this quote: 
“….it was interesting you know, it was good… I flagged those in the notes so that 
when people came in I could discuss the issues raised.” 
Views displayed by a specialist nurse show that, in her opinion, the benefits of a nurse or 
doctor providing feedback to the participating students are often the identification of 
practical issues: 
“…not lack of knowledge, it’s just experience, I think, and it’s probably why we 
were there to say well actually that wouldn’t work in them because you know 
they’re ninety and they’re blind, that type of thing.” 
One patient said that he was dissatisfied with a student’s consultation skills, possibly due 
to command of English, however, the student did improve during the medication review. 
“….I thought mine would be better, to start with, … but that was whether that was a 
language problem as well because I think, was she (country quoted), …., I wasn’t 
terribly impressed to start off with, it actually warmed up and I was quite happy at 
the end, …..” 
The following comments between two pharmacists, who had supervised and, therefore, 
witnessed medication review, demonstrates that students were able to engender honesty 
from patients during a medication review which resulted in the identification of previously 
unrecorded issues. 
“...I felt the students were empathetic with them so they wanted to tell them more 
and sort of probably be more honest than what they might be with the doctor as 
well…” 
One of the pharmacists proposed a possible reason: 
“And it’s was a bit more personalised for them as well wasn’t it, I mean your 
chronic disease management in most surgeries is tick, tick and you get asked to 
yes or no and you know people just say yes or no, whatever they think the answer 
should be.  I felt that they were a bit more honest.” 
More than one student demonstrated that ensuring efficient timing of the medication 
review is an issue: 
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“There were a lot of...slightly older patients that do that do like to come in for a chat 
as well (agreement and laughter)....something I did find quite hard was just getting 
the information needed from them it’s like one gentlemen I was like so tell me 
about your diet, he literally told me everything he ate and we were there for about 
20 minutes (laughter) …. A skill that is quite important for us to learn is how to get 
the information that you need...” 
A PCT pharmacist said that students demonstrated good consultation skills which, 
however, still required improvement: 
“…It obviously needs a bit of honing and refining, but basically they were all pretty 
good.” “They had obviously practiced consultation skills quite a bit at university, 
you could see that they had got the basics of the consultation skills...” 
A PCT pharmacist displayed criticism of the knowledge of the students: 
“I would have expected them to have a better standard of knowledge, sort of being 
a fourth.(year).. Just about everything, really, they were at a pretty basic level of 
knowledge for everything.” 
One patient criticised a student’s lack of knowledge: 
“… I’m a food technologist and I was a bit concerned that the students didn’t know 
which … various foods … to recommend to their diabetic patients and I .. 
recommend this book (unclear) and they hadn’t heard of it, that’s a very good book 
to learn what’s got sugar in and what hasn’t….” 
When asked their opinion of the students’ competence or confidence, another PCT 
pharmacist identified a variable level amongst the students: 
“It varied, a lot.” 
A specialist nurse said that some of her patients found the medication reviews interesting: 
“….patients did come back and say they found it interesting.” 
A specialist nurse who had met students to provide feedback following a student led 
medication review, said that they were knowledgeable: 
“….like when I spoke to the students afterwards they were very knowledgeable.” 
A doctor who had met students to discuss care issues following a student led medication 
review praised their communication skills: 
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“…they were very….bright and interactive and quite up for it, I think.” 
A patient, in common with several others, said that the student they had met was 
prepared to admit gaps in her knowledge: 
“…and she had the sense just to say I don’t know and turned round to the expert.“ 
General consensus was displayed amongst patients that students were nervous; 
however, no patients reported that this negatively affected the medication review: 
“They obviously getting good out of it, they’re just feeling uncomfortable while 
they’re getting the goodness, like I am with my diet (laughter), but it’s doing me 
good, but I’m not enjoying it.” 
One patient reflected the opinions of others that they expected the students to be nervous: 
“I think it’s inevitable at their stage, isn’t it?” 
Several patients praised the consultation skills of students with one patient actually 
providing a score for both knowledge and consultation skills: 
“But if I was to mark it out of ten, I would give my young lady eight out of ten for 
both and I take the two missing points from both things on inexperience because 
she is still learning.” 
Some negative comments, however, were made by patients about students’ consultation 
skills.  One patient was unhappy that a student had asked about alcohol intake: 
“I just thought it was a little bit insensitive but I suspect that that’s the sort of thing 
you’d learn not to do fairly quickly in practice, but I mean it was just a youngster 
learning her trade.” 
6.2.5.5 Patient expectations. 
Mixed opinions were displayed by participating patients about expectations from a 
medication review with a student pharmacist: 
“No, no expectations before.” 
 “I just thought they’d be competent.” 
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A patient displayed possible negative expectations by stating that the provision of 
information about side effects of medicines was the role of the doctor and not a student 
pharmacist: 
“Isn’t that a job for the doctor, I mean they’re only students, you’re putting a lot on 
them, aren’t you?” 
Another patient, however, disagreed with this view: 
“Yeah, but it’s nice to know what the side effects are…” 
One patient said that lack of expectations was due to comparison with a qualified 
pharmacist: 
“Well not really because he’s qualified, isn’t he, and they’re not yet.” 
One patient displayed a low expectation of the students’ knowledge: 
“I have to say mine was I thought much better than I’d thought, I didn’t think they 
would know anything about it, but they did.” 
One patient was unsure why there was a need for patients to meet pharmacists for 
medication review: 
“Yeah, but if you’re okay with the tablets you’re taking, I am, I mean what’s need 
for the consultation with the pharmacist?” 
The current lack of contact with patients by some pharmacists and the competence of 
staff in the medical practice, led to questions relating to the benefit of a pharmacist 
involvement: 
“My concern is how often does a patient have contact with the pharmacist?  …… 
and this is what I said to my student, if I’ve got a problem I would go first of all to 
the diabetic nurse, who is absolutely wonderful as far as I’m concerned, and if she 
was concerned she would refer me to then to the doctor, but where would the 
pharmacist come in?” 
Patients displayed opinions regarding the competence of pharmacists which may have 
influenced their expectations of the students’ performance: 
“I found that most encouraging that I was actually referred to a pharmacist rather 
than the doctor (general agreement), because as much as I like my doctor, I don’t 
always think that she’s got all that knowledge.” 
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However, comments displayed a wide range of opinions relating to individual pharmacist 
performance: 
“…by god he’s sorted it out, but he’s brilliant…” 
“Well my experience with pharmacists only comes down to one who was an 
obnoxious little …(laughter).” 
A specialist nurse stated that whilst, in her opinion, patients did not have expectations 
about the medication review with a pharmacy student, they would have enjoyed the 
opportunity to discuss their medical conditions: 
“I’m not sure they have a great deal of expectation other than just the joy of the 
ability to talk about their ailments for a little while (laughter), if you know what I 
mean, they just like talking about themselves.” 
Further opinions were expressed about this issue by another specialist nurse who stated 
that the older patients had no expectation of benefit but simply sought to help: 
“…yes, and the older ones would think well we’re just helping you out and you 
know I don’t think they’d come in thinking they’d potentially get any benefit at all, 
they’re there to help you know.” 
However, another specialist nurse stated that younger patients (i.e. in their 50s) would 
have had higher expectations of the consultation: 
“…we’ve got some who are in their sort of 50s I think would have much higher 
expectations of what they would get out of it.” 
One student said that they did not think the patients had major expectations of personal 
benefit: 
“I didn’t think they did really.  I think they came in knowing they were going to talk 
about, … primarily about diabetes, but mine actually ended up not really talking 
much about their diabetic medicine.  I think they just thought they’d have a bit of a 
check on their medicines and they’re helping us more than anything.” 
There was consensus amongst students that patients required more information, in 
advance, about the medication review: 
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“I don’t think all of them fully got why they were there, to be fair (general 
agreement to this), because I think they just turned up and like what are we doing 
today like yeah, so I think they need to be a little bit better informed….” 
A specialist nurse identified that there had been patient benefit from the student-led 
medication reviews due to a review of medication: 
“...when they’d had these meetings, certain medications had been queried and 
why was that, so yeah, so I think there were benefits to the patients.” 
A PCT pharmacist observed that whilst there had been benefits to students (educational), 
there had been no benefits to patients: 
“I can’t actually remember any benefits to the patient.” 
Patient benefit was identified by a specialist nurse who had spoken to patient recipients of 
student led medication reviews: 
“The patients found it useful talking about their medication, yeah, when they came 
back they’d say ooh this was pointed out and this was explained again, even 
though I’ve probably spoken to them about it a hundred times.” 
A patient described how they had benefitted from the intervention: 
“I mean the young chap who was interviewing me, he did actually say something 
quite useful because I seem to be taking far too many tablets and I tend to forget 
whether I have or not and he suggested doing ... splitting them up into separate 
containers, well … what I do is, every night now, I put the morning ones out by the 
kettle and the evening ones somewhere else and I think that’s great.” 
A specialist nurse displayed the opinion that no patient benefit had been obtained, as all 
final actions were dependent on the GP: 
“… I’m not sure how useful it is for the patients to be honest, because … they’re 
not really getting anything out of it, because the changes still have to be done by 
the GP ultimately.” 
One patient said that he had received no benefit, but that the exercise was all about 
providing benefit for students: 
214 
 
“Well surely the question is was it of benefit for the students (agreement) because 
it’s no benefit to us, it’s for the students.  If it’s useful for them…then it’s got to be 
right…” 
6.2.5.6 Comparison of level 3 medication reviews and Objective Structured Clinical 
Evaluations (OSCEs). 
A student said that the marking and structure of an OSCE is very rigid and that the less 
rigid format of the medication review enabled a successful retrieval of information from the 
patient: 
“…we’re examined so hard in pharmacy practice to those damned marking 
schemes that like there is room to manoeuvre like you were saying to just flow with 
it and you don’t have to stick to that particular sequence of how you should say 
things and so we managed to get the information across and got the information 
from the patient. It might not have been in the same order as what pharmacy 
practice would like in pharmacy practice you know dispensary sessions, but 
nevertheless the end of it is that we got the information that we needed and they 
received the information that they needed, so in that respect I think we did, you 
know I’m sure we’re all very capable and we all did well.” 
Another student expanded this idea further by saying that within a medication review it 
was possible to explore issues rather than follow a marking scheme: 
“It’s quite nice not having a marking scheme I think because like you can just kind 
of like you know it’s just quite nice to just explore like different things with your 
patient rather than having to like follow a mark scheme and go through stuff so that 
was quite nice.” 
Students displayed recognition that OSCEs are often simply about obtaining information, 
rather than obtaining information in order to enable identification of suitable actions within 
a medication review: 
“I think quite often when we’ve done things in dispensary apart from maybe 
responding to symptoms, everything is about collecting information, it’s not about 
using the information to make a change so it was quite nice to maybe collect things 
and then thing oh actually you could do this and give a kind of possible something 
they could do...” 
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However, it was stated that participation in this study which involved communication skills 
benefited students when they undertook OSCEs: 
“…we all really appreciated how much it helped us during OSCE...” 
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6.2.5.7 Presentation of care issues after the medication reviews (Level 2 or Level 3). 
A specialist nurse displayed the opinion that more time should be allocated for 
participating pharmacy students to present care issues identified during medication review 
to the medical practice and that this would enable oral feedback which is preferable: 
“Obviously, more time for feedback.  I actually prefer the feedback when I’m 
speaking to the student at the time than having the sheets of paper to look at on 
my own later.  It’s more useful.” 
Other quotes by specialist nurses observed that the process of a student making 
recommendations derived from a medication review to a nurse, demonstrated that the 
student did not always understand the importance (or significance) of care issues 
identified: 
“….they seemed to have been able to get the information but I think sometimes 
they didn’t know whether that information was important information, does that 
make sense?” 
One student said that the session which was planned to be undertaken with a doctor or 
nurse after medication reviews with the patients rarely happened: 
“…I don’t know that anybody got to feedback what they found to the real patients 
to a nurse or, I certainly didn’t, I didn’t see anybody after I’d seen my patients.” 
A specialist nurse said that the pharmacy students demonstrated confidence, competence 
and an awareness of their own limitations during the session when the student(s) 
discussed identified care issues with them: 
“Most of them were quite confident. …But also did seem to know their limitations. 
There wasn’t anyone saying it’s all wrong, I’m going to do this, you know they were 
quite thoughtful in their process….” 
A specialist nurse said that shortage of time would probably prevent GP involvement in 
meetings with students to discuss care issues: 
“…you know you’re looking at a system where there is no give in the system for 
extra patient slots, taking out three or four patient slots to talk to the students is 
probably not going to be very likely.” 
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The same nurse, however, said that discussing care issues identified with a GP, rather 
than a nurse, would be more effective as the GP would have greater generalist knowledge 
than the nurses did: 
“I think that the best thing that could have come out of it was that you maybe 
needed a GP rather than a specialist diabetes nurse because they (students) 
weren’t just looking at diabetes’ drugs, they were looking at patients with diabetes 
but have obviously got other co-morbidities and they were asking me questions 
that I simply didn’t know the answer to.” 
A specialist nurse said that the practicalities of providing sessions for students to present 
recommendations or care issues are difficult: 
“It would have been nice to have had a meeting with all of the students after every 
single session so yes but it’s always going to be tricky, because you know we’re all 
busy aren’t we, you’re busy, we’re busy and even if you book or allocate a time, 
that doesn’t mean that it will run to schedule, does it?” 
This same nurse, when asked about the likelihood of GPs being involved in process, gave 
the following reply: 
“Very low.” 
The only GP to be involved in the process said that, in her opinion, the availability of a 
doctor to provide feedback after medication review is more likely to be possible within a 
large medical practice: 
“It wasn’t a problem to me because it just meant that I had less patients booked 
into my surgery and I just did that in the middle, and I did find it quite interesting 
and it’s nice doing something different.  I imagine, we’re a big practice so we can 
probably absorb that whereas if you’re a practice with four doctors and you took 
one of them out to do that on an afternoon when there’s only two doctors there, it 
just wouldn’t be practical.” 
6.2.5.8 Student benefits. 
A student said that the training would be useful for them after graduation: 
“…it’s still kind of fresh in our minds for when we’re starting pre-reg and we’ll be 
doing it for real.” 
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A student stated that the improved confidence possibly came from a personal confirmation 
of their own knowledge: 
“I think it scared us but we’ve probably got that little bit more confidence as well 
ready for next year, like it’s kind of proved to us that we do have gained all this 
knowledge ...” 
There was consensus among students that their consultation skills had improved during 
the study: 
One student identified that the additional input received by them had provided a greater 
benefit in comparison to their colleagues who had not participated in the study: 
“And I think it probably did give us kind of that advantage over people who didn’t 
do the study because we’d just had that little bit more practice and that little bit 
more feedback from everyone.” 
Another benefit identified by one student was undertaking a medication review with a real 
patient as opposed to with actors: 
“…there’s only a certain level that you can go up to when you’re with an actor… .I 
was kind of like pushing myself… I just wanted to do for real because you don’t 
really know how it feels like to do it for real, then it was good to actually be with a 
patient and do it.” 
A student identified improved clinical skills as a benefit, not only with diabetes but also 
with other clinical conditions: 
“….I think when you’re looking at patient details and talking about them, it’s also 
clinical skills that you’re picking up, I think any opportunity to do that, because it 
wasn’t just diabetes they were on other medication as well, so you were kind of 
picking up more clinical knowledge as you went along as well. “ 
One student said that practice in care planning in addition to consultation skills was useful: 
“…I pretty much wanted to do it to improve my patient skills and actually like 
everyone else says to kind of get into that real life situation, but also it gave us the 
chance to do care plan.” 
Statements by students demonstrate that they found the patient contact to be useful as 
well as enjoyable: 
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“…it was so useful because we don’t get like patient contact (general agreement) 
so you know it really helped us.” 
A student said that it was useful to have the opportunity to experience a consultation with 
a real patient in spite of nervousness: 
“….we’ve never done anything with a real patient before, so we’ve always been 
told kind of they’ll talk on and on about something really irrelevant but you’ve never 
actually experienced that, you get there and it’s really useful to have done it but I 
was really nervous…” 
6.2.5.9 Completion of the performance questionnaire immediately post medication 
review. 
There was consensus amongst students that they marked themselves more harshly than 
patients did: 
“It’s like (Y) said, you’re always more critical of your own performance (general 
agreement to this).” 
Students said that patients gave high scores because they wanted to be nice, partly 
because they had enjoyed themselves: 
“They were just giving us all fives (laughter and agreement).  Patients scored you 
really high and that they just thought it was a really nice thing for us all to come 
and have a chat with them, they just really enjoyed and said oh we’ll give you five 
(laughter).” 
A student said that another possible reason for patients marking students’ performance in 
medication review highly was that they were concerned that the marks would be used 
against the students: 
“I’m not sure though when you when the patients mark like how well you did and 
stuff I feel like they thought …that something was going to happen to...and they 
were like oh don’t worry, love, we’ll mark you good (laughter) and I was like I don’t 
mind like if you don’t but l felt like they thought that something would happen to me 
if they marked me bad, so I don’t think it was like a true reflection” 
Students said that because the patient was marking in the same room as the student, that 
this may affect the score they gave: 
“It’s also that element that we were sat there when they were doing it….” 
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One student made the practical suggestion that the true score of the student’s 
performance within the medication review was probably somewhere between the high 
patient score and the low student score: 
“…..we were probably a bit harsh on ourselves and they were probably a bit too 
lenient.” 
There was no consensus displayed amongst participating patients with some, such as this 
one, saying that they scored highly to encourage the students: 
“I think it must be relevant to trying to encourage the student as well” 
Some patients said that the scores were a true reflection of the student’s performance: 
“I think from my point of view it was a fair reflection actually.” 
6.5.7 Patient questionnaire. 
This was the baseline and follow-on questionnaire which was comprised of EQ5D, SIMS, 
MARS, BMQ and DTSQ. 
Consensus was displayed that the wording of some questions was not ideal, which is 
exemplified by this patient: 
“I found a couple of questions wordy, that I struggled to answer…” 
Irritation with questions which apparently repeated issues caused annoyance for some 
patients when completing the questionnaire: 
“I think I found them why are you asking me that?  Why are there so many options 
and I found a little bit irritating, no doubt each one was there for a specific purpose, 
but was it?  And I think it felt that in some I can’t remember, but they were you had 
all going down and down and down and I thought well I’ve answered that, maybe 
not in the way it was asked but it seemed to be the same issue.” 
The frustration experienced by some patients about identifying the correct response when 
completing the questionnaire was demonstrated clearly in the response from one 
participating patient: 
“…when you get to the point of oh god what should I put down for this one…” 
Patients said that the time taken to complete the questionnaire was appropriate, which in 
some cases surprised them because it had been devised by academics. 
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“I mean I did it well within the time, but I mean academics are notorious for being 
appalling form fillers.” 
6.5.8 Future methods of undertaking this study. 
Opinions were stated by a number of participants about the best method of undertaking a 
study such as this in the future, if it was repeated. 
A PCT pharmacist suggested a possible method of organising the level 3 medication 
review: 
“Would it be possible to do it so you booked an afternoon full of patients and then 
students do the data gathering in the morning and then see the patients in the 
afternoon so then they’ve just got one day out, so if it was a term, although it’s 
quite intense, that might be, I don’t know if it would be any easier for booking 
patients.” 
This prompted another suggestion: 
“Perhaps do it as part of diabetic clinic within the GP surgery.” 
A specialist nurse identified that pharmacy and medical students working together would 
be a practical situation: 
“….I think they (pharmacy and medical students) could work together quite nicely 
actually.” 
One nurse expanded this to demonstrate the potential benefit of this joint 
working/learning, including appreciation of each other’s roles, although there is little 
mention of educational outcomes: 
“Well there will be certain areas that they are learning at certain times that could tie 
in … and I think it will probably interact quite nicely. And most of all, from the point 
of view of those are the next generation of doctors and the next generation of 
pharmacists who might work more closely together if they’ve more of an 
understanding of each other’s jobs.” 
One PCT pharmacist also suggested that a practical method of working would be to 
organise joint working of medical and pharmacy students: 
“...dual-working with medics and the pharmacy students...” 
222 
 
That comment prompted another PCT pharmacist to state that the problem is that, unlike 
medical students, pharmacy students do not have the opportunity to observe qualified 
practitioners undertaking consultations: 
“… the other thing is with the medics they probably actually on placements see 
other doctors doing that whereas the pharmacy students on placements usually 
don’t come into a consultation with a pharmacist.” 
One specialist nurse recommended a repeat of the study with more patients: 
“….it would be really interesting to do it with significantly more patients.  Just from 
the students being able to see more and more and more and more, because 
again, that’s the real world, isn’t it?” 
Patients suggested that it may be better to not have a supervisor in the room, in a repeat 
of the study, but to have remote supervision via a video link: 
“…if there was a room set up with a hidden, or not very obvious, camera with just 
the student, us, as you say somebody in another room, let them get on with it 
basically.” 
One patient suggested a preparative meeting between the supervising pharmacist and 
patients to suggest possible ideas to use during the medication review: 
“I think it could possibly be an idea to have the meeting with you and volunteers 
(patients) and throw one or two ideas in that we might bring up with the student, a 
sort of preliminary you know be aware that you could ask these questions…” 
6.6 Discussion. 
Strong support was reported for the supervised student-led medication review service with 
patients, supervisors and students all enjoying the experience.  Examples of potential 
patient benefit which derived from the service were provided, although the cost of 
supervising the service was questioned when considering tangible patient benefits which 
may accrue from the service. 
Those students attending the focus group identified the educational experience as positive 
as it increased their consultation skills, confirmed their knowledge and ability to apply it, 
thereby increasing their confidence and prepared them for their future pre-registration 
training and practice. 
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Whilst the preparation of students for the delivery of medication reviews with actors was 
well received, elements of the student preparation process were identified for 
improvement. Supervisors and patients were largely positive regarding the student 
abilities within the medication reviews. This, however, may reflect low expectations by 
patients and supervisors rather than good performance by the students. 
The research process was not identified as creating any significant difficulties but logistical 
issues such as the time period between training and service delivery, were identified for 
improvement in a future trial.  
A good variety of opinions were obtained from a wide range of stakeholders, which 
displayed useful and interesting data.  The student focus groups were independently 
moderated to ensure that the presence of the researcher, who was well known by the 
participants, did not affect responses given to questions. 
Individual quotes could not be attributed to particular participants.  This reduces some 
aspects of interpretation as it cannot be stated that one individual made connected 
statements or whether certain individuals dominated discussions.  The sampling strategy 
was pragmatic, with participants of the study invited to join focus groups, so they were 
self-selected.  This may have selected a particular type of participant, but is unavoidable. 
It proved impossible to agree a mutual date for a focus group of the four pharmacists who 
had undertaken supervision within the study.  This resulted in a semi structured interview 
of one pharmacist and a focus group for the remaining three.  The majority of negative 
comments were from the pharmacist who was interviewed individually, and exchanging 
views with other pharmacists could have been useful and may have revealed more data, 
possibly explaining why views were held[50 103]. 
It also proved impossible to agree a date for the specialist nurses to meet, and 
consequently individual meetings were arranged for one-to-one interviews.  These 
followed the same question guide as the planned focus group.  At one medical practice, it 
proved possible to arrange a meeting with two of the participant nurses in addition to the 
only doctor involved in meeting students, which provided some useful additional insights. 
No comments were received by students who had left the study, as none of those 
students volunteered to join the focus group.  Their views may have added to the data 
received, particularly about why they left and whether the reason could have been 
rectified, for them or students in similar situations the future. 
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Questions asked in the focus groups and semi structured interviews reflect conduct of the 
study and, therefore, sought to identify issues of importance to the study.  Homogeneity 
was demonstrated in groups[50], with the groups being naturally occurring[107] (i.e. 
individual groups of study participants) which is recognised as increasing the likelihood of 
obtaining useful data.  Minority, divergent and difficult opinions[50] were included in the 
data presented, as this adds depth to the data. 
Transcripts are available for viewing (Appendix H), although sufficient original data is 
presented in the thesis to satisfy the sceptical reader of the relationship between 
interpretation and evidence. 
The focus groups and semi structured interviews generated large quantities of useful data 
which facilitated a better understanding of the development of both student training, within 
the context of undertaking real life medication reviews, and improving the study protocol 
for a possible RCT.  This method is supported by a study in which Kassam[164] reported 
that the focus group process was a useful tool for developing a community pharmaceutical 
care syllabus.  In particular, it enabled the development of student learning activities.  
Focus groups have been shown to be an effective and efficient method of collecting data 
which would otherwise be lost, and which enables an understanding of the quantitative 
data produced within the study[83 103 107 111] 
There was agreement amongst the majority of participants that the idea of the study was 
good, and should be repeated.  Strong support was provided for undergraduate pharmacy 
students learning communication skills through real world experience.  Dewey[127] stated 
that “there is an intimate and necessary relationship between the processes of actual 
experience and education”.  The process was enhanced by the patients who stated that 
they wanted to help the students to learn.  Patients reported enjoying their medication 
review because the students had created the correct environment to listen to patients and 
provided greater time for discussion compared to that experience with their GPs.  These 
findings concord with Little[64] who reported that consultation style, in particular patient-
‘centredness’, resulted in greater patient satisfaction.   
The General Medical Council (1993) recommended that communication skills should be 
taught throughout the education of medical students, although by 1998 progress was 
reported to be variable[165].  Whilst teaching communication skills throughout pharmacy 
undergraduate courses is currently undertaken, funding is not provided to enable a high 
intensity level of experiential training.  This results in consultation skills being taught within 
the university, sometimes with the use of actors, but less commonly with patients. 
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Interestingly, it was not just the patients or students who enjoyed the experience, but also 
some pharmacists and nurses due to their interaction with students.  Some pharmacists 
also reported that their knowledge had been improved by the experience.  A study[166] 
(Italy 2005) using interviews with managers identified that when they took on the role of 
teacher, their own learning improved, partly through increased reflexivity and recognition 
of their own failings.  Busari et al.[167] (Netherlands 2002) identified that residents 
(doctors) held the view that teaching students helped them to be better clinicians, possibly 
through stimulating their own critical thinking and reflection on knowledge.  They also 
reported that enthusiasm and enjoying teaching were qualities of good teachers.  
Pharmacists reported that they enjoyed the process and also learned things themselves, 
and this may be useful in encouraging supervisor volunteering in any future study. 
There was limited, but strongly made dissention, with the view proposed that the student-
led medication review sessions, despite providing some benefit was expensive and 
possibly not cost effective in its present form.  The reason suggested was that the time 
commitment for supervising pharmacists, in addition to travel costs and time of travel, 
were not justified by the perceived patient benefits.  These views take no account of the 
fact that, as a pilot, this study would not be expected to determine this.  Whilst immediate 
cost–effectiveness may not be observed, the comments about cost take no account of 
potential, long-term benefits and costs.  The case has been made for the need to provide 
effective medication reviews by pharmacists.  This is made in the light of the criticisms of 
pharmacists’ consultation skills[67] and the course under evaluation is designed to 
address the consultation skills needs of pharmacists.  If pharmacists receive effective 
consultation skills training whilst undergraduates, they should later be able to conduct 
more effective medication reviews for patients.  The aim of these is to provide patient 
benefit, and according to one UK based study [33 34] they demonstrate cost-effectiveness 
in some scenarios.  There is, therefore, a possible long-term benefit to consider, rather 
than simply focussing on the cost and/or value of any education at the point of 
implementation. 
Students demonstrated a variety of positive reasons for enrolling in the study, including a 
desire to personally develop skills, which may benefit them in communication skills exams 
and which they could utilise in the future.  The ability to take part in experiential learning, 
which is not currently available to them, was a strong driver to enrol.  They also wanted to 
improve confidence prior to pre-registration training, and in some cases, to get involved 
with extra-curricular activities.  Altruistic reasons were also quoted which included a desire 
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to help other students by helping to evaluate the course and also to highlight the skills of 
pharmacists.  
Students who completed the trial displayed full consensus that they enjoyed the 
experience and would recommend it to other students.  The data demonstrates that 
recruitment of pharmacy students for a full RCT would be possible and that informing 
potential recruits of the results of this study may encourage a greater level of recruitment.  
The large number of positive comments and experiences quoted, combined with 
timetabling problems suggest that a practical solution is to provide this training for all final 
year pharmacy students within the timetabled curriculum, rather than as volunteers.  
Student comments demonstrate the need for support, through regular communication, 
which may, therefore, be expected to increase retention of students in a study such as this. 
A number of useful and practical issues relating to patient recruitment were identified, 
which could be incorporated into the protocol for an RCT.  This included avoiding 
recruitment at or around Christmas as patients may be less likely to respond then.  It was 
said, by nurses and patients, that a written request to patients is the most effective 
method of recruitment, with patients stating that the documentation used in this study was 
suitable and well presented.  A change in the criteria for patient recruitment could possibly 
be made in order to improve the cost effectiveness of the student-led medication reviews.  
This study recruited patients based on a limited diagnosis criteria.  Recruitment of patients 
with identified poor adherence to their prescribed medication, as identified by higher 
HbA1C levels, may prove to be more appropriate because students would have a greater 
potential for improving care. 
Discussion by students about individual aspects of the preparative training proved very 
useful.  There was no strong support for the podcasts which were seen to be either 
repeats of topics covered within the course or topics which should have been covered 
within the undergraduate course.  It may, therefore, have been the content rather than the 
delivery method which was the problem. 
A similar criticism was made of the care-planning workshops, although the key issue 
raised by students in relation to the workshops was timescale.  General agreement was 
displayed that the sessions could have been condensed into a shorter time and should 
have been closer to the medication reviews.  Disagreement was demonstrated about the 
training in the use of the IT medical records with some students supporting it and others 
not.  Disagreement may arise from a difference in IT literacy, with some students able to 
quickly use an intuitive-style system.  Prior assessment of IT skills may save time by 
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streaming students into groups with similar skills, thus resulting in differing levels of time 
input.  There was a useful and practical suggestion for a paper-based checklist to be 
produced about the use of the IT medical records, for use when students arrive at a 
medical practice. 
The role-play session was the most positively received preparative session, which is 
unsurprising as it has been reported as being a useful and popular technique to train 
students in consultation skills.[116 130].  The time efficiency[117] of the session was 
complemented; however, there were also calls for more time provided for feedback to 
students after medication reviews, as it was shown to be effective. 
In chapter 4, it was demonstrated that students, in spite of receiving preparative 
paperwork and an introductory talk as they arrived at the role-play session, did not know 
what to expect of the session.  This issue was raised during the focus groups and 
demonstrates, as reported elsewhere[117 130], that further work is required to ensure that 
this is fully understood by participating students.  Actors’ scripts were criticised for being 
too complete, which resulted in all actors having problems which required identification 
and resolution, in contrast to real life.  In addition, actors’ failure to perform consistently 
was perceived to be a problem; however, even with the stated concerns the role-play 
sessions were seen as vital preparation.   
Strong support was displayed for feedback from actors, supervisors and the GP, due to 
the subsequent improvement in performance.  Guidelines published in relation to role-play 
have also agreed that feedback is essential[130].  However, in addition to the individual 
feedback given, further group sessions were requested.  The use of the MRCF[87] to 
assess student performance and, therefore, provide more structured feedback was 
supported; however, it was recognised that students require practice and training in its 
use to maximise the benefits of its feedback.  This suggests that the regular use of such a 
tool in undergraduate work may benefit students.  Joyner and Young[117] recommend the 
use of a structured form for feedback to ensure that various aspects of the consultation 
are considered without omissions and the use of the MRCF which has been validated and 
widely utilised for evaluation and teaching of students, could provide that. 
Disagreement was displayed regarding the duration of the sessions when students 
accessed medical records of participating patients, but support was provided for students 
working in pairs.  There was recognition that the medical records of real patients can be 
more complex than expected, with conditions observed in the records which were new to 
the students, therefore, providing additional training and learning opportunities.  Students 
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valued the session due to the opportunity to create a care plan and the provision of 
structuring for the subsequent level 3 medication review. 
It was reported that students’ performance during the level 2 medication reviews 
demonstrated a lack of experience with respect to the use of medical records and creation 
the of real life care plans.  Pharmacist supervisors identified that this would improve with 
experience and that, as this is a training exercise, it is the aim.  These activities required 
students to demonstrate application of knowledge in addition to possession and 
understanding of knowledge, which is a criticism of university students[74].  This 
experiential learning experience is designed to provide an opportunity to develop these 
skills.  The modernising pharmacy careers discussion paper[74] encourages education 
initiatives to improve student ability to apply knowledge which they state is currently 
lacking. 
Although the original plan was to deliver the student-led medication reviews at the 
university, this was changed when strong support was demonstrated amongst 
stakeholders for undertaking them at the patient’s medical practice.  An unexpected, and 
additional, benefit from this decision was recognised by students as the opportunity to 
train outside the academic environment.  This is supported by published reports [124 168 
169].  Another unexpected benefit, described by nurses, was patients providing previously 
unreported information to students which the nurses utilised later to benefit their patients.  
Unfortunately, due to a lack of GP availability to receive students’ recommendations a 
large proportion were not implemented.  It is, therefore, reassuring to find that nurses 
utilised the student-identified care issues. 
Specialist nurses believed that shared record-keeping of all student-led medication 
reviews is essential as this not only displays good governance, but would also provide 
another mechanism for passing student recommendations to the medical practice if face-
to-face meetings prove impossible. 
Student meetings with doctors or nurses after student-led medication reviews were 
designed to enable students to present care issues identified to the doctor or designated 
specialist nurse after the medication reviews, whilst also receiving feedback on their 
performance.  Failure to achieve the attendance of a doctor or nurse on all occasions 
resulted in a failure to implement care issues identified, whilst students missed a valuable 
training opportunity.  The result was reduced opportunities for patient and student benefit.  
Participants described students displaying consultation skills which required improvement 
including nervousness; referred to in one instance as inevitable.  Boyatzis[75] suggests a 
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possible solution to nervousness with reports that it is suggested anecdotally that students’ 
confidence would have been improved if they were an established part of the health care 
team and received more training and education in medication review.  Patients said they 
appreciated the provision of information, e.g. side effects, and general agreement was 
demonstrated that students should be providing this information. 
Patient expectations of student performance prior to the student-led medication review 
varied widely.  Previous experience with qualified pharmacists demonstrating both good 
and bad practice had influenced some opinions[170].  A belief existed that unqualified 
students could not be expected to perform at the level of a qualified pharmacist.  The 
suggestion that expectations could be managed by providing patients with more 
information in advance about the medication review is potentially useful, but in a research 
context would require careful presentation in order to not bias patient views. 
Students displayed surprise at some patient characteristics.  This included the desire 
shown by some patients to discuss subjects at length, resulting in the student being 
unable to manage the discussion.  One patient identified a possible solution being that 
students needed to be taught how to terminate a medication review. 
Conflicting views were displayed regarding patient benefit from the medication review.  
Some participants stated a lack of benefit, other than students’ education, whilst others 
reported patient benefit.  Most student cohorts, including this one, display a range of 
abilities (see Chapter 4, section 4.2.2) and, in addition, it has been previously stated that 
there are patients who did not have issues which required intervention.  Hata[169] reports 
patient benefit from student-led medication review through accepted recommendations 
made to doctors.  However, in that study the training commenced earlier in the course 
whilst medication reviews were undertaken over nearly three months, which provided time 
for improvement.  Hata reported that students stated a desire to provide patient benefit.  
This demonstrates a desire by students to ensure good patient care which is encouraging 
in the present climate, with care forming a key issue in the Francis report[171]. 
An interesting issue raised, which was not an aim of the study but demonstrates a useful 
outcome, was that participation in the study and meeting a student for a medication review 
raised awareness of pharmacists’ roles by patients.  This may be accompanied by 
improved professional relationships with healthcare staff.  Increased awareness by 
patients and fellow professionals potentially increases opportunities to discuss patients’ 
medication and provide direct patient benefit. 
230 
 
Students reported that they valued the fluid structure of medication reviews with real 
patients, as opposed to working with actors in OSCEs.  A reason was stated as being the 
ability to explore issues as they arose in a medication review.  Students also preferred the 
evaluation used with medication review (MRCF[87]) rather than the rigid marking schemes 
used for OSCEs as that made them focus on scores, rather than the overall consultation.  
Students stated that undertaking medication reviews had benefited their performance in 
OSCEs. 
Specialist nurses indicated that, when meetings with students took place they were useful 
because they enabled them to present practical issues in addition to explaining the 
significance of any information retrieved by students from medical records.  Focus group 
and semi structured interview participants identified that GP involvement is unlikely due to 
time constraints; although possibly, with prior planning, larger practices may be able to 
help.  Jaffa[172] highlights the issue of involving clinicians early in research as “research 
and clinical perspectives are different and that accommodating both is not always easy”.  
He adds that clinicians should not simply be ‘providers of patients’.  Medical practices 
were involved at an early stage, but only one medical practitioner (GP) was available for 
practical participation in the study as planned.  It is evident that greater communication at 
the development stage is required with medical practices to understand the issues.  This 
could potentially resolve the lack of medical involvement to receive recommendations.  
The only doctor involved in feedback reported that students displayed good 
communication skills, and that she received useful recommendations from students. 
Participating students, as predicted, reported that they had benefited from the course to a 
greater degree than their peers who had not taken part.  Reasons given demonstrate the 
need to include real life working into the undergraduate pharmacy curricula.  These 
included skills such as the fact that patients communicate differently to pre-prepared 
actors, which cannot be demonstrated in an academic environment.  Meeting real patients 
for medication reviews was also quoted as requiring students to push themselves whilst 
gaining in confidence, which further demonstrates that real life working exhibits additional 
benefits over solely academic teaching.  Students reported that, in spite of the intensive 
teaching of these subjects at the university, they still learned more clinical skills during this 
study.  They also reported that this did not just apply to diabetes.  It is reasonable to 
speculate that the context and application of knowledge would have increased 
understanding and later recall of knowledge.  The modernising pharmacy careers 
programme discussion paper[74] notes that pharmacists in their early years demonstrated 
gaps in knowledge, even in subjects which had been intensively taught.  One possible 
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reason was the lack of knowledge of how to apply the knowledge in real life situations.  
Students reporting improved knowledge of subjects that they had been taught at the 
university provides further support for this teaching method. 
Comments regarding post-medication review questionnaires by patients and students 
reveal an insight into scores provided by them.  Whilst asking patients to complete the 
questionnaire immediately after the medication review provided immediate recall and a 
high response rate, the possible bias effect of the student in the room requires a change 
to the method in the future.  The issue of students scoring themselves ‘harshly’, due to 
previous experience cannot be overcome, but still provides a valuable insight to their 
views, and is, therefore, worth retaining.  The use of qualitative methods to identify the 
real meaning of the quantitative data are justified as demonstrated by Barbour[53].  
Questionnaires provided quantitative data and explained how many patients held set 
opinions, which is very useful data, whilst focus groups explained how these opinions 
were arrived at, or what they meant[50 51]. 
Patients reported problems with completion of the baseline and follow-on questionnaire, 
but that the time taken to complete it was appropriate.  This is evidence that researchers 
should not assume that validated tools in frequent use are always acceptable to patients, 
and evaluation of patient acceptability is required before a questionnaire is included in a 
final protocol. 
Suggestions for changes to the logistics within the study were recommended by all groups 
of participants with respect to a repeat of the study.  Timing of sessions and cost 
effectiveness, which were both criticised, also received practical suggestions.  These 
included undertaking the level 2 and level 3 medication reviews on the same day; 
however, the protocol stated a clear reason for separating these two functions.  Timing 
problems were reported to have adversely affected the benefit of preparation, with short 
timescales required between preparation and implemented sessions.  The logistical and 
scheduling problems encountered were significant and require resolution to ensure any 
effective future study, but the study has identified possible reasons and, therefore, could 
enable solutions.  Nurses recommended that medical and pharmacy students could work 
together when undertaking educational activities with patients, and that this would provide 
mutual benefit for them.  This form of shared working has been demonstrated to benefit 
both patients and students[81].  The need for students to undertake medication reviews 
with more patients than the two provided within this trial was highlighted.  It was also 
suggested that students may benefit from undertaking medication reviews with the 
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supervisor observing via a video link from another room, and also that patients and 
students should meet prior to the medication review.  This would have the benefit of 
increasing the relationship between student and patient, as previously recommended by a 
student.  In addition, it may reduce the student nervousness reported by patients, as 
observers can increase this[130].   
The MRC guidance recommends a review of a study[48] and the use of the post-study (or 
review phase) focus groups and semi structured interviews in this case provided data 
which will enable improvement of the student preparation, the medication review and 
research process.  Problems had been addressed and processes enhanced by the 
qualitative work undertaken before the service was implemented (development phase).  
However, the qualitative work in these post-study focus groups and semi structured 
interviews confirmed the appropriateness of the initial changes and identified further 
potential improvements with respect to student preparation, the medication review and 
research processes.  If this study was undertaken as a full definitive trial, based on the 
data from this thesis, it would still be appropriate to undertake a qualitative review pre-and 
post-implementation to understand the elements which worked and which could be 
enhanced further. 
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Chapter 7 Discussion and conclusions. 
7.0 Discussion. 
The aim of this study was to feasibility test and pilot student-led medication review clinics 
in primary care for the purpose of designing a future trial.  This study has provided 
evidence which is supportive of the teaching of medication review skills in the workplace 
(GP practice) to fourth year pharmacy students.  In addition, it identified that not only can 
undergraduate pharmacy students potentially provide some patient benefits, but that the 
service is acceptable to patients and stakeholders. The pilot study proved successful, with 
recruitment demonstrated to be feasible, effective randomisation, limited withdrawals and 
potential benefit within some of the outcome measures.  Data were provided which would 
enable the power of a future study to be calculated and for the research design to be 
optimised. 
The preparation of students is an important element of the process which could be 
improved by more closely involving them in its design.  Educationally, the students 
reported numerous benefits, thus supporting the concept. 
The limited evidence for effectiveness and the cost of delivery suggest that the patient 
benefits may not be sufficient to justify funding the service through the NHS.  The cost-
effectiveness of the intervention requires elucidation but may be improved by better 
selection of patients, i.e. those with proven need of medication review.  Whilst data from 
this study enables an estimate of cost-effectiveness to be undertaken, a full trial is 
required to accurately determine its costs and effects. 
The concept for the study resulted from the government stated aims to increase the 
patient facing and clinical nature of pharmacy services [16 115 173-175].  Whilst hospital 
pharmacy has, over many years[176], evolved to incorporate many more clinical roles and 
a resultant separation from the dispensary, community pharmacy is still largely focussed 
around the supply of medicine.  Increased automation and the simplification of medicines 
supply within community pharmacy has changed government expectations, with a current 
drive for community pharmacists to change their focus to medicines optimisation[175] and 
they must accept this challenge[177]. 
In recognition of the deficits within pharmacist undergraduate education and pre-
registration training in the UK to adequately prepare pharmacists for clinical service 
provision, all newly appointed hospital pharmacists are required to undertake 
postgraduate training, in the form of a clinical diploma.  Whilst community pharmacists are 
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starting to provide more patient facing services e.g. public health interventions and brief 
adherence interventions, the Royal Pharmaceutical Society of GB (RPSGB) has stated 
that this role will be further challenged unless it is developed to provide patient focused 
care.  In order to maintain their status, community pharmacists will be expected to assume 
greater responsibility for chronic disease management[177].  To undertake such roles 
effectively, similar to hospital pharmacy, it is anticipated that they will require significant 
further training. 
Further postgraduate education, similar to that seen in hospital, may be appropriate but 
more difficult to deliver due to the professional isolation and time constraints imposed on 
community pharmacists[177].  A longer term solution is, therefore, to revise 
undergraduate education and this is a recommendation within a recent national report 
which identifies the separation of undergraduate education and work-based learning as 
the most important weakness[74].  Work-based learning enables students to contextualise 
their theoretical learning, apply their knowledge in complex situations and to develop 
consultations skills which have been highlighted as a deficiency in the profession[67] 
Pharmacy students providing medication review services which involve paper-based 
reviews and one-to-one consultations, form one potential approach to addressing these 
educational needs.  Due to the complexity of organising and delivering such teaching and 
the need for close academic supervision, the cost is significant.  This study was set up to 
test the educational concept, identify any potential benefits which could justify the 
increased costs and to inform the design of a future definitive study.  This discussion will, 
therefore, consider each of these three components separately whilst, recognising the 
inherent overlap between them. 
This study sought to investigate the education of undergraduate pharmacy students in the 
provision of medication review services, and this required complex clinical decision-
making combined with patient consultation skills.  The literature review in this study 
established that pharmacy students in other countries, such as the USA and Australia, 
can be effectively trained to undertake consultation skills by working with real patients 
whilst, in some cases, providing benefit to patients [75 76 81]. 
During the development of the study it was identified that published research, in relation to 
student-led medication reviews, frequently fails to establish the academic ability of 
recruited students.  It was, therefore, decided to obtain this data for both those students 
volunteering to participate in the study (intervention) and those students not volunteering 
(control).  No pre-determined view existed about the academic status of the students, 
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although it could be predicted that those exhibiting a greater academic status would 
volunteer.  Data demonstrated that this was the case and, therefore, this reduces the 
generalisability of results.  It is recommended therefore, that studies recruiting students for 
any activity involving intellectual input should establish the academic status of both 
intervention and control group students.  Alternatively, the novel teaching approach should 
be incorporated into the timetable to ensure that all students participate. 
This study intervention commenced with a preparative training programme, to further 
develop skills and knowledge of participating students prior to meeting patients for a 
student-led medication review.  Knowles[178] believes that participants, similar to 
students in this study, can be considered to be adults and, therefore, andragogical 
principles may be applied.  The first assumption underlying the adragogical model of 
learning is that adult learners want to take responsibility for their lives, with this including 
planning, implementing and evaluating their learning needs.  It is recognised that whilst 
the training programme involved workshops and patient-directed activities, it was still 
essentially didactic in delivery.  Taking full account of the adragogical model would have 
required the participating students to be involved in developing learning outcomes and the 
subsequent training programme.  The result could have been an innovative and more 
effective preparation for meeting patients. 
The training programme included experiential elements, such as meeting patients and, 
therefore, meets the recommendations of Dewey[127] and Kolb[128] for undertaking real 
life experiences to facilitate training.  It is important to recognise, however, that they still 
emphasise the necessity of obtaining underpinning knowledge in addition to experience.  
This provides further evidence of the need for appropriate preparative training to provide 
the requisite knowledge.  The students in this study largely chose not to access the 
knowledge-based teaching materials, which may reflect previous adequate preparation in 
the undergraduate course, or that students sought the information via other routes. 
The preparative training programme received criticism from participating students during 
focus groups.  Primarily, they criticised content which had already, or should have been, 
provided within the undergraduate curriculum.  The modernising pharmacy careers 
report[74] notes that pharmacists in their early years of practice do not appear to retain 
knowledge imparted to them during their undergraduate training, and that real life 
experience is required to learn application of this knowledge.  It is probable, therefore, that 
meeting patients was more effective at training the students than classroom sessions. 
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A key criticism of the preparative training for this study was that, due to logistical problems, 
there were frequent and extended periods of time between training and implementation of 
medication reviews.  Problems were also exhibited with respect to the release of students, 
by academic supervisors, from activities associated with their final year project.  These 
problems were recognised as reducing the effectiveness of training and, again, this 
supports the concept of timetabling the experience within the undergraduate curriculum 
for all students. 
The development and planning of the role-play training session, which used professional 
actors as patients, was reported to be extremely effective.  This session, undertaken in 
consultation rooms in the clinical trials unit to provide reality, received almost universal 
support amongst participants who completed the study.  It has been reported Nestel 
(2006)[117] that students can recall more information from role-play than lectures.  In 
reality, it is reasonable to propose that this is due to application of information provided in 
lectures, as proposed by the modernising pharmacy careers programme[74].  However, a 
small number of students found the session too difficult, indicating that more preparative 
training was required.  Whilst a review of underpinning training in consultations skills may 
be required to better prepare students for patient contact, it may have been a lack of 
confidence in clinical knowledge, and the subsequent exposure of this deficiency which 
drove the decisions to withdraw.  Unfortunately, it was not possible to ascertain the 
opinions of those students.  Their views, if obtained, may have enabled additional 
improvements to be made to the preparative training programme.  Including this role-play 
session and its preparation into the curriculum could potentially resolve the problems 
which were experienced. 
Students in the review phase focus groups identified that more educational benefit would 
be obtained by them during role-play from a change in the scripts utilised by actors.  They 
perceived that actors using full scripts did not always display the same characteristics as 
patients.  This was because they always exhibited problems which required resolution and 
always knew the answer to questions.  This is an important issue, not always recognised 
by role-play guidance[117].  In common with scripts prepared for OSCEs, those prepared 
for role-play by teaching staff could, therefore, provide better preparation for medication 
reviews with patients if gaps are ensured, similar to real life scenarios.  Some students 
complained of being ill-informed about the aims and methods of the session, in spite of 
various written and verbal communications designed to inform them.  This provides 
evidence that assumptions should never be made in a study, and the guidance should 
have been evaluated by at least one student. 
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Student and nurse participants suggested commencing real life training for pharmacy 
students in years one to three of the course.  Smith et al.[179] (2012) reported a 
programme of real life training in which an iterative approach enabled pharmacy students 
to observe real life patient activities from year one and increase input throughout the 
course.  Smith[179] reports benefits from this approach.  Support is, therefore, 
demonstrated for the views of the focus group and semi structured interview participants, 
and if significant experiential elements are built into the pharmacy course in the future, this 
approach may, with further evidence, prove to be effective. 
Feedback, which was provided following role-play, level 2 and level 3 medication reviews 
with patients displayed consistent support, due to enabling students to improve their 
consultation skills.  In common with research into student education[117 130 164 180], 
students reported that feedback provided benefit, through increased confidence, whilst 
enabling improved subsequent performance.  All of the pharmacists involved in student 
supervision and providing feedback were experienced practitioners, having worked with 
GP practices and undertaken medication reviews, and it is probable that this form of 
supervision requires this level of experience.  The pharmacists are then able to provide in-
depth advice built on the experience of clinical input.  The fact that they generally enjoyed 
the experience of supervising students in both the level 2 and level 3 medication review, 
and would have wanted the opportunity to undertake this training themselves when they 
first started provides strong support for the course.  An unexpected, but welcome, 
educational benefit was pharmacist supervisors reporting improvement of their knowledge 
during the process, partly through their perceived need to ‘look things up’ prior to 
supervisory sessions.   
One pharmacist was not supportive of the educational programme, wanting more cost 
effective training.  This may, however, reflect a lack of awareness of the true cost of this 
intervention and the different funding sources underpinning undergraduate education, i.e. 
they may have based this comment on the assumption of the full cost being borne by the 
NHS.  This pharmacist may, in addition, have failed to consider the long-term benefits to 
patients and the NHS of educating pharmacy students in consultation skills.  The 
modernising pharmacy careers programme[74] discusses the funding for pharmacy 
training and reminds us that considerable funding is provided for medical and dental 
training, via both educational and NHS sources, to deliver clinical training. 
Medication related problems and care issues identified by participating students were 
judged as suitable by the experienced supervising pharmacists.  Due to the unavailability 
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of GPs to meet students to receive recommendations arising from identification of care 
issues during student-led medication reviews, these were not implemented by the doctors.  
Therefore, the potential clinical benefit to patients, which includes the co-primary outcome 
measures, from intervention by students within this study is reduced.  Interpretation of the 
clinical data is, therefore, further confounded. 
It was reported by specialist nurses, who met students to receive recommendations 
following student-led medication reviews, that they utilised a number of care issues 
identified by students within their own practice.  It could, therefore, be predicted, but not 
with confidence, that student intervention yielded some positive benefits for participating 
patients which were not captured within the outcome measures chosen.  The issue of 
ensuring that recommendations made by participating students, if deemed to be suitable, 
were implemented by the patient’s GP was a failure within this study and a future study 
would need to address this. 
Students identified that they preferred undertaking medication reviews with real patients 
compared to undertaking OSCEs, as they learned more with the patient.  One reason was 
stated to be the rigid marking scheme employed within OSCEs which, therefore, required 
students to act within constraints compared to medication reviews.  Students preferred the 
MRCF[87], for evaluation, which is designed to ensure that consultations have the most 
appropriate elements but enables the structure to be fluid and somewhat dictated by the 
patient.  Adoption of the MRCF within the undergraduate curriculum may, therefore, be 
appropriate and necessary if students are to be expected to provide real patient services 
later on within their degree. 
Dewey[127] recognised that each student obtains a different experience from any 
experiential learning and this was seen by the students who outlined a variety of benefits 
resulting from providing the service.  These included an awareness of the need to adapt 
consultations to different patients and how to deal with patients’ questions, resulting in 
improved confidence.  Kolb[128] states that experiential learning is the process whereby 
knowledge is created through the transformation of experience.  Students stated that the 
experience enhanced their knowledge of not only how to undertake a consultation, but 
also clinical skills and roles of healthcare professionals in medical practices. 
Schon[69] states that the rigorous professional knowledge held by professionals in order 
to resolve problems is based on technical rationality.  He refers to an artificial scenario in 
which practitioners remain on the high ground solving manageable problems which are 
resolvable through the application of research-based theory and technique.  He continues, 
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however, that these problems tend to be relatively unimportant, as in the “swampy low 
land” lies confusing problems which defy technical solution, and require communication 
and adaptive thinking.  This is referred to as reflection in practice, as opposed to reflection 
on practice.  It was gratifying to observe that students reported having to think on their feet 
and respond to new situations to effectively resolve patient care issues. 
The strength of many patients’ statements, during focus groups, of their enjoyment of the 
experience of consulting a pharmacy student was surprising.  In some cases, the reason 
was pragmatically stated as due to being able to do something interesting when retired, 
but data also demonstrates genuine enjoyment and benefit from the medication review.  
There were small numbers of dissenting voices and it was recognised that the students 
required further experience.  However, this was their first opportunity to undertake 
activities such as this and the study data demonstrates students improving their 
consultation skills between the first and second medication reviews.  An obvious 
interpretation would be that these skills would continue to improve during subsequent 
medication reviews.  Results from only two data points, however, is insufficient is to 
identify a trend and further work would be required to establish if this promising result 
improved with further experience. 
Post medication review questionnaires demonstrated that patients found the medication 
review to be acceptable, and more significantly that they would recommend it to another 
patient.  These results are similar to those reported in a previous study (Boyatzis and 
Batty[75]) in which fourth year pharmacy students met patients for medication reviews.  
Little et al.[64] assert that patient centredness is a vital element in patient satisfaction 
within a consultation.  Patient acceptance of student-led medication review provides 
indirect, but important, evidence of student competence.  Patients reported, during focus 
groups, that they valued the additional time available for student-led medication review 
versus those of GPs.  It could, therefore, be argued that this is a major reason for their 
stated satisfaction.  However, Ogden et al.[121] investigated the link between patient 
satisfaction with consultation and the time available.  They reported that ‘a doctor who 
listens and tries to understand their patient may make the patient feel more satisfied with 
the consultation length and subsequently more motivated to follow any recommendations 
for change’.  This, therefore, provides further support for an argument which states that 
patients’ stated satisfaction with the medication reviews was a result of students 
demonstrating good consultation skills which had been learned during this programme.  In 
addition, some patients who had met a pharmacy student for a medication review agreed 
that they would be more likely to consult a pharmacist for information as a result of the 
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medication review.  Further evidence is, therefore, provided for benefit in some cases 
beyond the immediate medication review. 
Students reported educational benefit from meeting and interacting with other healthcare 
professionals during the visits to medical practices.  One stated aim of future pharmacy 
undergraduate education within the modernising pharmacy careers programme[74] is to 
produce pharmacists, at registration, working in partnership with other healthcare 
professionals to deliver patient care through the use of medicines.  Medicines optimisation 
requires more multi-disciplinary team working than has been seen previously in the UK, 
with healthcare professionals working closely together to improve patient care [175].  It is, 
therefore, essential to ensure effective collaborative working at the undergraduate level. 
This training programme has evidently provided some opportunity for undergraduate 
pharmacy students to commence the process of integration and partnership working. 
Whilst undertaking medication reviews participant students identified large numbers of 
care issues, for the patients, which were agreed and approved by supervising pharmacists.  
Students, therefore, were able to demonstrate technical competence in identifying issues 
of importance for patient care, which meets with the requirements of the definition of 
pharmaceutical care [35].  Not only, therefore, was it demonstrated that participating 
students had learned from the programme, but that they were able to identify issues of 
clinical importance to patients. 
If we are to produce confident clinical professionals (pharmacists) who are able to apply 
their knowledge in practice, as required by modernising pharmacy careers programme[74], 
evaluation of their clinical activity within the workplace is required.  This will enable real 
assessment of the effects of such activity.  Clinical outcome of patient participants in this 
study was evaluated using the co-primary outcome measures of HbA1c, blood pressure 
and total cholesterol. 
No clinical benefit was demonstrated within the intervention group.  Observation of the 
patient clinical data (both at baseline and post-intervention) demonstrates that patient 
groups, as demonstrated by mean, were within accepted ranges.  With the wide standard 
deviation displayed, it is evident that some patients did require intervention to move 
outcome measures (HbA1c, BP and cholesterol) into range.  However, the small numbers 
in this study, combined with the baseline results present a difficult target for students to 
improve. 
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Results obtained by patient questionnaires at baseline and six months post-intervention 
demonstrated a significant superiority by patients who had received a student-led 
medication review compared to control, with respect to change in quality of life.  Whilst 
there were no changes in clinical outcomes, it might be predicted that providing patients 
with information to support their medication taking, and answering questions about 
disease and lifestyle, would reduce concerns and, therefore, improve quality of life. 
The patients in the intervention arm demonstrated significant improvement in elements of 
the SIMS scale[91].  Horne et al.[91] (2001) state that higher levels of satisfaction with 
medicines information were associated with higher levels of reported adherence.  The 
current study demonstrates that patients who had received a student-led medication 
review displayed lower concern about potential problems with their medicines than 
patients who had not received a medication review.  The improvement in reported SIMS 
by participating patients did not result in an expected improvement in adherence [91].  
However, the adherence tool utilised has not been fully validated and has been reported 
to show reduced confidence in results due to being a self-report scale[152-154].  Both 
groups of patients displayed a high use of medicine compliance aids (MCA) to assist with 
medicines taking.  It is probable that this would have exerted a considerable effect on 
adherence prior to participation in the study, thus reducing any possible effect from the 
student-led medication review. 
Patients within this study were required to have been diagnosed with T2DM for a 
minimum of two years.  It is possible that patients within a timescale much closer to 
diagnosis would exhibit a greater need for information and education about medicines, 
lifestyle issues and their disease state.  In such a scenario, students would have a 
significantly greater opportunity to improve patient outcomes.  Therefore, it may be more 
effective to actively recruit more recently diagnosed patients, by amending the inclusion 
criteria, in a future study. 
Undertaken within the guidance provided by the Medical Research Council (MRC)[48], 
significant changes to the original protocol have been identified as necessary for any 
repeat of the study.  This study meets the criteria of a complex intervention through the 
number of interactions, the number and difficulty of behaviours required by those 
delivering the intervention, the number of stakeholder groups involved and the number 
and variability of outcomes.  As the intervention is required to ‘work in everyday practice’ it 
is important to understand the whole range of effects, how they vary among recipients of 
the intervention, between sites, over time, etc. and the causes of those variations.  This 
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study, through the implementation of a full and well developed protocol sought to follow 
those concepts. 
Co-primary outcome measures were used within this study which is not usually accepted 
practice.  However, the MRC guidance allows this approach within a pilot study, as a 
means of identifying the most appropriate outcome measure(s) for a full study.  Data 
obtained showed that HbA1c is the primary outcome of choice for a future study, with a 
sample size calculation indicating the number of patients required in a full RCT. 
The most significant positive finding from this study was that it was possible to recruit 
patients, suggesting that a full RCT would be feasible.  However, whilst two medical 
practices recruited almost to target numbers and on time, with a third recruiting target 
numbers, but late: the remaining two practices recruited smaller numbers of patients and 
later than required.  The ability of some practices to achieve the targets suggests that 
much closer communication is required with all practices to ensure that targets are met.  
The delay in recruiting exerted considerable pressures on planning and implementation of 
the intervention.  Strong criticism was voiced by student participants that these delays 
reduced the effectiveness of training, due to the long time between learning skills and 
implementing them with patients. 
In this study patient participants were those with T2DM for at least two years.  The 
literature review identified that T2DM is responsible for extensive patient morbidity and 
cost to the NHS, whilst the prevalence is increasing dramatically.  Over 15 million people 
in England have a long term condition with 75% saying that if they had support from a 
professional, or peer, they would feel more confident about taking care of their own 
health[115].  Between 2005/6 and 2011/12 the total number of items used to treat 
diabetes in England rose from 27.1million to 40.6million[181].  Patients with type 2 
diabetes were chosen for inclusion in this study, as representative of a LTC with 
supporting guidelines which students could utilise.  Review stage focus groups and semi 
structured interviews recognised that, whilst the participating patients had T2DM, students 
within the medication review evaluated care issues for all of the patients’ existing 
conditions.  Agreement was demonstrated that this was the correct approach.  Therefore, 
recommendations were made that patients exhibiting other conditions should 
automatically be included.  This would also result in easier recruitment due to a larger pool 
of patients.  In a future iteration of this study it may be of value to use the patient criteria 
developed and used within the Australian Domiciliary Medication Management Review[41 
182] (DMMR) as this is a service which is widely implemented throughout Australia with 
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approximately 20% of pharmacy graduates applying for accreditation.  Use of the criteria 
would enable comparison to an established programme with a wealth of research to 
support this, with Prof Chen[183] being very active in this area.  The Australian DMMR 
notes the risk factors contributing to medication-related adverse events, and which can 
help to target DMMR: 
• currently taking five or more regular medicines, 
• taking more than 12 doses of medicine per day, 
• with significant changes to their medicine regimen in the last three months, 
including recent discharge from hospital, 
• taking medicine with a narrow therapeutic index or required therapeutic monitoring, 
• with symptoms suggestive of an adverse drug reaction, 
• having difficulty managing their own medicines because of literacy or language 
difficulties or impaired sight. 
• attending a number of different doctors, both general practitioners and specialists. 
Future studies may benefit from patients meeting a student pharmacist more than once.  
Within this pilot study it was pragmatically appropriate to limit medication review by each 
student to two patients.  Research published in the USA and Australia [75 76 81] 
demonstrated educational benefit from students meeting more than one patient, whilst 
additional patient benefit was demonstrated by more than one consultation meeting. 
Recruitment of students demonstrated approximately 50% of the cohort which is the figure 
predicted by a survey the previous year.  It is possible that with timely patient recruitment 
and a more innovative preparative training for students, that the dropout rate would be 
smaller.  Patient recruitment should commence earlier to enable planning of medication 
review schedules.  This would also provide information to enable the medication reviews 
to be scheduled into the undergraduate timetable. 
It was stated earlier, that involvement of students in the development of the preparative 
training programme may have produced a better outcome.  Obtaining their views 
retrospectively about the training, via a focus group, provided very useful information.  
Whilst earlier involvement of students is desirable, it is still valuable, as required by MRC 
guidance, to obtain their views after a study.  The use of on-line surveys proved to be an 
effective tool and is one with which most students are experienced.  However, the 
response rate from students of 40% is relatively low and better timing of the survey may 
have produced a greater response.   
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The key changes made following stakeholders’ focus groups and semi structured 
interviews during the development stage of the study were to move the location of the 
student-led medication reviews from the university to the patient’s own medical practice, 
and to provide transport to these locations for participating students.  The patients also 
provided a very useful insight into their view of recruitment documentation.  These 
included elements which were incorporated into documentation for this study, and which 
will be useful in the development of future studies.  Examples include a dislike of the 
terms intervention and control, simply because patients do not always understand them.  
A preference was displayed for terms describing the groups such as ‘the group receiving a 
consultation’.  Another example was the recommendation to include an invitation 
paragraph to act as a short précis.  Thirdly, strong dislike was displayed of the use of 
abbreviations, even if previously explained.  This data enabled the recruitment 
documentation to be made more user friendly, although an earlier focus group would have 
enabled a full rewrite and, therefore, potentially a better outcome. 
The late implementation of development phase focus groups and semi structured 
interviews was undoubtedly a key weakness of the study development process, as if 
implemented earlier they would have enabled better adherence to MRC guidance[48].  
During the process of recruitment for the medical practice focus group it proved 
impossible to recruit a GP, which resulted in recruitment of specialist diabetes nurses.  
The protocol required the availability of a GP to enable students to present 
recommendations, following level 2 and level 3 medication reviews.  The inability to recruit 
GPs for the focus groups should have been a signal that recruiting them to participate in 
the main study would also be problematic.  Increased and improved communication 
should be attempted and with hindsight we should have utilised the medical supervisors 
within the project more effectively to facilitate this.  The inability to provide a GP or nurse 
after each level 2 or 3 medication review session was a major failing, and highlights an 
issue requiring resolution before a full RCT.  Student inability to present issues identified, 
along with recommendations resulted in a failure to implement recommendations.  
Specialist diabetes nurses involved in the study, however, stated that they used student-
identified care issues in their clinical practice.  In some cases, they did not utilise issues 
which referred to non-diabetes issues, due to their lack of knowledge in those areas and 
an understandable unwillingness to work outside their own competence.  Failure to 
implement students’ recommendations not only reduced the educational benefit for them, 
but may also have resulted in reduced, potential clinical benefit for patients from student 
recommendations.   
246 
 
A number of issues have been discussed which were not planned or undertaken in an 
ideal manner.  The care plan designed for use within the study was in electronic format 
with drop-down boxes and was to be used for collection of patient data and formulation of 
care plans.  However, with insufficient testing, full identification of student opinions was 
not obtained.  It was assumed that students would prefer electronic records to paper 
records, but in practice, when given a free choice, they chose paper records on every 
occasion.  The care plan was still effective, in paper form, in providing a guide to the 
students’ care planning and for recording of care plans.  This is evidence that 
assumptions should not be made in a research study, and that further testing of the care 
plan should have been undertaken. 
When undertaking medication review with patients, students failed to record all care 
issues identified.  This may have been predicted, as undertaking their first medication 
review with patients would have been stressful and they were working in an unknown 
environment.  Even if not predicted, the researcher and supervising pharmacists should 
have observed this and undertaken the recording themselves.  Failure to record this data 
reduced the ability to effectively describe the student activities.  A recommendation by 
specialist nurses during review phase semi structured interviews was that supervising 
pharmacists should fully record the student-led medication review in the patient’s medical 
record.  Copies of this would resolve both governance and data collection requirements. 
Another research design issue is the use of validated tools in the study.  The main 
questionnaire and post- medication review questionnaire were both based on previously 
validated tools such as SIMS, MARS, BMQ, EQ5D, and DTSQ.  Non-validated tools 
included care planning forms for presenting recommendations to GPs and intervention 
criteria to evaluate care issues identified by participating students.  An attempt was made 
to identify validated tools which proved unsuccessful but a more prolonged search, if 
successful, may have presented more valid data.  In the case of the post- medication 
review questionnaire, a published tool [75] was utilised, but following MRC guidance, the 
research protocol was evaluated with the use of focus groups and semi structured 
interviews.  The patient stakeholders clearly identified that students displaying a lack of 
competence or confidence would not be acceptable within a medication review.  Therefore, 
this issue was taken to the study steering group and questions asking about these two 
issues, worded in a manner acceptable to the patient and student members of the group, 
were added to the questionnaire.  At this stage they also requested the addition of a 
question, for students, about required levels of knowledge.  Evaluation of the protocol by 
the use of focus groups and the use of management and steering groups is recommended 
247 
 
by MRC[48].  Whilst this questionnaire was not fully validated, it was based on a validated 
tool with additional input following stakeholder and management input. 
Review stage focus groups of stakeholders in the study provided invaluable information 
about the study and also ensured further compliance with MRC guidance[48].  Strong 
support was displayed that the study was enjoyed by participants.  Practical issues 
identified included the time available for medication reviews, use of care plans by students, 
preparative training, logistics and students’ performance.  Recommendations from 
participants in each stakeholder group recommended methods of providing the 
intervention in the future. 
7.1  Reflexivity. 
Reflexivity entails the researcher being aware of his/her effect on the process and 
outcomes of research based on the premise that knowledge cannot be separated from the 
knower[184].  Hamersley and Atkinson[185] observe that reflexivity acknowledges the 
effect on the researcher imposed by their previous social interactions which may have 
conferred values and interests on them.  Tong et al.[84] state this simply as qualitative 
researchers being unable to completely avoid bias.  The result may be the researcher 
unwittingly affecting data during collection or affecting data analysis.  The effects, if 
observed, may also involve the researcher unwittingly imposing possible effects on 
responses provided by research participants. 
Recognition of effects is not sufficient, as data must be presented to the reader of a 
qualitative paper to enable him/her to see that the researcher has dealt with this 
phenomenon effectively.  Therefore, the data must enable the reader to evaluate for 
themselves the true effect of reflexivity.  Mays and Pope[186] confirm this when reporting 
assessment criteria for qualitative research which includes reflexivity of the account.  They 
define this as “the degree to which the effects of the research strategies on the findings 
are assessed or the amount of information about the research process that is provided to 
readers”.  They further state that reflexivity means sensitivity to the ways in which the 
researcher and research process have shaped the collected data and recommend 
reporting biases to enhance credibility of findings, with discussion also required about 
personal characteristics. 
The COREQ criteria[84] further expand this by presenting a formal reporting checklist for 
in-depth interviews and focus groups, in which Domain 1 discusses the research team 
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and reflexivity.  They recommend that researchers should recognise and clarify for their 
readers their identity, credentials, occupation, gender, experience and training to enable 
assessment of possible influence exerted by these factors.  The COREQ criteria also 
recommend reporting the relationship and extent of interaction between the researcher 
and their participants.  This is due, as stated earlier, to the potential effect exerted by 
relationships on participants’ responses and the researcher’s understanding of the 
phenomena.  Accordingly, detail of relationships existing between the researcher and 
participants in focus groups or semi structured interviews is presented below to enable 
reader assessment of reflexivity within this study. 
The researcher was new to qualitative research but was mentored by a Professor 
experienced in qualitative research for the first focus group.  He gained experience 
through undertaking focus groups and semi structured interviews and subsequent 
reflective practice during the research, in addition to extensive reading. 
Male, age 60+years, pharmacist with 30+ years clinical pharmacy and management 
experience in hospital pharmacy.  In 2007 he commenced teaching at the UEA in addition 
to work with a PCT as a practice pharmacist and CPD mentor for PCT pharmacists.  The 
researcher is committed to the development of clinical pharmacy in order to improve 
patient care and it is possible that this enthusiasm was unwittingly conveyed to 
participants.  As this was the first qualitative research undertaken by the researcher bias 
cannot be ruled out, although the desire to fully learn this technique created an internal 
desire to ensure a lack of bias. 
Development phase semi structured interviews/focus groups: 
Students had recently completed their pharmacy degree and knew the researcher well 
due to his role in teaching, but having just left the university were not in a dependent role.  
However, the previous repeated contacts will have influenced interactions and may have 
influenced students’ comments.  
PCT Pharmacists were all colleagues with whom the researcher had worked and enjoyed 
a good working relationship.  
Patients were unknown to the researcher before the meeting.  As topics included the roles 
of pharmacists such as information provision by them, it is of relevance that the 
researcher is a pharmacist. 
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Only one specialist nurse was known to the researcher prior to the meeting.  That nurse 
worked in a GP practice at which the researcher had worked as an advisor on a part-time 
basis, and they experienced short episodes of professional communication.  The 
researcher had worked with large numbers of nurses in patient care for many years and 
was relaxed in communicating with them. 
Review phase semi structured interviews/focus groups: 
A number of the students volunteered to participate in the study because they knew the 
researcher and his strong views on the future of clinical pharmacy.  In addition we had 
worked closely together both during their undergraduate teaching and especially during 
the study.  Due to the possible influence of this I requested two colleagues undertaking 
PhDs in the school of pharmacy at the UEA, who were unknown to the students, to 
facilitate the meeting.  One was a female former secretary (mid 30’s) and now research 
manager at the local hospital, with previous experience of facilitating focus groups.  The 
other was a male psychology student (mid 20’s).  He had provided statistics teaching to 
pharmacy students, but not this cohort.  The questions for the focus group were provided 
by the researcher.  Participant students were informed that the meeting record would be 
typed and an anonymised version provided to the researcher, so that he could see their 
comments but not ascribe comments to individuals. 
All four of the PCT pharmacists had attended the development phase pharmacist’s focus 
group and had worked closely with the researcher during the stage of the intervention 
when students accessed patient records and met patients for medication reviews.  It 
proved impossible to arrange a focus group for all four pharmacists due to commitments 
and the pharmacist providing negative comments on the research met the researcher for 
a one to one semi structured interview, whilst the other three attended a focus group. 
The two patient focus groups represented patients from two different geographical 
locations.  A number had met the researcher during student-led medication reviews, but 
for very short periods of time, during which introductions were made and then thanks for 
participation. 
Specialist nurses were the same nurses represented at the development phase semi 
structured interviews.  In addition a GP who met two students for feedback after student-
led medication reviews participated in a meeting with two nurses from the same GP 
practice.  Contact was very brief during that session.  
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Negative comments from some participants demonstrate that they were not inhibited from 
making these by the presence of the researcher.  No further contact was planned between 
the researcher and participants. 
7.2 Conclusions. 
This thesis identified that patients do not always benefit from their medicines as planned.  
Whilst medication review (MR) may provide assistance with this issue, resulting in patient 
benefit, no compelling evidence exists for the provision of this service by pharmacists 
within the UK.  Suggested reasons for the failure to demonstrate this are poor study 
design, inappropriate intervention location and limited consultations skills demonstrated by 
pharmacists, with this last issue providing support for the proposal that UK pharmacy 
students should receive additional education to prepare them to undertake medication 
reviews.  It has been demonstrated outside the UK, primarily in Australia, USA and 
Canada, that this can be effectively undertaken through pharmacy students undertaking 
medication reviews with real patients.  Justification, therefore, exists that this should be 
evaluated within the UK. 
The work in this thesis, undertaken as a feasibility and pilot study in accordance with MRC 
guidance, demonstrated that it is possible to effectively prepare final year pharmacy 
students to undertake medication reviews with patients with type 2 diabetes.  Patient 
acceptability and some patient benefit were displayed in addition to educational benefit for 
students.  Success was, therefore, demonstrated as a feasibility and pilot study not only 
through identification that the intervention is possible and acceptable to participants, but 
also through the demonstration of high rates for important issues such as recruitment, 
retention and completion of patient questionnaires.  A number of negative findings were 
identified; however, these will prove to be effective in informing the amendment of the 
protocol for the implementation of a multi-site study.  The key negative results related to 
the design and implementation of the preparative training for participating students and 
the engagement of GPs with the study. 
Results obtained support the implementation of a multi-site study following retention of 
some elements of the current study and implementation of key changes to the current 
protocol identified during the study: 
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• Patient Information leaflets must be reviewed to ensure elimination of 
abbreviations and to replace any reference to control or intervention groups with a 
simple descriptor of the role of each group, 
• within the patient questionnaire Medication Adherence Report Scale (MARS) 
should be replaced by Moriskey 4[159], 
• development phase focus groups or semi-structured interviews should be 
undertaken with stakeholders early to inform and enable further amendment and 
improvement of the current protocol, 
• the intervention should form part of the curriculum for all final year pharmacy 
students at participating sites, including preparative training, level 2 and then level 
3 medication reviews at GP Practices, 
• a review of student education should be undertaken at each participating site to 
assess the need for each element of the preparative training.  It is likely, however, 
that this will identify that additional training in the use the I.T. medical records and 
consultation skills training should be retained, 
• each student should undertake a role-play session with actors to practice 
medication review prior to meeting real patients for a medication review, 
• the medication related consultation framework (MRCF)[87] should be utilised both 
as a training tool within undergraduate teaching and for evaluation of consultations, 
• recruitment of GPs should be undertaken by medical academics participating in 
the study to ensure at an early stage that a GP will be available to receive student 
recommendations and to provide feedback, 
• patient recruitment criteria should be changed to enable recruitment of people with 
type 2 diabetes closer to diagnosis.  This should be at any point after diagnosis 
agreed by the patient’s GP to allow for exclusion of potential problems.  Skyler[147] 
when reporting a position statement of the American Diabetes Association states 
that “glycaemic control early in the course of type 2 diabetes may have CVD 
benefit”, and notes that intensive glycaemic control of relatively young patients with 
type 2 diabetes was associated (in studies reviewed) with a 57% reduction in 
major CVD outcomes.  In addition it is reasonable to propose that patients nearer 
to diagnosis display a greater need for information about their medicines.  These 
factors would provide pharmacy students with greater opportunities to provide 
benefit to patients, 
• assessment of potential patient recruitment must be undertaken.  Using the 
chosen criteria, assessment is required to evaluate if 20% (approximate 
recruitment rate identified within the study) of such patients represent sufficient 
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numbers.  Within each school of pharmacy each final year student should meet 
two patients for medication review.  Therefore to enable a similar sized control 
group four times the number of students in the year will be required as patient 
participants, 
• if suitable numbers of patients with type 2 diabetes are not available for 
recruitment, then it is recommended that the Australian Domiciliary Medication 
Review[41] criteria (see page 245 in thesis resubmission) should be adopted, 
• negotiation with participating GP practices is required to agree a read code for 
‘student-led medication review as part of a research study’.  Supervising 
pharmacists should ensure that this code is attached to the medical record of all 
patients receiving a student-led medication review(MR) and that a précis of the MR 
is recorded there. 
7.3 Recommendation for future work. 
A multi-site study is justified by the data presented within this study.  However an internal 
pilot would be required to ensure that recruitment rates were the same at other sites.  
Patient benefit was only demonstrated with respect to a small number of aspects of care 
and a future study should seek to clearly provide this.  A possible method of achieving this 
would be by changing the patient inclusion criteria to include those patients with a greater 
need of pharmaceutical care input.  This may be achieved by including those patients with 
demonstrated or suspected adherence problems, or by including medical conditions other 
than diabetes and closer to diagnosis. 
The results obtained suggest that focus groups should be used at an early stage in the 
development of a future study to facilitate optimal identification of the aims and 
development of the protocol for a full study. 
Better communication with medical practitioners to ensure opportunities for students to 
present recommendations arising from medication reviews must be ensured, which might 
be best undertaken by the medical supervisors already working with the study.  Students 
reported that even the minimal contact they obtained with other healthcare professionals 
in the medical practices provided benefit.  A realistic contact at the undergraduate stage 
would benefit future integrated working. 
This study identified the value of utilising both qualitative and quantitative research 
methods, and these should be incorporated into a future study.  Early involvement of 
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stakeholders, and in particular patients, is advised.  This should include evaluation of 
recruitment documentation and methods. 
Further evaluation is required to establish the most effective, appropriate and if possible 
validated tools to incorporate into questionnaires, with the aims of the study and patient 
outcome measures driving the decision.  Early evaluation of a questionnaire by patients 
would facilitate suitable changes. 
The data from this study must be analysed to establish the cost-effectiveness: this is 
currently being undertaken and aims to calculate quality of life years (QALYs) for patients 
receiving a medication review from a student. 
Further publications have been recorded since the literature review was undertaken for 
this study.  A full systematic review of the available literature examining the role of 
pharmacists in undertaking medication review and training of pharmacy students with 
patients, with particular emphasis on undertaking medication review, is required.  This will 
further facilitate the production of a protocol for a full study. 
Preparative training models must be reviewed to establish the most effective and 
appropriate methods of preparing students for patient medication reviews.  This must 
include evaluating if this training can be incorporated into the undergraduate curriculum. 
  
254 
 
References 
1. Banks.J, Muriel.J, Smith.J. Disease prevalence, disease incidence, and mortality in the United 
States and in England. Bonn: Institute for the study of labour, 2010. 
2. Health and Social Care NHS. Information Centre. Prescription Cost Analysis England 2011. 
Prescription items dispensed in the community in England. 4th April 2012 2011.Accessed  
29th Dec 2012 Available at 
https://catalogue.ic.nhs.uk/publications/prescribing/primary/pres-cost-anal-eng-
2011/pres-cost-anal-eng-2011-rep.pdf. 
3. Harker.R, Social and General Statistics. NHS funding and expenditure. 2012.Accessed  27th 
March 2013 Available at http://www.google.co.uk/#hl=en&sclient=psy-
ab&q=nhs+budget+parliament&oq=nhs+budget+parliament&gs_l=serp.12...10967.12449.
1.14835.6.6.0.0.0.1.358.1091.1j3j1j1.6.0...0.0...1c.1.7.serp.c0PXCKPelRU&psj=1&bav=on.2
,or.r_qf.&fp=59e6f794b694dacd&biw=1680&bih=873. 
4. Garfield S, Barber N, Walley P, et al. Quality of medication use in primary care - mapping the 
problem, working to a solution: a systematic review of the literature. BMC Medicine 
2009;7(1):50  
5. Taskforce on Medicines Partnership National Collaborative Medicines Mangement Services 
Programme. Room for review. A guide to medication review: the agenda for patients, 
practitioners and managers. London: Medicines Partnership, 2002. 
6. MHRA. Additional monitoring list Q&A. 2012.Accessed  Aug 1st 2013 Available at 
http://www.mhra.gov.uk/Howweregulate/Medicines/Pharmacovigilancelegislation/Quest
ionsandanswers/Theadditionalmonitoringlist/index.htm. 
7. Avery.T, Barber.N, Ghaleb.M, et al. Investigating the prevalence and causes of prescribing 
errors in general practice: the PRACtICE Study. Prevalence study: General Medical Council, 
2012. 
8. Wu TY, Jen MH, Bottle A, et al. Ten-year trends in hospital admissions for adverse drug 
reactions in England 1999-2009. J Royal Society of Medicine 2010;103(6):239-50 doi: 
10.1258/jrsm.2010.100113published 
9. Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to 
hospital: prospective analysis of 18,820 patients. BMJ 2004;329(7456):15-19 doi: 
10.1136/bmj.329.7456.15published 
10. Patel.H.et.al. Trends in hospital admissions for adverse drug reactions in England: analysis of 
national hospital episode statistics. Clinical Pharmacology 2007; 7(9). 
http://www.biomedcentral.com/1472-6904/7/9 (accessed 13 April 2011). 
11. Lazarou J, Pomeranz BH, Corey PN. Incidence of Adverse Drug Reactions in Hospitalized 
Patients. JAMA: The Journal of the American Medical Association 1998;279(15):1200-05 
doi: 10.1001/jama.279.15.1200published 
255 
 
12. Huang.B.et.al. Innapropriate prescriptions for the aging population of the United States: an 
analysis of the National Ambulatory Medical Care Service Pharmacoepidemiology & Drug 
Safety 2002 1997;11:127-34  
13. Ernst.FR, Grizzle.AJ. Drug-related morbidity and mortality: updating the cost-of-illness model 
Journal of the American Pharmaceutical Association (Wash) 2001;41(2):192-9  
14. Strand.L.et.al. The impact of Pharmaceutical Care Practice on the Practitioner and the Patient 
in the Ambulatory Practice setting: Twenty-Five years of Experience. Current 
Pharmaceutical Design 2004;10:3987-4001  
15. Winstein.A, Sauer.B, Hepler.C, et al. Preventable Drug-Related Hospital Admissions. The 
Annals of Pharmacotherapy 2002;36:1238-48  
16. Audit Commission. A Spoonful of Sugar: Medicines Management in NHS hospitals, 2001. 
17. Alberti.K. Medical errors. BMJ 2001;322:501-2  
18. McDonnell.P, Jacobs.M. Hospital Admissions Resulting from Preventable Adverse Drug 
Reactions. The Annals of Pharmacotherapy 2002;36:1331-36  
19. Dept of Health. Medicines and Older People: Implementing medicines-related aspects of the 
NSF for Older People. 2001.Accessed  12th Jan 2014 Available at 
http://webarchive.nationalarchives.gov.uk/20130107105354/http:/www.dh.gov.uk/en/P
ublicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4008020. 
20. Meiechenbaum.D, Turk.D. Facillitating treatment adherence: A practitioner's guidebook. Ne 
York US: Plenum Press, 1987. 
21. Cramer JA, Roy A, Burrell A, et al. Medication Compliance and Persistence: Terminology and 
Definitions. Value in health : the journal of the International Society for 
Pharmacoeconomics and Outcomes Research 2008;11(1):44-47  
22. Benner.JS, al e. Long-term persistence in use of statin therapy in elderly patients. JAMA 
2002;288:455-61  
23. Cramer JA, Benedict Á, Muszbek N, et al. The significance of compliance and persistence in the 
treatment of diabetes, hypertension and dyslipidaemia: a review. International Journal of 
Clinical Practice 2008;62(1):76-87 doi: 10.1111/j.1742-1241.2007.01630.xpublished 
24. Hansard. Report of debate in Parliament Unused Medicines. 10 Jun 2008.Accessed  22 Jan 
2012 Available at 
http://www.publications.parliament.uk/pa/cm200708/cmhansrd/cm080610/halltext/806
10h0009.htm#08061078000004. 
25. Dept of Health. Medication Review. 2004.Accessed  4 May 2011 Available at 
http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndG
uidance/Browsable/DH_5354376. 
26. Dept of Health. National Service Framework for Older People. 2004 2001.Accessed  14 Oct 
2009 Available at 
256 
 
https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/198033
/National_Service_Framework_for_Older_People.pdf. 
27. BMA and NHS Employers. Quality and Outcomes Framework for 2012/13. Guidance for PCOs 
and practices, 2012. 
28. Clyne.W, Blenkinsopp.A, Seal.R. A guide to Medication Review. 2008.Accessed  12th April 2011 
Available at http://www.npc.nhs.uk/review_medicines/intro/. 
29. National Precribing Centre. An introduction to Medication Review, Definition. 2008.Accessed  
12th April 2011 Available at http://www.npc.nhs.uk/review_medicines/intro/ 
 
30. Furniss L, Burns A, et.al. Effects of a pharmacist's medication review in nursing homes. The 
British Journal of Psychiatry 2000;176(6):563-67 doi: 10.1192/bjp.176.6.563published 
31. Zermansky.AG, Et.al. Clinical medication review by a pharmacist of patients on repeat 
prescriptions in general practice: a randomised controlled trial. 2002; 6(20). 
http://www.hta.ac.uk/pdfexecs/summ620.pdf (accessed 12th April 2011). 
32. Zermansky.A, Aldred.D, Petty.D, et al. Clinical medication review by a pharmacist of elderly 
people living in care homes - randomised controlled trial. Age and Ageing 2006;35:586-91  
33. RESPECT Trial Team Richmond.S et.al. Effectiveness of shared pharmaceutical care for older 
patients: RESPECT trial findings. The British journal of general practice : the journal of the 
Royal College of General Practitioners 2010;60(570):e10-9 doi: 
10.3399/bjgp09X473295published 
34. Wong.I, Campion.P, Coulton.S, et al. Pharmaceutical care for elderly patients shared between 
community pharmacists and general practitioners: a randomised evaluation. RESPECT 
(Randomised Evaluation of Shared Prescribing for Elderly people in the Community over 
Time). BMC Health Services Research 2004;4(11) doi: doi:10.1186/1472-6963-4-
11published 
35. Cipolle.R, Strand.L, Morley.P. Pharmaceutical Care Practice: McGraw, 1998. 
36. Holland R, Lenaghan E, Harvey I, et al. Does home based medication review keep older people 
out of hospital? The HOMER randomised controlled trial. BMJ 2005;330(7486):293- doi: 
10.1136/bmj.38338.674583.AEpublished 
37. Zermansky AGG. Is medication review by pharmacists of any use? PharmacoEconomics 
2007;25(2):91-2  
38. Zermansky.A, Silcock.A. Is Medication Review by Primary-Care Pharmacists for Older People 
Cost Effective? Pharmacoeconomics 2009;27(1):11-24  
39. Holland.R, Brookesby.I, Lenaghan.E, et al. Effectiveness of visits from community pharmacists 
for patients with heart failure: HeartMed randomised controlled trial. BMJ 
2007;334(7603):1098 doi: 10.1136/bmj.39164.568183.AEpublished 
257 
 
40. Sorensen L, Stokes JA, Purdie DM, et al. Medication reviews in the community: results of a 
randomized, controlled effectiveness trial. British Journal of Clinical Pharmacology 
2004;58(6):648-64 doi: 10.1111/j.1365-2125.2004.02220.xpublished 
41. Australian Government Department of Health and Ageing. Medication Management Reviews. 
2012.Accessed  23rd Dec 2012 Available at 
http://www.health.gov.au/internet/main/publishing.nsf/Content/medication_manageme
nt_reviews.htm 
 
42. NHS Employers. Quality and outcomes framework. 2013.Accessed  28th March 2013 Available 
at 
http://www.nhsemployers.org/PayAndContracts/GeneralMedicalServicesContract/QOF/P
ages/QualityOutcomesFramework.aspx. 
43. NICE. Measuring effectiveness and cost effectiveness: the QALY. 2010.Accessed  28th March 
2013 Available at 
http://www.nice.org.uk/newsroom/features/measuringeffectivenessandcosteffectivenes
stheqaly.jsp. 
44. Pacini.M, Smith.R, Wilson.E, et al. Home-Based Medication Review in Older People: Is it cost 
effective? Pharmacoeconomics 2007;25(2):171-80  
45. Desborough JA, Sach T, Bhattacharya D, et al. A cost-consequences analysis of an adherence 
focused pharmacist-led medication review service. International Journal of Pharmacy 
Practice 2012;20(1):41-49 doi: 10.1111/j.2042-7174.2011.00161.xpublished 
46. Respect Trial Team. Cost-effectiveness of shared pharmaceutical care for older patients: 
RESPECT trial findings. Br J Gen Pract 2010;60(570):e20-7 doi: 
10.3399/bjgp09X482312published 
47. Pope G, Wall N, Peters CM, et al. Specialist medication review does not benefit short-term 
outcomes and net costs in continuing-care patients. Age and Ageing 2011;40(3):307-12 
doi: 10.1093/ageing/afq095published 
48. Medical Research Council. Complex interventions guidance. 2008.Accessed  5 Sept. 2013 
Available at http://www.mrc.ac.uk/Utilities/Documentrecord/index.htm?d=MRC004871. 
49. Zermansky AG, Petty DR, Raynor DK, et al. Randomised controlled trial of clinical medication 
review by a pharmacist of elderly patients receiving repeat prescriptions in general 
practice. BMJ 2001;323(7325):1340- doi: 10.1136/bmj.323.7325.1340published 
50. Kitzinger J. Qualitative Research: Introducing focus groups. BMJ 1995;311(7000):299-302  
51. Jones R. Why do qualitative research? BMJ 1995;311(6996):2-  
52. Silverman.D. Doing Qualitative Research. 3rd ed: Sage, 2010. 
53. Barbour.RS. The case for combining qualitative and quantitative approaches in health services 
research. J Health Serv Res Policy 1999;4(1):39-43  
258 
 
54. Krska J, Cromarty JA, Arris F, et al. Pharmacist led medication review in patients over 65: a 
randomized, controlled trial in primary care. Age and Ageing 2001;30(3):205-11 doi: 
10.1093/ageing/30.3.205published 
55. Leendertse A, de Koning F, Goudswaard A, et al. Preventing hospital admissions by reviewing 
medication (PHARM) in primary care: design of the cluster randomised, controlled, multi-
centre PHARM-study. BMC Health Services Research 2011;11(1):4  
56. Holland.R, Desborough.J, Goodyer.L, et al. Does pharmacist-led medication review help to 
reduce hospital admissions and deaths in older people? A systematic review and meta-
analysis. British Journal of Clinical Pharmacology 2008;65(3):303-16 doi: 10.1111/j.1365-
2125.2007.03071.xpublished 
57. MacRae.F, Lowrie.R, MacLaren.A, et al. Pharmacist-led medication review clinics in general 
practice: the views of Greater Glasgow GPs. International J of Pharmacy Practice 
2003;11:199-208  
58. Bradley CP. The future role of pharmacists in primary care. British Journal of General Practice 
2009;59:891-92  
59. Emblen.G, Miller.E. Home Medicines Review: The how and why for GPs. Australian Family 
Physician 2004;33(1/2):49-51  
60. Bryant.L, Coster.G, McCormick.R. General Practitioner perceptions of clinical medication 
reviews undertaken by community pharmacists. J Primary Health Care 2010;2(3):225-33  
61. Street R, Jr., Haidet P. How Well Do Doctors Know their Patients? Factors Affecting Physician 
Understanding of Patients’ Health Beliefs. Journal of General Internal Medicine 
2011;26(1):21-27 doi: 10.1007/s11606-010-1453-3published 
62. Kaae S, Sørensen E, Nørgaard L. Exploring communications around medication review in 
community pharmacy. International Journal of Clinical Pharmacy 2011;33(3):529-36 doi: 
10.1007/s11096-011-9502-5published 
63. Little P, Everitt H, Williamson I, et al. Preferences of patients for patient centred approach to 
consultation in primary care: observational study. BMJ 2001; 322. 
http://www.bmj.com/content/322/7284/468#alternate (accessed 5 April 2013). 
64. Little.P, Everitt.H, Williamson.I, et al. Observational study of effect of patient centredness and 
positive approach on outcomes of general practice consultations. BMJ 2001;323:908-11  
65. Kenten.C, Bowling.A, Lambert.N, et al. A study of patient expectations in a Norfolk general 
practice. Health Expectations 2010;13:273-84  
66. Nair.K, Dolovich.L, Cassels.A, et al. What patients wants to know about their medicines: Focus 
Group study of patient and clinician perspectives. Canadian Family Physician 2002;48:104-
10  
67. Salter C, Holland R, Harvey I, et al. "I haven't even phoned my doctor yet." The advice giving 
role of the pharmacist during consultations for medication review with patients aged 80 
259 
 
or more: qualitative discourse analysis. BMJ 2007;334(7603):1101- doi: 
10.1136/bmj.39171.577106.55published 
68. Salter.C. Compliance and concordance during domiciliary medication review involving 
pharmacists and older people. Sociology of Health & Illness 2009;32(1):21-36  
69. Schon DA. Educating the Reflective Practitioner: Towards a new design for teaching and 
learning in the professions: Jossey-Bass, 1987. 
70. Silverman.J, Kurtz.S, Draper.J. Skills for Communicating with Patients. Oxford: Radcliffe 
Medical Press, 1999. 
71. King's College London. Free dental care by undergraduate students at Guy's and St Thomas' 
Hospitals. 2013.Accessed  5 Sept 2013 Available at 
http://www.kcl.ac.uk/dentistry/patient/index.aspx. 
72. General Medical Council. Tomorrow's Doctors: Outcomes and standards for undergraduate 
medical education. 2009.Accessed  18 Jan 2014 Available at http://www.gmc-
uk.org/TomorrowsDoctors_2009.pdf_39260971.pdf. 
73. School of Optometry & Vision Sciences Cardiff University. Eye examinations. 2013.Accessed  5 
Sept 2013 Available at 
http://www.cardiff.ac.uk/optom/eyeclinic/eyeexaminations/index.html. 
74. Medical Education England. Modernising Pharmacy Careers Programme: Review of pharmacist 
endergraduate education and pre-registration training and proposals for reform. 
2011.Accessed  12 Dec 2011 Available at www.mee.nhs.uk. 
75. Boyatzis.M, Batty.K. Domiciliary medication reviews by fourth year pharmacy students in 
Western Australia International Journal of Pharmacy Practice.  12(2):73-81, Jun 2004 
2004;12(2):73-81  
76. O'Neil C, Berdine H. Experiential Education at a University-based Wellness Center. American 
Journal of Pharmaceutical Education 2007;71(3):Article 49 doi: 
10.5688/aj710349published 
77. Mobley Smith MA, Koronkowski MJ, Petersen NM. Enhancing Student Learning Through 
Integrating Community-Based Geriatric Educational Outreach Into Ambulatory Care 
Advanced Practice Experiential Training. American Journal of Pharmaceutical Education 
2004;68(1):Article 20 doi: 10.5688/aj680120published 
78. Pound.M, Miller.S. Written Versus Oral Recommendations Made by Pharmacy Students 
During Internal Medicine Rotations. Pharmaceutical Education 2007;41:772-76  
79. Willis.J, Hoy.R, Jenkins.W. In-Home Medication Reviews: A Novel Approach to Improving 
Patient Care Through Coordination of Care. J Community Health 2011.  (accessed 29th 
Dec 2012). 
80. McCollum.M, Nuffer.W, Ellis.S, et al. Physician acceptance of Pharmacotherapy 
recomendations made by pharmacy students in a rural pharmacy-based diabetes care and 
education clinic. Am J Pharm Educ. 2009;7(73):24  
260 
 
81. Janson.S, et.al. Improving Chronic Care of Type 2 Diabetes Using Teams of Interprofessional 
Learners. Academic Medicine 2009;84(11):1540-48  
82. National Institute for Health and Care Excellence. CG66 Type 2 Diabetes: full guideline. 
2013.Accessed  5 Sept 2013 Available at 
http://guidance.nice.org.uk/CG66/Guidance/pdf/English. 
83. Huston SA, Hobson EH. Using focus groups to inform pharmacy research. Res Social Adm 
Pharm 2008;4(3):186-205 doi: 10.1016/j.sapharm.2007.09.001published 
84. Tong.A, Sainsbury.P, Craig.J. Consolidated criteria for reporting qualitative research (COREQ): 
a 32-item checklist for interviews and focus groups. Int J for Quality in Health Care 
2007;19(6):349-57  
85. Taskforce.on.Medicines.Partnership, 
National.Collaborative.Medicines.Mangement.Services.Programme. A guide to 
medication review: the agenda for patients, practitioners and managers. London: 
Medicines Partnership, 2002. 
86. Roter.D, Larson.S. The Roter interaction analysis system (RIAS): utility and flexibility for 
analysis of medical interactions. Patient Education and Counseling 2002;46(4):243-51  
87. Abdel-Tawab R, Higman-James D, Fichtinger A, et al. Development and validation of the 
Medication-Related Consultation Framework (MRCF). Patient education and counseling 
2011;83(3):451-57  
88. Bradley.C. Handbook of Psychology and Diabetes: A Guide to Psychological Measurement in 
Diabetes Research and Management: Harwood Academic Publishers, 1994. 
89. EuroQol.Group. What is EQ-5D. 2013.Accessed  2nd April 2013 Available at 
http://www.euroqol.org/home.html. 
90. Horne.R, Hankins.M, Jenkins.R. The Satisfaction with Information about Medicines Scale 
(SIMS): A new measurement tool for audit and research. Quality in Health Care 
2001;10:135-40  
91. Horne R, Hankins M, Jenkins R. The Satisfaction with Information about Medicines Scale 
(SIMS): a new measurement tool for audit and research. Quality in Health Care 
2001;10(3):135-40 doi: 10.1136/qhc.0100135..published 
92. Gelliatry.G, Cooper.V, Davis.C, et al. Patients' perception of information about HAART: impact 
on treatment decisions. AIDS Care 2005;17(3):367-76  
93. Horne.R, Weinmann.J, Hankins.M. The beliefs about medicines questionnaire: The 
development and evaluation of a new method for assessing the cognitive representation 
of medicine. Psychology and Health 1999;14:1-24  
94. U.K. Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular 
and microvascular complications in type 2 diabetes: UKPDS 38. . Brit Med J 
1998;317(7160):703-13  
261 
 
95. Lowey.A, Moore.S, Norris.C, et al. The cost-effectiveness of pharmacist-led treatment of 
cardiac risk in patients with type 2 diabetes. Pharm World Sci. 2007;29(5):541-5  
96. McGowan N, Cockburn A, Strachan MW, et al. Initial and sustained cardiovascular risk 
reduction in a pharmacist-led diabetes cardiovascular risk clinic. The British Journal of 
Diabetes & Vascular Disease 2008;8(1):34-38 doi: 
10.1177/14746514080080010801published 
97. Peterson GM, Fitzmaurice KD, Naunton M, et al. Impact of pharmacist-conducted home visits 
on the outcomes of lipid-lowering drug therapy. Journal of Clinical Pharmacy and 
Therapeutics 2004;29(1):23-30 doi: 10.1046/j.1365-2710.2003.00532.xpublished 
98. Issett.B.et.al. Clinical and economic outcomes of medication therapy management services: 
the Minnesota experience. J. Am Pharm Assoc 2008;48(2)  
99. Horne.R. The Medication Adherence Report Scale: Document supplied by Prof Horne, 1991 
updated 2006. 
100. Bradley.C. The DTSQ. Health Psychology Research, University of London, 2009:1-3. 
101. Pope.C, Ziebland.S, Mays.N. Analysing qualitative data. BMJ 2000;320(7227):114-16  
102. Ryan.G, Russell-Bernard.H. Techniques to Identify Themes. Field Methods 2003;15(1):85-109  
103. Krueger.R. Analysing & Reporting Focus Group Results. London: Sage Publications Inc, 1998. 
104. Campbell.M, Machin.D. Medical Statistics. Second ed. UK: John Wiley, 1995. 
105. MRC. Developing and evaluating complex interventions: new guidance. 2006.Accessed  28th 
March 2013 Available at 
http://www.mrc.ac.uk/Utilities/Documentrecord/index.htm?d=MRC004871. 
106. Bradburn.J, Maher.J, Adwuyi-Dalton.R, et al. Developing Clinical Trial Protocols: The use of 
Patient Focus Groups. Psycho-Oncology 1995;4:107-12  
107. Krueger.R, Casey.M. Focus Groups: A practical guide for applied research. London: Sage 
Publications Inc, 2000. 
108. Powell.R, Single.H. Methododlogy Matters  - V. International Journal of Quality in Health Care 
1996;8(5):499- 504  
109. Morgan.D. The Focus Group Guidebook. London: Sage., 1998. 
110. Gibbs.A. Focus Groups. 1997.Accessed  6 June 2013 Available at 
http://sru.soc.surrey.ac.uk/SRU19.html  
111. Mays.N, Pope.C. Qualitative Research: Rigour and qualitative research BMJ, 1995;311:109-12  
112. Bloor.M, Frankland.J, Thomas.M, et al. Focus Groups in Social Research. London: Sage 
Publications Inc, 2002. 
262 
 
113. Dickinson.D, Raynor.DKT. What information do patients need about medicines? Ask the 
patients - they may want to know more than you think. BMJ 2003;327(7419):861 doi: 
10.1136/bmj.327.7419.861published 
114. National Research Ethics Service. Information Sheets& Consent Forms. Guidance for 
Researchers and Reviewers. 2011.Accessed  9th Oct 2013 Available at 
http://www.hra.nhs.uk/resources/before-you-apply/consent-and-participation/consent-
and-participant-information/. 
115. Dept of Health. Pharmacy in England: building on strengths - delivering the future. 
2008.Accessed  29th August 2010 Available at www.official-
documents.gov.uk/document/cm73/7341/7341.pdf. 
116. Nestel D, Calandra A, Elliott R. Using volunteer simulated patients in development of pre-
registration pharmacists: Learning from the experience. Pharmacy Education 2007;7:35-
42  
117. Joyner.B, Young.L. Teaching medical students using role play: Twelve tips for successful role 
plays. Medical Teacher 2006;28(3):225-29  
118. Bokken.L, Rethans.JJ, van.Heuren.L, et al. Students' views on the use of real patients and 
simulated patients in undergraduate medical education. Acad Med 2009;84(7):958-63  
119. General Pharmaceutical Council. Standards of conduct, ethics and performance. 
2012.Accessed  9th Oct 2013 Available at 
http://www.pharmacyregulation.org/standards/conduct-ethics-and-performance. 
120. General Pharmaceutical Council. Code of conduct for pharmacy students. 2010.Accessed  27 
April 2014 Available at. 
121. Ogden J, Bavalia K, Bull M, et al. “I want more time with my doctor”: a quantitative study of 
time and the consultation. Family Practice 2004;21(5):479-83 doi: 
10.1093/fampra/cmh502published 
122. Leikola.S, Tuomainen.L, Ovaskainen.H, et al. Continuing Education Course to Attain 
Colaborative Comprehensive Medication Review Competencies. American Journal of 
Pharmaceutical Education 2009;73(6):Article 108  
123. Kassam R, Poole G, Collins J. Development of an instrument to assess the impact of an 
enhanced experiential model on pharmacy students' learning opportunities, skills and 
attitudes: A retrospective comparative-experimentalist study. BMC Medical Education 
2008; 8`17. http://www.biomedcentral.com/1472-6920/8/17 (accessed 31.3.11). 
124. Owen S, Stupans I. Australian pharmacy programme experiential placements: comprehensive 
planning for assessment and evaluation. Assessment & Evaluation in Higher Education 
2009;34(5):579-94  
125. Skedlar S, McKaneney T, Ward C, et al. Advanced Practice Internship: Experiential Learning in 
a Drug Use and Disease State Management Program. American Journal of Pharmaceutical 
Education 2006;70(3):Article 68  
263 
 
126. Hall.K, Musing.E, Miller.D, et al. Experiential Training for Pharmacy Students: Time for a New 
APproach. Can J Hosp Pharm 2012;65(4):285-93  
127. Dewey.J. Experience and education. New York: Macmillan Co., 1938. 
128. Kolb D. Experiential Learning: Experience as the source of learning and development. NJ: 
Prentice Hall Inc, 1984. 
129. Kimberlin.C. Communicating with patients: skills assessment in US colleges of pharmacy. Am 
J Pharm Edu 2006;70(3):Article 67 pages 1-9  
130. Nestel.D, Tierney.T. Role-play for medical students learning about communication: 
Guidelines for maximising benefits. Medical Education 2007; 7. 
http://www.biomedcentral.com/1472-6920/7/3 (accessed 16 July 2013). 
131. Nestel D, Cecchini M, Calandrini M, et al. Real patient involvement in role development: 
evaluating patient focused resources for clinical procedural skills. Medical Teacher 
2008;30(5):534 - 36  
132. Nuffer.W, McCollum.M, Ellis.S, et al. Further Development of Pharmacy Student-Facilitated 
Diabetes Management Clinics. American Journal of Pharmaceutical Education 
2012;76(3):Article 50 pages 1-6  
133. Harden.RM. What is an OSCE? Med Teach 1988;10:19-22  
134. Hodges.B. Validity and the OSCE. Medical Teacher 2003;25(3):250-54  
135. Brannick MT, Erol-Korkmaz HT, Prewett M. A systematic review of the reliability of objective 
structured clinical examination scores. Med Educ 2011;45(12):1181-9 doi: 10.1111/j.1365-
2923.2011.04075.xpublished 
136. Kurtz.S, Silverman.J. The Calgary-Cambridge referenced observation guides: an aid to 
defining the curriculum and organising the teaching in communication training 
programmes. Med Educ 1996;30:83-9  
137. NIHR. Feasibility and Pilot studies. 2014.Accessed  16th Jan 2014 Available at 
http://www.ccf.nihr.ac.uk/RfPB/Documents/Feasabilityandpilotstudies.docx. 
138. Arain M, Campbell M, Cooper C, et al. What is a pilot or feasibility study? A review of current 
practice and editorial policy. BMC Medical Research Methodology 2010;10(1):67  
139. Farmer AJ, Perera R, Ward A, et al. Meta-analysis of individual patient data in randomised 
trials of self monitoring of blood glucose in people with non-insulin treated type 2 
diabetes. BMJ 2012;344:e486 doi: 10.1136/bmj.e486published 
140. Lee JK, Grace KA, Taylor AJ. Effect of a pharmacy care program on medication adherence and 
persistence, blood pressure, and low-density lipoprotein cholesterol: A randomized 
controlled trial. JAMA 2006;296(21):2563-71 doi: 
10.1001/jama.296.21.joc60162published 
264 
 
141. Staessen JA, Li Y, Thijs L, et al. Blood Pressure Reduction and Cardiovascular Prevention: An 
Update Including the 2003-2004 Secondary Prevention Trials. Hypertens Res 
2005;28(5):385-407  
142. Cholesterol Treatment Trialists C. Efficacy of cholesterol-lowering therapy in 18 686 people 
with diabetes in 14 randomised trials of statins: a meta-analysis. The Lancet 
2008;371(9607):117-25 doi: http://dx.doi.org/10.1016/S0140-6736(08)60104-Xpublished 
143. National Collaborating Centre for Primary Care. LIPID MODIFICATION: Cardiovascular risk 
assessment and the modification of blood lipids for the primary and secondary prevention 
of cardiovascular disease: Royal College of General Practitioners,, 2008 revised 2010. 
144. National Institute for Health and Care Excellence. Cardiovascular disease - statins (TA 94). 
Issued Jan 2006.Accessed  5 Sept 2013 Available at http://www.nice.org.uk/ta094. 
145. Newcastle Guideline Development and Research Unit, British Hypertension Society, National 
Collaborating Centre for Chronic Conditions. NICE Clinical Guideline 34, Hypertension: 
management of hypertension in adults in primary care: National Institute for Health and 
Clinical Excellence, 2006. 
146. Diabetes UK. Diabetes in the UK 2012. Key statistics on diabetes. 2012.Accessed  10 Jan 2014 
Available at http://www.diabetes.org.uk/Documents/Reports/Diabetes-in-the-UK-
2012.pdf. 
147. Skyler JS, Bergenstal R, Bonow RO, et al. Intensive Glycemic Control and the Prevention of 
Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials. A 
Position Statement of the American Diabetes Association and a Scientific Statement of the 
American College of Cardiology Foundation and the American Heart Association. Journal 
of the American College of Cardiology 2009;53(3):298-304 doi: 
10.1016/j.jacc.2008.10.008published 
148. Lundquist LM, Moye PM. Resident Physicians’ Acceptance of Pharmacy Students’ 
Pharmacotherapy Recommendations During an Ambulatory Care Advanced Pharmacy 
Practice Experience. American Journal of Pharmaceutical Education 2009;73(8):145 doi: 
10.5688/aj7308145published 
149. Pound.MW, Miller.S. Written versus oral recommendations made by pharmacy students 
during internal medicine rotations. . Annals of Pharmacotherapy, 2007;41(5):772-6  
150. Pilnick A, Dingwall R. On the remarkable persistence of asymmetry in doctor/patient 
interaction: a critical review. Social science & medicine 2011;72(8):1374-82 doi: 
10.1016/j.socscimed.2011.02.033published 
151. National Collaborating Centre for Primary Care. Medicines Adherence: involving patients in 
decisions about prescribed medicines and supporting adherence. London: Royal College 
of General Practitioners, 2009. 
152. Grunfeld.E, Hunter.M, Sikka.P, et al. Adherence beliefs among breast cancer patients taking 
tamoxifen. Patient Education and Counseling 2005;59:97-102  
265 
 
153. Senior.V, Maerteau.TM, Weinman.J. Self-reported adherence to cholesterol-lowering 
medication in patients with familial hypercholesterolaemia: the role of illness perceptions. 
Cardiovascular Drugs & Therapy 2004;18(6):475-81  
154. Farmer.A, Kinmouth.AL, Sutton.S. Measuring beliefs about taking hypoglycaemic medication 
among people with type 2 diabetes. Diabetic Medicine 2006;23(3):265-70  
155. Ajzen.I, Fishbein.M. Understanding attitudes and predicting social behaviour. Englewood 
Cliffs, NJ: Prentice-Hall, 1980. 
156. Ajzen.I. The Theory of Planned Behaviour. Organisational Behaviour and Human Decision 
Process 1991;50:179-211  
157. Wright EC. Non-compliance—or how many aunts has Matilda? The Lancet 
1993;342(8876):909-13 doi: http://dx.doi.org/10.1016/0140-6736(93)91951-Hpublished 
158. Cramer.J. A Systematic Review of Adherence With Medications for Diabetes. Diabetes Care 
2004;27:1218-24  
159. Morisky.DE. Donald Moriskey's Website. 2014.Accessed  14 Jan 2014 Available at 
http://dmorisky.bol.ucla.edu/MMAS_scale.html. 
160. Morisky.DE, Green.LW, LevineDM. Concurrent and Predictive Validity of a Self-Reported 
Measure of Medication Adherence and Long-Term Predictive Validity of Blood Pressure 
Control. Med Care 1986;24:67-74  
161. Soto.C, Kleinmann.K, Simon.S. Quality and correlates of medical record documentation in the 
ambulatory care setting. BMC Health Services Research 2002; 2(22). 
http://www.biomedcentral.com/content/pdf/1472-6963-2-22.pdf (accessed 3 Jan 2014). 
162. Medicines and Healthcare Products Regulatory Agency. Dronedarone (Multaq▼ ): 
cardiovascular, hepatic and pulmonary adverse events – new restrictions and monitoring 
requirements. Oct 2011.Accessed  6th Nov 2013 Available at 
http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON131928. 
163. National Institute for Health and Clinical Excellence. Medicines adherence Involving patients 
in decisions about prescribed medicines and supporting adherence. NICE clinical guideline 
76. 2009.Accessed  5 Sept 2013 Available at 
http://guidance.nice.org.uk/CG76/NICEGuidance/pdf/English. 
164. Kassam.R, Volume-Smith.C. Focus Group Methodology to Develop a Community 
Pharmaceutical Care Clerkship Program. American Journal of Pharmaceutical Education 
2003;67(3):Article 88  
165. Hargie.O, Boohan.M, McCoy.M, et al. Current trends in communication skills training in UK 
schools of medicine. Medical Teacher 2010;32(385-391)  
166. Cortese CG. Learning through Teaching. Management Learning 2005;36(1):87-115 doi: 
10.1177/1350507605049905published 
266 
 
167. Busari JO, Prince KJAH, Scherpbier AJJA, et al. How residents perceive their teaching role in 
the clinical setting: a qualitative study. Medical Teacher 2002;24(1):57-61 doi: 
doi:10.1080/00034980120103496published 
168. Haddad.RAM, Coover.KL, Begley.KJ, et al. An advanced pharmacy practice experience in 
community engagement. American Journal of Pharmaceutical Education 2012;18(5)  
169. Hata.M, Klotz.R, Sylvies.R, et al. Medication Therapy Management Services Provided by 
Student Pharmacists. American Journal of Pharmaceutical Education 2012;76(3):Article 51  
170. Twigg.M, Bhattacharya.D, Desborough J, et al. The current and future roles of community 
pharmacists: the views and experiences of patients with type 2 diabetes. Research in 
Social and Administrative Pharmacy 2013;9(6):777-89  
171. R.Francis Q.C. Report of the Mid Staffordshire NHS Foundation Trust Public Inquiry. 
2013.Accessed  3 Jan 2014 Available at http://www.midstaffspublicinquiry.com/report. 
172. Jaffa T. Qualitative Research: Research meets clinical practice. BMJ 1995;311(7001):380-  
173. Department of Health. The Way Forward for Hospital Pharmaceutical Services HC 88(54). 
London, 1988. 
174. The Nuffield Foundation. Pharmacy: the report of a committee of enquiry appointed by the 
Nuffield Foundation. London, 1986. 
175. Royal Pharmaceutical Society. Medicines Optimisation: Helping patients to make the most of 
medicines. 2013.Accessed  24 Dec 2013 Available at 
http://www.rpharms.com/promoting-pharmacy-pdfs/helping-patients-make-the-most-of-
their-medicines.pdf. 
176. Calvert. Clinical pharmacy—a hospital perspective. British journal of clinical pharmacology 
1999;47(3):231-38 doi: 10.1046/j.1365-2125.1999.00845.xpublished 
177. Royal Pharmaceutical Society. Now or Never: shaping pharmacy for the future. The Report of 
the Commission on future models of care delivered through pharmacy. 2013.Accessed  24 
Dec 2013 Available at. 
178. Knowles.M, Holton.E, Swanson.R. The Adult Learner. 6th ed: Elsevier Butterworth 
Heinemann,, 2005. 
179. Smith.WJ, Bird.ML, Vesta.KS, et al. Integration of an introductory pharmacy practice 
experience with an advanced pharmacy practice experience in adult internal medicine. 
American Journal of Pharmaceutical Education 2012;76(3):Article 52  
180. Mills.E, Blenkinsopp.A, McKinley.R, et al. The Assessment of Observed Practice: A Literature 
Review. 2011. 
http://www.pharmacyregulation.org/sites/default/files/The%20assessment%20of%20obs
erved%20practice%20final%20report%2024th%20June%202011.pdf (accessed 17th June 
2013). 
267 
 
181. Duerden.M, Avery.T, Payne.R. Polypharmacy and medicines optimisation: Making it safe 
sound. 2013.Accessed  26 Dec 2013 Available at 
http://www.kingsfund.org.uk/sites/files/kf/field/field_publication_file/polypharmacy-
and-medicines-optimisation-kingsfund-nov13.pdf. 
182. Pharmaceutical Society of Australia (PSA):. Quality Care Pharmacy Program Domiciliary 
Medication Management Review Service Implementation Module,. 2014.Accessed  3 Jan 
2014 Available at 
http://beta.guild.org.au/uploadedfiles/Medication_Management_Reviews/Pharmacy/Res
ources/Section%203a%20-%20QCPP%20Implementation%20Module.pdf. 
183. Chen TF, de Almeida Neto AC. Exploring elements of interprofessional collaboration between 
pharmacists and physicians in medication review. Pharm World Sci 2007;29(6):574-6 doi: 
10.1007/s11096-007-9130-2published 
184. Thorpe.R, Holt.R. The SAGE Dictionary of Qualitative Management Research. 2008.Accessed  
19 April 2014 Available at http://srmo.sagepub.com/view/the-sage-dictionary-of-
qualitative-management-research/n86.xml. 
185. Hammersley.M, Atkinson. P. Ethnography Principles in Practice. Third edition ed: Routledge, 
2007. 
186. Mays.N, Pope.C. Qualitative research in health care: Assessing quality in qualitative research. 
BMJ 2000;320:50-2  
 
 
		
	
	
Volume 2 Appendices                
Development and Feasibility Testing 
of a Supervised Pharmacy Student-
Led Medication Review of Patients 
with Diabetes in Primary Care
 
 
 
Richard	Paul	Adams	
 
 
 
 
 
 
 
 
 
 
PhD 
2014  
 
 
   
"This copy of the thesis has been supplied on condition that anyone who consults it is 
understood to recognise that its copyright rests with the author and that use of any 
information derived there from must be in accordance with current UK Copyright Law. In 
addition, any quotation or extract must include full attribution.”
1 
 
Table	of	Contents	
APPENDIX	A:		APPLICATION	TO	RFPB	.................................................................................	2 
APPENDIX	B:		DEVELOPMENT	.................................................................................................	6 
APPENDIX	C:		DEVELOPMENT	STAGE	FOCUS	GROUPS	................................................	36 
APPENDIX	D:		ETHICAL	APPROVALS	AND	APPROVED	DOCUMENTS	....................	137 
Appendix D1:  Ethics Committee Correspondence .................................................................................... 138 
Appendix D2:  Ethics Approved Documents – Development ..................................................................... 223 
Appendix D3:  Ethics Approved Documents – Intervention ...................................................................... 244 
Appendix D4:  Ethics Approved Documents – Review ............................................................................... 292 
Appendix D5 :  Ethics Approved Documents – UEA ................................................................................... 313 
APPENDIX	E:		STUDENT	PREPARATIVE	TRAINING	.....................................................	321 
APPENDIX	F:		INTERVENTION	MEDICATION	REVIEWS	.............................................	345 
APPENDIX	G:		TOOLS	.............................................................................................................	381 
APPENDIX	H:		REVIEW	STAGE	FOCUS	GROUPS	............................................................	421 
APPENDIX	I:		PUBLICATIONS	..............................................................................................	531 
 
	 	
2 
 
	
	
	
Appendix	A:		Application	to	RfPB	
Funding Approval 
 
 
 
 
   
3 
 
4 
 
5 
 
    
6 
 
	
	
	
Appendix	B:		Development	
Protocol Version4 
Pharmacy Student Medication Review RISP Final 
Flowchart for Supervised Pharmacy Student‐Led Medication Review in 
Primary Care 
   
7 
 
8 
 
9 
 
10 
 
11 
 
12 
 
13 
 
 
14 
 
15 
 
16 
 
17 
 
18 
 
19 
 
20 
 
21 
 
 
22 
 
23 
 
24 
 
25 
 
26 
 
27 
 
28 
 
 
29 
 
30 
 
31 
 
32 
 
 
33
 
 
34
 
 
35
 
 
36 
 
	
	
	
Appendix	C:		Development	Stage	
Focus	Groups	
Medical Practices 
Students 
Pharmacists 
Patients 
37 
 
38 
 
39 
 
40 
 
41 
 
 
42 
 
43 
 
44 
 
45 
 
46 
 
47 
 
48 
 
49 
 
 
50 
 
51 
 
52 
 
53 
 
54 
 
55 
 
56 
 
57 
 
58 
 
59 
 
60 
 
61 
 
62 
 
63 
 
64 
 
65 
 
66 
 
67 
 
68 
 
69 
 
70 
 
71 
 
72 
 
 
73 
 
74 
 
75 
 
76 
 
77 
 
78 
 
79 
 
80 
 
81 
 
 
82 
 
83 
 
84 
 
85 
 
86 
 
87 
 
88 
 
89 
 
90 
 
 
91 
 
92 
 
93 
 
94 
 
95 
 
96 
 
97 
 
98 
 
 
99 
 
100 
 
101 
 
102 
 
103 
 
104 
 
105 
 
106 
 
 
107 
 
108 
 
109 
 
110 
 
111 
 
112 
 
113 
 
114 
 
115 
 
116 
 
117 
 
118 
 
119 
 
120 
 
121 
 
122 
 
123 
 
124 
 
125 
 
126 
 
127 
 
128 
 
129 
 
130 
 
131 
 
132 
 
133 
 
134 
 
135 
 
136 
 
137 
 
	
	
	
Appendix	D:		Ethical	Approvals	and	
Approved	Documents	
	
Appendix D1:  Ethics Committee Correspondence 
 
Appendix D2:  Ethics Approved Documents – Development 
Medical Practices 
Students 
Pharmacists 
Patients 
 
Appendix D3 :  Ethics Approved Documents – Intervention 
Medical Practices 
Students 
Pharmacists 
Patients 
	
Appendix D4 :  Ethics Approved Documents – Review 
Medical Practices 
Students 
Pharmacist 
Patients 
	
Appendix D5 :  Ethics Approved Documents – UEA 
 
	 	
138 
 
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Appendix	D1:		Ethics	Committee	Correspondence		
   
139 
 
 
 
140 
 
141 
 
142 
 
 
143 
 
 
144 
 
 
145 
 
 
146 
 
 
147 
 
148 
 
 
149 
 
150 
 
151 
 
 
152 
 
 
153 
 
 
154 
 
155 
 
156 
 
157 
 
158 
 
 
159 
 
 
160 
 
161 
 
162 
 
163 
 
 
164 
 
165 
 
 
166 
 
 
167 
 
168 
 
169 
 
170 
 
171 
 
 
172 
 
173 
 
174 
 
175 
 
176 
 
177 
 
178 
 
179 
 
180 
 
181 
 
 
182 
 
183 
 
184 
 
 
185 
 
186 
 
187 
 
188 
 
189 
 
190 
 
 
191 
 
192 
 
193 
 
194 
 
195 
 
196 
 
 
197 
 
198 
 
199 
 
 
200 
 
201 
 
202 
 
203 
 
204 
 
205 
 
206 
 
207 
 
208 
 
209 
 
210 
 
211 
 
212 
 
213 
 
 
214 
 
215 
 
216 
 
217 
 
218 
 
219 
 
220 
 
221 
 
222 
 
223 
 
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Appendix	D2:		Ethics	Approved	Documents	–	Development	
   
224 
 
225 
 
226 
 
227 
 
228 
 
229 
 
 
230 
 
231 
 
232 
 
233 
 
234 
 
235 
 
236 
 
237 
 
238 
 
239 
 
240 
 
 
241 
 
242 
 
243 
 
244 
 
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Appendix	D3:		Ethics	Approved	Documents	–	Intervention	
   
245 
 
246 
 
247 
 
248 
 
249 
 
250 
 
251 
 
252 
 
253 
 
254 
 
255 
 
256 
 
257 
 
258 
 
259 
 
260 
 
261 
 
262 
 
263 
 
264 
 
265 
 
266 
 
267 
 
268 
 
269 
 
270 
 
271 
 
272 
 
273 
 
274 
 
275 
 
276 
 
 
277 
 
278 
 
279 
 
280 
 
281 
 
282 
 
283 
 
284 
 
285 
 
286 
 
287 
 
288 
 
289 
 
 
290 
 
291 
 
292 
 
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Appendix	D4:		Ethics	Approved	Documents	–	Review	
   
293 
 
294 
 
295 
 
296 
 
297 
 
298 
 
299 
 
300 
 
301 
 
302 
 
303 
 
 
304 
 
305 
 
306 
 
307 
 
308 
 
309 
 
310 
 
311 
 
312 
 
313 
 
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Appendix	D5	:		Ethics	Approved	Documents	–	UEA	
   
314 
 
31
5 
 
31
6 
 
317 
 
318 
 
319 
 
 
320 
 
321 
 
	
	
	
Appendix	E:		Student	Preparative	
Training 
Full Preparative Training Schedule 
Workshop Information 
Role Play 
   
322 
 
 
323 
 
324 
 
  
 
325 
 
326 
 
327 
 
328 
 
32
9 
 
33
0 
 
33
1 
 
332 
 
333 
 
334 
 
335 
 
336 
 
337 
 
 
338 
 
339 
 
340 
 
341 
 
342 
 
 
343 
 
344 
 
345 
 
	
	
	
Appendix	F:		Intervention	Medication	
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Appendix	G:		Tools	
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Appendix	I:		Publications	
Age & Ageing (not related to this study) 
Abstract presented as a poster at HSRPP Cork 2012, published in IJPP vol 20, supp S1, 2012 
Abstract presented orally at RPS Birmingham 2012, published in IJPP vol 20, supp S2, September 
2012 
Abstract presented as a poster at ESCP Barcelona 2012, published in Int. J. Clin. Pharm. (2013) 25, 
p901 
Abstracts presented as posters at RPS Birmingham 2013, published in IJPP vol 21, supp S2, August 
2013 
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